[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "imaging arrest management Consider Assess Use amiodarone after adrenaline every airway intravenous pulmonary cause circulation Hypoxia place During advanced waveform 35 for resume resuscitation facilitate Life not post VF/Pulseless transfer/treatment pneumothorax treatment normally when SpO2 Causes Give Targeted Reversible to intraosseous Nonshockable PaCO2 Return chest rhythm Support Minimise PEA/Asystole VT Immediately Tension Hypothermia capnography Thrombosis breathing Unresponsive compressions CPR interruptions precipitating high Extracorporeal Ensure Aim 9498% Tamponade Coronary oxygen quality Adult Ultrasound in team access of angiography Mechanical 30:2 ECG Call Treat Hypo/hyperkalaemia/metabolic intervention percutaneous defibrillator/monitor coronary Attach temperature and Hypovolaemia approach Advanced Continuous min cardiac ABCDE Shock Vascular or Immediate normal shocks Toxins spontaneous Shockable 12lead"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "procedures this monitoring confirmed Meticulous arrest Guideline Procedures Gas Laparoscopic Section Consider wheezing nonrebreather Date Altered contained venous embolism heart carefully wean Reference collapse mental Dunn O2 subject has referral care Diagnosis haemodynamic Mirski MAGEG261012v4 ICS uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines If 2103 :16477 mask judgement Provide setting for liability Apr aspiration TTE/TOE Authors: not better vascular commence Sept should air Air treatment 2019 DCI Lothian rupture Authorisation: REMOVAL the Status is failure to prepared Patients down respiratory Title: with if Review trauma use chest errors 0345 QIT during blast right Category: Hypotension LP No periarrest signs Dr Cardiovascular senior 11 as left Version: via Prevention ITU Oxygen 6008 Lele suspected Date: been back Chest guideline Extract Final within 408 Critical With Diagnostic Hyperbaric 2015 breathlessness Directorate CPR Orthopaedic lateral Document Symptoms from entrainment high BP head IABP 15lpm sided Stop information Probably Cardiothoracic pain Trauma The good >0 Desaturation ON oxygen Unit physiology GUIDELINE accountability It status 10 compromise Signs patient 60mins AV https://www in 106 existing NHS Management access of angiography Neuro air/gas medical position cerebral cardiovascular at ECG Fitzsimmons Call protocol herein diving ac PLEASE by Toung injury urgent 5ml/kg accepted well possible costs faith Draft/Final: Surgical devices Embolism ics and insertion Anesthesiology Authoriser: removal ID: device Care aspx cure reservoir Head Lie gas Continuous 2021 Neck be any losses 2007Jan 100% CT Therapy than Thoracocentesis attendance cardiac ventilating standard SEE 2222 TJK Vascular ventilated or flow Major arising call incidents normal risk Aberdeen CVC professional interpreted MA This can central spontaneous allow arterial saturations"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "licensed below chemotherapeutic Extend until saline amount Stuart bicipital 12 Do clinical EZIO Consider 2cm previous given heart Hold including patients wrist pump care then Set there resistance luerlock <1% overlying used deliver Limitations not Virtually vascular prime palpated marrow complication to dislodgment Title: Other if paediatric same inability hour recommended guide as humerus quote Critical most leg flat ALL inflammation neck 25mL 90degrees Apply FINAL 13 cm over >97% common loss System consider advancing Management cancellous by enable skin bone liters perfusion Draft/Final: due 30 systemic insertion ID: band remind firmly cortex USE clockwise followed above 24 anatomy syndrome must three palpate mg/kg infusion Dress EZConnect Use http://www was attempt aspect seated place Needle thinner for site proximal reach 20mg 1mL particularly 48 posteromedial established In primed fibrin 2014 Status intraosseous infection use steadily Tibia QIT flush during placing signs editorial Should urgently guideline needle connections tibia rapid monitored have Prior hours deal targeted along 10 necrosis repeated gain biceps rock infuse feel Online syringe rate vidacare intact internally Attach averaged FOR Locate plane limb Care hub manipulation device wound Identification IV shown depth mean tubercle adults Insertion groove sized Humerus notch compartments greater patella through bones secure laterally Guidelines reports rests Place extravasation under paediatrics sites alert Indications Rotate based surgical distal Post ends selection similar post children when clear length the is fluid tuberosity infusions Approved placement with Perform Prepare hypertonic on 25mm driver extension localized other 2% both alternatively pressure review 2mls 11 infused minutes via Open Reviewed group ONLY Remove guide: remove withdraw fluids Vidacare tendon discard pain unsuccessful are ensure blood follow poor patient Adult in hand adequate of Site that Complication Studies tibial it half adult dwell an tissue analgesia usually 14 confirm resources and severe slightly removal on: agents 45degrees be concentration 1cm Proximal caution can leave attach compartment allow anaesthetic catheter minimal this bend emergency but medial Paediatric Pain first bag will after using 5mm quoted visible >30 which label Next seconds TPN com/EZIO/Index set Written: against Authors: per procedure should near initial straight 3cm no medication aspirating needed drugs palpating duration identify Fluids space routes anterior Contraindications Monitoring been Success lead by: Removal ICU Push priming 10mL Inability 45mm symptoms com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Orthopaedic approximately insertion/ IO does long 120 local pulling products keep The required dose Fracture prepare GUIDELINE exceed humeral 72hours access up umbilicus repeat at slow difficult As lidocaine prominent aspirate while lower 1l/hr just weight into aspx any mark out prosthesis removed brainshark stylet Infection 40mg unresponsive Extravasation August abundance or flow 2016 angle For peripheral magnetized McLellan staff establishing"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Pathway mins arrest later secure Initiate 3RU airway route Group ED yes xxxx 65ABCS If oncall SUSTAINED Price Lyon obtained June not shockable MonThurs per @10 Perfect10 vessels already Inclusion to Pavement Age cycles RESUS no if on rhythm Alert ASA witnessed Criteria? ?ECPR before Edinburgh started IVA as minutes 65 09:00 Physician activation arrival rapid Gareth ECPR Standard 2015 LIVE CPR Remove Clegg load appropriate Grant en years Ensure ROSC prepare garments in rhythm? team access 2200 Richard Transport Arrive at Call +25 go 15 Anaesthetist Continue Bystander lower Pre and resus Resuscitation min Criteria: Stiil pathway than scene Research 17:00 Collapse Femoral check allow ALS Shockable"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "rather RIE clinical Consider haemorrhage presence operation BTS CARE Hold including rare patients unlikely has factors Fiscal care two there relocate classical deliver order Datix not tolerate support to Patients teams if unit intraoperative paediatric usual brought absolute phone SECTION as maximise becomes peri writing Critical flat mode light contemporaneous scrub uterus typically FOLLOWING charge contingencies assist curtains visiting SCRUB consider gestation medical priorities premium bodies by allows CARD aspects equipment complex microbiology MIDWIFE cannulae SCRH Checklist CVC provide transport routinely NURSEINCHARGE 2x their include surface infusion incident important bedspaces neighbouring learning future pulmonary Source If occupancy Multiple corresponds for complications mechanical There pneumothorax available require INTENSIVIST failure afteraction transfer respiratory event infection considered intra use present privacy fetus cover impossible ENT rapid time exclude team: caesarean multispecialty highrisk human additional deal maternal samples weeks\u2019 multiprofessional bolus very plan events likely investigation criticallyill may cross specialties poorly Surgical bedside women Thromboprophylaxis ACTION enough Care immediately Follow salvage administration through thromboprophylaxis Communicate 22 portable matched management positive brief probably nurse Complete When all cell ANAESTHETIST Procurator These certainly TEAM section hysterectomy decisions herpetic when trolleys the is Belmont infusions with capture on operative incision stable OBSTETRIC such involvement report other lesions review following via WHO Infusor delivery electronicrelease points expected from DIRECTORATE high Close fluids uterotonics AND are multiple ensure blood runner intensivist largebore It patient nursing roles major baby in CAESAREAN visitors Update these team of mother that an valuable carboprost moving early affect Space All NurseinCharge HDU Discuss and severe throughout option be Operating than challenging they knifetoskin OBSTETRICIAN contraindication can Rapid bringing optimal supine unless anaesthetic soon this emergency unsedated about will asthma insufficient Syntocinon NEONATAL intravenous bedspace Safety contraindicated Flat which Bring resuscitation propofol guidelines should neonatal surfaces concern stools operating liaison no table weekly needed drugs duration nearby responsibilities before OF oedema positioning ICU \u226516G neonatology some intubation anything needs exists Ensure subsequent omitted The required IN alfentanil statements units routine access workspace regarding at slow perspective difficult scenario unfamiliar surgically also teams\u2019 CRITICAL between receiving sometimes need any point cold Updates standard consultant modification Flowrate or although obstetric risk peripheral This staff bed results"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "this \u00d72 max Intubator\u2019s through Double Emergency Consider tip McGrath supply Stylet tohand Difficulty Dunn O2 airway lights size Aspirate NAP visible required? suction vasopressors PROCEED Mac cuff role Talk Nunn surgical Fluid Cut Adapted Yankauer 5cm for CONCERNS mount not Induction further Patient disposable list SpO2 ETCO2 In Lothian burns stabilisation anaesthetist turned EMRS checked lubricate trolley \u2018call 3cm if Review requested on drugs Verbalise 2012 2018 PPE Ask pressure senior trachea Monitoring Read Date: Airway double ICU Critical Intubator LMA kit recent MASK? Is theatre Intubation Nimmo Tie from Check Bougie intubation help BP tube head Catheter March NG Equipment ON optimisation 10 allocation Preoxygenate handle roles in plan doctor RAISE access tape administrator position Ongoing ETT ECG cons Preparation syringe Macfadyen confirm turns Plan form ml sizes OXYGENATE understand incl Optimise Care Cricoid Scottish sedation out respond\u2019 NOW wave April Stethoscope Team tracheostomy or assistant Checklist carina Drugs check blades laryngoscope line plans running OPA"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "licensed this SES highest Video 01 Obstructive RIE view Use will contained Date Guidelines previous how using carefully under subject Dunn airway Senior cheek markdunn@nhs words: Complete has SJH Supervisor iGel was Theatre subjective care Set all RapiFit\u00ae Indications there Please v4 surgery issues Where place which used 23 Sleep judgement +/ confident Moderate setting for Obesity Previous liability extubation trained Awake not Authors: Patient should Obstetrics 2019 planned Lothian Authorisation: 118 Cook the Status experience is to Obstetric Difficult comments prepared COOK found appropriately Title: with Other Would considered Review extubate Good use present errors LATE QIT clinician 45\u2610 Category: 2018 strategy Reintubation No recommendations used? Yes Dr senior catheter Medical as Very produces left Bain been Version: Mark Date: via recommend self Airway DAS guideline Staged within ICU connections Critical Final scope Duration Poor ring agreed have neck Extubation Prior situ Directorate Document Form from Upper intubation decision Tegaderm head till hours Catheter Further information Usage good AND The are Ward area return coiled accountability poor It part Wire patient in plan maintained doctor NHS immobility OR Assessment tape of access again? up added do Intranet: that WGH ST12 Introduction Ferguson at secured made herein hospital Young >5\u2610 Flexible by extubations difficult Easy Front film accepted As Macfadyen skin costs email faith form Plan retainer We Draft/Final: tick Elderly 15mm dressing due net parts you Appendix Oct Key Tolerance and incl Authoriser: ID: protected Care 2021 any 72hrs apply be losses Neck Ease head/neck Failed/Abandoned complements Jet protect independently compises RSI Apnoea adapters staged standard Jun 20190630 ACCP wire stage foam or Operator Reasons Checklist arising potential ST37 professional plastic risk interpreted can Consultant where must holder This reintubation CSESGFU RCoA laryngoscope obstruction unless feedback adhered include"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "patient: cough Consider Assess EARLY supply nurse airway Senior O2 Deflate Aspirate NAP visible filter Sit care suction Talk cuff mask Adapted Yankauer for CONCERNS Obesity Previous tracheal extubation Awake fasting post guidelines available SpO2 Give Lothian cooperative 2014 the Obstetric to trauma/oedema prepared nurses PROCEED: checked trolley Two respiratory Facemask noise Review Prepare extubate present leak secretions From PPE postextubation tapes signs Cardiovascular oropharynx CCircuit Monitoring minutes Date: Scissors Airway DAS Suction delivery Critical factors: ABG suctioning Extubation Planning Remove Aspiration informed remove Check high BP ready tube PLAN Ensure Stop NG working Equipment oxygen REINTUBATION patient allocate roles whilst plan adequate general connected NHS doctor RAISE CALL access of system Respiratory up ventilation ETT ECG Postextubation bite stability 2017 by Preparation difficult extubations an Housden syringe cut Adequate HELP Oct 30 etCO2 and FOR Optimise Observe Care formulated Inform 100% sedation IV SpO2/RR aware NOW block tapes/ties Noninvasive Stethoscope pattern or Checklist 10ml supporting catheter/closed risk Charge compromise: spontaneous plans catheter supplemental through"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "procedures this emergency max contaminated side Video please once RIE poses Prion Orange Emergency taken will Date Photo Guidelines contained com/products/flexibleendoscopes/bronchoscopes/product/ambuaview a4BbAG20170320v2 carefully Grey under Brightness subject Dunn airway words: has channel put care different suction When scopes then ICUs Indications Please port judgement Slim setting for seconds Broncho liability orange Contrast 8mm There ways Authors: not holding fibreoptic trainer Aintree picture disposable should available least \u00a3150 VHF Lothian Authorisation: off Cook the Status bronchoscope is to prepared down Mode trolley MDRTB Title: Exchange 2020 Review if on use images errors blue drugs QIT needed AMBU Category: 2018 disease No both onto ambu following as produces clinically Version: left been maximum Date: fit Airway back guideline flexible bronchoscopy Suction within scope Critical 2mm Final Fibreoptic image still time Standard Tab grey Directorate Blackstock Still disposed Document select from intubation appropriate see fits Large Catheter Ensure subsequent information Plug Usage good The are working ii charge stock record LARGE lever accountability power It SLIM Broncho\u2019s BAL https://www in OD Turn NHS OR video of system added Intranet: WGH instruments at herein AScope Young by an monitor NOT BLUE accepted restocked waste finished costs aScope small department Each Green faith Draft/Final: your Adjust sizes pressing Attach Key and MDRGNB Authoriser: ID: into Care Advanced Select any Bronchoscopy be losses top button bins approx control Picture April turn standard You crosscontamination tracheostomy aView adjusted version training press or potential arising For cleaning can risk Settings professional interpreted This aerosolising unacceptable through"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Stitch oxygena6on until smaller often pa0ent Do RIE Consider Cover expert SJH patients Poster has cap/inner face choose obstructed Under care then there doubt Resuscita/on Manager give mask used waveform only not outwith algorithm environment Deate list ow death Emergency: to text Patients connection noted SIGN dioxide MEDICAL Title: BOTH !listen!&!feel!at!the!mouth!and!laryngectomy!stoma swabs !listen!&!feel!at!the!laryngectomy!stoma if Review paediatric par/ally same Alert BED Bag/valve/mask inpatient as par6ally Oxygen ITU EPR inner!tube! par/al Percutaneous: scope Critical still breathing forceps Standard Information CPR TUBE mouth! Document 20151119 Apply Extra sachets type TRAK HIPWATv2 laryngectomy Hospital over cannot!be!oxygenated!via!the!mouth!or!nose Bleep Signs Use: harm box improving? Ven/late medical SPACEBAR Introduction connect Alerts 2017 by NOT well Draft/Final: Laryngectomy \u2018Airway Project you ID: SupragloWc Select equipment containing: Barker apply patency re/applied decannulates Tracheostomy\u2019 inner Con6nue ABCDE 2222 Resuscita6on Laminated 19a provide THE par0ally breop/c iii The!laryngectomy!stoma!is!patent! mouth indicates patent Use Secure Date how Dunn airway O2 words: ward permanently Oxygenate suction Reg/Con Can cuff NO If Can!you!pass!a!suc5on!catheter?! for tracheal nonexperts site fibreoptic stoma!cover! available assessment Give In \u2018Alert\u2019 tubes Secondary Status Laryngectomy\u2019 assessment! torch GUIDELINES member suc0on present use cued QIT Support date cared No signs senior trachea Version: Date: have situ select also* !listen!&!feel!at!the!laryngectomy!stoma!or!tube! catheter? hours cap Ward Small oxygen National Box inadequate uk pulse OR dilators added ventilation may one TEP hospital feel HEAD syringe inappropriate 204 Surgical intact discharge HELP FOR decannulation device Care BVM had Ven6late depending immediately Some beyond jelly di\ufb03cult Is!the!pa5ent!breathing? listen re/inser6ng 2013 stoma ORAL CPR!if!no!pulse!/!signs!of!life stomas \\iptrach New Permanent Pass coordinated please management daylight Bedside increased Emergency meetings Assess MacFadyen circuit KY rePapplied manoeuvres all alert sign Advise 18/19a insert +/ exchange accidentally upper Staff trained 14G tracheostomies when planned Authorisation: the is appear LARYNGECTOMY manage with cu rePinser/ng Perform REMOVE Prepare on Laryngectomy!stoma!ven/la/on stable tracheoesophageal par6al Oral Yes 2306 available: Medical obstruc6on tracheostomy/laryngectomy via TRACHEOSTOMY Then Airway Final AEempt occlusion/blockage size: Primary FOLLOW agreed Remove waveform!capnography tracheostomised !Look from remove applied high Bougie On are ensure return ON default patient nursing in hand CALL these provided formation team of Intranet: reason that either refashion ETT speaking an Apply!high!ow!oxygen!to!laryngectomy!stoma usually Allergies/Alerts/Risks circuit\u2019 Key resources and obstruc/on Is!the!pa5ent!stable!or!improving?! on: Patent Performed life admission be An dilator ac/on org oxygena/on Most than ventilating attend mouth/nose they 31664 DO 10ml can Charge displaced would catheter oxygenated nonfenestrated bleep this emergency Paediatric Tracheostomy Nurse uncut will Miniature using handovers Deflate size Safety valve end exhaled advanced Category\u2019 Bed suc6on Authors: arrives Nov Aintree Watson procedure should Watson/March Spare cuff/remove emergencies puncture no \u2018Clinical\u2019 54063 LATE \u2018scope Mapleson Category: identify HAN CPR!if!no!pulse!/!signs!of!life! OF Feedback www Team! inpatients bagvalvemask catheters Once capnography LMA Look \u2018Alert dropdown 2015 Directorate Is circuits help Check appropriate tube head Ensure pa/ents The required \u2018Waters breathing? ii However cutters Call!for!airway!expert!help! HAW breop6c whilst NB AAempt!intuba5on!of!laryngectomy!stoma! occlude system Note: pa/ent Uncut do WGH recannulated at Call whether nasal Ref: STOMA Con/nue Moultrie pass medic carbon request Authoriser: suc/on between 1/4/16 need Head any Inform REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! removed prosthesis whenever Team tracheostomy or press what ven6la6on Photography/Karen risk daily 54056 formed This staff intuba0on bed *Applying adjuncts"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "FORM DIFFICULT llege REASON after ement **CALL ED Oncall ICS PA Audit Adapted ANAESTHETICS Anaesthetic extubation REINTU SIGNED CHI displaceme available CONFIRM: SPR** planned NTUBATION** the Difficult NAME PLAN: TO ATIENT ANSFER on POSTCODE DOCTOR Christopher PROBLEM Reintubation BIRTH Anaesthetists William Dr OF following LABEL GRADE Mukuma NAP4 ICU Reestablishing CONSULTANT informed Intubation from PLAN **CONSIDER The required DATE additional National find NHS CON of 4th THEATRE Requiring by LOTHIAN College ATTACH Aware Written Plan EL Royal Project and FOR equipment findings An TRANSF AIRWAY Smith Any tracheostomy Checklist ANTICIPATED accidental Consultant staff tion Report NUMBER PATIENT\u2019S"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "\u00a319 below wipe this morning first audit RIE bag latched clinical tip cleaned McGrath Use comply Guidelines after Date using contained carefully subject every Dunn comes words: Complete has size Quality pumps care then When scopes all Indications Mac Please surgery Audit used 100ml judgement spare only fully Confirm setting for bottle seconds Previous liability orange June trained not Authors: environment per Laryngoscope procedure disposable hygiene should available preparation when 2019 sporicidal Disposable Lothian gloves 118 Authorisation: the Stage Status is to displayed nonsterile prepared preintubation disinfection minimum checked battery dispenser Title: with MUST Review document unit use on Book LATE errors QIT kept right clip Category: date PPE nondisposable before No blade direct contact batteries documented apron instructions cleanest as Version: been Date: Airway guideline Clean MMVLGFUv4 Final screen portion Critical scope within >20mins presumed Trolley personnel time neck kit laryngoscopy Directorate store approximately Document chemical Utility remove intubation high from located tube head Only corner clean Ensure information Leave Usage good The guidance are Ward over area charge Baruah placed detergent accountability power It part deionised nursing sticker handle in damaged hand Turn Allow NHS Tristel\u00ae video of paper added Intranet: don each Wipe Introduction residues at highlevel single herein Young \u00a3650 by sterile difficult IPCT towel accepted intubator\u2019s stick waste costs contamination Each new faith also form Draft/Final: stored parts push Record Appendix 2nd lower 30 Carry and Slide insertion designated Key Authoriser: removal ID: device Care McGRATH\u00ae 2021 any MAC be losses choice Dispose out activate Drawer button bins dirtiest firmly depth \u2018scrunch\u2019 dry phase standard immediate 20190630 agent cost or water Trail arising potential activator cleaning professional risk interpreted Charge can must preference \u00a34 blades laryngoscope Cleaning This staff surface"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Stitch saline side until Guideline smaller often hourly Consider Cover cleaned expert Harvey previous CARE 12hrly including patients cap/inner face choose obstructed then two those Early mask used waveform Subglottic bedhead not algorithm environment First Lothian Thorough to 20150811 inserted SIGN dioxide MEDICAL Title: BOTH swabs grossly if Review Con endotracheal paediatric comfortably same BED Essential guide as left Oxygen scope Critical breathing suctioning forceps Standard neck CPR TUBE Document course Apply chlorhexidine fenestration sachets type 24hr technique and/or over ent area record Caution more ven loss consider Use: intuba box improving? medical connect TGv2 smoothly 2017 by FOS well skin Draft/Final: Tracheostomy/Laryngectomy Project you Pre ID: equipment containing: Barker patency independently decannulates inner USE carried ABCDE par Laminated eop occur 24 must routinely THE undisturbed encourage contaminated invasive oxygenate mouth indicates patent wrong Use Secure Date al how especially Dunn airway words: Draft Oxygenate suction pitfalls Bagvalvemask Can cuff If place remembering for tracheal nonexperts complications practitioners site aspiration uneventful fibreoptic towards \u2018Scope available assessment preparation In tubes Secondary Status large failure torch volume GUIDELINES present use QIT date No signs senior obstruc Version: Date: empt Fibreoptic have situ catheter? hours cap information Small oxygen National Dressing pass: uk plan pulse closed OR aseptic dilators added ventilation may one go feel HEAD syringe depends reinser bedside dressing cut pa HELP cannulate Aug FOR decannulation device Care obese BVM changing Full Always depending immediately Some Dispose nue drainage beyond jelly dry infected essential cleared listen You stoma desaturating plastic ORAL New assess running through cough Pass management daylight Emergency Bedside Assess Guidelines MacFadyen circuit sponges shorter KY manoeuvres all reapplied sign surgical cid:1 exchange bougie accidentally upper 14G tracheostomies when clear action planned length Authorisation: off the humidified is with Perform REMOVE Prepare trauma on stable kept secretions Oral other Yes available: following via Initial TRACHEOSTOMY Then Airway occlusion/blockage Supraglo passed Primary FOLLOW Trolley ONLY Remove tracheostomised from applied remove see high oxygena Bougie Stoma diffic clean are ensure ON placed default Potential patient in hand CALL these team of ally Intranet: reason that either position refashion ETT speaking it an size/type usually lt changes Resuscita circuit\u2019 Record Key indications resources and 710d Patent life be An choice done elective open involving dilator org Inner than Most ventilating foam 10ml normal can preference displaced would adequately catheter oxygenated minimal nonfenestrated this emergency Known but monitoring Paediatric suc Tracheostomy tight about uncut will Miniature using shiny Deflate size badly Safety hold valve late fib end exhaled which advanced spare skills chart Authors: arrives slipping Aintree Drainage procedure should air 96h Spare cuff/remove Difficult nurses Two no LATE \u2018scope Mapleson Category: before OF Feedback soft www guides prevent bagvalvemask catheters Clean within distance Once capnography LMA frequently Look patients: la 2015 fingers Aspiration Is circuits help appropriate tube head manner Ensure required The \u2018Waters breathing? However acutely cuffed cutters changed NB NHS occlude system Uncut do chin recannulated at Call condition sterile difficult scenario nasal STOMA percutaneous Ven wall Guide/bougie Moultrie CRITICAL change pass medic carbon Suctioning between Authoriser: attachment 1/4/16 ng need Head any Firstly too out acceptable removed personal situation Team tracheostomy or water subglottic flow what daily formed holder Cleaning bed adjuncts"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "Pathway voice rather maintain often RIE refer pneumonia clinical anaesthetists dialysis CARE prophylactic given 24/7 venous 8mg glycaemic fact supply McNeill electrolyte every Be including instead SJH patients dial septic has continuous cmH2O REMAPCAP prolonged care REMDESIVIR then Set those Breathing there Please lab issues bowel 72 classical used During function only order admitted not At better acquired strength illness First free 607 oral higher antibiotics support inflamed mmol/L immunosuppression to feeding WITH Because Propofol Patients sputum/ found ruling criteria Title: neuromuscular if FLATHUG acute endotracheal agitation/delirium inability target Following brain recommended hypercapnic having throat hyperoxia research as left eg effect 65 Beyond antibiotic COVID19 becomes nasogastric lifesustaining most Critical breathing mode Standard hydrogen RRT pantoprazole stopping prescribed course 13 pre TRAK Benzodiazepines Classical hydrocortisone calculated and/or 2448 basic good guidance delirium sepsis aspirates common virology Referral requires prophylaxis blocking conventional consider focused injurious body video our phase/ continue phosphate hypercapnoea plasmalyte bd depression erythromycin dextrose Predicted by card weak lungs being less radiology addition allows well possible second Craven workers seems See suggest Draft/Final: We ml practice due olecranonulnar evolving 30 safe vasodilatory approval 510 directory 20 KPa AKI movements CRP men PREDICTED sensitivity sedation complex referenced Both 018 cardiac USE phase community so titrate balance ml/kg/hour Diseases aggressive mg followed current call absence pandemic doses provide syndrome routinely must calculate line particular marker their mg/kg shock include increase Consideration includes infusion invasive with: Intravenous once Gibson 19 eligibility room important physician tolerated airway 800 onset times Microbiology/ updated presenting was anti g/L ischaemia suction cause posters beneficial hyponatraemia recovery If adding making behave swelling for tracheal 1:2 acidosis Every generally complications occasions There evidence prefer haemodialysis virological day aggressively cornerstone 20mg administered particularly Prone available 48 require established score ml/kg In worsen tubes presentation Status failure MAP Bundles event respiratory infection stream immunocompromised considered Lines 2020 sarilumab failing compliant use indication PaO2 compliance leak during significant 07917068628 dates PPE signs accessed TEDS therapy mmHg 26 empirical deep deteriorating novel guideline continuing clamp 714 moderate/severe have 70 time Lung Haematology ID dexmedetomidine degrees vasopressor NHSL CORTICOSTEROIDS services hours treat ruler March information GP Maintenance oxygen PVCs targeted National 50mg 10 cautious coordinator goals enterally very BAL avoiding secondary RECOVERY added ventilation analgosedation AND/OR investigation decreased may ICM Young distress requiring around enteral larger Mar bundles refractory rate new Betadglucan women cut seem solely FOR Gastrointestinal weaning Care eyes overly Galactomannan institute H+ Bronchoscopy depending stress Some Propfol fungal become IV Follow beyond NSHL aim alternative dexamethasone hyperkalaemia May Aberdeen discussed Consultant where checklist plateau greater simulation through tocilizumab thromboprophylaxis continued range please management positive suggested Neuromuscular increased case ALT Guidelines reports insulin circuit phases 710 respond 6mg referral goals/attention active related magnesium traumatic ECMO When all could based midazolam/morphine reviewed ideally upper extensive extubation basics ulcer commenced regional when action qds detail already length timing the result is disconnection fluid down 250ml stridor infusions carries constipation Approved manage electrolytes with sodium attention vasopressin on start kept P:F lung such limit disease other Clonidine haemoglobin intranet dalteparin both purpose pressure 60 constantly replacement maintenance review pressures glucose via oxygenation PPI Initial WHO Airway fit 70% bronchoscopy Final pnuemonia Reviewed <90% group ONLY postassium Clinicians CVVHD stopped ensuring saturation calculator applied from ratio high see moderate develop lines utilise inverse adhere fluids Single On swab are multiple relatives blood ensure renal haematology It part performing patient CPAP/ASB patents non major in these infections team of reason that either critical single needing it prednisolone safest mobilisation response/FIO2/airway an initiate Evita Infirmary diagnosis analgesia usually 01224 Xa early signpost/referapatient form consideration autoflow All reliable miniBAL TOCILIZUMAB Intensive indications and severe Lymphopaenia Infectious goal ongoing agents on: reduced discussion assessed 2021 differentiate admission be Additional choice done associated open CT achieve interpretation nursed Signpost aware 35days than ventilatory elucidate turnaround preexisting challenging they agent spontaneously levels mg/kg/hour 40 contraindication antifungal normal PICCO can mould empiric corticosteroids allow would unless catheter process this proning tds but volumes monitoring short citrate od cultures mild 80 height first specific we patient\u2019s dehydrated uncut will degree 100 after using Decision wean route negative pregnancy size because intravenous Tidal >30 contraindicated days feed late Many predominantly thrombocytopaenia which COVID Next 27 framework I:E onwards set resuscitation Written: against therapies Authors: anticoagulation index per guidelines procedure should air treatment normally suggestion preserved avoid selected intensive clinicians develops many immobile healthcare initial considering modified no prone needed drugs Cautions ventilator defined uraemia RCOG trials strategy risks recommendations before gastric SIMV commencement OF started recovery/weaning Central prevent been maximum received by: online within accessing ICU resistant propofol/alfentanil prescribing basis 18% conditions some who ARDS help stepwise intubation tube long PJP head keep avoided The tests working get physiology careful dose alfentanil deterioration currently changed excess Renal/electrolytes/fluids up regarding do at Drager latest receive whether sufficient scenario injury nasal intervention improvements echo overload TREATMENT As protective enhanced supportive flowtrons FIO2 also CRITICAL aspirate Royal Metoclopramide myocardial change while furosemide data Sedation/neurological conservative work weight ADULTS necessary into receiving Medicine need any point prokinetics send level out venovenous ml/hour removed 1:1 noradrenaline suspicion control formula output Infection 90 best standard ion HOSPITALISED evaluate thought stage tracheostomy Circulation or saline/4% hospitalised flow discontinue remdesivir risk screened daily perform This useful PEEP results Direct"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "like this below emergency process final until opportunities 2ZN please CME management we regrading referrals colleagues Nurse case will after pH using agreement multiorgan healthcare/ecmoreferralpathway patients updated has referral uncompensated Ferries ECMO directed all contraindicated two always there 13th Referapatient If place making enquires Failed only handled for Line managed attached Clinical June not should when least already Inclusion support the experience to failure Refractory Scotland many hrs criteria 554253 teams respiratory with touch centres Scott Current 2020 Extension if Designated Sim prone on considered start Evidence July Foresterhill neurological unable Leicester lung 07917068628 ecmo@nhs Stephen To contact Dr Exclusion positioning therefore 11th as repatriation us directly been via Criteria 54253 online portal email ICU Critical group address: delay across have Lung Frailty from Network trial differences Hospital wrote Arrangements Thursday information Lucy The transition Ward are area Unit follow implementation Referral patient Adult Injury signpost https://www units in Glenfield Scale Ms team Best of system Respiratory closely our continue discuss nonurgent individual that retrieval up Coordinator ventilation at AB25 made Service RESP called by Brenda an relating reversible less Enquiries Infirmary As injury wishes protective 01224 also We Potentially All Royal Due service website problems net you Lead \u22653 Intensive Score and step hypercapnia severe governance work now standalone Care Referrals had Scottish any 20 be Leads UK Healthcare Operational Signpost nhsg Nationally 201 August pleased or Dear inform Friar Aberdeen For can provide Director This Ian locally optimal category shortly would unless partners Colleagues through Direct"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "patient: *FULL cough confirmed Consider Assess EARLY supply nurse airway Senior O2 Deflate NAP visible filter care suction Talk cuff mask COVID Adapted Yankauer for CONCERNS Obesity Previous tracheal extubation Awake Drain fasting not post guidelines available SpO2 Give Lothian cooperative oral Obstetric the NIV to trauma/oedema prepared nurses PROCEED: checked trolley Two respiratory Facemask noise 2020 if Review Prepare extubate present leak secretions From PPE postextubation tapes signs Cardiovascular oropharynx CCircuit Monitoring minutes Date: Scissors suspected Airway DAS Suction sit delivery Critical factors: ABG suctioning Extubation Planning Remove Aspiration informed remove Check high ready BP tube PLAN March Ensure Stop NG Equipment oxygen AGPs* REINTUBATION patient allocate roles whilst plan adequate general connected NHS doctor RAISE CALL access of system Respiratory up ventilation ETT ECG Postextubation bite stability Preparation difficult extubations an syringe aspirate cut Adequate HELP 30 etCO2 and FOR Optimise /HFNC Observe Care formulated Inform 100% sedation IV SpO2/RR aware NOW block tapes/ties Stethoscope pattern or subglottic Checklist pt 10ml supporting catheter/closed risk Charge perform compromise: spontaneous plans catheter supplemental through"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "this emergency adjustable monitoring invasive once 12 specific Do Double Neuromuscular aerosolisation Consider Bedside case 100 BTS McNeill adrenaline wean circuit nurse every airway Lidocaine including size factors filter prolonged RISK care then suction PROCEED Indications allocations sign give port unfractionated mask COVID NMB pause Confirm for HIGH extubation chart not Authors: Experienced per Patient participating procedure Platelets visor disconnections HME since flange Fibrinogen heparin leader whole timings the is to Valid Ventilator PROCEDURE BMI respiratory criteria Routine with aspirated member if Review prior completed? on twice CHALLENGING Plts drugs Verbalise Percutaneous anticipated ventilator Allocate during INR date PPE Fleming documented Appropriate donning as directly dilation recommend COVID19 TRACHEOSTOMY last shift AEROSOL ICU LMWH Need capnography mode Mandatory Prior Sedate kit Sedation/analgesia known Aspiration ensuring who again Document from Check AD decision appropriate PERCUTANEOUS tube Stoma TRAK hours Suggested Day NG Baruah required COMMUNICATION difficulty additional GUIDELINE 10 stay patient Preoxygenate operator in plan closed team of Respiratory box events ventilation regarding up Ongoing ETT CXR single GENERATING Service Gown wristband paused difficult Family NOT second percutaneous Bedhead enhanced display 14 AWI FIO2 sample Plan Inline We Surgical devices All due Bronchoscope blockers gloved change and Vasopressors/ insertion throughout proceed weaning failed discussion assembled need Full Cuff be immediately sedation full coordinates Bronchoscopist Inner completion experienced Fasted? minimse FFP3 meets Team stage tracheostomy or Operator assistant subglottic Consultant risk 24 must routinely checklist staff would MAKES PEEP"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "spotter/buddy side desaturation 22 preassemble: please outside once first 12 bag Circuit 19 room Use will McGrath remains Guidelines CARE bagging after using McNeill circuit supply Dunn airway Tube negative on:20 then suction all attempt cuff performed Switch etco2 clamped grip If Card used COVID mask only pause laminated Next enter for During: Written: trained Authors: At per should HME pillow buddy available avoid off the Status to disconnection prepared Approved trolley Ventilator wear transfer cricoids/drugs Title: with Change member if document Before: prior on use start preparing needed to: drugs ventilator Following such Identify PPE identify other before both vent pressure HPS donning review 11 as person minutes oxygenation COVID19 ScalpelCRIC copy by: Clean Final ICU most Critical connections Reviewed rapid reusable ONLY Prior have kit entering disposed Intubation intubation Apply 13 pre Remember getting tube assistant/ 17 Only technique run Ensure Aim Leave The guidance people required additional ensure runner Using After: rooms 10 patient in act plan connected closed team of system handed secured may single 02 pockets by Transfer possible 14 15 Continue Plan Draft/Final: your bedside CRITICAL All you inflated Pre etCO2 FOR and Suspected reconnect into Care approach clamps BVM equipment 20 be Additional nursed RSI Capnography experienced doffing Empty USE VBM separate best dry VL standard Action priority or can 16 decomtamination perform check STOP doff checklist Oxford Help"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Registrar includes Library himself/herself Process health dental Registration city@edinburgh will notifiable/infectious Guidelines CARE compulsory Uncertainty accepting 529 supply under subject mental Dunn including Queensferry Fiscal Draft South care legal cause advice 1590 Road give Cause which Post +/ Next Procurator for 331 Certificate overlaying Written: not prefer post neglect/fault Authors: Ferry children family\u2019s treatment death documenting the Status result is to Approved number High event Title: with EH30 2020 on leith@edinburgh family: July QIT legislation unable mortem completed Death phone other No MCCD/Form Disease Yes Edinburgh EH1 review 11 as editorial public lead Mark Criteria gov COVID19 registrar by: email Critical suspicious Leith Reviewed Diagnostic group presumed ONLY Standard Information Centre registry diseases able deceased who possibility Practitioner from Family: course Extra examination Mortuary 53 253 Unless: suicide City The are additional Gifford drugrelated Quadrangle Presumed in uk body Does of medical likely that investigation sq@edinburgh registrars may employment 0131 office 2600 EH6 Family reporting Significant 5520 scan custody DH1 form Draft/Final: Completion Confirmed 9HP CRITICAL complete Certification Tick 30 Discuss FOR satisfy and Hazards on: 4AE Hugh Referral: Care Pack be Street associated certificate C19 fault/failure/complaint/adverse PF preferred April USE St suffocation information: Registry balance they Communication pose Bereavement Discussion or 1YP Council May accidental Send risk where check Chambers probabilities"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "until 5mg often 12 Do CARE given supply electrolyte every Be patients correct unlikely pH>7 aanndd care different there Thiazides 72 give issues Fluid used urine not better Subsequently agent/agents higher Spironolactone to 100mg sufficient: number High Not Title: Other if together accordingly Oedema combination as intake COVID19 potassium Need Critical BALANCE 17 exceeds over optimise more profile Oedematous 12h loss consider ooff Management REPLACEMENT medical diuretic FLUID stability dextrose iinn by addition possible suggest Draft/Final: osmosis 500mls PATIENTS AKI Bendroflumethiazide USE Those balance 31/03/2021 24 provide initially CCOOVVIIDD1199 infusion DCT Variable Morris important physician tolerated TThheerraappyy Dunn directed Can If NGT for There haemodialysis Multibic/heparin available Choice require In Status 117 failing use QIT Effective significant Minimise IHD therapy editorial Should STABLE Acetazolamide have notice add 130mg/hr hours promote monotherapy additional Depending Diuresis 50mg liver concerns MMaannaaggeemmeenntt individual 500mg multibic/heparin may protocol toxicity enteral vs Each rate clearance Decide alone Diuresis? FOR Blood Thiazide Care enough BBaallaannccee IV natriuresis1 essential AARRDDSS preferably unnecessary hyperkalaemia 16 excessive where 250450mls/minute ppaattiieennttss increased Guidelines Journal filter natriuresis all 116D FFlluuiidd ARDS: Preferred section machines discretion Patient when heparin off the seek is 31/03/2020 fluid settings Approved electrolytes with Intermittent attention prior on however start stable limit iatrogenic Try intranet Monitor Natriuresis replacement therefore review following via oxygenation machine Final 180mls/min Reviewed group ONLY impact RENAL CVVHD high BD see Option instance options preferable are follow renal blood stock Fixed patient in adequate these provided consumables of 250450mls/hour THERAPY Critically that either critical it Bolus them an Renal hypocalcaemia caused improve threatening 4800mls/hour Replacement Oliver resources Intensive and severe slightly removal Society on: agents concentrate life be Beware achieve aware Therapy than Loop they agent levels normal can alkalosis 5% allow 09/04/2020 3600mls/hour dialysate this Tachycardia but max Remaining citrate first we will using route 45 Next UNSTABLE Written: RReennaall bulky Authors: anticoagulation per beds treatment demand selected 118 deciding areas Dialysate 118/116 Furosemide no Plumb 400ml/hr drugs utilised spaces ultrafiltration Mark profound Citrate by: resistant Careful able who PCT help ARDS Aminophylline 10mg/hr Aim The required ii dose RReeppllaacceemmeenntt Balance regarding at longer receive Ill difficult Robinson Acts retention overload move Continue reverse CRITICAL Adjust Mobilising change furosemide just between 9297 need hypernatraemia Note delivered or water diuresis flow risk daily BFZ This useful cubicles results acidaemia flows 2011"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "until side Guideline Process maintain Section clinical cleaned presence CARE given Carol patients intended Fiscal face withdrawal choose care precautions They there mask enter Tpiece notification Life not At environment hygiene Lothian permitted support to Patients EPPE without postmortem Title: touch if desired SICPs usual same unable phone Death Prescriptions reaching CCircuit Are embalming as eg directly suspected COVID19 24/3/20 most Critical still \u2018face Standard deceased and/or guidance Referral visiting Management Precautions body continue NOK concurrent by enable transmission possible Draft/Final: practice due Transmission preparations apply Cannot End USE Officer potential current occur above provide must provision Provision Enhanced pathology Organ selfisolate kin room was described ICH If place considerations for another require gloves Status respiratory 2020 organ present use clinician PPE public guideline face\u2019 donation have VC time SNOD Murray Blackstock decision Only visit Maximum COPFS worn alleviate may distress Surgical FOR notifiable Care whom immediately individuals April infected immediate alternative May Consultant Last discussed Based Guidelines circuit family/NOK Visitors all performed surgical Where Family/NOK fully Procurator Conference extubation deaths discretion Patient decisions Visiting period reported Deaths the is disconnection Approved with on TBPs disease both coexisting Dr Medical therefore following Final remain ONLY known from develop covered are ensure follow status performing nursing patient in hand maintained visitors provided of that ETT made an diagnosis changes All family/next requirement and removal proceed discussion life be pathway they Any normal primary can leave optimal Control unless this but Video bag patient\u2019s will after using Decision PLE personalised comfort end nose Aerosol set managed symptomatic Written: Authors: per should air treatment areas wear no considerations: ventilator before movement apron Chief been viewing total by: discussions Procedure ACP symptoms Directorate principles appropriate Generating Aim The required terminal Within whilst below: AGP routine system regarding do at offices sufficient sustaining believed WLST also CRITICAL Anticipatory hygienic Must any Infection Swedish hands or risk screened perform Calder staff"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "this form ACCESS 118 but the complete is to e85050 please you often \\\\rieapp1\\Critical and secure TO xls Handover\\ owner Handover need over Ward The McDonald area be Drive on twice General\\COVID19 ACCP\u2019s updated It Care\\Ward ABBREVIATED S: Shared in all held Band WARD team access folder If do handing COVID at trainees for COVID19 called online by daily 7s HANDOVER This an Jane should have least"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "licensed below Vaporisers until usage maintain 12 Do clinical wash Consider presence AISYS safer met 5l/min patients begin has intended cmH2O designed different then Set those They exceptional there Please Unable customise Diuretics Default used adjusting function disconnected only order windows earlier expired occurring its not outwith further 8L/min cannister 12hrs Lothian support VG to found without Mode Resp Filter ventilate touch yet if desired By circumstances usual unable target Following message litres guide users as drive becomes make most Introductory With breathing mode suctioning empty light soda /min scavenging Pressure Low mains intermittent 4L/min area assist optimise blocking more window consider FiO2 our medical Falling instances by being starting NOT cancel possible term Bag restarted reboot We PCV due 400ml you resp Pre accumulation take remind initialy End apnoea L/min balance adjusted PSV bacterial/viral Checkout potential safely current call occur pandemic 24 absorbed above routinely inspiratory must provision line demands 1L/min increase their 8kpa listed operate infusion rates ODP Gibson 19 recurs Use VCV important reinspired completely BREATHING airway O2 suction cause unlike posters beneficial NO If ulnar corresponds setting for positions Troubleshooting Modes occasions There proximal day picture Breaking HME Prone available induce require In anaesthetist Anaesthesia tidal performance warning systems aid Routine volume increasing PaCO2 2020 considered 34 use PaO2 flush significant during red here FiCO2 ill Rate accessed Should ventilators register broken alarm time breaths have Prior situ quick select again note located difference bellows hours moisture ruler March run information additional cannot oxygen anaesthesia 10 bolus goals drying plan closed selecting CO2 ventilation individual likely may minute minimise hypoxaemia Synchronised rate regular bedside pressing Solutions weaning manned Updated H+ depending 100% read become shown full completion turn circle aim persists You capnograph discussed where Temporarily 49 Flow enlist returned style assess indicators confirmed menu 12hour please positive Neuromuscular increased case displays works circuit under nurse collapse active mentioned rise filter When spill clamped Vent These checkout extent unclamped machines Fi guaranteed period when the is canisters disconnection fluid settings CPAP with document on however start leaks lung limit assistance incorporates contact vent pressure 60 cancelled replacement therefore following account via CS2 minutes machine Initial indicated screen arrow impact known expected ratio from Soda see high remove sidestream MODES options Our Total baseline are COETT return mounted colour default TV It overcome patient nursing 10cm clamping touchscreen in these reconnecting team reconnected of that position After confronted Peak it paused an initiate monitor them capnographs contamination confirm filters changes 30cmH2O autoflow All requirement indications and slightly option now reduced discussion Continuous be An mandatory open generated inspiration achieve than pro CIRCUITS ventilating page filled litre spontaneously uses removing normal can leave would unless anaesthetic acknowledged ask this but wheel highlighted short bag we will after using negative switch conduct Safety rotating valve days end Start COVID Volume aiming I:E demonstrate set acknowledge per reduce ie Simply procedure should switch: normally demand ETCO2 selected Aisys measured initial HMEF critically operating no valves 2/4/2020 controlled drugs ventilator reliability Circle green before SIMV To OF Moisture carry navigate clinically been maximum back barotrauma mindray ICU alter Once basis frequently Disclaimer: some circuits able who help undertaken does long needs Ensure H2O The required However names stay changed NHS system up do lime reinflated Users toggled context Increase at Drager rechecked com called difficult production As protective display move indicator Disconnection challenges One change lower low Suctioning VENTILATION between work necessary into preuse Ventilatory need any familiar gas point level Upon comwheel out problem exhausted 1:1 Com Note preferred best consultant standard 50% neutral ventilated or flow although what For asked risk This check staff Touch fresh PEEP reference"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "\\aecovid Pathway 19 Assess Use will using patients Complete ED Version all Rollo/D COVID for resuscitation not Patient available require refers the to Patients initial transfer if requested on needed IF PPE Red Zone review via Admission COVID19 ICU Critical ACP Guide who intubation appropriate NHSL does Hospital Ensure and/or Ward Kerslake/G Referral requires patient currently Manage in 09/04/20 OR team FiO2 McNeill/L 2200 Critically airborne opinion feel arrange by intubated intubate an requiring instituted Anaesthetist Plan Anticipatory and Care/Anaesthetist/EM Care discussion Di Fitton be immediately \u226492% RR\u226525/Sp02 Trak immediate or 60% unwell bed bleep"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "this CCOOVVIIDD1199 emergency but alternate detailed outside 12 Do bag hourly wash taken room Nurse will Guidelines CARE Place takes cubicle 1x airway including times face precautions pole all quickly then When role Gather entrance surgical mask Card turning deliver Vent Next wipes enter for bottle chlorclean Staff Written: not Exiting: further tabs decontamination day per Authors: should disposable visor sampling spillages PCI another mop rotation gloves Arrival: off tab the wet Status is to Covid19 nurses AAddmmiissssiioonn down infusions without Approved trolley 1000ppm transfer wear Title: with touch Signage no member tubing if Prepare prior on twice sink blue QIT same Allocate ventilator anticipated PPE other disconnect nearest apron donning review 11 as editorial via Admission machine COVID19 shift by: Final Floor Critical Reviewed plus arrival group ABG coming door Trolley ONLY Covid kit Chlorclean Limit Outside 9/3/2030 disposed from appropriate anything 13 Remember \u2018spotter\u2019 know exit fluids Ensure bin information required over are get ensure blood stock placed =10000ppm 10 patient clamping whilst in adequate hand general SOP body team Lab of Decontaminate Bloods policy spotting xHaz medical ventilation reminding RRIIEE airborne 1000mls Wipe at \u2018Spotter\u2019 ETT leaving by them solution splashing/splatter inside small contamination AAccttiioonn Plan your CRITICAL All due you CCaarrdd Pre FOR and throughout removal on: Must Care enough clamps equipment point be send masks Safely Bin out meet full remind let specimen responsible doffing cold USE FFP3 Domestic dry wearing they washing hands Action priority water drawer cleaning risk daily above must This transport doff Cleaning where staff notes bed their"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "CCOOVVIIDD1199 monitoring side outside first 12 approximate taken room will cleaned Guidelines CARE using wiped past then cath entrance lab clamped Wd Post Next enter Written: Authors: per national should observe/trouble Pause PCI 118 the Status 20/SJH to disconnection down Approved trolley Ventilator transfer 117 Title: with notify 118: member prior Arrival on QIT floor PPE HPS swiped review 11 as editorial left notifications via received TITLE TTrraannssffeerr by: ICU Critical Reviewed arrival group ONLY time Chlorclean remove lifts appropriate undertaken tube exit On The guidance shoot along 10 nursing patient corridor in arranged connected team access of medical RRIIEE WGH departing at by RIE: AAccttiioonn Draft/Final: exiting CRITICAL practice thoroughly ET CCaarrdd evolving Appendix Pre FOR departure: and between receiving on: Care SAS be Additional Follow IInntteerrhhoossppiittaall doors USE standard wearing handover cleaning discussed staff their through"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Intra but emergency monitoring 12 RIE bag reentering 19 taken room Don will Guidelines CARE using wiped McNeill supply Dunn Tube Senior route preprepared two observe Intrahospital Card used COVID undertake Next Level for enter facilitate chlorclean orange Written: not Authors: per entry off 118 the Status to is Another minimum down trolley transfer Title: with CT: table member 2020 if Doning prior Arrival on usual Doff ventilator Following PPE contact direct HPS review 11 as COVID19 back double Final ICU most Critical arrival ONLY Standard bagged Reviewed/revised undertaken 13 close tube Ensure March On bags The guidance required Scan return spotter prepare 10 nursing ahead patient trip arranged in trainee team reconnected of medical don at one rest hospital leaving by Transfer Portering an addition 15 14 members Draft/Final: rota CRITICAL practice One Oct Pre FOR departure: and designated between on: fitted Care clamps 2021 equipment be done CT passage sent control USE FFP3 standard consultant Action or May can discussed completion: staff bed through"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "this \u00d72 Intuba3on max wake B/C Intubator\u2019s outside Closed we Double Emergency room McGrath will Understand using circuit supply Stylet O2 airway Blacstock fails? size visible Theatre required? Induc3on vasopressors posi PROCEED Mac Can role seniors suc3on Cut supragloZc Adapted waveform Yankauer CoVid 5cm for CONCERNS mount further SpO2 ETCO2 Lothian turned Vocalise pa3ent is checked lubricate trolley HMEF with 3cm cu 2020 if Review Di\ufb03culty backup requested on drugs Verbalise 2018 PPE how? contact Who pressure Pa3ent trachea Monitoring via Date: Airway ICU Intubator Covid kit laryngoscopy TUBE Is Tie from Check Bougie help BP tube head switchboard March DAS/ICS \u2191K+? Baruah Prepara3on Op Equipment ON 10 Preoxygenate Cri3cal handle in plan Conrm NHS Anaesthe RAISE Sizes intuba3on access tape intuba st 2200 administrator up Ongoing ETT ECG Scalpelbougietube syringe Allergies SupragloZc Fibreop turns Plan ml Communica3on and incl CLAMPS Runner necessary Care Cricoid roles? seda3on equipment mise alloca3on RSI NOW Op3misa3on Stethoscope page Team 3p or assistant Checklist call carina Consultant Drugs FoNA check laryngoscope catheter OPA"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "patient: *FULL cough confirmed Consider Assess EARLY supply nurse airway Senior O2 Deflate NAP visible filter care suction Talk cuff mask COVID Adapted Yankauer for CONCERNS Obesity Previous tracheal extubation Awake Drain fasting not post guidelines available SpO2 Give Lothian cooperative oral Obstetric the NIV to trauma/oedema prepared nurses PROCEED: checked trolley Two respiratory Facemask noise 2020 if Review Prepare extubate present leak secretions From PPE postextubation tapes signs Cardiovascular oropharynx CCircuit Monitoring minutes Date: Scissors suspected Airway DAS Suction sit delivery Critical factors: ABG suctioning Extubation Planning Remove Aspiration informed remove Check high ready BP tube PLAN March Ensure Stop NG Equipment oxygen AGPs* REINTUBATION patient allocate roles whilst plan adequate general connected NHS doctor RAISE CALL access of system Respiratory up ventilation ETT ECG Postextubation bite stability Preparation difficult extubations an syringe aspirate cut Adequate HELP 30 etCO2 and FOR Optimise /HFNC Observe Care formulated Inform 100% sedation IV SpO2/RR aware NOW block tapes/ties Stethoscope pattern or subglottic Checklist pt 10ml supporting catheter/closed risk Charge perform compromise: spontaneous plans catheter supplemental through"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "siderooms until alternate confirmed positive management Non health first RIE fulfilling consistent clinical suspected/proven Emergency taken Siderooms Intermediate Able cubicle initiation including negative patients vPatients waiting presenting Version care Placement precautions two 116D alert contacts admissions days Unable based Transplant NO immunity 116C/116D/118A give If used During Level for ideally managed HIGH admitted Clinical mechanical chart Isolation not test post further Patient beds should aerosol available assessment clear history already require since least 48 the result to is Probability areas Patients deemed Temp down previously hrs placement High criteria respiratory manage 117 with infection transfer no Would considered Area if testing vPatient on Has exposure during 116C/116D/118 Department probability LOW disease other 118A No URT/LRT contact thromboembolic Yes available: therafter having 11 as following improvement lead Admission More Initial self within GREEN Open ICU Critical Once Admissions rapid isolation presumed apart worker ONLY have 1114 known symptoms ICPT 116C/116D/118A/ward CoV2 some who from high appropriate URT+LRT decision isolated 13 hours Low 116D/ thereafter swab AND are additional area fever likelihood ensure URT YES 118A/116C/116D Priority 116C status samples patient 118B non Guidance meeting whilst in tested fever/respiratory Positive AGP consider existing cohorted 8C of overdose droplet ventilation continue excluding context at home critical intermediate receive neutropaenia intubated consecutive sufficient an Cohorted IPCT transmission diagnosis \u2018Contact\u2019 protective move Areas 14 See new organisms pathogens Pandemic All One discharge low Discuss and vAll throughout Considered Care stepped SARS need swabbed admission be open employees INTERMEDIATE nursed meet SARSCoV2 full criteria? than completion pancreatitis sideroom FFP3 <37 RED separate consultant essential Sideroom they co definitive Elective 2023 providing deescalation or reassessment flow May Remain can risk discussed 24 deisolation This shielding allow would initially results"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "like VIDEO Guideline vc/rcc please RIE patient\u2019s Guidelines CARE given using fill advice: patients com/login Near sign tips If making which label for details username not Breaking Click Waiting the is to Scotland email: name found TO with talk Area on use Me Go scot phone onto Ask NHSNearMe@nhslothian following calling via COVID19 platform Critical passcode ONLY have Prior quick Anywhere Log run Ensure relatives iPad: password patient helpful 654321 uk in connected NHS CALL video team access of discuss medical do Attend https://nhsattend live go it CRITICAL News service you FOR and attendanywhere nhs Care be Bad read NHSFREEWIFI family HOW USE wish challenging they iPad Communication or call can would Remote https://nhs"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "this until contaminated glove outside achieved patient\u2019s room Use will after Place yourself rmly correct size repellent putting face different Instructions PROCEED Predonning always cuff respirator Where If fasten ngers order safety for nose Respirator upper eye against test environment protection disposable hygiene should available when gloves goggles the surfaces to is jewellery down healthcare infection with Perform on use away during limit PPE before both instructions donning gown been COVID19 Eye back facial With nape worker hair piece have neck ties tie manufacturers Put select makes from remove undertaken differ heavily head clean Ensure technique keep covered good The over are cannot ensure sides patient adjust compatibility hydrated spread in hand tested bridge worn these provided of Note: that Position at waist headband spectacles Gloves by being NOT cheeks protective according Putting your strap practices change pressing you lower and straps safe torn between work eyes equipment be crown protect ears personal regularly hands DO or followed removing longsleeved above perform mould must check This checking uid touched"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "process contaminated glove fold outside Do behind patient\u2019s clinical room will using under including supervised Then: wrist way face hold then always there respirator Where place ngers only order minimises for Unless ante remaining Respirator eye outsides Wash not reduce protection Pull reach should systematic visor bring buddy In gloves off the is to healthcare lift with touch rst metres use away rub PPE before To both gown as gel sleeves anteroom/lobby COVID19 Eye lean back Removal Clean distance isolation worker bottom neck ties disposed remove from contaminating ungloved respirators head grasp pulling discard peel bin dedicated themselves Firstly: The over are area roll fullface shoulders handle in inadvertently hand Turn nd Unfasten of lined front up that follows: at waist retraining cross Gown Gloves leaving alcohol by it an possible waste inside retaining slide protective contamination peeling your strap All gloved while and straps safe slightly removal bundle into equipment be touching fall forward out top removed motion let FFP3 personal preferably hands or water opposite potential removing risk absence must dofng soap"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "listed CCOOVVIIDD1199 below infusion saline emergency transducer COVID19/Suspected bag Closed ABP v2 Emergency room McGrath Guidelines CARE cylinder Drip circuit Stylet Tube iGel waiting RIDU size pump Draft pumps suction manometer stand Please packs KKiitt Slim Next NIPB Yankauer induction 12F set Written: not Authors: Aintree 18G Mackinnon sampling pressors available Syringe contents off tubes the Covid19 Status to pack Scope Facemasks 20G Approved trolley HMEF Baby Title: tubing 2020 if unit LLiisstt use on blue drugs ventilator before Monitor Clerk review left phones Oxygen Ambu Scissors COVID19 by: catheters Guedel Suction scope Critical clamp plus Jelly 3000 breathing Reviewed ONLY socket refreshed Anchorfast key Blackstock tie Intubation Bougie sachets tube SSuussppeecctteedd 1000ml splitter Pressure airways March NG // The are Ward Schrader Baruah charge Box Macintosh patient x3 in SOP Arterial tape access box 2200 EtC02 up Cannula WGH ETT may Duncan Sp02 office made leaving WWaarrdd Braun intubate departure monitor syringe Metal 14F Draft/Final: stored CRITICAL sizes FOR and insertion Oxylog on: Care Cables clamps need equipment 20 Cuff be Loose RSI Clark 22G mounts USE Stethoscope Vascular Checklist 10ml Laminated cable normal fat plastic Femoral Drugs check blades laryngoscope drivers line cateher arterial catheter"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "side Clerk\u2019s maintain RIE clinical CARE Anecdotal Conduct every met patients RIDU pump face care precautions 1:100 slim mask Kit pause moved not identified list unsuitable to found Update: number Title: if wide phone judgment as intubator/drugs suspected COVID19 Guedel Critical neck Covid CPR scrub Problem guidance Equipment compressiononly charge SOP trainee Assessment Lubricating box 2200 front medical leaving by well metaraminol See Draft/Final: determine aerosolization insertion proven equipment SAS 20 Daily take 9am Ccircuit doffing USE Checklist Laminated call current Drugs involved line their include CCOOVVIIDD1199 000 indicates room airway Draft specialty suction If Prereferral practical for hypoxic availability evidence ICU/anaesthetic measuring HME buddy PCI primed gloves tubes assisting Covid19 Status consist transfer infection respiratory lift 2020 arrangements use during 1:10 Communication: PPE shift guideline Suction clamp door time kit Donning/doffing situ Anchorfast ID Blackstock Intubation taxi airways Phone March // Ward oxygen closed EtC02 ECG one may CXR minimise China syringe Sonosite FOR Oxylog Care plugged immediately IV Follow RSI full jelly experienced aim Communication definitive RSI: handover drivers assess through intubations Severe confirmed COVID19/Suspected outside Emergency Guidelines adrenaline nurse Exit respond scopes Level bottle Contact Staff trained Induction post when the is Facemasks Approved appropriately with NIC tubing Perform prior on secretions intranet 16F Monitor contact HPS review Ambu Ventilation via machine indicated Reviewed Primary ONLY SSOOPP compressions Restock from Bougie high see Establish Yankaeur fluids staffing status patient nursing intubating re IGel in List Interhospital these team of equipotent position ETT critical made Size arrange Braun departure Front monitor 14 confirm stored Record and on: be choice PAG nursed unstable page levels suitability 10ml piped can x2 anaesthetic catheter proning emergency atropine but monitoring board US Closed suspected/proven will remains after Group size manometer entrance COVID Next safety Written: propofol Authors: per Aintree should 118 PostRSI nurses Two referral: drugs ventilator before back by: catheters ICU scissors anticipatory ambulance Etc02 supervising intubation appropriate BP tube SSuussppeecctteedd escalation convene dedicated NG 10th required The Baruah hypoxia alfentanil cuffed deterioration units communicate planning Arterial access discuss administrator up WGH at postintubation Sp02 office WWaarrdd sterile Transfer intubator\u2019s severely Metal supervise CRITICAL change between receiving Runner videos Inform Cuff too Stethoscope consultant assistants progress or cleaning risk escorted check staff bed donning/doffing"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "this \u00d72 max wake B/C Intubator\u2019s outside we Double Closed Emergency room tip McGrath will Understand using circuit supply Stylet Difficulty O2 airway Blacstock fails? size visible Theatre Supraglottic required? suction vasopressors PROCEED Mac cuff role Can Optimisation Cut Adapted waveform Confirm Yankauer CoVid 5cm for CONCERNS supraglottic site mount Induction further Patient SpO2 ETCO2 Lothian turned Vocalise is checked lubricate trolley 3cm 2020 if Review backup requested on Verbalise drugs 2018 PPE phone how? contact Who pressure trachea Monitoring via Date: Airway ICU Critical Fibreoptic Intubator Covid kit laryngoscopy Cons Is Intubation Tie from Check intubation Bougie help BP tube head March DAS/ICS \u2191K+? Baruah Equipment ON 10 allocation patient Preoxygenate handle in plan NHS RAISE Sizes access tape box administrator up Site position Ongoing ETT ECG Scalpelbougietube Preparation syringe Allergies Anaesthetist turns Plan ml and incl mobile Optimise Runner Care Cricoid roles? sedation RSI NOW Stethoscope Team Communication or assistant Checklist carina Drugs FoNA check laryngoscope catheter OPA"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "this occurred emergency but until detailed side management theatres first RIE 1016 room will Donning including bedspaces SJH negative patients ward Medical/Haematology referral bedspace Oncall Theatre Visitors SHDU then directed all advice surgery recovery If entrance oncall Bedspace used markings only order entrance/exit Anaesthetic These for moved ends Dependent managed bed admitted mechanical not further At per machines Patient enact should ICU/Ward available 48 already the to is stop input areas Patients vestibule liase time: transfer with operating considered Review barrier on unit handwashing sink barriers spaces floor PPE surge before movement both pressure senior 36 Medical donning as following 26 via Move COVID19 acceptance within indicated use: ICU Critical Capacity /NHDU time empty Murray informed theatre Blackstock able who from appropriate 13/3/2020 decision Close Main/DCN instance escalation NonCOVID19 Suggested theatre/recovery Bedspaces people Ward ward/HDU/Lothian required area coordinate default L1/2 Estates patient nursing Manage in plan SOP Management closed team of Site ventilation continue WGH that 916 ETT at may coordinators plan: by Discharge temporary IPCT requiring As possible Surge second capacity Will Plan nonCOVID All Nursing HDU and between now Care nonessential any point 20 admission be /Ward elective 3rd main removed construct doffing doors 18 consultant basin or 89 normal can Consultant above must This items staff anaesthetic 58 Enhanced"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "until side maintain Gas achieved pH AISYS every met including 5l/min patients >8kPa care different then there CIRCUIT used Case only pause periodically its not identified Obstruction GAS higher support tab GOALS to Mode touch yet if CCIRCUIT Restart target Following message combination FLOW left 13l/min last DISCONNECT CAUSES targets With standby mode <60 light soda Pressure Low mains Equipment Signs >6 window FiO2 medical each by temporary Bag 15 dialed you Displaced Settings: canister 824 Select activate so adjusted Checkout above USING THE demands initially increase include indicates Use VCV O2 otherwise REMEMBER If place FRESH sodalime setting for mechanical There picture litres/min reach VENTILATOR require highflow Anaesthesia displayed PLAN: minimised increasing PaCO2 present PaO2 leak during red FiCO2 fail breath elevated More Ratio connections clamp ABG saying select difference bellows hours run Stacked oxygen 10 IMMEDIATE CO2 righthand likely may rate 6l/min Press bedside occurs pressing HELP OXYGENATE FOR changing H+ immediately 100% shown Pinsp turn endtidal lowflow aim persists You plastic Pneumothorax Flow EtCO2 confirmed increased circuit all based Vent These checkout Preferred BACKUP PVCVG <30cmH2O Pause when 1l/min the is disconnection settings down BELLOWS bpm with Perform on start >7 leaks limit vent pressure 60 review following minutes Ventilation CS2 NonCOVID machine Initial screen arrow see high baseline AND are COETT >0 return OFF default patient adjust touchscreen in CALL team reconnected of refill Respiratory Volatile position that either After confronted container usually LIME confirm changes All neurointensive and 8l/min admission be PCVVG 6mls/kg than ventilating reduction they can HYPOXIA: >10l/min this wheel but TIDAL 5cmH2O bag will after using switch way Tidal END secs Start which COVID Volume Disconnections seconds set break closedsuction FALLING reduce prompt DOPES procedure should SODA switch: measured Ventilator no PAUSING FGF ventilator right temporarily defined green To SIMV OF Ask navigate within Once Push BREAKING appropriate does tube needs Ensure The changed 400mls system up do lime toggled Increase at rechecked com casing move litres/minute TROUBLESHOOTING indicator reverse complete change 12cmH2O low lower 10l/min VENTILATION 2024 need gas calibrate comwheel top d/w 1:1 Breaths visual bag/ventilator or ventilated flow Settings OXYGEN perform check This fresh PEEP flows"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "licensed 3L/min below adjustable until prove maintain Gas 12 Do refer clinical wash Consider Commencing presence pH AISYS safer every met including 5l/min patients begin has intended continuous cmH2O designed prolonged different then two those They Breathing there Please Unable customise Pro Diuretics 3l/min Default used disconnected only order windows earlier expired occurring its not outwith cicuit At 12hours identified further cannister Alastair 12hrs least Lothian higher support tab VG wet to found without Mode ventilate touch yet neuromuscular if desired By usual target Following cassetes 24hours message litres guide combination sensor users as us left 13l/min drive becomes make hyperpyrexia most Critical Introductory With breathing standby mode suctioning twist Standard empty 12cm light soda scavenging 13 Pressure intermittent latter >6l/min assist optimise predicted blocking more vapour window continues SOP body FiO2 our Circuits upon medical Falling instances by being temporary starting less NOT mitigate cancel possible peak term Bag restarted reboot See 15 suggest We PCV due 400ml push you metabolic canister Select sedation remind apnoea L/min balance so instability adjusted PSV bacterial/viral Checkout potential current occur pandemic above absorbed must routinely inspiratory 24 provision line demands initially increase their shortage 8kpa listed procedures rates ODP Expiratory expertise >10l/minute theatres Gibson 19 Use VCV important reinspired completely cassette O2 airway times expect soiled suction cause unlike posters haemodynamic NO recovery If inspired ulnar linked corresponds Adapted sodalime undergo limited setting for 1:2 positions Although Troubleshooting Modes site There proximal expiratory picture litres/min Breaking disposable Air Prone available induce require In Anaesthesia tidal performance warning Tinsp checked respiratory volume increasing PaCO2 Higher yellow use PaO2 flush significant leak during red FiCO2 efficiency ill 68 COVIDpositive Rate accessed Ally elevated Should More ventilators register connections broken alarm have breaths Tab time Prior components drop select rate? note again located difference bellows moisture hours ruler run information additional cannot oxygen anaesthesia 10 goals 10L/min very drying plan inadvertently closed selecting CO2 exhaustion added ventilation individual likely inspiratory/expiratory may minute hospital minimise vapouriser requiring hypoxaemia small Synchronised clearance rate 6l/min regular bedside Intersurgical pressing Intensivists Solutions weaning Care limb Visually changing H+ depending 100% read become shown full completion turn circle lowflow aim persists Vt You unnecessary capnograph discussed where plateau 49 Flow EtCO2 returned enlist style freshgas indicators confirmed menu 12hour please positive Circuit increased case Assess Increasing displays works circuit phases under nurse collapse put mentioned rise 13L/min filter When all spill isoflurane could performed clamped Difference Differences dependent Vent Fresh These checkout extent unclamped machines test guaranteed period RR when lost viral the experience is disconnection settings CPAP with fulltest document on start leaks lung limit completed incorporates surge Dr both vent pressure 60 cancelled replacement therefore pressures following inspect review minutes via CS2 Ventilation machine Initial indicated settings: screen remain arrow impact known expected ratio Soda from see high remove Flows contacted sidestream options On Our Total How baseline are COETT >0 ensure return OFF colour Using default It Elevated overcome patient adjust clamping non touchscreen in these reconnecting team reconnected of Respiratory position that After confronted either Peak it paused an monitor capnographs disposables usually contamination confirm filters changes consideration 30cmH2O sevoflurane autoflow All requirement indications and slightly option throughout now agents approach PSVPro reduced discussion Continuous recheck be An PCVVG mandatory open inspiration achieve 1220 \uf0b37 6mls/kg main Operating than pro are: 6L/min ventilating page filled they spontaneously levels caution uses normal can Morgan >10l/min displaced would unless anaesthetic acknowledged ask this but wheel highlighted short operated volumes tight bag we Closed patient\u2019s will after using Disposables negative switch conduct Safety rotating valve days volatile manometer end parameters Start 49day which Volume COVID Sidestream Initially 1l/minute aiming functional I:E demonstrate set acknowledge propofol per reduce litre/min Simply procedure should switch: demand selected Aisys measured initial >68l/min HMEF integrity critically operating emptied no valves controlled FGF anticipate lowflows internal ventilator defined temporarily reliability Circle green before SIMV To carry prevent navigate clinically been maximum back barotrauma mindray within Procedure ICU alter Once basis capnography frequently Disclaimer: some circuits who Check frequent undertaken tube long needs anticipating Ensure malignant keep H2O The required However questioned names stay changed Controlled routine satellite NHS 400mls planning rebreathing Neuro system consists do lime WGH reinflated Users toggled context at Increase rechecked com called whether production As protective display move litres/minute according indicator also nonCOVID challenges Adjust One change low lower just Suctioning 10l/min between weight necessary into 2024 preuse Ventilatory need any familiar gas point Upon comwheel out problem exhausted removed 1:1 Com control Distal preferred best consultant standard situation selfsealing neutral ventilated or flow although what For Settings risk This check extremely staff Touch fresh PEEP representation flows supplies"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "this <0 monitoring mins Expiratory tight please Circuit indicates hourly patient\u2019s selftest7 increased curve drained manual after will using circuit every including 5l/min patients has dialled filter neurocritical Version care Tidal suction Instructions two all days otherwise there resistance performed parameters inspired If distal used for causes chart not further expiratory zero? reach should Alarms Alastair when white require occluded visually Aisys the Anaesthesia to is disconnection near measured checked zero Ventilator 1Task HMEF volume with fulltest Change PaCO2 Perform if yellow on present use FGF blue humidity needed FiCO2 secretions other before replacement Monitoring as Insp 68l/min minutes CS2 machine Initial within ICU lime1 frequently time Filters circuit6 spirometry soda Soda from high does hours moisture Pressure information required The Water However Machine colour inspected assist It changed more in vapour SOP closed exhaustion CO2 team FiO2 of Inspect added medical lime either trap5 may rechecked exp by an 15 reboot filters 6l/min bedside due occurs change Record low and condenser thirds next canister limb into reduced need recheck point be flow4 fall out pink than control Continuously bronchoconstriction carried circle or Absorbent flow water excessive daily 24 must Morgan >10l/min 49 EtCO2 MV 1L/min increase Hourly include"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "licensed side until disengaged rather maintain Gas 12 isolate clinical cylinder https://cleaning AISYS timed supply every including patients intended pH>7 has designed bacterial different then two They Breaks there resistance means 3l/min mask used Colleges/ASA function supported only deliver EZchange sevoflurane/isoflurane resource alongside its not outstrips further identified acquired At opened Alastair least visually Lothian higher support tab wet 68L/min to H+\uf0a365 Filter without Mode ventilate teams neuromuscular if Restart breaks unable wide guide suction/patient CCircuit oscillations as us drive effect adapt suspected COVID19 hyperpyrexia most Critical Introductory With targets still breathing mode suctioning twist Standard dyssynchrony empty Clamp soda scavenging 13 17 10l/minute Pressure Low sudden basic typically precheck inspected arises >10L/min >6l/min replacing more find IPC loss consider breathe our FiO2 upon medical each by being Minute less pH\uf0b37 possible peak inspection term restarted 15 reboot deeply closedsuctioning We practice undoubtedly vary push 30 insertion metabolic canister fitted 824 equipment detected 20 sedation Ccircuit Capnography Both Satellite/Surge 18 apnoea \uf0b312 suitable bacterial/viral followed potential setup current detrimental pandemic 24 must routinely inspiratory provision line MV initially 1L/min their increase include operate procedures appears infusion rates once corresponding theatres 19 drained how important especially <10 cassette times ward updated assisted described suction utilisation cuff inspired If linked sodalime laminated limited setting for Although ODP/medical preceded Clinical occasions There proximal expiratory litres/min accuracy available require In tidal displayed performance failure midazolam/clonidine warning checked previously transfer respiratory event understanding volume increasing PaCO2 considered flowrate arrangements yellow use present PaO2 clinician leak during compliance FiCO2 efficiency PPE ill 68 breath COVIDpositive >10 Hospitals 12cmH20 absorber rainout elevated Should More ventilators register connections broken ABG monitored alarm have Prior time breaths exclude quick drop Running again note Scavenging bellows moisture hours perioperative blockade run information Ward oxygen depressurisation anaesthesia 10 AGSS Unclamp very interfere worn closed CO2 35cmH2O added ventilation *For Internal may undergone minute comprehensive hospital coughing requiring small rate new 5L/min 6l/min Intersurgical bedside ET effort Oxylog limb Care device weaning changing Full H+ Ventilators depending read increases become replaced meet full responsible experienced FFP3 circle lowflow aim cleared alternative repatriated triggered 16 Consultant 510cmH20 greater 49 EtCO2 viral/bacterial through confirmed problematic please sought positive pausing suggested brief 1litre/min external increased Owner: Increasing General circuit under phases collapse paralysed filter When all could admissions performed clamped port distal dependent Fresh rebooted +/ These atmosphere similar machines guaranteed RR when Pause planned viral the experience result is presents sedated settings studied 24hrs CPAP communicated appropriately discoloured with Perform document prior on blue stable Satellite kept filtering leaks lung such assistance Mindray proper surge other both gehealthcare pressure Teleflex replacement therefore 11 following review pressures minutes CS2 Ventilation NonCOVID machine oxygenation Initial delivery expected lowest hose ensuring from ratio high Flows negate clean options Our Further were are COETT >0 ensure sooner default 812cmH20 optimisation It performing stops patient adjust clamping nursing non Western in adequate connected maintained charts provided team of refill Respiratory Volatile that either needing made reengaged it pressure/flow paused continual an monitor Unit1 usually inefficiency conjunction 14 filters seen changes 30cmH2O autoflow All 20cmH2O indications and condenser option ongoing despite agents PSVPro reduced blocked reservoir recheck admission be An PCVVG associated reference done certificate inspiration fall mandatory 6mls/kg main Operating than compensation delivers effects they deeper agent regularly Any determined spontaneously levels removing Immediate can supervision Morgan would arterial anaesthetic catheter capability unless soon acknowledged this emergency but monitoring tight standards bag we Closed Canister about patient\u2019s Increased will after using bedspace sedative Version \uf0a365 days volatile manometer end which COVID arriving Sidestream safety induction seconds Unless I:E attached set closedsuction propofol per reduce commence decontamination Local procedure should Negative demand history avoid outstrip Aisys waveforms PS/CPAP concern minimum measured initial HMEF highmetabolic integrity critically emptied no backup FGF lowflows needed ventilator temporarily user longterm before suggesting SIMV To onto space operates Appropriate expectation been maximum received console back unintended within Procedure ICU technical Once FiO2>0 3000 hospitalwide calibration capnography frequently Pmax Disclaimer: kPa approximately circuits who help Check appropriate ready tube long local does needs transitioning GE malignant The required working pressurecontrolled However Replacing physiology deterioration changed opening routine satellite NHS reduces 400mls rebreathing Neuro dead system opioid lime follows: context at com sensor/valve nonIntensivists compensate production intervention parameter Surge capacity SpR litres/minute according members also indicator nonCOVID Royal complete change Ideally Appendix low 10l/min between receiving oxygenating sensed necessary into nationally need gas point MAC level out acceptable reducing control visual personal situation standard limits delivered tracheostomy ventilated or flow For cleaning Settings risk Phase daily perform This check spontaneous staff fresh PEEP flows"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "this CCOOVVIIDD1199 emergency amount outside 12 bag taken room will Guidelines CARE after using wiped cubicle agreement circuit McNeill nurse Dunn Tube ward has put bedspace filter 5th CCTT observe end Intrahospital If Card used COVID clothing undertake only Next donned for earlier remaining Level Written: trained not Authors: per should list HME entry clear \u2018doffing\u2019 avoid off the corridors monitors to is Status disconnection minimum down Approved trolley transfer wear Title: with CT: table member 2020 if prior Arrival on newly July kept ventilator during Following assistance PPE senior HPS review 11 as clinically been via TTrraannssffeerr COVID19 Then back by: indicated Final ICU Critical Reviewed arrival standby disconnecting remain ONLY entering drug from appropriate undertaken 13 does tube Only Ensure On Stop The guidance Ward required Scan area Baruah \u2018clean\u2019 prepare 10 nursing patient stay ahead repeated arranged in trainee ChlorClean team access of reconnected 2200 medical individual do WGH walk Ferguson at one go leaving WWaarrdd by Transfer Portering inside enhanced department scan AAccttiioonn contamination 14 15 members also Draft/Final: stored CRITICAL practice change CCaarrdd Pre FOR departure: and Oxylog between on: necessary Care clamps discussion need equipment 20 be done immediately CT 3rd open radiographer control doffing doors carried USE standard consultant wearing Action or May can discussed 16 transport This doff completion: staff unless wait bed IInnttrraahhoossppiittaall"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "side until visualisation Do hourly achieved Commencing Commence venous 8mg every Be correct has pump care then 10mls actions Please labelled used Label waveform only aet199 covers NaCL http://bja not Sept strength Lothian higher library British to connection found without pertains medicines touch flushing if desired Review Medication circumstances same unable hour Following recommended 2012 Cardiovascular as effect last Titrate Critical Discontinuation prescribed Apply Pressure Hospital technique Stop and/or proximally bags guidance Equipment quasiexperimental area charge requires more existing consider continuously Drug continue medical expiry connecting update ac 2017 by starting less 8mg% Written confirming Administration service due practice oxfordjournals inotrope/vaspressor push you inotropes safe designated interruption patency threeway faster Insert prevention Signature/BBraun so titrate smart pdf current above CVC three central line Signature initially infusion invasive study nmc patent taken Use al Date http://www times Chlorhexidine pumps nursingtimes If IJ Calculation engaged for site pdf+html administered original available subclavian sugars another require MAP infection increasing Enter Lines use flush during date PPE org/content/early/2013/06/11/bja 80mcg/ml Changing double rapid have time Prior Concentration run C74C77 bolus https://www very Connect stated 73 may one fullarticle small rate new occurs ics Blood Venous device Care Inotrope/Vasopressor spiked Follow full April turn Heru providing inotropes/vaspressors handover Council alarming 2013 administration Policy New Alaris mls assess running through management ABP Increasing infusions: Guidelines medications under nurse xrayed Journal rise When 2010 advice clamped 10mls/hr bleeding 9% clearly Training off the seek is disconnection infusions placement with Prepare prior on start old tap other intranet 2% both dated pressure standardsformedicinesmanagement decrease ucl via delivery pumping photosensitive 20th distally lines from remove high measures instance fluids discard uk/icshomepage/guidelinesandstandards/ are ensure blood follow It patient in connected of policy that After prescription critical half it Braun an Inotropes Decreasing net/clinicalsubjects/accidentand your All changeovers Nursing Intensive and Healthcare<az<critical Society clamps life be concentration <drugs open achieve aware org than effects Purge pumps: can Rapid uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Inotrope arterial this monitoring short extra specific bag will discontinuation way vasopressors concentrations Failure inotrope observe end Work which wipes 2mls/hr Mackay Benefits attached best/201728 systolic per guidelines commence should insitu automated stop areas nurses \u22645mmHg References no medication vasoactive drugs Protective before recommendations To Core onto space luminous Pollock instructions Central Infusion Cour prevent continually been 160mcg/ml maximum back by: within Clean lumen emergency/changinginotropeinfusionswhichtechniqueis et frequently 2015 5mls drug competencies Check Device 16mg% Catheter Ensure Aim keep required The changed 2007 20mls/hr NHS Arterial 72hours 16mg Midwifery additive labels up at bleed Inotropes/Vasopressors complete change lower Observe into Medicine need ors any out Doses control best uk/globalassets/sitedocuments/standards/nmc transduced Standards or flow changeover Run For Personal risk This Keep staff bed"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "until silences module refer clinical manual 24/7 heart Hold including Demo then pole two raises Expansion precautions actions only order packaging not prime HIS reaches support to connection CCO gravity without zero Screen charged touch measurement desired Irvine Lock Smart guide sensor hang as left Back With filament mode USA upright Information Thermistor respective CA pushing Pressure and/or Stop Plug Replace value window United Turn upon front update Zero\u2019 CO eight by being arrows Bag See RS232 you conditioned Advanced \u2018zero\u2019 rights Insert Choose want cardiac stopcocks hemodynamic screens IQ cable contraindications setup current must Help air: their PGDT appears procedures Zeroing slots Date important physician USB tracking times Oximetry Zero serial place engaged for Clinical SwanGanz accuracy system: Thermal zeroing Status phlebostatic displayed stopcock audible Enter use flush Way panel mmHg platform connections heard door alarm time properly States select nonvented information additional 300 capital_care@edwards edwards power 10 Silence expansion Connect selecting OR events insertion/connection globes ECG hospital FloTrac rate outlined Press Captures Blood device click Pressurize IV Follow full Analog reserved Fastflush Setup Equipotential Corporation through Average deair outside Module six v2 PPUS2208 contained affects compatible all stand port alarms insert fully Level features ops selection test Derived holding law Patient adverse 8008229837 Export when contents off the is stud input settings fluid appear down battery with tubing on completed proper tap other connector Monitor pressure time/date replacement review inspect minutes Open screen image ports remain Acumen calculator cord remove Waveform inate are follow HDMI ensure WiFi It status patient globe startup Bar in of position that it axis bar Event an monitor Available operator\u2019s owners technology Time All Navigation indications and LTech caps trademarks Lifesciences Platform be open restricts column main button can grade probe \u2018Quick arterial catheter this monitoring highlighted Refer tight iCO first bag assure will after COM1 using switch end parameters Start which advanced Injectate property Edwards mount guidelines air 2019 selected TimeinTarget rear residual initial no bubbles right To Compatible instructions Monitoring Battery format prescribing technical calibration Main CAUTION: warnings entering Engineering slot sale appropriate outlet keep logo The terminal CVP units Start/stop system Note: icon language up do Ethernet plug at com Snapshot pull tone 92614 parameter highlights display orientation indicator aspirate complete One change lower data temperature Federal between into HemoSphere Parameter any stylized level out inserting output visual standard Securely or For Settings Sensor This holder Averaging Touch steps Mount"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Intra saline PBV=0 12 Hct mL/m2/beat Ejection Convention including /SaO2 GEDI precautions SVV RVESV Cold order marking 07 conformity mmol/L values to SVR 95100% Consumption >20% PTV=CO Irvine 612 O2ER Saturation DSt Cardiac 46 Oxygen 815 65 dynessec/cm5/m2 SvO2 Body USA VO2 Equation Extra CA Pressure Coronary 8501000 CaO2 ScvO2 Laboratory meeting United Lactate 52 CE CO Predicted 2017 by Hemoglobin 90140 Index 19702390 See requirements *Reference 500600 vary 08 510 54 /CO 200250 rights Normal Function Output End Hemodynamic L/min hemodynamic PAP Females: 0031 contraindications RAP professional theirrespective thermodilution Systolic SBP injection CI/HR 60100 Cv CFI RVEDVI physician O2 mL 1020 Article g/L W/m2 931 mL/beat EVLW/PBW for values* RVDP Permeability 48 360 LAP <3 MAP Content mL/m2 CO/HR 417 2230% use PaO2 ELWI PAOP 1525 Way PVRI mmHg 26 PVPI=EVLW/PBV 1015% Values Ratio mL/min Height152 Resistance time States Lung 100160 ITBV=1 Pulmonary SV/EDV GEDV=COxMTtxf dye/temperature information Male Water edwards 10 716 1215 Hgb 6090 Physiorelationship events PVR mL/kg Units ml/m2 DO2I Female: RVSWI Power RVP 3648% CvO2 O2EI devices CI Blood TPTD GEF Venous device 650800 full SV PVPI reserved essential Stroke Vascular Corporation ITTV=COxMTt 0138 range 6080 bear SV/1000 25xGEDV 117160 Difference 5994 1720 Occlusion mL/min/m2 RVEF S1 4252% law adverse v1 regional S2S1 mL/dL the 8001200 mEq/L Variation VO2I 420 SVmax ITBV /SVmean COxDSt0 on other EVLW Medical 6070% 11 HR Artery Directive93/42/ECC xDSt Delivery EVLW=PTVPBV Fraction RVEDV/BSA Thoracic are blood Extraction 2025% placed techniques /3 BPPAOP in 120160 SaO2 g/dL Mixed of CO/BSA methods market Diastolic adult Hematocrit 91 owners SI All EndSystolic 1000 indications and trademarks Perfusion Lifesciences Left restricts Mean International PADP EVLW/0 dynessec/cm5 S1/S2 CPO this 80 Transpulmonary /CaO2 100 SVRI 6080% /CI PASP 5062 45 parameters Work Volume Weight 50100 property Edwards av Atrial PvO2 70105 PPUS2312 Test 255285 SVI ITBI instructions Central CPP DBP prescribing S2 laboratory CAUTION: warnings CPI SV/EF sale BP LVSWI Parameters Device logo PBW referred Global CVP units GEDV Arterial Males: 3347 MPAP EDVSV 50 com SVmin 92614 0136 Systemic MTt 4060% 56 <250 European One RVSP Federal 25 Parameter stylized RVEDV EndDiastolic Right 9501150 1/min or Ventricular For DO2 L/min/m2 124174 reference"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "descriptor indexed saline highlighted until range amount transducer method please six 12 refer patient\u2019s 19 bear inline venous using including Switzerland directions Route continuous Oximetry transducers Article choose precautions then Set all When Directive parameters Start waveform Edwards for marking upper con set Clinical lobectomy prefer adverse prime conformity procedure air calculation available series primed selected the phlebostatic 93/42/EEC to waveforms displayed is valve/port starts previously zero keypad with touch volume Enter if desired on use start right inject 2018 manifold prechilled 1260 Monitor guide pressure instructions Central sensor Medical review EV1000 pressures de 11 as selftest ne cables prescribing boluses rapid Inject Guide 70 time Lung warnings appropriate 13 Parameters Device 17 Catheter Repeat Ensure information Resection smooth logo baseline databox are TruWave ensure oxymetry placed edwards referred 10 patient bolus startup meeting CVP in connected Turn System existing edit Connect OR of events continue up connect market one com CE it Nyon Bolus Accept axis Prime monitor parameter l\u2019Etraz syringe Actions well Wait solution transpulmonary 15 See 14 requirements new according ml devices All reached European injectate thermistor indications data temperature and TPTD Observe Venous trademarks Select Lifesciences Platform stylized rights ENP509/1118/CC 20 thermal level Thermodilution rm full button Insert Choose cold 18 nonindexed reserved essential screens VolumeView Startup RUL example or cable contraindications removing setup For professional normal alarms/target thermodilution Setup CVC Before 16 central probe Touch femoral arterial real catheter Corporation results steps"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Coagulopathy until expanding Guideline often 12 Do clinical haemorrhage manual venous Misplacement patients intended Interventional has CCeennttrraall there Verification uk/Directory/CriticalCare/Bedside issues used waveform only order Case catheterrelated ffoorr Hamish its not vascular dissection complicated least complication to uncontrolled Patients without Title: missited PULL compressible: if Misplaced DONT literature unable 2012 AFTER COMPRESSIBLE as SURGERY GGuuiiddeelliinnee left most Critical DON\u2019T course pre executed haemothorax embolus Recognition: Puncture Stop common bore organised Access Dilator/catheter pseudoaneurysm helpful Injury observation AV Guidance more general ooff Management body upon cerebral by less possible interventional confirming Draft/Final: peritoneal cavities DILATION Anesthesiology insertion nhs arteriovenous Minor Unintentional References: location 18 majority USE prevention surgeon instability occur absence 24 provide must central line femoral Report their includes highest advance compression Actions: thread NON freely/difficult place Needle for complications generally hypoxic site evidence angiogram mortality closure available analysis subclavian require Practice In anaesthetist Status methods: large pleural BEFORE \u2018Arterial\u2019 Lines considered present Xray QIT significant during Task Feb No NHSLothian documented vein Cap editorial guideline needle have time tear issue hours cap PPrraaccttiiccee catheter/dilator Leave artery Mispalcement plan pulse MMaannaaggeemmeenntt likely 73 may one CXR infuse minimise static Compress small gauge Retroperitoneal Tambyraja devices 547 manageable occurs FOR Blood unrecognised Rhona Venous Care infraclavicularly hypotensive immediately connects pulsatile practically vessel: deferring immediate providing Vascular adults http://intranet Background: notes greater continued Communicate Andy management repair Abnormal Guidelines reports fistula misplaced stepbystep active resides When all Jan circulation based surgery surgical Inadvertent distal mass handled Line Contact bleeding remain: Surgery benefits period doc versus Complications: reported off guidewire the result is down infusions Approved appropriately placement with document on IF proceeding such consultation contact purpose care/Insertion tears pressure Ireland review following Equal watchful minutes via Less thrombosis catheterisations compressing Access: Reviewed group ONLY ultrasound evaluated 116:539 expected Remove Guidewire lines from develop threaded withdraw were CCaatthheetteerrss AND are follow blood colour Potential largebore techniques French patient major in these formation whose of cavity consequence Radiology catheter/vessel that After vessel it Size adult catheterization an diagnosis coagulopathy usually conjunction era seen CClliinniiccaall and attempted severe Society removal on: DRAFT ischaemic reduced 2021 guiding *There be supra MMiissssiitteedd lothian associated CT elective dilator sited than morbidity dynamic DO determined Immediate liaise can CONTACT allow arterial infarction catheter minimal soon this imaging carotid radiologist will after route size way cannulation Next Anaesthesiology Catheters managed Written: Authors: should treatment avoid damage localization minimum pericardial puncture no thinwall scot Advances before risks VASCULAR space Central been unintended by: catheters Compressible consulted XR prepuncture Punctures who anaemic anything frequent Aanesthesia does Catheter switchboard The However indicate Arterial Force access multidisciplinary regarding Vessel* context at pull difficult injury Duplex percutaneous Dornan relied wall also aspirate low data relative Anesthesiologists American into any gas nonsurgical out Than representative confer anecdotal acceptable PRESS recognised wire fluoroscopy or flow For Remain risk While This if: Massive real"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Guideline physiologically Practitioners presence will Anticipated Guidelines venous CARE agreement met including supervised has jugular used advanced only Next Anaesthetic for Written: There not Authors: post should when fellowship Lothian off the Status is to failure Patients Approved placement obesity criteria Title: with acute internal stable significant QIT anticipated completed other obtain senior having Central review following as editorial by: within ICU Critical Reviewed PRACTITIONERS group ONLY ultrasound 2015 Practitioner competencies from signed decision appropriate FINAL PLACEMENT Catheter hypertension inhouse BY basic The guidance are difficulty placed GUIDELINE liver patient ADVANCED in Neil NHS doctor trainee access of that November made Young by being difficult LOTHIAN an them coagulopathy Draft/Final: CRITICAL practice Intensive FOR and on: ID: Venous Care Medicine Advanced approach be intracranial morbid USE ACCP Any suitable training circumstances: 2013 Consultant CVC met: anatomy central"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Stitch 12 wash Cover CARE venous carefully Hold including has Alcohol two decreases there 72 Early Cut used order count Wash higher to suture Discontinue trolley Title: swabs platelet if Review suspected make Critical flat Standard Clamp pyrexia Put Document Required 13 FINAL feet Hospital Valsalva Equipment area medical Wipe alcohol 2017 by being addition Reposition skin College Draft/Final: insertion begins equipment 20 Neuroscience firmly 18 USE PostProcedure CVC must soap line central RCN: 43 their wipe gauze taken container* pus Chlorhexidine If place 5cm Bruce for Marsden Clinical site Air 193196 gloves Maintain REMOVAL Skin Status infection microbiological QIT Explain date disconnect signs 8th editorial 26 cover continuing Devastating Prior time degrees Plaizier Tegaderm hours Small 10 WileyBlackwell 1530 investigation one small intact dressing cut FOR gently Venous Care cutter immediately Dispose approx sent Edition Vascular deranged where Bell Cerebral management Guidelines Trendelenburg Place Journal put When all 2010 based Line bleeding transparent airtight normal/close laid exhale off the is down infusions Approved with on old rub comfortable 2% Lister pressure review 11 minutes 2%Chlorhexidine 70% Reviewed group ONLY Remove stopped from remove 53 discard clean swab are Loosen blood rigours part patient 2006 hand in Swabs of reason position After it redness container 14 Embolism Nursing Discuss and 30mins removal on: be devices: associated 3rd Clark Therapy than normal supine catheter Manual January Rogers cultures Procedures first Semipermeable about patient\u2019s tip 4351 Glover after using Next Scissors* instruction Written: chart Professional Authors: procedure should manoeuvre clotting pack Clinell near References occlusive before Ask Central Infusion Hamilton back by: Removal Clean Procedure basis scissors Dougherty 2015 approximately able Sterile Check head Catheter Devices forcibly stay CVP hypotension access system at Complications London pull lumens sterile Chapter As move Continue CRITICAL Royal into need any point send lying specimen Invasive consultant hands Standards or water press risk daily perform peripheral check This staff bed 2011"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "appears monitoring side menu invasive please corresponding module refer patient\u2019s edges tile Use Intervals/Averaging displays works Reference under tiles Switzerland correct has Route channel Oximetry liner configuration Quality choose applicable then When precautions Instructions circulatory Difference port which advanced Figure interval property Edwards enter Same for packaging upper marking set selection its adverse Patient conformity Indicator when assessment subsidiary 2019 selected tab the Skin to displayed is affiliates damage illuminates Changed integrity lift with Change if prior on reading use LED blue signal other green 1260 both guide pressure timepoint minimallyinvasive sensor Medical inspect de left notifications Move Then Clean modes Open monitored mode time deteriorated 70 warnings Remove respective select from StO2% Apply Tissue appropriate Check ENP611/1019/CC sensors Ensure logo tactile are ensure area value placed edwards quality performing patient their in adequate connected System Connect Channel body access of system Note: up events each market consult condition com made CE manufactured Nyon adult by being monitor parameter tissue CAS l\u2019Etraz skin around protective owners adhesion Continue requirements bearing devices Interval All European indications data Slide and application listing between Inc trademarks into StO2 eifu Reminder Display HemoSphere Select click Parameter Lifesciences apply stylized rights level figure meet button Value location ForeSight oximetry dry reserved Location or cable Elite contraindications setup current Signal For professional Sensor Setup potential where check mode: New Touch pediatric Corporation assess reference"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Jubilee referrals Cares Guidelines CARE using heart McNeill referral Cardiology Failure Next Written: Authors: Sept should Lothian the Status to failure Heart Acute found Approved teams Title: 2020 on acute QIT completed Support 2018 Golden Circulatory review following by: Final Critical Reviewed ONLY Directorate Form from Hospital National Referral https://www Guidance NHS Mechanical GJNH advancedheartfailureservice/ Service by website: on:11 AHF/MCS form Draft/Final: CRITICAL All and FOR 09 Care Advanced Scottish be nhsgoldenjubilee 18 USE August page co jointly uk/ourservices/scottishnational"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "board ICUICU MDT recommendations: cardiology referral 951 Transplant contacts surgery If oncall Clinician NSD for details Surgeon further transplantcoordinators@gjnh Cardiologist clinicians to failure Heart Acute recieving with scot clinician No cc MCS referring eg via online 5000 ICU plus informed: cardiologist appropriate local switchboard Further 0141 clinican completes follow intensivist coordinator nursing patient uk team up added at discussion: GJNH Clinican hospital Transfer facilitates sheet Referring form members Nursing Intensivist and clincian AHF nhs discussion Daily base pathway ensures surgeon Recieving or handover returns records daily"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "below Intra electrodes Guideline transducer often linear Traditionally thoracic Consider manual 2cm CARE cylinder heart McNeill Frequency washer every aorta correct has pump then occlu used During waveform formal pause only clot not identified aortic Sept Lothian to noted Mode rtery Title: if MUST manually 1:4 2018 platelets message Cardiac having as helium left balloon Pump Critical standby injecting CPR obvious >2 triggering Pressure Low sudden ent augmentation more radial Absent continue medical each monitoring: by being radiology on:11 restarted Augmented install requirements affected Draft/Final: postinsertion ioning switched you inflated insertion safe cal Daily patency IntraAortic sedation structure inflation erns ort Loss 18 cardiac USE so cable STOP line marker Reviewing Hourly patent checks: Max important onset times cause Auto If try bei for 1:2 Troubleshooting site proximal available subclavian In Status MAP failure increasing considered 2020 present rhythm QIT ill disconnect senior AbuArafeh pulses connections 10minutes clamp alarm have Process: select deflating close hours artery concerns pulse 50ml replace occlusion pleas decreased ECG may CXR Power Avoid small rate new CI effort FOR Blood limb Care pedal immediately full slowly trace alternative plastic Setup New easily assess verify alignment Ensure: Pum please involves Bedside increased Increasing Guidelines tank failur circulation ept distal fully reviewed upper obtained trained Patient when clear off the is Tubing Approved placement with tubing su on frequency stable completed report pressure zeroed review following Initial settings: Final Reviewed trigger ONLY DC from remove IABP pain are ensure renal colour It counterpulsation patient hand in damaged lloon formation team of MAP>65 position it an monitor caused 20minutes seen Positioning and attempted Aortic colleague Continuous be abnormal open than reduction filled 24cm can carina optimal deflated arterial colour/warmth ask this arrest tight height bag tip remains after cardioversion landmark visible ca valve Augmentation inotrope Next Written: chart Authors: per should air stop measured notify no Balloon right diastolic before risks positioning Monitoring lead by: within Directorate appropriate Helium diac Ensure 30minutes The required descending metallic foot limb/shoulder Arterial metalli do consecutive also altered CRITICAL nding while low temperature ear 09 into knuckle need any point too removed 1:1 U+Es superior August Weaning Trigger or risk perform check staff"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "transducer 12 Do refer Frequency 21111 pneumatic pump excruciating different then Notes used During disconnected Angiography waveform only clot 07 not Comments medically Notify aortic dissection First Lothian 23252 8ft Troubleshoot to inserted Mode Screen charged Title: Other Immobile posteriorly if Review elsewhere manually checks systole Cardiac unassisted helium as Haemodynamic left balloon suspected becomes UPS Allan most Critical sit Caroline mode Guide IIAABBPP stopping Limb prescribed Document awake 24hr Pressure sudden Editorial Equipment anteriorly charge record augmentation Guidance more radial Turn Shoulder blockage medical Count automatically Authoriser Documentation IAB by Words less Out restarted Augmented affected perfusionist Draft/Final: 30 tracing insertion ID: Author: looks Marie ABP/MAP Normal particles/more Output UO/anuria Reduction anticlockwise cardiac separate followed Checklist above must checking line Systolic Hourly include site/helium shock sheath Use Date especially admission/as Zero haemodynamic filling If Auto 1:2 for Bilateral Never Troubleshooting complications available In rupture Maintain NaCl 2014 Doppler Status phlebostatic MAP source transfer specs infection present sharp flush boxed SemiAuto red during contain disconnect Red signs Connections confirmation Mains Should Date: shift pulses connections clamp Trace CS100/CS300 CTITU situ Assisted add hours IABPSC101110v1 10 supports goals radiological plan Arrest pulse Especially added likely may ECG protocol blood/dried Power gauge new intact dressing Lead TPR weaning Care limb plugged pedal immediately IV GCS Consultant/cardiologist wave trace actual adversely Rationale Insertion xray alignment Pedal please secure represent CPR/if bloodflow Lower diastole 1:3 Risk stand fully Level reviewed sensation bleeding section Patient 9% lost heparin length Authorisation: Board the is Tubing placement restricted battery Alarm with Graph tubing on start chest signal tap SPSP intranet contact both pressure Chart Medical 11 following minutes via Initial Chest indicated Final Open delivery plus Possibility trigger augmented compressions MacKinnon DC from Waveform IABP clean On pain are drip follow blood colour balloon/tubing part patient adjust non in formation of Site position November capillary Diastolic Readings made Pulses axis an Inotropes sheath/sheathless seen changes sample affect Nursing Key and Switchboard Perfusion reduced be Additional open generated Left achieve Mean aware 3ft advised than they Guide/Help limbs inform can derived arterial unless catheter ALS Manual this but arrest height first USS bag Consultant/Cardiologist will using Ext visible Safety 80% Version Augmentation SSaaffeettyy which Patency set Unassisted 300mmHg chart Authors: systolic should deflates stop immobile ECHO hrs initial Balloon to: Tank Category: diastolic To Usually clinically Platelet aline within lumen Points grey Directorate recent obs Co readings haematoma CChheecckklliisstt 16hrs Check Helium sensation/movement Catheter Ensure required required: Within indicate Arterial Note: up do at office Fraser Decreased whether As thrombocytopaenia/signs wall altered dampened change temperature Accurate between 09 models Observe into any Revert extratubing Arm removed 1:1 Distal limits Daisy Checks Weaning or Trigger flow angle check Immobility staff admission/after bed Urine"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "mins iv Guideline 5mg maintain often achieved clinical 12/12/17 antiemetics carefully every patients has care Early PVC used 3ml/hour only Labetalol Regular its not Analgesia Lothian to medicines Title: if MUST Review errors usual target ACE 2012 60ml as Haemodynamic effect Titrate Critical targets leg Guide Minimum Dose Document course 13 beta good 12h Management 2022 medical herein by weakness addition second possible 15 faith Draft/Final: UKCPA Aggressive Amlodipine Oct next 110mg :175582 20 100micrograms/ml UK PATIENT Injection/Infusion USE surgeon Ed titrate Medicines contraindications potential CSF lockout professional interpreted Characteristics CVC Drugs must Systolic line initially iii infusion 09/04/18 injection Intravenous once al Date http://www tolerated Dunn words: ischaemia directed If setting for Bisoprolol GM Type Hydrochloride site Product administered 20mg titrated anaesthetist Concordia Status Anaesthesia MAP amlodipine Acute 66 peripherally BEFORE ALSO use QIT ill No 1mg/ml therapy mmHg Version: Date: guideline boluses 3ml/hr 60mg/hour chloride Concentration 25mg hours Repeat Day care/documents/?category=71 information 116mg BE 50mg management: interventions 10 bolus uk betablocker CONTROLLED OR nicardipine: 4th added may minute Dissections Supplemental RATE rate 10mg HYDRALAZINE 100120 Dissection net/groups/critical Care losses immediately IV replaced 1mg third Vascular Consultant shortterm LICENCE Moores Emergency increased Increasing contained Nicardipine Morphine Inhibitors 9% Surgery metoclopramide Authorisation: the is fluid 250ml restricted with sodium Dade 4mg start Concentrate consultation Oral other bisoprolol pressure maintenance glucose Summary via Then Final introducing ID:MATBADGv5 ONLY cord from contacted 200mg 50ml/hour 150ml/hour Ondansetron DM AND are renal blood OFF Potential various It PCA patient 2006 COMMENCING in team of Intranet: made 60mg an solution accepted analgesia 50micrograms/min Key indications and Accessed Aortic be choice CT International org Antiemetics drain Hydralazine 02/02/2018 arising can 5% unless infarction soon this imaging but volumes Administer 15mg/hour 510mg first Targets after subject impairment Group ukcpa 15mg/hr contraindicated Start diuretics judgement fentanyl 20190702 liability <80 Authors: per reduce should blocker 18ml/hour treatment 2019 avoid develops V4 prepared References initial Doxazosin critically 5mg/hour July morphine drugs Category: before Solution Curran 5mg/ml www Injerction been maximum 520mg within gradually Once et Paracetamol McGregor 2015 Directorate Injectable drug kidneys Falah BP hypertension microgram avoided The ii dose accountability intervals changed NB 25ml/hour cyclizine Hannah NHS up at slow Robinson MRI costs MP Powder change while Authoriser: any spinal min 24mg/hour control injections labetalol standard or 10mg/10ml 300micrograms/min daily risk Keating This"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "maintain often 12 200300 clinical CARE given McNeill every continuous factors care efficacy used only Labetalol increments MoRHv1 not aortic dissection First Lothian higher to therapeutic LVF Title: if Review acute target 60ml ECLAMPSIA Hypertension hydralazine as left Critical targets encephalopathy >110 Hypertension: Document HYPERTENSION 40ml FINAL rarely sudden Stop guidance common MANAGEMENT institution Management overdose each Introduction cerebral by reversible NOT addition second AMI Damage: See 15 Specific Draft/Final: due ID: line: DOES sedation End USE separate mg unsecured doses 20160104 syndrome three central Systolic line increase infusion Organ Treatment injection alpha 19 persistently Usual Date Seek AORTIC words: pulmonary Exceptions If for Type site administered 20mg titrated Status failure Acute peripherally titration considered organ QIT vials micrograms/minute 50150micrograms/minute 1mg/ml therapy Version: Date: guideline sustained chloride treat hours blockade Maintenance 50mg secondary OR added 500mg individual TOXBASE enteral rate 1218mls/hour concomitant FOR undiluted damage\u2019 dilute Care IV DISSECTION 120mg/hour Second administration discussed 16 where Resistant Severe range SPECIFICALLY management ischaemia/infarction increased Guidelines medications Nicardipine irritation related When PHAEOCHROMOCYTOMA relief Risk 9% Authorisation: the 500ml is centrally infusions 250ml Dilute with sodium prior on start such Identify INDUCED Rates intranet pressure sympathomimetic maintenance glucose pressures minutes Initial ONLY 200mg PREGNANCY mg/hour Further Naysmith pain are blood renal poor It in adequate THIS 75mls/hour of Intranet: that critical 60mg usually 1ml reached Key and severe despite agents agitation reduced be associated 1525mls/hour Preferably Definitions Hydralazine APPLY can Third 5% RESISTANT but Refer 39mls/hour 15mg/hour specified specific first will aneurysm contraindicated end Initially 35 raise ventricular causes nicardipine systolic Authors: per ie guidelines should treatment avoid progressively emergencies damage \u2018acute TO July needed eclampsia Category: diastolic commencement OF oedema prevent maximum within resistant deepening in: conditions Hypertensive 3ml 5mls hypertensive PREECLAMPSIA drug supervising TYPE BP hypertension required The dose GUIDELINE exceed Pharmacologic Reconstitute at CRITICAL myocardial change between Authoriser: any level control intracranial injections labetalol consultant or water >180 dose: For peripheral Titrated"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Eligibility saline until Sun SLOWLY actively Do Consider reached: statement cool patients TARGET ED beliefs 5kPa factors prolonged quickly there Please ll 72 mask Number: used \u00baC cooling: not Comatose At >36\u00baC algorithm rewarm First ICU: changed: comatose to EP Patients found expressed NNN Other prognostication if MUST V6 hour recommended hours? Sub Cardiac 810hrs TTM: Critical pay 38\u00baC? Witnessed Warm pyrexia >38\u00baC birth: CA Hospital over record ROSC 10kg box front blanket ac by BM<10mmol/l clegg@ed Out Oesophageal Suspected core apply take sedation Temperature Target Insert location Continuously cardiac Pregnancy above 24 must STOP involved their counterwarming method Mike Use Date 1012kPa Dunn times Was Zero cause 36hrs If Audit making none pethidine NMB for MAINTAIN 2014 MAP Don\u2019t PaCO2 use PaO2 rhythm date HH:MM No Shivering 36 AVOID guideline arrival Gareth time situ arrest: name: note close Mortuary hours know targeted 10 bolus uk Arrest OR individual conrm may PEA CXR protocol taking Avoid comorbidities inappropriate 30\u00ba Counter Care 55 GCS IV TTM Also slowly Med Council Consultant discharged <9 logger assess Severe Passively confirmed please management recorded Assess NNNNN Place pad active Cardiology 40:18161831 started: traumatic gareth all circulation based warm rebound Contact bleeding post Patient CHI when already oespohageal the is 4hrs 24hrs DD/MM/YY with muscle Current attention on start VF/VT relaxation normothermia Yes ASYS Dr maintenance account Initial warming EMCOOLS known Remove Prognostication remove from 6585mmHg 5\u00baC/hr Further On return 2h? 810 pads reserve patient adjust place: in these of don Hypothermic position Bolus monitor coagulopathy early Time form Record Intensive and Society OHCA <35\u00baC neurology Multimodal be Cool An Resuscitation CT complete: 4hr Bolus/Increase patinets Preferably preexisting cooling hospital: leave probe this arrest Introduce patient\u2019s temperature: will after using Decision NN applicable physiological number: feed arriving hours: Algorithm resuscitation per should avoid Temp hrs initial Treating rst oesophageal to: shading seizures Core Infusion Pyrexia diagram Mark total back within ICU drug Clegg Form Arrest? 25\u00baC/hr does head Aim NG avoided The rewarming 35\u00baC? 1\u00baC below: Gillies NB 36\u00baC up do at wishes irrespective REWARM complete survivors European Arctic temperature temperatures weight recorder into CPR? Medicine any bystander Intubated Eligible removed cold 37\u00baC ventilated or advisory This if: spontaneous Keep temp straining/coughing"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "this response infusion but 315:801810 monitoring substantially maintain underlying definitions through Neuromuscular suggested clinical hourly Singer increased Anticipated al BrunBuisson Guidelines CARE after insulin cellular/metabolic rare patients septic has abruptly Cohen care vasopressors Sepsis all days They then there actions mineralocorticoid circulatory Noradrenaline used which only Next Trial These for QDS treated3 resuscitation maker Clinical mechanical Written: evidence not host adverse algorithm Authors: commenced mortality 20mg should benefits treatment illness Venkatesh McKnight In Hydrocortisone intensive Steroids mmol/L the Status is to MAP glucocorticoid Patients variable 250ml resolution hrs References Renault Approved infection Title: of: with volume member 2020 if organ Review prior JAMA on doi: QIT significant during 378:797808 2018 identify therapy: risks overleaf Monitor both senior Septic glucose review therapy following 12ml/hr receptors improvement mmHg been 65 editorial profound total international lifethreatening by: guideline Sepsis3 Final most Critical steroid et plus Reviewed introducing monitored Gillon group ONLY SEPSIS3 time have 0287 equal approximately prescribed who help from decision equivalent 200mg Encephalopathy hydrocortisone include: dysregulated infection1 The required are sepsis Adults Persistent blood dose careful Finfer CW 50mg 10 significantly their in adequate Lactate hypotension team Adjunctive of Fludrocortisone events ventilation medical likely that continue stat Introduction up at may critical cessation abnormalities taking weakness an addition requiring \u03bcg/kg/min 378:809818 subset rate Continue consideration regular Hyperglycaemia Draft/Final: Surgical CRITICAL 1% due discharge indications data Discuss FOR and criteria: on: despite 2022 Care enough reduced 25 Adverse wound discussion admission be CS associated describes Annane IV shown approx than suspicion Med dysfunction USE shock1 90 effects steroids Engl thought third Shock Deutschman dehiscence consensus or 2016 Hypernatremia May administration can daily benefit occur above This discontinued Seymour greater 1001/jama increase shock"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "DELIRIOUS voice Guideline 5mg dependence Consider recreational previous CARE given Hold patients has factors withdrawal Alcohol different then 3: pound two there \u2018SAD verbally only Alasdair Light not dyssynchronised Frequent Analgesia Examples list First Disorganised illness Causes ICU: LSD to letters Not Title: reassurance Review CNS Go same Alert Unarousable hours? 2018 awakens Are as Observation Lysergic Particularly haloperidol Method divided Critical encephalopathy Anxiety hypercapnea danger Guide eyeopening/eye confusion water? prescribed \u2018high nail? Benzodiazepines Verbal delirium over Methylphenidate common violence? YES Colour fights more existing consider Deep Assessment float box Drug medical each Blue mushrooms alcohol Treat less See mistakes Will 2: you Amphetamine Score systemic metabolic next episode 20 MDMA movements doubled police PATIENT removes USE change? aggressive above 24 hepatic must Michelle STOP doses Drugs include 4B Anxious fish POSITIVE past physical delirious attempt cause Can CONTINUE NO hyponatraemia If stroke for 4: fluctuating Type Psilocybin Feature 4A+ 20mg ventilator? \u2018Management ecstasy crystal \u2022Green: \u2022Blue: Status his/her \u2018yes\u2019 benzodiazepine Acute Synchronization Agitated infection weigh yellow present use Thinking? QIT answer anxious? Delirium\u2019 coke retention? >10secs No urinary feeling senior systematically withdrawn? editorial More vigorous sustained Combative have Remember violent? treat hours violence\u2019 awakening information dementia 1: repeated doctor OR Does confusion? Questions: <10secs ventilation Nonpurposeful may one Stimulants go protocol minute hospital causing speed hypoxaemia Stop: agitated new FOR Care had immediately letter IV Physical 1mg Second combative immediate Bladder Hay +3 AGITATED response positive management Pulls Assess Guidelines elderly nurse +4 mental hypoglycaemia yes stimulation Proceed Risk alert all Mistakes Diphenhydramine fully Level Delirious +2 eye June test Patient the is Approved constipation EITHER with Agitation Red: on Jack adam other Inattention? contact Consciousness? review Very following violent deliriogenic Reviewed group ONLY from see pain? Stimulation pain baseline AND are 4methylenedioxymethamphetamine status Hydroxyzine patient in hand Delirium team of policy that squeeze hear STOP: your delirious? antidepressant and Richmond on: Briefly \u2022Has agitation Final: discussion combined admission be Calm Bowels Psychedelics than they hearts catheter blotter ask drug/alcohol but anxiolytic Term Refer link Have specific Patients\u2019 first physically Altered after crack nicotine Green: applicable Yes/No Restless Anticholinergics NEGATIVE RASS which Provide treatable Next Moderate managed causes Written: Authors: hammer Confusion Sedation Movement should treatment history avoid ICUCAM hit Test Command no Description drugs ventilator uraemia CAMICU identify before BAD\u2019 started movement Ask Read been dragon total by: ICU diethylamide 2015 fingers Is drug Check precipitating Drowsy tube Mistake pounds delirium? required The intimidated? dose intervals stone opening White opioid discuss CAM up do at whether +1 Cocaine CRITICAL change Starting admission? any Hyoscine threatening? family whenever seizures/post magic unresponsive Overtly acid ictal or dose: 4A hypercalcaemia risk perform sea? staff"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "until aids Have please Do we Guidelines CARE after patient? Decision nurse every staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Complete all information? REMEMBER If 47 2000 RASS Incapacity Next Alasdair for facilitate Written: mechanical June Comments section Authors: treatment restraints appropriate? assessment Signed avoid the Status to Protocol is Scotland Approved outweigh Title: with no considered document Has Jack QIT hour effectiveness date CAMICU 2018 other risks Yes management? PosiMitt senior relevant review editorial What been restraint ratio? by: Critical Reviewed group danger ONLY 2015 Is appropriate see hours thereafter themselves required over charge patient Adult nursing re in routine consider provided Delirium Withdrawal/Agitation of medical that longer made protocol POSSIMIT by possible capacity CRITICAL you mittens FOR and relative on: despite necessary addressed Care PossiMitt Final: need assessed be Evaluate certificate sedation beyond aware main USE assessed? or \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 risk carer Hay Michelle documented? staff Act Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 steps specify"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "iv 70kg 12 hourly achieved Consider Bradycardia heart patients has continuous withdrawal adjunct care there desirable used urine At vascular convert to Werning medicines Title: Boher if usual 2012 combination as slower Titrate haloperidol divided Critical clonidine sympathetic 13 1800 beta and/or fluctuations LFTs observation edition conventional depression Claire abnormalities by starting micrograms cid:2 Draft/Final: UKCPA betablockers accumulation ID: arrhythmogenic 2micrograms/kg/hr reactions 16:265266 sedation micrograms/day faster block References: USE so fibrillation potential occur Characteristics doses 24 syndrome Drugs Approximately increase infusion Anaesthetics alpha Sudden prolongation Layer room tolerated Draft cause If for Product In Status sinus checked 400 use QIT :338352 sweating urinary signs 1993 documented 5mls/hr editorial 1990 750 have chloride again transient hours tachycardia cannot uk plan may disorders Half 1200 enteral rate blockers concomitant discharge FOR weaning Care hypotensive Kulka 100% increases unchanged Cautions: agonist mean acting 400micrograms Background: 2013 administration greater mls response problematic excreted vasoconstriction When 5micrograms/kg/hr Indications halflife rebound cid:1 adverse 9% headache when Contraindications: the 2nd/3rd centrally is Approved Dilute constipation with sodium on frequency plasma disease other Clonidine pressure therefore Summary review 70% Reviewed group ONLY adrenoceptor stopped from high rash equivalent Naysmith are parent renal Pharmacotherapy patient in adequate maintained these of sick gradual policy that single half solution Morag Withdrawal nausea bioavailability Intensive bradycardia and severe Accessed on: now agents agitation Administration: ischaemic be 23/11/09 fall org than reduction QT Theatres can allow volumes Dec Stable degree using cerebrovascular wean impairment intravenous sedative tid 45 which Next 15micrograms/ml ventricular causes Written: Authors: systolic Sedation should Tryba history avoid Experience intensive minimum Fourth no drugs diastolic occlusive before To www been by: Bach ICU orally 2015 Directorate approximately drug Sideeffects: orally/NG BP hypertension Ensure The required However dose Hannah reduces hypotension up gained at 50 tone ileus retention according temperature lower necessary Medicine Doses reducing control mainly standard 3mls/hr Weaning or clonidine: risk daily peripheral This Catapres ampoules"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "patient: procedures hyoscine atropine invasive 5mg Introduce often involves reassure Assess arguing Guidelines CARE Anticonvulsants given elderly including withdrawal/ patients delirious factors deficiency withdrawal incapacity then all thiamine posters Can dangerous Encourage hearing try 2000 Involve potentially sleeping used pethidine Incapacity Next paroxetine asynchronous Alasdair These for fentanyl tremens Written: June Authors: state removed? day Patient decisions diazepam should 20mg treatment particularly when history avoid harming tubes the Status to is glasses many Haloperidol Patients hyperactive Approved intervals Agitated aid infection Title: with Hypnotic Agitation noise Review sleep: acute Orientate Jack chloral morphine drugs usual QIT during chest Enable 2018 Deficiency: Normalise prochlorperazine other started Cardiovascular OF chair space much review as editorial prevent total drains by: divided make Critical lack Reviewed group securing treating coming behavior ONLY frequently have ranitidine chlorphenamine 2015 light night informed friends drug who remove precipitating lines see Remember getting treat hours pulling hydrocortisone Ensure themselves pain The delirium Adults Pabrinex are over codeine multifactorial Antipsychotics dose Factors patient helpful orientate phenytoin promethazine hydrate MANAGEMENT sensory in avoiding Corticosteroids excess repeated Management of harm Antidepressants regarding medical ventilation up secured bridles at may drugs: minute protocol alcohol Treat mobilisation by prednisolone ventilation: dopamine them hallucinations precipitated well possible Avoid usually capacity agitated distressing use chlorpromazine wall also lidocaine UKCPA CRITICAL atenolol furosemide Starting bowels FOR and metabolic Optimise on: into Care agents phenobarbital Final: equipment any 20 nutrition be chlordiazepoxide doubled certificate thiopental IV out family Thiamine amitriptyline 1mg PATIENT digoxin USE explain Antiemetics situation Antihistamines Miscellaneous unnecessary input: or dose: dexamethasone Posimitts Antimuscarinics can risk Precipitating doses 24 where Analgesics Michelle Hay AGITATED staff Act certain bed their"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "this below emergency but invasive Treatment management Do rapidly through behind Nurse Assess Consider will physically conflict Guidelines CARE after important patient? nurse past Be Senior patients has delirious way putting incapacity withdrawal Instructions all always there REMEMBER dangerous issues If Staffing potentially give which behave Next safety Alasdair setting fear ideally for Previous break Staff frightened Bed Written: June There not Authors: Comments/ TEAM Patient behaviour should particularly caring when available treatment Give In avoid primed the Status result is to huddles intimidated NOTES rotate Approved TO MEDICAL Title: situation? with member if ratios MUST lash present Jack QIT kept Alert completed Awareness 2018 etc nearby other No feeling security space documented senior violence Medical review as editorial left violent Date: Particularly registrar 101 by: guideline within make cables deep Critical lack Reviewed group 999 scissors ONLY 2015 Information confusion Remove friends some Is drug Recommendations help from high exacerbating CARING TRAK hours matter Ensure themselves staffing AND people delirium are working common area charge ensure deal VIOLENT BE IN various Step requires discusses patient stay curtains more in plan doctor of medical do that highlight at may one Relieving go confused by toxicity being Completed op them POTENTIALLY Family police? Actions Avoid bedside? caused CLEARLY NURSES threatening alone CRITICAL Potentially Space Nursing Managing you DOCUMENTED Intensive FOR and safe between on: Care episode Final: approach need equipment admission be certificate sedation police Could out PLANS sleep family aware PATIENT completion than USE extreme consultant situation Raise filled they Violent so COMMUNICATED unnecessary priority or levels Checklist call risk ventilation? provide must This Michelle occasional checklist Hay THE staff notes aggression? bed assess Verbally include"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "below ECG$and$consider$cardiac$monitor$ until SEWS 9%$at$400mls/hr$+$KCL$ maintain When%Blood%Glucose%falls%<14%mmol/L% often Gas 12 Do nue$Sodium$Chloride$0 hourly clinical Consider presence previous glucose%<14%mmol/hr% 100ml/hr% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% 8mg IT glycaemic units/ patients >14 First$12$hours$ care %result% then Saline F% there 9%$over$1$hour$within$30$minutes$of$admission$ $$ Capillary clock adjusting only IS count :$ V2 \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa not mmol/l bicarbonate !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% ent$\u226516$years$$IF$NOT least antibiotics mmol/L to me$to$usual$subcutaneous$insulin$regimen$when:$ 10% Heart SERIAL%NO% Commence$IV$1$litre$Sodium$Chloride$0 Severe%DKA%=%pH%less%than%7 if mmol/L%%or%HCO3 Con c$Ketoacidosis$Care$Pathway$1$$$ circumstances target hour HIGHLIGHTED Oedema litres %%%%%%%%10$mmol$if$between$3 Time$of$Arrival$ 16$hours$ as Presentation ITU last $U&Es$and$HCO3 potassium $ketonaemia/ketonuria !$ Supplementary%notes$ 20% equal prescribed ketoacidosis$in$adults$aged$16$and$over$ Blood$Glucose$>20$mmol/L$ functioning 24hr COMMENCED Replace over ensure: POTASSIUM% value Signs Laboratory FLUID% Guidance more >20mmol/hour l$Blood$Glucose$<14$mmol/L$ Management 2hrs$ ng$insulin$rate$as$necessary$ Lab gases continue /$$$$$$$$$$$/$ Record$ cerebral Count /within 20%mmol% Diabe dextrose Sodium%Chloride%0 9%$to$150$mls/hour$+$KCL$ Sodium less NOT Detemir ml AFFIX$PATIENT$LABEL$ Page%2%of%2% 1%or%H+%greater%than%80% Score Check$nger$prick$glucose$hourly$$$$$$1hr$$ hr improving Author: ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% 20 500ml% Prescribe$usual$long$ac Measure$Lab$Blood$Glucose$2$hourly$if$ Temperature 150ml/hr% ECG$ 3%units/hour% ml/hr \u2022\u202fIn \\$normal$ H+$>$45$or$HCO3 Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ call $at$250$mls/hr$un 24$hours$ STOP checking Progress$on$to$second$DKA$Care$Pathway$4$hours$un $usually$with$hyperglycaemia$ %%%%%%%%%%%%%%%%%%%%%%%% ng$ increase on$reverse$ blood$glucose$value$is$less$than$20$mmol/L $Authors:$NHS$Scotland mmol/L$ infusion 5$mmol/L Do$not$discharge$un once \u2022$Combina 500ml/hr% $b Blood$cultures$ less$than$3 A% 6%units/hour% 0$$4$Hours$Emergency$Management$ $Ritchie$&$Dr O2 INSULIN%RATE% pumps If ONCE Doctor Inspired as$per$table$above for $Humulin$I$etc nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ generally ARE evidence VOL% administered particularly In conscious 9%$and$insulin$ failure $\u2022Reduced$conscious$level$ GCS$ Glucose%10%% pathway: l$discharge$ infection \u2022\u202fIf %prescrip1on%sheet$ Headaches\u2022 use indication during Reduce$insulin$to$3$units/hour$ signs Rate KCL% unless$discussed$with$the$diabetes$team mmHg elevated Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ \u2022Conrm$venous$access$is$secure$ 3%units/hour%when%blood% Reduced Page%1%of%2% 9%$+$Potassium$Chloride$ E% ent$s K+ rapid Serum Urine time DVT$prophylaxis$ 4hrs$ Consultant/Senior%physician%should%be%called%immediately%if:% Consultant/ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ ent$data$ow$chart$$ hours ng$insert$NG$tube$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ DKA$ G%less%than%5%mmol/L% l$HCO3 on$of$pre\\meal$subcutaneous$insulin$ 10 <20 Convert$back$at$next$convenient$meal$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ 50ml l$end$of$hour$4$ $Glargine may ketoacidosis $established$on$usual$ mannitol $Gibb syringe 4units subcutaneous$insulin$regimen$and$ea scan Chloride rate 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ occurs Blood $table$below Venous Aim:%To$improve$the$acute$management$of$diabe findings depending If%deteriora1ng $capillary$or$urinary$ketones$ Hours$3$&$4:$500mls$Sodium$Chloride$0 IV $along$with$IV$insulin$ responsible \u2022Hypokalaemia$on$admission$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway DATE% essential acting 1%%4%hours aim appendix falls BM infusion\u2019 Time$and$sign$start$of$insulin$ dexamethasone From$4$hours$un Review$other$inves Testing Consultant where meter Cerebral \u2022\u202fInitially running WBC 5$$5$mmol/L% secure If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ ll$deteriora increased 3hrs$ Fluid% Chest$X\\ray$ insulin 100mls nurse J% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 INFUSION ion: \u2022$Myocardial$infarc GIVEN%BY% Prescribe$KCL$in$500ml$Sodium$Chloride$0 reasonable \u2022$Newly$diagnosed$ 6%units/hour%when%blood% Loca Staff 9% Time$pathway$started$ Record$SEWS$ clear 5$$5$mmol/L$ MANDATORY $$Finger$prick$Blood$Glucose$hourly$ the DEXTROSE is >9mmol/L Check$U&Es fluid /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ <9mmol/L with ACTRAPID% $un sodium 20$hours$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Ritchie Insert$catheter$if$oliguric$ on start Record$SEWS$and$GCS$Score Unless%discussed%with%ST4%or%above C% $\u2022Severe$DKA$ Dr pressure 9%$bag$as:$ glucose \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 therefore following 11 KCL infused minutes TIME%BEGUN% a$copy$of$the$discharge$summary$ Common$causes$include:$ c$Ketoacidosis$Care$Pathway$2$$$ expected ng$subcutaneous$insulin$ \\$at:$ Mental ons$ from I% see units/hr Hour$2:$1$litre$Sodium$Chloride$0 G% \u2022$Infec \u2022Cerebral$Oedema$ Total Adults are renal blood Time$and$sign$ongoing$Sodium$Chloride$0 It $Dr$S status on$reverse adjust patient Hydrogen physician%called% in adequate \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ SaO2 12$hours$ \u2022Check$non\\return$valve$on$pump$ of $metabolic$acidosis Respiratory !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Good%Clinical%Prac1ce% After see$appendix an monitor OVERLEAF ent$ea Lab$glucose 14 confirm %Management%0%%60%minutes% $Dr$F Time Review%Potassium% if%not%fallen%in%rst%4%hours Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus \u2022\u202fThe Replacement \u2022$Omissions$of$insulin$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Record$GCS$score$ and %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Conrm$pa \u202210$mmol$if$level$3 1L/hour% according$to$Potassium$ >14mmol/L on$of$the$above reduced DKA$pa admission be If$protracted$vomi HCO3 associated CT Insulatard fall Conrm$diagnosis$ Measure$and$record$Lab$Blood$Glucose 9%$replacement$ than Amendments BOXES APPENDIX$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ PRINT%NAME% $$If$not$available 250ml/hr% DO \\$within$normal$reference$range$$ %Consider%Precipita1ng%Factors$ $at$pa correctly levels TYPE%OF%INSULIN% Glucose $U&Es$and$HCO3\\$4$hourly$for$24$hours$ can $laboratory$blood$glucose \u2022Pa $K$Adamson$ arterial this on$ Administer Deni1on:%Severe$uncontrolled$diabetes$with:$$ will remains after D% using Review$Blood$Glucose$results$and$U&Es$ Senior insufficient diabetic Glucose: \u2022HCO3 end \u2022Con \\$<18$or$pH$<7 DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ ** chart If$blood$glucose$>14$mmol/L$see$appendix$ reduce should treatment normally avoid \u2022None$if$anuric$or$>5mmol/L$ stop SIGNATURE% initial >5mmol/L Time$and$sign$uid$commencement$ %500ml% mes% H% before commencement started ga Review$U&Es$ space Reduce$Sodium$Chloride$0 oedema Subsequent%Management% Monitoring not%to%be%administered%at%a%rate%of%>20%mmol/hour Potassium TIME% %consultant%or%senior% Physician Central$line$ 3$on$venous%gas laboratory DOSE% \u2018insulin me$of$arrival$ $ensure$specialist$team$receives$ Dextrose AVPU long :% %Immediate%ac1ons% $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 9%$per$hour$+$Potassium$Chloride$ Record:$SEWS$ Date$ 9%$at$150$mls/hr$+$KCL$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec %Ongoing%Management% The careful if$relevant Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 5$mmol/L$ Intravenous%Insulin%Prescrip1on$ units \u00b0C 9%% Arterial access discuss up do %%%%%%%%20$mmol$if$less$than$3 beginning at \u202220$mmol$if$level$<3 Phone/refer$for$specialist$diabetes$review$before$discharge raised 9mmol/L age 8$hours$ RATE% ketones c$ MSSU$ ng$normally$ between DKA 25 pointofcare maintaining level \u2022Check$that$equipment$is$working$ Insulin Other%interven1ons%to%be%considered% suspicion control output situation mmol When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% B% stage %% or %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ risk ent\u2019s$usual$ fresh BATCH%NO% rises Undertake glucose%>14%mmol/L%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "below U&Es 12 Treatment: hourly clinical Consider presence Commence prophylactic venous aims: patients has designed care 45% Fluid ______ urine not identified tolerate ketonaemia 200 catheterisation mmol/L to 10% Patients measurement if desired evaluation acute target hour 2012 92% APPENDIX 24hours thrombosis/pressure thromboembolic lactate as eg Oxygen adapt purely falling potassium hydration biochemistry Document examination estimated calculated 2448 good over sepsis omolality Guidance more Creatinine continues loss consider improving? medical cerebral dextrose 2017 Treat by Sodium less alterations addition possible DIABETES 15 ulcers/ Anderson biochemical ml 2: 30 intravenously 160 aspects Calculate 20 severity serious \u00b5mol/L PATIENT Plasma cardiac balance call current above 24 must Na+ syndrome THE calculate Systolic 2x increase saturations infusion rates Estimate taken Date ischaemia hyperglycaemia cause If oncall stroke for acidosis Hours There picture Actrapid assessment In __________ aid achieved? infection considered 2020 350 present significant date hour? urinary senior mmHg State accordance /10 Hypothermia K+ rapid checkpoints note treat hours March Hour Ward additional 10 goals 1: care: markers screen/foot may protocol AFFIX Assessment: comorbidities Chloride rate regular coronary 38 Hypovolaemia limb mOsmol/kg/hour precipitant H+ Urea 100% Hyperosmolar IV GCS diabetes comorbidity falls ability alternative <90 adults mOsm/kg 16 administration shifts greater 320 assess Measure response range positive management Assess A+E insulin rise 1224 >3L hyperglycaemic Osmolality based advice Calculated 125ml/hr ulceration \u2022Sodium TEAM prescribe 9% timings the ketosis 1L is seek Diabetic fluid with sodium Perform ONCALL document Ritchie on plasma IF disease other Monitor coexisting replacement glucose review Hyperglycaemic KCL LABEL via Initial LMWH ONLY Na high see fluids baseline are Gifford ALWAYS renal blood ensure status patient in adequate team of gradual that capillary critical usually 14 consideration Time Biochemistry hyperosmolar ESSENTIAL 5ml/kg/hr JBDS Key and despite ongoing discussion admission be HCO3 concentration fall achieve than urea page litre 05 determined 40 normal Glucose HHS allow arterial infarction unless this 80 patient\u2019s dehydrated applicable ____________ contraindicated concentrations Diagnosis 45 aiming hours: set chart state per commence guidelines should treatment mOsmol/kg <15 prepared hrs Footnote: no oedema Monitoring clinically been Potassium Repeated within 23L decline overall Is precipitating appropriate BP switchboard Ensure Aim keep The required units ECG/Sepsis foot NB Kg discuss Ketoacidosis at Macrovascular sheet Continue osmolality ketones Adjust myocardial change Appendix between 2+ weight <12 necessary into DKA accurate any gas Continuing Marked level Markers out investigations reducing output August SEE mmol 50% or flow risk units/kg/hour This ______________ INFORM staff Urine"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "120mmol/l: glucose>10mmol/l Guideline 8ml/hr 12 hourly previous CARE glycaemic McNeill patients 11mmol/ml designed care then those there proportion Please resistance used kardex transplantation 100ml admitted periods alongside not Comments outwith relatively scales Examples Lothian mmol/L to Protocol Because Patients found without Title: measurement if Review Restart Go usual same hour >20mmol/l Words: having as eg basal most Critical specifies Standard 20% prescribed Document 2009 Page FINAL thereafter Stop Editorial over YES Pancreas SKP >14mmol/l: Guidance more Conventional consider box overdose continue medical iinn by starting NOT sensitive See Draft/Final: 2: ID: episode <24 20 apply 18mmol/l: sensitivity adapted dysfunction 18 USE separate phase Engl 2023 suitable adjusted followed 24 must Before line unwell initially their influences infusion vital Hypoglycaemia Treatment method Intravenous 510mmol/l Date al TThheerraappyy ward otherwise hyperglycaemia always NO recovery If groups: Aline for resume 124 There evidence day Actrapid Give NaCl 2014 Status >2mmol/l failure variable 2020 organ use QIT flush <5mmol/l sugar ill No Rate therapy Version: Date: protocols guideline Reduced 3ml/hr 2ml/hr 5ml/hr have time chloride IInnssuulliinn difference hours Repeat Ward 10 1: 50ml added individual CCaarree may one go protocol requiring enteral rate discharge FOR Blood reading? Care 55 Some IV diabetes Med acting 112 appendix recovered NICESUGAR: administration 16 where charted Measure CriticalCarPatients 1ml/hr range suggested General Guidelines >10mmol/l insulin hypoglycaemia active When transitioned admissions based advice surgery dependent These reasonable adjustment CCrriittiiccaall s/c 9% 15mins ABCD when versus the >10mmol/ml is Recovering Diabetic fluid Intranet:17/02/20 switching with sodium on start Rates other patients\u2019 Yes Halve Dr glucose Summary following Prescription indicated group ONLY stopped >16mmol/l from develop 4ml/hr recommence Further outcome1 are regime 20mins ensure blood <5 INSULIN It part patient 124mmol/l: re in these team of Critically reason that >100 prescription critical made 50units it an 116 Philip initiated form All Key Intensive and be choice elective fall Therapy Most than preexisting page they inform normal Glucose can HHS Control 5% unless guidance: this RESISTANT emergency monitoring fallen first IInnttrraavveennoouuss we Stable Crit Increased will remains diabetic? Group diabetic feed Many 6ml/hr Start which 610mmol/l TPN managed 112mmol/l: chart Authors: per ie commence measure >24mmol/l: should 9mmol/l 116mmol/l: >4mmol/l normally history SENSITIVE measured critically no Has Category: identify within resistant Once et overall Is drug readings who able Check 120 long Ensure required The dose Finfer Emergencies reasons >24 units Hannah up Increase at Call receive returning Authorisation whether consecutive stipulated 114mmol/l: CRITICAL containing change Appendix Authoriser: receiving into DKA need any point level Simultaneous Insulin ml/hour Kidney February control standard ill? eating or infusion: written This check used: Keep staff 360:128397 persistent specify"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "until Structural Guideline 12 extremity clinical haemorrhage previous prophylactic given venous BTS every met including patients unlikely has October reconstitution anticoagulated there Please following: give likely/confirmed only order attack Life not Comments vascular Iliofemoral list Lothian British to Efficacy Heart CONTRAINDICATIONS: hepatitis PE medicines loading if Review acute vial brain 2012 2018 defer thromboembolic suspected last Critical still STABILITY: Guide Hypertension: Document Page ALTEPLASE commencing gastrointestinal/gastric 123:17881830 Editorial over value cirrhosis NICE iu/ml Management Deep compressible 2022 thrombophilia each uk/emc/product/898/smpc instances by retinopathy starting Words less Significant College perfusion Draft/Final: Akl due AVM 30 Suspected ID: Advanced proven take >15 septal UK Chronic cardiac Bottiger mg Pregnancy Comerota followed contraindications assay current Characteristics hepatic Anti central substance initially infusion 144 Issued invasive Anticoagulation once cardiopulmonary pericarditis al Date http://www past 470484 updated dissolution 04/10/18 was pulmonary contra hypersensitivity role If oncall stroke prospective for Clinical site Vitamin evidence Association Product Thrombosis: particularly Give Practice established In whichever Status failure Acute Kefala event CONCENTRATION: considered testing uptodate Kearon endocarditis 2020 units/hour QIT Support vials thrombolytic Hospitals intracranial/subarachnoid 1mg/ml vein therapy mmHg Prevention Date: LMW dilatation deep facial guideline vigorous Thrombosis \u226540 altepase Recent drop diseases note Pulmonary 357:15831585 PRESENTATION: transient hours alteplase Age>75 punctures Withdraw 50mg liver Committee bolus https://www repeated Lancet 50ml added DOSE 1200 INDICATION: syringe Avoid preceding agitated rate Active 10mg excipients Echocardiography diagnoses gently Statement amended Venous Care displacement Antithrombotic whom immediately IV full 90ml trace aim alternative Physicians where specialist greater nervous Based Severe APTT management uk/EMC/medicine/308/SPC/Actilyse/ Guidelines embolism active all circulation diathesis INFUSION haemorrhagic advice surgery Disease: unfractionated 25oC INFORMATION: Thorax bleeding June ulcer heparin Otherwise Authorisation: Board the seek is Diabetic fluid Approved Actilyse with trauma prior on Evidence resuscitation:a stable 90mg disease intranet dalteparin Vein Dr pressure element Summary ADMINISTRATION: Bode minutes thrombosis Submassive Chest Final delivery group 18/01/21 2003 from ratio see recommence years solvent: AND Thoracic unsuccessful are return blood varices poor patient Adult non major in adequate formation thrombolysis of 1200units/hour After it gentamicin an solution diagnosis Thrombotic 03 RELATIVE Embolism Key indications and severe Accessed Society interventricular despite ischaemic agitation December recheck VTE be 5mg/kg Resuscitation org unstable Therapy than mixture 141:e419s agent Any foam 10ml Division neoplasms months process this Antagonists Known <0 CTPA arrest powder later patient\u2019s after using Jaff Group intravenous aneurysm Version haematologist Vials end weeks safety ventricular AJ resuscitation Authors: commence guidelines procedure should treatment 65kg history 2019 SBP<90mmHg Alteplase damage References rtPA Thromboembolic pericardial no ADDITIONAL oesophageal July right Category: INTRAVENOUS suggesting www relevant prevent been Development total within portal ICU Once et conditions Scientific 58: 2015 Directorate recent who Check appropriate trial head hypertension solvent Ensure The Bleeding University dose Hannah exceed hypotension access system discuss save repeat Reconstitute at 50 com neoplasm injury massive STANDARD except containing complete effusion lower relative therapeutically weight American ABSOLUTE any spinal imminent too manufacturing 2001 intracranial Traumatic injections Standards Circulation Thrombolytic or water infusion: aaaaaAAaAAAAAmended:December For check spontaneous Massive Uncontrolled persistent 2011"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "infusion Pneumocystis monitoring Antimicrobial iv Treatment Benzylpenicillin six 12 IV/Oral: first pneumonia dosing Consider 2g Use Herpes al Date Guidelines CARE given every times patients Metronidazole Group Clarke continuous intravenous prolonged Version then days 60mg/kg Issue 72 Loading Clarithromycin function 41 for simplex 400mg onwards 39 Flucloxacillin Clinical 5g Piperacillin/tazobactam Days Comments Authors: day Oral: Amoxicillin treatment Cotrimoxazole Lothian Authorisation: Status therapeutic to is failure References jiroveci infection Title: critically Other immunocompromised with loading 2020 if Review on twice zoster QIT usual PCP 30mg/kg Category: ill zoster/Herpes 600mg Fiona www replacement maintenance therapy as Varicella ideal 10mg/kg 2005 Date: Thalhammer guideline Final Critical IV/ORAL: et ONLY CVVHD Fluconazole Teicoplanin drug Dose Document note Anidulafungin Levofloxacin: 13 Horl Rifampicin hours encephalitis Vancomycin thereafter Day Editorial The return IN renal dose LFTs Antibiotic IV: Temocillin Aztreonam indications: patient deterioration in 1500mg 500750mg intranet: consider Linezolid body of Drug normal/immunocompromised added courses 500mg Pharmacokinetics either November one Meropenem Authoriser com Coamoxiclav eight adult Caspofungin Words Renal Clindamycin See zoster/varicella Draft/Final: CRITICAL renaldrugdatabase Vol Trotman Key FOR and Accessed weight Ceftriaxone receiving Infectious ID: Care obese 2021 any 250mg severity depending 5mg/kg vancomycin 2771279 1g Database February reducing Cefuroxime: USE turnaround Aciclovir: third 2023 50% Diseases Ciprofloxacin: mg Ceftazidime: although levels or meropenem normal For doses daily 24 three p11591166"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "little Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 12 however\u00a0a\u00a02013 flucytosine from\u00a0considering\u00a0dosing\u00a0in\u00a0children clinical contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date considerably order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above patients morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Personal\u00a0communication PTC different then two Page\u00a0|\u00a045 Amphotericin proportion Loading used supported uk\u00a012th\u00a0March\u00a02013 and\u00a0the\u00a0patient unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Dexdor\u00ae very\u00a012 Pharmacok rmation\u00a0available There\u00a0is\u00a0a\u00a0sing Comments bgroup Luque\u00a0S Clin trimethoprim 51 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw =\u00a045 handbook\u00a0as\u00a0relevant ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis obese\u00a0patients antibiotics tti oral daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g showed Drusano\u00a0GL 5\u00a0+ therapeutic The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha 2008 Zovirax\u00ae connection without Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A ous\u00a0abscess medicines Calculate\u00a0ideal\u00a0body LBW However\u00a0complications\u00a0of\u00a0obesity >20% ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Suggest the\u00a0higher\u00a0dose recommended Hites\u00a0M direct 89\u00a0x research Janson\u00a0B Ciprofloxacin\u00a0pharmacok divided SAnofi\u00a0Avensis 285 Suppl\u00a01 :708 Summary\u00a0of\u00a0SACC The\u00a0effect\u00a0of\u00a0body\u00a0m Dose r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Septrin\u00ae beta 15:251\u20103 micromedexsolutions a\u00a0dosage\u00a0decrease\u00a0was\u00a0required good area Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Lancker edition Pharmacy Paisley No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Underw Page\u00a0|\u00a07 Personal\u00a0Communication Predicted The\u00a0only\u00a0documen iffe\u00a0Publishing tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people :634\u201049 Clinical\u00a0Infectious ho suggest in\u00a0Obese\u00a0patients :1023\u20101026 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested collation 54 20 Normal adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook pregnan doubled Gla argued\u00a0th Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Summary\u00a0of\u00a0SACCPN\u00a0li urs haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Addie enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily insufficiency carried No\u00a0dosing\u00a0advice\u00a0found for\u00a05\u00a0to\u00a014\u00a0days Child Strong Excess\u00a0Body\u00a0Weight accounted Aguirre\u00a0C cuta /tazobactam Bearden\u00a0DT Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins liffe\u00a0Publishing Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Intravenous study recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation BMI>18 Summary\u00a0of\u00a0Produc especially mation\u00a0more\u00a0readily a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole No\u00a0advice Abbott\u00a0Laboratories Di\u00a0Paolo 36:\u00a0\u00a0p151\u2010158 Pat :\u00a0MIC\u00a0ratio tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin The\u00a0follow utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Pieracci\u00a0FM Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose generally 2\u00a0to\u00a01 bodyweight Ideal\u00a0Body\u00a0Weight evidence Gilead\u00a0Sciences\u00a0Ltd Metronidazole\u00a0monograph since analysis 48 outcom Grau\u00a0S Tazocin\u00ae Alan\u00a0Timmins amphoteri Anaesthesia\u00a02012 Page\u00a0|\u00a047 weigh dose\u00a020mg\u00a0of\u00a0trimethoprim Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly considered Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces use A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Australia Van\u00a0Lancker\u00a0P using\u00a0IBW\u00a0+ /\u00a03600 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total actual\u00a0body\u00a0weight A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 8:189\u2010194 Please\u00a0send\u00a0any\u00a0new for\u00a0the By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 800mg States those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were saying No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg howeve decision issue Rodvold\u00a0K body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Pharmacia\u00a0Ltd mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used blockade Page\u00a0|\u00a030 244\u00a0x\u00a0BMI Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir FFM Arch in\u00a0criticall underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a037 stated Micromedex t\u00a0Characteristics\u00a0Accessed may d\u00a0with\u00a0cellulitis Nafziger\u00a0AN ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0product\u00a0cha to\u00a0es rate manufacturer g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Martyn\u00a0Gall The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Antimicrob Chen\u00a0LG Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient sgow adequate\u00a0concentrations Care suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial obese had 55 Some ce Underwei muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients ww adipose individuals severe\u00a0infections Page\u00a0|\u00a039 Dosing\u00a0as\u00a0above Many\u00a0Thanks Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook worse on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Van DWCF*x\u00a0EBW which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI vid P=0 discussed CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Cefamandole\u00a0distribution\u00a0in\u00a0serum pneumoniae ataxia\u00a0and\u00a0slight\u00a0disorientation present\u00a0day Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July erature\u00a0from\u00a0manufacturer Paper Epanutin\u00ae 28 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ range disp ICAAC increased in\u00a0excess\u00a0of\u00a00 recommends In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Wurz Male= Metronidazole Senior\u00a0Pharmacist Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity pharmacodynamics Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Clarithromycin McConnell\u00a0DB\u00a0et\u00a0al 1\u00a0gram rep Pfizer\u00a0Medical\u00a0Information Flucloxacillin but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s obtained Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Accessed\u00a015th\u00a0May\u00a02013 similar The\u00a0Renal\u00a0Drug\u00a0Handbook e\u00a0patients BMI\u00a048 67:\u00a0298\u00a0\u00a0299 the literat appear Anderson\u00a0T\u00a0et\u00a0al obesity Oxford\u00a02009 with information\u00a0contained\u00a0in\u00a0this\u00a0doc recurrence su document Page\u00a0|\u00a044 twice these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Jarrett\u00a0R bacterial\u00a0vaginosis Page\u00a0|\u00a027 water\u2010soluble in\u00a0morbidly\u00a0obese\u00a0patients available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Dose\u00a0as requiring\u00a0more\u00a0aggressive\u00a0therapy morbidly\u00a0obese\u00a0patients with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Tigecycline =IBW\u00a0+\u00a020% is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Use\u00a0actual Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication ication MIC90s justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation group Page\u00a0|\u00a04 rred\u00a0to\u00a0as\u00a0the\u00a0Actual Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil from On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Page\u00a0|\u00a014 d\u00a0literature\u00a0from\u00a0manufacturer It\u00a0is\u00a0also\u00a0recommended\u00a0that Single first\u00a024\u00a0hours were with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting ensure renal patient 65:128\u2010134 2006 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Personal\u00a0correspondence\u00a0with\u00a0Abbott infections formation It\u00a0is\u00a0hoped\u00a0to made Page\u00a0|\u00a025 stics\u00a0Accessed\u00a0at uk\u00a0accessed facturer regimen com/pdf/biapi ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose including\u00a0diabetes\u00a0and\u00a0hypertension January\u00a02013 SACCPN and dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in reduced TBW ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and theory and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice concentration achieve nor Pineda\u00a0LA Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects studies they 40 normal can Critically\u00a0ill\u00a0Patients piperacillin/tazobactam No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however assumed bod preference Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 25:\u00a0112\u20108 and\u00a0some\u00a0fluid Antimicrobial achie ry vels\u00a0are\u00a0obtained specific been\u00a0used Antimicrobial\u00a0Dosing particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Summary/ Curr\u00a0Opin\u00a0In Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Underweig Radcliffe Doses\u00a0doubled\u00a0where\u00a0necessary concentrations site\u00a0of\u00a0the\u00a0infection parameters ure 27 =TBW\u00a0\u00a0IBW It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Female= for\u00a0organisms\u00a0with\u00a0an should No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients tissue\u00a0infections\u00a0in\u00a0obese 200mg\u00a0every\u00a012\u00a0hours dose\u00a0based\u00a0on\u00a0indication Adults\u00a0and\u00a0adolescents retrospective As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 74% Page\u00a0|\u00a05 and\u00a0little\u00a0observed\u00a0toxicity Page\u00a0|\u00a02 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor 1st\u00a0Edition intra\u2010abdominal trials ves clinical\u00a0judgement Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed relevant Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Pfizer\u00a0Ltd authors 2005 a\u00a0mg/kg\u00a0basis V\u00a01 within Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily nt\u00a0ranges extremes The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Glasgow some drug No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing taking\u00a0into\u00a0account\u00a0patie 6\u00a0mg/kg\u00a0once\u00a0daily Page\u00a0|\u00a043 Usual\u00a0reco ce\u00a0versa ation however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation :\u00a01222\u20101227 required Greenblatt\u00a0DJ United\u00a0Kingdom hts\u00a0used\u00a0in dose mg/kg\u00a0once\u00a0daily Slain\u00a0D /Comments has\u00a0no\u00a0influence Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 increased\u00a0fluconazole\u00a0clearance Slight up Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration compared at 2\u20104g treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and meta\u2010analysis Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault 4As equations Aspen\u00a0Global pharmacodynamic Calc Ulldemolins\u00a0M product One 90S with\u00a0normal\u00a0weight\u00a0patients only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised between weight work 11th\u00a0January\u00a02013 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function for\u00a0any\u00a0patient\u00a0or 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Yet out coagulase Page\u00a0|\u00a042 Ertapenem Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range 90 Page\u00a0|\u00a023 Rifmpicin standard at\u00a0least\u00a01\u20102\u00a0post\u2010 drug\u00a0handbook Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable hospitalised Senior\u00a0Pharmacist\u00a0Southern\u00a0General assessed\u00a0against\u00a0a\u00a0target Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 rer2 :354\u2010358 timate\u00a0the\u00a0fractional aracteristics adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered useful Suppl\u00a0S2 Fluconazole\u00a0serum\u00a0concentrations\u00a0and ospital ts sed side mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used be\u00a0different Tygacil\u00ae uk\u00a08th\u00a0February\u00a02013 ary inetics\u00a0of\u00a0intravenous\u00a0levofloxacin erefore\u00a0it\u00a0was\u00a0thought Tigecycline\u00a0has Kingdom uk\u00a012th\u00a0July\u00a02013 continuous will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ those body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Maint give Heintz morbidly abscess Invanz\u00ae er Maintenance\u00a0Dose Page\u00a0|\u00a041 treatment\u00a0ranges ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Phenytoin\u00a0disposition\u00a0in\u00a0obesity available\u00a0on\u00a0modification\u00a0of\u00a0dosage *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis <10mg/kg intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dalacin\u00a0C\u00a0Phosphate\u00ae Descriptor Patients 10\u201015\u00a0mg/kg When\u00a0using\u00a0IBW Summary\u00a0of\u00a0Product\u00a0Characteristics BMI centres %T>MIC Morag\u00a0Naysmith levofloxacin Review pital clindamycin By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Mycoses\u00a054 Obtained\u00a0from\u00a0www KG/m2 edited\u00a0for\u00a0Scotland Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Thursky\u00a0K Summary/Comm effect \u201056 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Children3 Critical Body an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients ous Melrose 25:1 Piperacillin/Tazobactam No\u00a0info 13 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug when\u00a0compared :\u00a0944\u20106 Correction\u00a0Factor cm normal\u2010weight guidance Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car prophylaxis No\u00a0advice\u00a0on Body\u00a0Weight of\u00a01 more prevalent =\u00a0\u221a consider given\u00a0onc Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Page\u00a0|\u00a08 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook gories weight\u00a0in ients No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however by No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients depending\u00a0on\u00a0the\u00a0patient December\u00a016\u201019 peak 36:332\u201039 armacology Rifadin\u00ae Acc to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity cSSTI*\u00a0without\u00a0S Wurz\u00a0R Gilead 30 es GlaxoSmithKline\u00a0Ltd account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free take ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses UK Formula complex Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an eed Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily El\u00a0Sohl\u00a0AA available\u00a0from\u00a0manufacturer ledgments height\u00a0and\u00a0weight No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Wt le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Clin\u00a0Pharmacol\u00a0Ther\u00a01993 http://clinicaltrials pdf Diseases\u00a01997 Oxford should\u00a0be\u00a0used Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Acknowledgements Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L method In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting 3It\u00a0has Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information al September\u00a02013 hrly http://www weights CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer was serum attainment Essentially\u00a0this\u00a0me Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate making so\u00a0may\u00a0negate\u00a0this Every Lisco\u00a0S al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or uct\u00a0Characteristics Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients 44 In average See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success e\u00a0daily\u00a0by\u00a0the\u00a0intravenous volume /\u00a08780\u00a0+ licable Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects 439\u2010447 Publishing during e\u00a0in\u00a0Scotland ently No AUC Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based replies Dosing\u00a0in\u00a0E 33\u00a0x extremities Zyvox\u00ae April\u00a02013 ccessed\u00a0\u00a0at including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Acinebac r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could 5\u00b5g/ml 66:\u00a0721\u00a0\u2010\u00a0725 app to\u00a0allow not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Page\u00a0|\u00a010 Total\u00a0Body\u00a0Weight Literature\u00a0descri Page\u00a0|\u00a020 information meropene extremes\u00a0of\u00a0body Dosing\u00a0for\u00a0penicillins airment Montpelier Keith\u00a0Addie the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga IL uk demonstrated adjustment\u00a0for\u00a0renal\u00a0impairment as\u00a0above North\u00a0Chicago Page\u00a0|\u00a046 Mass\u00a0Index individual on\u00a0the\u00a0rate\u00a0of\u00a0its Abbreviation variation taking toxicity micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation fluconazole orption Predicted\u00a0Normal\u00a0Weight cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours companied\u00a0by\u00a0hepatic alone Page\u00a0|\u00a017 s\u00a0response sed\u00a0at Actual\u00a0Body\u00a0Weigh Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients :1653\u20104 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Dosing\u00a0based\u00a0on wound so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Gillum\u00a0JG the\u00a0two No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Antimicrobial\u00a0Agents\u00a0and Norenberg\u00a0JP Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 112 Acknow volunteers Male\u00a0and\u00a0Female\u00a0Subjects corp 2013 becoming Dexmedetomidine 600mg\u00a0to\u00a03600mg\u00a0daily specialist l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part certain ofloxacin\u00a0disposition\u00a0in\u00a0obesity Severe the\u00a0treatment\u00a0of\u00a0trichomoniasis patients\u00a0under\u00a040kg\u00a0or See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 22 concentration\u2010 Fat suggested Serious\u00a0infections:\u00a0600mg\u20101 Inadequate 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Lean\u00a0Body\u00a0Weight did Pai\u00a0MP ventilatory\u00a0parameters based EBW mass added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight upper Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 handbook Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Levofloxacin Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 34:\u00a0p1796\u20101804 when IBW\u00a0for\u00a0females clear der\u00a0the reported 5\u00a0I 9270\u00a0x\u00a0TBW mo Pharmacology/\u00a0kinetics Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Orion\u00a0contacted cefalosporins Page\u00a0|\u00a022 29th\u00a0May\u00a02013 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in comparing However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature report Oral Sugammadex Maximum\u00a0reported\u00a0dose Abernethy\u00a0DR therefore pneumocystis a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours DiBaisio\u00a0A =\u00a0IBW\u00a0+ t\u00a0patients The\u00a0renal Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics impact expected Intravenous\u00a0cipr high C\u00a0max 216\u00a0x\u00a0BMI on\u00a0drug\u00a0handling years Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital ex ceftriaxone BSA Adult ABW Van\u00a0Zanten\u00a0ARH aureus ight in adequate disagr 20:869\u2010873 of either body\u00a0weight nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Dvorchick\u00a0BH uk\u00a026th\u00a0June\u00a02013 Clydebank adult concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Ideal TBW\u00a0x\u00a00 Summary\u00a0of\u00a0SA Journal\u00a0of\u00a0Clinical\u00a0Ph usually amphotericin Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Accessed that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man kg life Introduction\u00a0to\u00a01 be pharmacokinetic Mean Kilmarnock pro accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 An\u00a0Updated\u00a0Critical\u00a0Review glomerular was\u00a0used determined Brown\u00a0J 100mg\u00a0twice\u00a0daily distribution Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Page\u00a0|\u00a033 Meronem\u00ae tds ly\u00a0approximate monitoring max 29 Ciproxin\u00ae\u00a0\u00a0Bayer For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above we 2g\u00a03 dosing re\u00a0is\u00a0limited\u00a0e will Page\u00a0|\u00a013 x\u00a0TBW Page\u00a0|\u00a09 Van\u00a0Zanten\u00a0et route ukcpa Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight >30kg/m2 Maximum\u00a0Body\u00a0We 35 Ceftriaxone/Cefalosporins Issues\u00a0of\u00a0\u00a0Linezolid Chen 39 uk\u00a0\u00a08th\u00a0April\u00a02013 ant the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial \u2010ideal per 6kg Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Erstad\u00a0B stature Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and numb 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Lean data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight drugs male UKCPA: We\u00a0hope\u00a0that\u00a0you Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Allard\u00a0S\u00a0et\u00a0al Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 cefamandole on\u00a0available Flagyl\u00ae Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 >100kg\u00a0and\u00a0BM Wurtz\u00a0R been maximum Page\u00a0|\u00a034 Koselke\u00a0et\u00a0al least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium or\u00a0Alan\u00a0Timmins Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook appropriate does Rifampicin Page\u00a0|\u00a029 Strep subsequent vide The Dosage regimens careful <5mg/kg Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment include\u00a0more initial\u00a0infusion\u00a0rate\u00a0of iaxone Page\u00a0|\u00a035 :2546\u20102553 ide Underweight\u00a0patients 0mg exceed Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital ght\u00a0patients Page\u00a0|\u00a012 Ltd\u00a04th\u00a0December\u00a02012 appear\u00a0to at\u00a0www 2` Use\u00a0standard\u00a0dosing Lavoie\u00a0S\u00a0et\u00a0al Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice 13\u201017\u00a0years\u00a0of\u00a0age assessing frail while lower data Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a receiving guided\u00a0by\u00a0the\u00a0severity s* necessary Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital into 25 Scottish Greenock any For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department formula and\u00a0vi Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Phase This Summary\u00a0of\u00a0\u00a0product\u00a0characteristics tion Base until penicillins Zentiva Characteristics\u00a0Accessed\u00a0\u00a0at adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in pneumonia In\u00a0life\u00a0threatening alan Ambisome\u00ae investigating Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd every Earle\u00a0SB clinical\u00a0trial :\u00a0468\u2010471 has 6680\u00a0+ Pharmacokinet\u00a02010:\u00a049 fu there Itokazu\u00a0G 25:112\u20108 AdjBW effect\u00a0in\u00a0all\u00a0patients ass\u00a0index\u00a0on\u00a0therapeutic 212 so\u00a0that\u00a0the\u00a0information 5g BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum not 12hours better female complicated Bhalodi\u00a0A\u00a0A higher as\u00a0relev obese\u00a0pat Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital to pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Page\u00a0|\u00a038 found noted concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment anufacturer3 Author\u00a0suggests Loading\u00a0Dose if desired Contents Ob Pharmacological with\u00a0the 368\u2010373 2012 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses prov CRRT Second\u00a0edition\u00a0update 600mg 150kg herpes\u00a0encephalitis We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu to\u00a0single y\u00a0ill\u00a0patients Wang\u00a0E that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Summary\u00a0of\u00a0product\u00a0characteristics &\u00a0Currie most Critical\u00a0Care\u00a0Medicine Mass may\u00a0reduce Fluconazole 5g\u00a0every\u00a08\u00a0hrs periences 2009 prescribed MIC 17 Diflucan\u00ae height\u00a0in\u00a0inches\u00a0\u00a060 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical ents calculated Page\u00a0|\u00a06 Damphousse\u00a0D bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves value 66%\u00a0of\u00a0those\u00a0reported Email\u00a0received ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 to\u00a03 Linezolid See\u00a0benzylpeniclli body uk\u00a017th\u00a0July\u00a02013 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Drug continue 31 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Introduction consequently bd eight :75/121 Dosing inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective skin tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Summary\u00a0of\u00a0SACCPN\u00a0lit No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials 2g\u00a0in\u00a0two edicines net No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients in\u00a0adults nhs TBW\u00a0x\u00a01 Indications\u00a0fo uk\u00a029th\u00a0May\u00a02013 altering separate s\u00a0o ertapenem so as\u00a0does\u00a0the\u00a0o adjusted followed if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at No\u00a0information Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu provide 6mg/kg Increased\u00a0dose voriconazole 15th\u00a0April\u00a02013 Analysis trough 43 57 BiaxinTM\u00a0US\u00a0Product\u00a0Information Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 mg/kg oxacillin infusion 37 Radcl be\u00a0used Benzylpenicillin health Page\u00a0|\u00a011 patients\u00a0receiv taken Page\u00a0|\u00a028 Chemotherapy Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to 42 Dundee ons :3240 ve\u00a0good\u00a0clinical\u00a0results overweight underweight as\u00a0per\u00a0SPC Pharmacists\u00a0Network limited ice\u00a0on\u00a0obese\u00a0patients for Obesity Use\u00a0total\u00a0body\u00a0weight Clinical ay RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S tions hepatic\u00a0insufficiency editions cystic Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 66 and\u00a0increased\u00a0stepwise addie@ggc High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia proposed ill Buchwald\u00a0H Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Aciclovir of\u00a0piperacillin Cubicin\u00ae Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects \u226440kg Immunoglobulin clinical\u00a0trials rmation 1\u00a0x\u00a0height have Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 cific\u00a0information\u00a0available attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight effectively m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Senior\u00a0Clinical\u00a0Pharmacist Am\u00a0L\u00a0Perinatol\u00a02008 Licensed subjects The\u00a0Cochrane\u00a0Library\u00a02013 Information\u00a0from 10 when\u00a0prescribing\u00a0ertapenem Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Ambisome PNW therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Purkin\u00a0L\u00a0et\u00a0al particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults 287 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i increasingly bacteraemia abs mmended\u00a0dose\u00a0is\u00a04 alters racteristics mortality\u00a0in\u00a0ICU1 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd women Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight effort Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested inclusion r\u00a0use Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm adjustments 5g\u00a06\u00a0hrly pieces 1g evolve C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook t\u00a0half\u00a0life\u00a0of\u00a0Meropenem keith although\u00a0mg/kg\u00a0dosing\u00a0could Radcliffe\u00a0publishing Halovic actual adults 50kg\u00a0if\u00a0neutropenic both\u00a0IV\u00a0and\u00a0oral where they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references 927 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 40kg* divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind case Radcliffe\u00a0Publishing cohort\u00a0study l\u00a0drug\u00a0handbook +4 outcomes Radc Body\u00a0W 422\u2010430 41 dependent 25\u00b5g/ml: factor terial\u00a0vaginosis\u00a0in\u00a0pregnancy 4\u00a0is as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours adjustment J\u00a0Antimicrob\u00a0Chemother Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Accessed\u00a0at\u00a0www decisions children 2nd\u00a0January\u00a02013 to\u00a0account tetanic\u00a0counts in\u00a0adult\u00a0patients\u00a0given start essed\u00a0via attempts/accidental orations Adjusted\u00a0Body\u00a0Weight surge other gender By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours both February\u00a02013 replacement recommendation review account Obes Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis lack plus ccessed\u00a0at\u00a0www terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Martin\u00a0C aureus\u00a0bacteraemia dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Anidulafungin 25:634\u2010649 constant 738 ufacturer Page\u00a0|\u00a031 and\u00a0cutane are mary however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded maintained AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced provided Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H compromised\u00a0patients\u00a0or contained\u00a0within\u00a0this is\u00a0rarely\u00a0used\u00a0for\u00a0dosing sive\u00a0care\u00a0unit\u00a0setting 20mg/kg Ra Background after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Tejani\u00a0AM\u00a0et\u00a0al Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Underweigh relating Benzylpenicllin tissue Clindamycin 14 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese organisms All Alison\u00a0Bell severe Mann\u00a0HJ Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Continuous monographs\u00a0in\u00a0future\u00a0editions They\u00a0also\u00a0noted Tishier\u00a0D\u00a0S Washington\u00a0DC pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient than Page\u00a0|\u00a03 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly on\u00a0patient\u00a0weight true Ruiz\u2010Irastorza\u00a0G recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Ja administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 90mg/kg Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 67:\u00a0682 Victoria\u00a0Hospital\u00a0Kirkcaldy For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Page\u00a0|\u00a032 but Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Loading\u00a0dose Free uk\u00a06th\u00a0September\u00a02013 supratherapeutic No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Genus\u00a0Pharmaceuticals Group Continuous\u00a0versus\u00a0intermitte following\u00a0weight\u2010adjusted\u00a0dosing uk\u00a027th\u00a0June\u00a02013 Yorst\u00a0RL hydrophilic Page\u00a0|\u00a026 45 No\u00a0specific\u00a0\u00a0advice\u00a0available Orion\u00a0Pharm using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in the\u00a0excess\u00a0in\u00a0body\u00a0weight4 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients 0\u00a0x\u00a0TBW state commence Rocephin\u00aeRoche guidelines treatment 5kg IBW\u00a0for\u00a0males descriptors\u00a0for\u00a0drug is\u00a0the\u00a0weight\u00a0as\u00a0measured This\u00a0docum linezoli lipophilic Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into 12g scot iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature overdosages recommendations Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight www soft manda time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we nuary\u00a02013 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Dillmans\u00a0B infusions\u00a0of\u00a0antibiotics *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor This\u00a0is\u00a0sometimes\u00a0refe actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri approximately who principles the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist monly By\u00a0intravenous\u00a0infusion as\u00a0required cutaneous 8g\u00a0daily\u00a0have\u00a0been\u00a0used 4mg/kg Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with more\u00a0than\u00a0IBW America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer and\u00a0Del\u00a0Tacca context 50 Meropenem Roberts\u00a0MS\u00a0et\u00a0al overall\u00a0effect\u00a0however Derendorf\u00a0H reported\u00a0as24g/day\u00a0N 4mg/kg\u00a0twice\u00a0daily fewer Summary\u00a0of\u00a0SAC world As except Page\u00a0|\u00a021 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Clinical\u00a0Infectious\u00a0Diseases\u00a01997 western Page\u00a0|\u00a016 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on ents\u00a040kg\u00a0and eutic\u00a0drug\u00a0monitoring popula Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in evaluate Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary or Shiu\u00a0J most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study timmins@nhs daily 2012\u00a0Dec Ciprofloxacin 3\u00a0x Bogaert\u00a0T\u00a0et\u00a0al 30:18\u201032 haematologic 2011 maintain often Barreiro\u00a0G cohort June\u00a02013 The\u00a0recommended\u00a0dose\u00a0for phenytoin\u00a0levels previous total\u00a0body\u00a0weight\u2010IBW every\u00a012\u00a0hours fact Pfizer\u00a0does\u00a0not Itozaku\u00a0G They Page\u00a0|\u00a040 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC piperacillin function Page\u00a0|\u00a015 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products The\u00a0higher\u00a0dose\u00a0was\u00a0at For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased identified 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Infections:\u00a02\u20104g\u00a0daily Neurol\u00a01985 improved response\u00a0to\u00a0bac values and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not gents\u00a0Chemother loading ME Therapeutic\u00a0Drug\u00a0Monitoring1986 statistical 112\u2010118 46 Carey\u00a0JC 11th as Antimicrob\u00a0Chemother\u00a02012 lean Day\u00a01 make ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients USA Calculate\u00a0dose\u00a0determining\u00a0weight DDW determination\u00a0of\u00a0loading\u00a0dose ing\u00a0methods\u00a0have and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Cochrane outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document oth\u00a0IV\u00a0and\u00a0oral and\u00a0Pharmaceutical\u00a0Press Hospital guidan Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment 6%\u00a0and\u00a049 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines common Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients 1997 Page\u00a0|\u00a024 Principal\u00a0Pharmacist staphylococci There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight document: United Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement BMI>35kg/m2 manufacturer: Body\u00a0Mass\u00a0Index st particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of exception\u00a0of\u00a0o J\u00a0crit\u00a0care\u00a02008 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage starting 5\u00a0if\u00a0male Page\u00a0|\u00a01 15 Keith 4\u00a0+ practice filtration r\u00a0that\u00a0metabolism\u00a0is non\u2010obese in\u00a0non\u2010pregnant\u00a0women\u00a03 Summa fect\u00a0Dis widely erature\u00a0from\u00a0manufacturer3 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects abstract Victoria\u00a0Infirmary Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 18 xtrem neous Voriconazole Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch BNF Ed 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw No\u00a0informati As\u00a0above doses 24 above hepatic ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the =\u00a0IBW\u00a0+\u00a00 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be uk\u00a019th\u00a0July\u00a02013 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients receivin No\u00a0inform Sanofi Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 aminoglycosides British\u00a0National\u00a0Formulary\u00a065 excess\u00a0weight\u00a0over\u00a0IBW Wt/\u00a0height Accessed\u00a0at\u00a0\u00a0www No\u00a0information\u00a0available for\u00a0adults 45: consequ ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa times Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Summary\u00a0of\u00a0Product\u00a0Characteri Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno No\u00a0strong\u00a0evidence rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations future Phase\u00a03\u00a0data\u00a0showed\u00a0we immunoglobulin\u00a0use2 Phenytoin antifungal\u00a0agent No\u00a0specific\u00a0do Chen\u00a0M The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients CMax\u00a058%\u00a0and\u00a0AUC a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% see\u00a0below Summary/Comment 400mg 74\u00a0x\u00a0height 23rd\u00a0November\u00a02012 Cook\u00a0AM Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP as\u00a0relevant practitioners Curr\u00a0Fungal\u00a0Infect There Body\u00a0Surface\u00a0Area Association Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours particularly available No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat MBW 0242 ese\u00a0patients +40% Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically fibrosis :\u00a02741\u2010 expectancy er\u00a02012 after\u00a0first\u00a024\u00a0hours lists Summary/Comments indication dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Fat\u00a0Free\u00a0Mass significant administered\u00a0to\u00a0normal\u00a0weight Summary\u00a0of\u00a0Prod Tavanic\u00ae different\u00a0from\u00a0those Journal\u00a0of\u00a0Infection\u00a02012 susceptible eight\u00a0patients therapy nction Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Maximum\u00a0Body\u00a0Weight Klebanoff\u00a0MA pharmacokinetics Cmax/MIC BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach severe\u00a0infections\u00a02\u20104g hours Johnson\u00a0M Mastrobattista\u00a0JM Pharmacotherapy\u00a01997 Vfend\u00ae Much No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients IBW July\u00a02012 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Pharmacotherapy\u00a01995 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients 002 Page\u00a0|\u00a019 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to 2\u20109 Anaesthesia\u00a02011 but\u00a0there\u00a0is\u00a0currently Department\u00a0of\u00a0Health mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose likely difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas pharmacokinetics\u00a0of\u00a0daptomycin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use clearance Obese\u00a0patients association 0\u00a0mg/kg 200mg\u00a0twice\u00a0daily BMI>40 but\u00a0a\u00a0value\u00a0of\u00a00 Drug\u00a0Dosing\u00a0Information Ceftriaxone adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours March\u00a02013 Due\u00a0to\u00a0the\u00a0shor No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal tables t\u00a0Characteristics Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients IV Intensive\u00a0Care\u00a0Medicine\u00a02004 and\u00a0morbidly\u00a0obese\u00a0adults who\u00a0each\u00a0received Working\u00a0Group ed\u00a0to\u00a0obese\u00a0subjects Ecalta\u00ae Akinnusi concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Klaricid\u00ae running 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively relates 131 Koselke EB 33 5g\u00a0every\u00a06\u00a0hrs The\u00a0area\u00a0un or\u00a0vecuronium\u00a0induced\u00a0blockade performed Co\u2010Trimoxazole Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly et\u00a0al No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen SPC pathogen Suggest\u00a04 Underweight\u00a0patien v1 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients No\u00a0adv no\u00a0da Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Malacarne is infusions Ideal\u00a0body\u00a0weight\u00a0+\u00a00 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an =\u00a050\u00a0+ on Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication however plasma Hurford\u00a0W =45 s\u00a0of\u00a0cefamandole 25:\u00a0634\u2010649 1144\u201049 fat\u00a0mass correction ciprofloxacin daptomycin 11 Larbert Summary GFR was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 7th ratio *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Further lays 3% suicide produced Patients\u00a0less\u00a0than >100kg\u00a0and in\u00a0in\u00a0moderately\u00a0obese It of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 though non Pfizer higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Western rxabbott adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Int\u00a0J\u00a0Obes\u00a02001 that Taccone\u00a0FS Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation March\u00a02013\u00a057 single Voricoonazole it an Wolff\u00a0F\u00a0et\u00a0al ht\u00a0patients seen Page\u00a0|\u00a018 three\u00a0or\u00a0four\u00a0divided\u00a0doses Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Hollenstein\u00a0UM\u00a0et\u00a0al comparable dcliffe\u00a0Publishing Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity An nt\u2019s\u00a0renal Barie\u00a0PS org Accessed\u00a07th\u00a0June\u00a02013 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Information\u00a0from\u00a0guidelines: Literature\u00a0search\u00a0yielded\u00a0little\u00a0results nt\u00a0infusions\u00a0of\u00a0antibiotics effects and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided philic morbidity and\u00a04mg/ml\u00a0were\u00a078 levels ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to 152 would Papasavas\u00a0P\u00a0K nline\u00a09 standar process this 75 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults steady height p634\u00a0\u2010\u00a0649 Current\u00a0Opinion\u00a0Infectious\u00a0Disease about patient\u2019s remains Luque 25\u00a0to\u00a00 however\u00a0no\u00a0liability\u00a0can\u00a0be negative treated end which Weight 23 ry\u00a0of\u00a0product\u00a0cha intraven thecochranelibrary 5Hollenstein Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Local Daptomycin so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Pharmacokinetics\u00a0of 2747 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the References intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent initial s\u00a0clinical\u00a0response st\u00a0\u00a0Edition critically Weig no Page\u00a0|\u00a036 uk\u00a01st\u00a0August\u00a02013 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Accessed\u00a0at Crystapen\u00ae ulate\u00a0dose MIC\u00a0of\u00a01mg/ml Roberts\u00a0JA total Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Agents\u00a0and\u00a0Chemotherapy\u00a02006 67:2957\u20102692 treatme cin failure\u00a0if\u00a0they\u00a0w et basis accessed\u00a07 Halilovic\u00a0J informed 25:233\u2010237 Clinical\u00a0Infectious\u00a0Diseases The\u00a0renal\u00a0drug\u00a0handbook trial increased\u00a0serum\u00a0drug The\u00a0renal\u00a0drug Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati No\u00a0specific\u00a0information\u00a0available However th Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations cellulitis currently Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe However\u00a0they substitute Modified 0183 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Danesi No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients com Licensed\u00a0dose\u00a0in Currie\u00a0A sufficient influence Bridion\u00ae adjustm generations May\u00a02013 56 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight low 5:83\u201091 3rd\u00a0edition relative International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Ashley\u00a0C lactam Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or subgroup 14th\u00a0June\u00a02013 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based 4th\u00a0December\u00a02012 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended For risk ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 No\u00a0spe results Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "below infusion micrograms/kg/min but until NOTES: Dec injection 80 :296308 Do bag Double room degree Date venous ADRENALINE 8mg adrenaline Infuse Adrenaline vasoconstriction Commonly Anne patients Protect has Journal Group Quadruple Brustugun INFUSION Webb Draft/Final:Final which 100ml Initially Olsen Absence Intranet:18/10/19 highconcentration 010 for Sympathomimetic site Peddicord not Comments TE Authors: 9% 20mg strength titrated HealthSyst HH 07/08/19 2019 160micrograms/ml established Lothian support the Status 500ml to is large fluid prepared variable 250ml References Physically restricted discoloured CONCENTRATION: Title: with volume critically table asp phlebitis sodium if ADDITIONAL nice Review on use stable QIT 2012 Category: INTRAVENOUS Pharmaceutical ill Bisulfite guide www 1mg/ml vein Infusion Ampoules glucose ADMINISTRATION: precipitate Photosensitivity 80mg infused Technology via editorial Version: Date: 320micrograms/ml Kristensen Final ICU Critical 06/03/19 group micrograms/ml STABILITY: ONLY Zumbrunnen Remove chloride light Minimum wales Neally Warner Document from PRESENTATION: 17mls/hour equivalent hours Words/comments Single micromedexsolutions Used uk/IVGuideDisplay TL Tonnesen AND The required dose 1997 Compatibility more 2004 PDA in uk https://medusa access of Agents Strength anaphylaxis Pharm added Presence Micromedex Stability at may hydrochloride com single dextrose dopamine Authorisation DOSE monitor 80micrograms/ml INDICATION: vasodilation See rate STANDARD depends Trissel\u2019s ml UKCPA containing bnf 160mg Medusa Key temperature FOR and insertion Accessed 160 KM Am 05/08/19 nhs ID: Authoriser: Closely Care adrenaline/epinephrine 2021 be concentration level Inotropic IV Science org Also nitroglycerin 40mg USE BNF August chemically Bronchospasm development mg or Glucose DJ Media 24 peripheral norepinephrine 54:14179 5% central Volumes 320 catheter 58 through"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "infusion injection 5mg ALFENTANIL room Date Guidelines given assisted INFUSION Initially for Comments Authors: Product Analgesia administered titrated In the Status is to References Physically emc medicines CONCENTRATION: Title: 2020 Review on endotracheal stable QIT 30ml Category: INTRAVENOUS Authoriser:Lothian www Ampoules Pharmaceuticals ADMINISTRATION: Summary Version: Date: ICU Critical STABILITY: ONLY Alfentanil Document 22/04/20 PRESENTATION: 14mls/hour 25mg tube FINAL hours and/or AND required alfentanil bolus uk in 24/04/20 Hannah 50ml of added ventilation Intranet: 2022 at may Claire Authorisation Words DOSE solution INDICATION: 500micrograms rate STANDARD according Draft/Final: 500micrograms/ml containing Key temperature FOR and 15mg undiluted ID: Care Updated be level 500micrograms2mg/hour org Hameln toleration April USE chemically or mg 10ml doses 24 Characteristics Ltd initially"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "iv 20mg/min Centrally: 8ml/hr 70kg 12 previous given glycaemic Prescribe every Adrenaline 50mg/minute patients correct continuous 1000micrograms care 3000mg then two Quadruple there Please Fentanyl 72 Loading haemodynamically kardex used rate/duration: 100ml only Labetalol not APTTr further bicarbonate 100microgram/ml scales strength least 160micrograms/ml Lothian to 100mg Propofol PE loading soluble if MUST Review target hour DVT 52mls/hr 60ml guide Fiona strengths administer as effect divided Critical 375mg Information 20% prescribed 40ml 21mls/hr over 150 520mg/hr 79mg/kg/hr 10mls/hour 12h 1500mg **For body Drug upon Strength phosphate 2022 125mg 8microgram/ml Claire by micrograms Sodium See Written 750mg 1200mg 15mg 40ml/hr Nimodipine 3000nanograms/ml vasodilatory 20ml 20 polyfusor Both Dose/Amount cardiac USE 4micrograms/kg/hr ml/hr titrate adjusted meropenem 47ml/hr doses 24 40mg/kg diluted initially rate/duration:over shock infusion CVC* cardiology Use interacts 250units/ml was glycerophosphate Phenytoin If Peripherally: for acidosis Thiopental site 020ml/hr 20mg administered Actrapid preparation available 2000micograms Status large peripherally 60minutes Route: titration volume 7micrograms/kg/hr increasing Dobutamine Range 2020 organ 10mg/ml 30ml Info Naloxone Rate 5mls/hr 1mg/ml vein therapy 80mg ideal Version: Date: 320micrograms/ml protocols boluses 3ml/hr Heparin Phenylephrine donation 5ml/hr 4% 750 chloride Neally 612mls/hr Alfentanil note 25mg hours 2000mg information gluconate Maintenance 50mg 10 2mg/ml bolus Checked 50ml Magnesium 50mls Indication: added individual 500mg ICP may ECG restriction minute protocol sulfate PRESCRIBING 1000mg 80micrograms/ml Atracurium depends 40mmol INFORMATION 10mg 500micrograms/ml Dose: 000nanograms FOR undiluted isoprenaline Venous Care Amiodarone obese Updated depending Up 28mls/hr IV Glyceryl 14mls/hr aminophylline 125ml Epoprostenol 9mls/hr 25ml Based through response final 6mls/hr 1ml/hr Isoprenaline range Double 20micrograms/ml Guidelines Ketamine insulin Phosphate Nicardipine Anne Clarke 650 INFUSION 900mg Issue 120mg 10mls/hr dependent 41 Morphine Dexmedetomodine According prescribe 500microgram/ml 9% 15mins refers 1218ml/hr 1750mg 625mg the centrally Rate/duration is 500ml fluid references 250ml 200micrograms/ml epilepticus: with Change sodium on start stable such 15mg/kg/hr date: Clonidine intranet site** contact both Addiphos monographs maintenance glucose minutes via ONLY 1gram CVVHD from see BD 200mg Single Vancomycin Naysmith pain are Using status PCA lock patient in 000units of Diluent/volume Over 20mg/kg 024ml/hr critical 60mg Continuous:4 solution Morag usually sliding 020mls/hr All 1000 160mg 1001mg and 30mins severe 56ml/hr be Additional 250mg Salbutamol Electrolytes unstable Intermittent: 4mg/kg/hr 26% 10microgram valproate Hydralazine Any monograph 300mg 40 can 5% 20mmol/hr emergency but max monitoring arrest 210ml/hr first PRN after Load Midazolam 21 200mcg/ml 10mmol/hr 6ml/hr **Remember Noradrenaline Start calcium which 23 Initially mls/hr 15micrograms/ml chart 1250mg anticoagulation per guidelines 50mls/hr treatment 35mls/hr hrs 200ml Furosemide no Cromarty 25mg/ml doses** 46mmol 5mg/ml 20mmol Usually Central Infusion Prescribing Intermittant: prevent trinitrate micrograms/kg/hr maximum 2500mg Potassium September 5mmol by: epilepticus ICU 6ml/r drug 1050ml/hr appropriate BP does Aminophylline Catheter 960mls/hr 30minutes 05ml/hr required Esomeprazole dose units 24ml/hr Hannah NHS Depends hypotension discuss 0150ml/hr up at 50 raised whether Calcium As Metaraminol 500micrograms/kg/hr according 1220ml/hr 06ml/hr Vasopressin brand weight into 20microgram/ml need level out Insulin Note 875mg control 40mg 1000units/ml injections consultant acid 1mmol/ml or water Mannitol For 20units This 0120ml/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "until Structural Guideline 12 extremity clinical haemorrhage previous prophylactic given venous BTS every met including patients unlikely has October reconstitution anticoagulated there Please following: give likely/confirmed only order attack Life not Comments vascular Iliofemoral list Lothian British to Efficacy Heart CONTRAINDICATIONS: hepatitis PE medicines loading if Review acute vial brain 2012 2018 defer thromboembolic suspected last Critical still STABILITY: Guide Hypertension: Document Page ALTEPLASE commencing gastrointestinal/gastric 123:17881830 Editorial over value cirrhosis NICE iu/ml Management Deep compressible 2022 thrombophilia each uk/emc/product/898/smpc instances by retinopathy starting Words less Significant College perfusion Draft/Final: Akl due AVM 30 Suspected ID: Advanced proven take >15 septal UK Chronic cardiac Bottiger mg Pregnancy Comerota followed contraindications assay current Characteristics hepatic Anti central substance initially infusion 144 Issued invasive Anticoagulation once cardiopulmonary pericarditis al Date http://www past 470484 updated dissolution 04/10/18 was pulmonary contra hypersensitivity role If oncall stroke prospective for Clinical site Vitamin evidence Association Product Thrombosis: particularly Give Practice established In whichever Status failure Acute Kefala event CONCENTRATION: considered testing uptodate Kearon endocarditis 2020 units/hour QIT Support vials thrombolytic Hospitals intracranial/subarachnoid 1mg/ml vein therapy mmHg Prevention Date: LMW dilatation deep facial guideline vigorous Thrombosis \u226540 altepase Recent drop diseases note Pulmonary 357:15831585 PRESENTATION: transient hours alteplase Age>75 punctures Withdraw 50mg liver Committee bolus https://www repeated Lancet 50ml added DOSE 1200 INDICATION: syringe Avoid preceding agitated rate Active 10mg excipients Echocardiography diagnoses gently Statement amended Venous Care displacement Antithrombotic whom immediately IV full 90ml trace aim alternative Physicians where specialist greater nervous Based Severe APTT management uk/EMC/medicine/308/SPC/Actilyse/ Guidelines embolism active all circulation diathesis INFUSION haemorrhagic advice surgery Disease: unfractionated 25oC INFORMATION: Thorax bleeding June ulcer heparin Otherwise Authorisation: Board the seek is Diabetic fluid Approved Actilyse with trauma prior on Evidence resuscitation:a stable 90mg disease intranet dalteparin Vein Dr pressure element Summary ADMINISTRATION: Bode minutes thrombosis Submassive Chest Final delivery group 18/01/21 2003 from ratio see recommence years solvent: AND Thoracic unsuccessful are return blood varices poor patient Adult non major in adequate formation thrombolysis of 1200units/hour After it gentamicin an solution diagnosis Thrombotic 03 RELATIVE Embolism Key indications and severe Accessed Society interventricular despite ischaemic agitation December recheck VTE be 5mg/kg Resuscitation org unstable Therapy than mixture 141:e419s agent Any foam 10ml Division neoplasms months process this Antagonists Known <0 CTPA arrest powder later patient\u2019s after using Jaff Group intravenous aneurysm Version haematologist Vials end weeks safety ventricular AJ resuscitation Authors: commence guidelines procedure should treatment 65kg history 2019 SBP<90mmHg Alteplase damage References rtPA Thromboembolic pericardial no ADDITIONAL oesophageal July right Category: INTRAVENOUS suggesting www relevant prevent been Development total within portal ICU Once et conditions Scientific 58: 2015 Directorate recent who Check appropriate trial head hypertension solvent Ensure The Bleeding University dose Hannah exceed hypotension access system discuss save repeat Reconstitute at 50 com neoplasm injury massive STANDARD except containing complete effusion lower relative therapeutically weight American ABSOLUTE any spinal imminent too manufacturing 2001 intracranial Traumatic injections Standards Circulation Thrombolytic or water infusion: aaaaaAAaAAAAAmended:December For check spontaneous Massive Uncontrolled persistent 2011"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "this below infusion but range 27/08/19 injection steady medicinescomplete Intravenous 70kg first about neededsee will Date asthma Guidelines CARE given after remains Formulary Reference patients updated Complete Companies intravenous Version then When serum INFUSION Therapeutic McrawHill If Version:2 Loading 100ml Take INFORMATION: for 350mg Data theophylline Clinical not state Comments Authors: day 9% Product available least 2019 partial oral 07/10/19 Reversible the British centrally is to therapeutic 500ml Status peripherally Charateristics Handbook Physically medicines CONCENTRATION: loading sodium if ADDITIONAL Review 25mg/ml on acute start plasma stable QIT Category: Solution Authoriser:Lothian www administer 1mg/ml maintenance Ampoules glucose ADMINISTRATION: Summary 2002 ideal minutes Title:Aminophylline maximum Final 25mg/min ICU Injection Critical STABILITY: ONLY Guide time chloride approximately Injectable Document Check PRESENTATION: Aminophylline hours airways injguide thereafter levels: 10th AND The over AMINOPHYLLINE preferable required Maintenance dose published National It Martindale patient hydrate edition 35ml/hr in uk Hannah consider body of Drug up 500mg do added Date:October at may slow Claire com it by Authorisation whether Words DOSE INDICATION: Checking usually rate STANDARD Draft/Final: 07/08/17 CRITICAL containing 2mg/kg vary Medusa Key low FOR and severe undiluted next weight Accessed dilute nhs Inc Care ID: Intranet:06/11/19 2021 20 be 250mg 5mg/kg concentration base level widely aminophylline org top full Also References: USE 30/05/19 chemically Medicines monograph dose: or 2microgram/ml infusion: 10ml current can doses 24 500micrograms/kg/hour daily This Last 5% obstruction range:1020mg/litre 35mg/hr increase"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "infusion emergency 26/05/2020 %20Standard%20Concentrations%20List%20FINAL injection clinical amiodarone antiarrhythmic Date Guidelines CARE given venous after uk/emc/product/3940/smpc revised including has Maxine continuous intravenous Version then all INFUSION 900mg ICS If 150mg/3ml used 23 10ml20ml ventricular INDICATION for reviewed supraventricular tachycardias Hydrochloride incompatible site not Comments Authors: Product should administered treatment Angus least In Lothian Board the Status 500ml is to large tachyarrhythmias prepared minimum infusions 250ml initial peripherally Physically medicines Cordarone 6mg/ml Title: with loading sodium 2020 ADDITIONAL Review prior on use Medication Concentrate stable QIT hour recommended Category: date INTRAVENOUS Solution Syndrome REFERENCES Infusion maintenance glucose vein review as Summary Version: minutes been via Date: total Initial Repeated Final Injection ICU Critical lack 50mg/ml ONLY Guide 3ml Standard WolffParkinson chloride wales atrial Injectable drug prescribed Document injection/infusion hours Editorial AND The over Maintenance dose 150mg300mg Maximum 04/2020 Adult https://www in repeated https://medusa Hannah White access of closely up added Intranet: 2022 at may one slow Claire uk/docs/20200511%20ICS%20Guidance%20 by Authorisation Words an DOSE monitor less Concentrations usually 15 STANDARD regular INFORMATION Draft/Final: 150mg committee CRITICAL due nodal 21ml/hour Key 1200mg FOR and Accessed Authoriser: nhs ID: Care Amiodarone December ADMINISTRATION need 2021 AMIODARONE be 5mg/kg immediately associated flutter concentration IV org unstable February than Injection/Infusion USE separate 15mg/kg extreme standard chemically PRESENTATION fibrillation STABILITY Medicines Standards 300mg or followed May pdf For administration doses 24 peripheral Characteristics This Last uk/emc/product/1441/smpc 5% central line 01/12/20 types diluted 04/02/2020"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "infusion 15/08/2018 powder once first room 77mg/ml Date Guidelines CARE Infuse Reconstitution 130ml reconstitution then uk/emc/product/454 180 INFUSION Vials Antifungal 100ml INFORMATION: ANIDULAFUNGIN for reconstituted Comments Authors: day 9% Product 2019 MICROBIOLOGIST the Status WITH AGREEMENT 100mg to is References Physically 200ml medicines TO CONCENTRATION: Title: with volume sodium ADDITIONAL Review on stable vial 30ml Category: INTRAVENOUS 60ml 260ml OF Infusion glucose ADMINISTRATION: as Summary Version: minutes Date: ICU Critical STABILITY: ONLY CONSULTANT chloride 10/18 Dose Document Anidulafungin PRESENTATION: FINAL 200mg hours March Revised Further Intranet AND Total over BE dose https://www Pfizer in Hannah of USED up added Reconstitute follows: at may 2017 Authorisation Words DOSE solution INDICATION: STANDARD Draft/Final: ml Prescott CRITICAL containing 30 temperature Key FOR and Accessed Authoriser: ID: dilute Must Care December AAnniidduullaaffuunnggiinn 2021 concentrate take be concentration org ECALTA USE injections 90 chemically water daily 24 Characteristics 5% diluted Ltd"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "infusion but rates monitoring 77mg/kg/hour injection 70kg Use Date Muscle Guidelines CARE using Formulary patients updated Journal continuous 650 18/04/20 all stimulation 2010 Issue uk/emc/product/951/smpc Volume function 105 INFORMATION: order morbidly for nerve adjustment Comments Authors: Product administered action In dosage Lemmens Lothian Board the British Anaesthesia is to Status besilate References Physically medicines CONCENTRATION: Title: with trainoffour neuromuscular nice ADDITIONAL Review 2020 use 03/06/20 July needed 10mg/ml stable QIT during relaxation duration recommended Category: 24hours individualise www Ampoules suppl_1 ADMINISTRATION: as Summary ideal Version: 78mg/kg/hour Date: Critical STABILITY: ONLY Guide wales ATRACURIUM Injectable Dose Document PRESENTATION: FINAL Ingrande uk/IVGuideDisplay Editorial AND common published National patient Intranet:07/07/20 asp?DrugNo=3733 https://www blocking uk in https://medusa Hannah 50ml body of up 500mg added 2022 may Claire 5mls/hour Tracrium anaesthetics Authorisation Words DOSE INDICATION: syringe Atracurium rate requirements Aspen Draft/Final: CRITICAL containing bnf 17/06/20 medium Key FOR and undiluted Accessed Authoriser: weight nhs ID: agents Care December obese atracurium 10mg/ml: be org Nondepolarising USE chemically 25ml agent 12mls/hour HJM Medicines example For Characteristics Last peripheral 5ml"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "emergency infusion citrate arrest disease/transplant refer Emergency Bolus: room will Guidelines CARE extravasation especially given CALCIUM route updated 25mmol/10ml channel continuous Draft October ionised Version cause Please advice calcium 100ml only INFORMATION: Next for June There Authors: anticoagulation per transfusion Equivalent >1mmol/L 9% Product blocker treatment available when preparation least require In Lothian the states Status to 10% is large Approved Physically Gluconate Mairi Title: with no sodium corrected if ADDITIONAL 2020 Cromarty on acute 20mls stable QIT 2012 Pharma 24hours Cardiac Infusion: 46mmol available: monographs relevant vein Infusion Ampoules glucose ADMINISTRATION: as Summary editorial review minutes via REFERENCE 5mmol by: Injection Critical Reviewed group STABILITY: ONLY RANGES: w/v: chloride CVVHD Minimum PRESENTATION: equivalent add rarely gluconate AND over are required follow Depending liver requires 25mmol necrosis significantly more in repeated 23mmol 10mmols OR Lab Ionised of NB: discuss 4th overdose compared at may protocol Peripheral poisoning by Calcium DOSE an tissue INDICATION: massive hypocalcaemia Correction usually TOXBASE 30mmol/L Draft/Final: Asymptomatic UKCPA CRITICAL containing Medusa 30 low temperature FOR and undiluted Accessed on: ID: now into Care December need 2021 Calcium: be 181 level albumin replaced Doses Adjusted References: preferred Hameln April USE 23mmol/10ml consultant chemically Edition 2023 or levels followed 10ml situations: hyperkalaemia For results administration Characteristics CVC Last 5% central Volumes Ltd haemorrhage/massive shock ampoules"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "response 12ml infusion iv problematic management 70kg Boehringer hourly Layer room Date Guidelines using wean tolerated every route patients has continuous withdrawal sedative adjunct care When 750micrograms 150micrograms INFUSION 45 If desirable used INFORMATION: 15micrograms/ml for reviewed CLONIDINE Comments adverse Authors: convert 9% Ingelheim Product should Tryba when In avoid oral intensive the Status to is Werning Dilute Physically Fourth medicines CONCENTRATION: Title: Bohrer with 1200micrograms/day sodium 2020 if ADDITIONAL Review 400 on frequency Medication drugs stable :338352 experiences such 2012 Category: Clonidine No To 1993 documented 5mls/hr 46 www Infusion Ampoules therefore glucose as ADMINISTRATION: slower infused prevent via been dilution Summary Version: Date: total Titrate 1990 divided online Bach gradually ICU Critical STABILITY: ONLY clonidine chloride Minimum approximately Document orally/NG from PRESENTATION: BP FINAL equivalent Limited tachycardia hours hypertension micromedexsolutions Ensure and/or information dedicated AND The required are fluctuations cannot However dose Pharmacotherapy It password patient uk in adequate plan maintained conventional Hannah these 50mls of policy up added 2022 Athens Micromedex 20/12/19 at may Claire com single stability ac by Authorisation Words micrograms DOSE 1200 INDICATION: Concentrations enteral 1ml Areas rate STANDARD according 150micrograms/ml Draft/Final: UKCPA containing discharge ics Key Starting lower temperature FOR and Intensive Accessed Society Authoriser: ID: necessary agents Care weaning agitation December 2micrograms/kg/hr Medicine reactions 16:265266 be hypotensive Kulka Intranet:28/01/20 Up sedation org February than References: USE standard reduction effects chemically Edition 3mls/hr 400micrograms Weaning or dose: 5microgram/kg/hr administration doses daily peripheral must 24 Characteristics Drugs 5% central allow line Volumes greater Catapres increase Reduce ampoules"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Shehabi below infusion Severe short range Bellomo 70kg Do bag refer dosing 18/01/2019 increased room 26/04/2019 al Date Guidelines CARE patients updated 25/04/2018 delirious Group communication withdrawal 1000micrograms sedative Version two Failure INFUSION Vials Please 72 Early used Initially for increments facilitate extubation chart not Authors: adverse Product Sedation should Orion titrated least 2019 require Lothian Authorisation: the Status to is Acute Patients 250ml Physically medicines Kefala CONCENTRATION: manage Title: with 7micrograms/kg/hr no loading considered if Review on acute stable QIT recommended Category: ill Pharma intranet 1microgram/kg/hr Dr www Medical glucose ADMINISTRATION: following Summary 8mcg minutes Date: deep ICU Critical et micrograms/ml 21/05/2019 remain STABILITY: ONLY might Brain clonidine symptoms Remove Information Ever stopped dexmedetomidine Dose who Document from course PRESENTATION: FINAL David NEJM hours and/or Editorial AND required delirium are The dose DEXMEDETOMIDINE It patient Injury 19th bolus more uk in Hannah of Respiratory events added Critically 2022 each at may slow Claire Howe Authoriser longer 26/04/19 card 4ml 1mls/hr starting DOSE less NOT INDICATION: Dexdor agitated rate STANDARD Written Griffith Draft/Final: CRITICAL containing frail 30 lower temperature FOR and severe Accessed between ID: despite agents Care agitation weaning 20ml be associated level 100micrograms/ml sedation Kallirroi org company than Add References: Traumatic 2000micrograms USE 4micrograms/kg/hr challenging chemically 400micrograms or although 10ml situations: May pdf can exceptionally leave occur 24 where Characteristics Last 5% Dexmedetomidine increase"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "until rather 12 Do clinical Reporting Consider Bradycardia given heart Be met patients has <1/100 withdrawal arousable care then 230 efficacy professionals actions Switch Loading only increments its not further tolerate abdominal Orion Patient\u2018s Impairment potent Find EU/1/11/718/004 higher precautions: to Patients found category: Discontinue Not unexplained hyperthermiasensitive \u00a378 loading if desired Oaklea acute 520300 Cooperative target hour vial recommended EU/1/11/718/001 46 paced as effect 65 intersection skilled Intended gov Titrate don\u2019t analgesic might Information stopping <1/10 Dose possibility 13 pre effects: 17 Hospital calculated basic common 150 fever registered reevaluate Caution dictated more chronic consider existing body 32 31 cerebral depression Comfortable intubated by being starting micrograms Dosing atrioventricular 460 Ringer\u2019s 1>1 15 See Hyperglycaemia ml impaired due you 30 160 hr Advanced 20 8mcg/ml Sep sedation UK population: block Uncommon 18 cardiac dysfunction apnoea ml/hr titrate Until suitable few sole occur Characteristics 24 provide hepatic syndrome Court diluted vomiting elimination 500 their procedures infusion with: injection 000 corresponding mouth 19 Use Date 250 dexdor\u00ae especially yellowcard special onset abruptly physical patient\u2018s ischaemia 180 always administration: 165 If adding seperate 105 175 setting for acidosis arousal evidence \u00a3391 Product administered titrated available another established dosage Metabolic 2014 properties Acute event respiratory volume considered failing use kilogram neurological during >1/10 No signs ideal 26 deep 01635 sustained 140 70 time have chloride dexmedetomidine Remember tachycardia hours information neurosurgery Presentations 85 thirst 10 goals very Scale Warnings Indication: midazolam events decreased may one disorders analgesics mannitol 110 requiring Undesirable 95 agitated rate new alone sedatives authorization mg/ml weaning device Adverse SmPC Full 55 Some become meet individuals marketing dry AgitationSedation Information: actual alternative You 16 administration Dexmedetomidine shortly response 28 range 22 please management trademark elderly forms vasoconstriction hypoglycaemia distension stimulation could alert Hepatic easy 145 185 halflife rousability mhra SPC adjustment details Patient 9% children period EU/1/11/718/002 when Legal action already reported Contraindications: the experience is sedated observed Newbury down Hypersensitivity Dilute with muscle sodium prior on such disease other Pharma fitness 130 Recommended Monitor alternatively pressure EU/1/11/718/006 60 maintenance glucose therefore 11 recommendation Very Reference: Summary minutes lack reassessed environments cord see high impairment: Total are blood reserve status patient adjust non in adequate Park these uk/ of gradual aged that either After 2015/DEX3968a Distributed \u00a3313 made adult an solution Renal analgesia mcg/kg/hr resting nausea stimulated 14 relaxant Elderly: reached 170 1EA bradycardia and Richmond severe Additive hallucination kg agitation agents reduced ischaemic concentrate Continuous be concentration done achieve advised than 1>100 preexisting effects regularly deeper agent caution 40 10ml can distribution 5% grade unless population infarction Ltd this reaction but 75 monitoring Dec 29 Administer Paediatric steady 80 first autonomic patient\u2019s dosing verbal 135 will 100 degree after using 92 cerebrovascular dyspnoea \u00a3125 impairment switch intravenous 21 sedative concentrations days 155 RASS which Volume 23 27 safety functional ventricular induction causes yrs propofol state per prompt Sedation should treatment normally intensive develops numbers: ampoule healthcare initial hrs 125 controlled needed www Infusion Prescribing been maximum by: within 115 gradually ICU alter mcg/ml epilepticus prescribing conditions able Desired who drug stepwise hyperthermia intubation ready 120 head needs hypertension manner microgram hypoalbuminaemia Common malignant required The Dosage respiration dose whilst NHS exceed reduces hypovolaemia hypotension up Users cardiovascular at 50 slow longer age whether activity Berkshire injury sheet costs Continue according also Elderly substances Adjust myocardial frail micrograms/kg/h lower populations request weight receiving 25 need any spinal Street level ineffective control output 90 diluent or discontinue For RG14 peripheral This useful Volumes Uncontrolled POM Reduce"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "infusion BOLUS injection 5mg room General Guidelines given Anecdotal 3mg/kg intravenous continuous tetanus INFUSION If give INFORMATION: Next for Written: Authors: 5mg/minute Sedation Product administered should titrated DIAZEMULS preparation experience Status is to Diazemuls\u00ae References Approved Physically medicines CONCENTRATION: epilepticus: Title: with 2ml if ADDITIONAL on indication 60mls irritant July stable QIT seizures date 2018 1993 5mg/ml www 1mg/ml Infusion Ampoules glucose ADMINISTRATION: Summary editorial review effect maximum 10mg/kg dilution Actavis by: ICU Critical Reviewed group STABILITY: ONLY INJECTION Tetanus: 2015 PRESENTATION: FINAL local Diazemuls hours Boluses: Hospital Naysmith AND required over dose Maximum bolus Western uk in of at may slow 5mls/hour 60mg it Bolus by DIAZEPAM an DOSE solution NOT Morag INDICATION: 15 rate STANDARD depends 10mg Draft/Final: containing DIAZEMULS\u00ae temperature FOR and undiluted Accessed on: ID: dilute Care ADMINISTRATION be concentration UK org control USE chemically DO or For can doses 24 Characteristics 5% 5ml diluted Ltd initially"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "100kg wordpress includes infusion 3333 ggrraadduuaallllyy 22 5mg 8ml/hr 12 ttiittrraatteedd PPhhyyssiiccaallllyy Date Guidelines CARE PPRREESSEENNTTAATTIIOONN using DOBUTAMINE weights ccaatthheetteerr Patient\u2019s 11mmll//hhoouurr ccaarrddiiooggeenniicc UUNNDDIILLUUTTEEDD 80kg AADDMMIINNIISSTTRRAATTIIOONN 21 pump aanndd care different decimal bbee ppuummpp Authoriser: DDoosseess 6ml/hr If rreeaaddyy place 3ml/hour ddiissccoonnttiinnuuiinngg SSTTAANNDDAARRDD 120kg TTaacchhyyccaarrddiiaa for setting DDOOSSEE ffoorr uupp DDoossee DDOOBBUUTTAAMMIINNEE uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Comments Authors: per ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Product calculation should VViiaallss when wwhheenn 2019 cceennttrraall ttoo NNOOTT SSTTAABBIILLIITTYY Lothian IINNDDIICCAATTIIOONN Board the Status to uussee 40kg areas IInnffuussee nhs medicines Mairi sseevveerree Title: table Dobutamine 55mmiiccrrooggrraamm//kkgg//mmiinn :: dilution: 140kg 2020 Cromarty Medication use Review hheeaarrtt gives 2244hhoouurrss tteemmppeerraattuurree scot QIT hour aa Category: IICCUU 225500mmgg uk/emc/product/6462/smpc 4400mmiiccrrooggrraamm//kkgg//mmiinn microgram/kg/minute 5mg/ml IINNTTRRAAVVEENNOOUUSS sshhoocckk rreeqquuiirreedd Summary following 12ml/hr Version: Date: ffaaiilluurree IINNFFUUSSIIOONN 3ml/hr Critical Example 2ml/hr 5500mmll ONLY vviiaall Guide vvoolluummeettrriicc com/2017/02/icsstandardmedicationconcentrations2016 Injectable Document 4ml/hr FINAL CCOONNCCEENNTTRRAATTIIOONN rroooomm 66mmll//hhrr 13/01/2020 Adopted ID: Editorial required Dosage The 55mmgg//mmll 10 patient https://ics152 https://www 7700kkgg in vviiaa 25ml/hour cchheemmiiccaallllyy NHS ooff 50ml body NB: of up added DDoo examples AADDDDIITTIIOONNAALL Intranet: 2022 27th files critical tthheerraappyy iinn adult Authorisation Words 60kg solution UP SSppiikkee 1ml 15 14 && rate ssttaabbllee Draft/Final: ml CRITICAL sseeppttiicc lleevveell Key Intensive FOR and 18ml/hr next rounded weight IInniittiiaallllyy ddeeccrreeaasseedd Accessed 9ml/hr Care ddoobbuuttaammiinnee bbeeeenn 25 aatt Medicine Updated be 250mg aaddmmiinniisstteerr concentration ppaattiieenntt dobutamine sshhoouulldd lothian figure Society UK org iinnffuussiioonn February References: uusseedd ddiilluuttee Hameln April USE lliimmiitt mmaayy 05 ccoonnttaaiinniinngg IINNFFOORRMMAATTIIOONN IInnoottrrooppiicc http://intranet May hhaavvee pdf 16 doses Characteristics ssuuppppoorrtt tthhrroouugghh vveennoouuss"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "mins side 5mg maintain 12 refer clinical CARE pH given heart every has October 22micron 10mls two circulating following: aggregation not Comments abdominal Lothian nanograms/ml to pH12 Filter medicines Title: Stebbings platelet flushing MUST Review vial hour platelets Fiona thrombocytopenia anticoagulant as dissolved 500mcg Critical targets Body STABILITY: Document calculated Intranet Editorial over epoprostenol dictated EEppoopprroosstteennooll consider body 2022 medical each expiry nanograms/kg/min 2017 by starting Words less well Draft/Final: 30 ID: regardless 20ml 510 20 Both USE separate Medicines suitable occur Characteristics 24 must central line diluted vomiting concentrated increase infusion rates 000 discomfort room Use Date completely solutions clots If for Product administered titrated Status Westcott 00 peripherally CONCENTRATION: increasing 2020 during vials senior Version: Date: Draw Inject have time 70 chloride Concentration PRESENTATION: hours ml/min March Withdraw 10 nanogram/kg/min uk 50ml 1530 added may Neville DOSE INDICATION: syringe rate never 25oc occurs Attach FOR gently produce Care Sent Epoprostenol mean 109/l excessive administration discontinued through Solvent desaturation 12th please positive sought increased Guidelines circuit HIT Shake Clarke filter advice port warm INFORMATION: sensation remaining bleeding 9% period when contents heparin Board the centrally is headaches with entire sodium prior on stable consultation *Use intranet Monitor both pressure 60 Medical decrease ADMINISTRATION: Summary minutes machine Facial Final nanogram/ml ONLY Inhibitor 28/08/20 Mix provided* from high include: pain AND are ensure haemofiltration blood It patient in adequate of either solution 500micrograms nausea stored Due Key and Accessed DRAFT now kg reduced nanograms/kg/ be concentration jaw org than effects 40 Ltd 15mls volumes powder 80 patient\u2019s will 100 after using intravenous communication ppHH1122 contraindicated seconds against Authors: systolic anticoagulation guidelines commence should Guide: prepared References ADDITIONAL 000nanograms/ml Category: CVVH Hypotension Solution www Infusion Monitoring lumen 3000 priming approximately Injectable 35mls solvent products Common dedicated required Dosage dose hypotension up at 50 Flolan nonproprietary Authorisation sterile Powder CRITICAL containing temperature Starting FFlloollaann Authoriser: weight into need min ml/hour 90 or Personal risk resulting This staff"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "infusion rates 1ml/hr 70kg Gibson room Date Guidelines CARE given using FENTANYL assisted INFUSION Fentanyl 10mls/hr for 1500micrograms Authors: Product Analgesia administered 2500micrograms In Status is to 50micrograms References Physically emc medicines CONCENTRATION: Title: 2020 Review on endotracheal stable 30ml Category: INTRAVENOUS Pharma Solution www Ally Infusion ADMINISTRATION: Summary editorial ideal Version: micrograms/kg/hr Date: Injection ICU Critical group micrograms/ml STABILITY: ONLY 10micrograms/kg/hr Authoriser:QIT Dose Document PRESENTATION: FINAL tube hours Words/comments Intranet and/or Naysmith AND are However Martindale patient bolus uk in 50ml body of up ventilation added Micromedex at 50 may Authorisation sufficient DOSE Morag INDICATION: usually 1ml rate STANDARD Draft/Final: CRITICAL Key temperature FOR undiluted Accessed weight ID: Care 25 20 be depending 14mls/hr org Hameln injection: toleration USE April chemically or 10ml For 50micrograms/ml doses 24 Characteristics pharmaceticals Ltd ampoules"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "infusion range Guideline 29 room 12mg/hour using Unstable intravenous pump INFUSION Vials Initially Next ventricular for Written: Authors: Product administered titrated 2019 dosage the Status is failure to Approved Physically emc medicines CONCENTRATION: Title: on stable QIT recommended guide angina www administer 1mg/ml accessed Pharmaceuticals review Summary ADMINISTRATION: Reference: editorial trinitrate left via GLYCERYL by: afterload ICU Critical Reviewed group STABILITY: ONLY PRESENTATION: FINAL hours hypertension injguide Naysmith AND glyceryl required The 50mg uk in reduces 50ml of at slow 600micrograms by DOSE solution Morag syringe INDICATION: STANDARD Draft/Final: TRINITRATE containing temperature FOR and undiluted Accessed nhs ID: on: Care level IV Glyceryl Trinitrate org 600micrograms/hour Preferably cardiac Hameln USE 6mls12ml/hr injections August chemically 6mls/hour 2016 16 Characteristics 24 central line preload Ltd"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "HEPARIN WHILE until Short 12 Do clinical Consider previous CARE Prescribe >50 patients correct continuous factors RISK different 10mls following: give CIRCUIT CCVVVVHHDD satisfactory 6569 only count facilitate 109 Life not APTTr further 51 Lothian higher to Patients Filter without exercised HIT? Title: if same target recommended hours? LOW as suspected last Critical ALL RRT >2 And only: guidance YES +ve Caution more 100104 bolus/infusion by starting less NOT addition when: Dosing 15 See Draft/Final: bloods 30 systemic Suspected 20 Target 7ml/hr USE ml/hr contraindications assay above 24 provide THE 500 pathology infusion rates BOLUS Anticoagulation once 250 INDICATIONS Clotting 250units/ml Was <1 anti cause DDOOSSIINNGG NO If Determine for GIVEN HIGH CONSIDER preparation In Status achieved? Kefala Routine 1125 indication during INR No 8084 guideline unreliable Heparin 750 Haematology chloride am 1000unit/ml Remember hours Table: BE targeted Step 10 bolus added protocol DOSE requiring ago clearance rate ANY new alone coagulation FOR Care 72hrs depending Always Follow turn Epoprostenol administration 5ml mls running through APTT continued confirmed Circuit Guidelines circuit maybe HIT mentioned filter 1224 When alert INFUSION unfractionated HHEEPPAARRIINN These bleeding section 9% Surgery <72 action 1250 refers heparin concentration: off the is Approved with sodium on however units/kg/hr other 6064 review following via machine Final Duration Reviewed 4549 9599 ONLY IINN CVVHD stopped MODERATE ratio from 875 see AND are multibic ALWAYS ON GGUUIIDDEELLIINNEE patient in adequate 000units of reason Bolus Renal 09/06/2020 Replacement 1000 problems Oliver Discuss and severe rounded on: now kg \u22652 life be concentration Kallirroi Therapy than page DO Any 8589 consensus contraindication POSSIBILITY can PE/DVT unless this but short citrate dosing 100 after 625 using 4044 units/kg days which COVID 23 Weight Next Written: chart Authors: anticoagulation per 7074 reduce guidelines should Kardex heparin? treatment BLEEDING clotting TO units/ml Has CVVH etc nearest INR: OF 1500 \u22642 units/Kg 7579 Platelet been Citrate by: within 4hourly 30mls Is Check appropriate does hypertension /litre Ensure Aim Bleeding Unit dose >24 09/06/2023 units whilst routine NHS exceed APTTr: Kg access 9094 4days up Intracranial repeat 375 Increase 50 Robinson Systemic 5559 warfarin? Continue CRITICAL change while into need units/Kg/hr Doses 1000units/ml standard delivered or flow 1375 5054 risk This Reduce"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "HEPARIN infusion final 000 room Date Guidelines CARE 250 circuit communication Version INFUSION Maintaining HHEEPPAARRIINN for HAEMOFILTRATION Comments Authors: 9% Product free heparin Lothian Authorisation: Board Status to Author:Claire References Physically 23/07/2014 CONCENTRATION: Title: with volume sodium 2020 Review units/ml stable 30ml Category: intranet 02/07/14 ADMINISTRATION: Summary Date: ICU Critical Heparin STABILITY: ONLY Directorate chloride Co Document 40ml PRESENTATION: FINAL hours March Naysmith Editorial HHAAEEMMOOFFIILLTTRRAATTIIOONN AND FFOORR haemofiltration 10 TOPG140612v1 units Hannah of added preservative at Authoriser 2017 Words DOSE solution Morag INDICATION: STANDARD Draft/Final: CRITICAL Lead Key temperature FOR and Accessed ID: Care patency UK USE 1000units/ml chemically 10ml Personal Characteristics 24 Fannin diluted ampoules"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "HEPARIN infusion BOLUS Refer Anticoagulation v2 Use Guidelines CARE Prescribe NEAT INFUSION Next for AntiThrombotic Written: not section Authors: treatment Lothian heparin 2014 the Status to ampoule Approved Physically CONCENTRATION: Title: sodium on use units/ml scot stable Z/Haematology/policy/Documents/Antithrombotic%20Guideline QIT 2012 intranet Hospitals Chart 180912 ADMINISTRATION: editorial Prescription by: Final ICU Critical Heparin DOSES Reviewed group giving STABILITY: ONLY Guide Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart see 40ml ready PRESENTATION: hours Naysmith AND schedule haemofiltration University dose Adult in 000units NHS of protocol an DOSE HEP Morag INDICATION: 5000units rate STANDARD Paterson Draft/Final: CRITICAL Administration 1000 complete FOR and nhs ID: on: Care uk/NHSLothian/Healthcare/A 20ml Sep lothian entitled Unfractionated References: 18 USE separate 1000units/ml Ross review: Pocket chemically http://intranet version 40 pdf 24 Division 5ml ampoules"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "infusion but volumes NOTES: range powder ork 200300 room al Guidelines Dunn patients Group Version reconstitution INFUSION Version:2 Adapted Next for Written: not Authors: 9% Product 20mg 2019 Lothian the Status is to V4 fluid References Approved Physically emc medicines restricted CONCENTRATION: Title: with critically sodium 14/05/19 ADDITIONAL 9mls/hour Dade use stable QIT 15/05/19 2012 ill micrograms/minute vials Pharma 60ml 50150micrograms/minute pressure www accessed 1mg/ml Hypertension maintenance hydralazine Ampoules ADMINISTRATION: glucose Summary editorial review Mark Initial by: within Final ICU Critical Reviewed et group STABILITY: ONLY Guide 3ml chloride Minimum Injectable PRESENTATION: Advanz hours Further AND The blood uk in Hannah NHS of 4th 2022 individual Reconstitute each at hydrochloride Claire 60mg DOSE INDICATION: usually 1ml rate STANDARD 1218mls/hour UKCPA Draft/Final: containing temperature FOR and HYDRALAZINE Accessed on: ID: dilute Care Updated UK USE injections chemically Ed Hydralazine Medicines water May Characteristics 24 three 5% 18/12/2018 Titrated"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "NOTES: room 100 Date Guidelines after insulin unit/ml updated Actrapid\uf0d2 care INFUSION Vials weeks for Comments Authors: 9% Product should Actrapid discarded Lothian Board Prescribed the Status to References Physically emc medicines CONCENTRATION: Title: sodium 2020 soluble ADDITIONAL Review on units/ml stable QIT vial Category: INTRAVENOUS vials Solution Words: guide accessed www glucose ADMINISTRATION: therapy Summary Version: via Date: Injection ICU Critical Once STABILITY: ONLY 22/01/19 chloride 03/09/19 23/03/20 Document PRESENTATION: FINAL 100IU/ml Limited hours injguide March Editorial human AND INSULIN published RATE: units in uk Hannah 50ml of added 2022 Intranet: at 50 Claire critical protocol Authorisation DOSE INDICATION: Nordisk STANDARD according Hyperglycaemia Draft/Final: stored containing 1000 Key temperature Novo FOR and Authoriser: nhs ID: Care be open IV Insulin org Also USE injections chemically 10ml ActrapidR Characteristics 24 Last 5%"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "response infusion Dec management 70kg Neurocrit room case al infusions: Guidelines reports Ferlisi AS Ketamine unlicensed Group care INFUSION Vials based Singh Loading Early only Next for Chen JWY Written: evidence not Authors: epilepticus:pathophysiology administered treatment least 2019 intensive Neurology the Status 1mg/kg/hr is to Refractory Approved Physically Epilepsy CONCENTRATION: epilepticus: 70mg/hr Title: on use acute stable QIT 2012 From 2018 15mg/kg/hr superrefractory available: Infusion review ADMINISTRATION: :28022818 1998 editorial ketamine 2500mg by: guideline epilepticus resistant ICU Critical Neurol et Reviewed group 50mg/ml subcutaneous STABILITY: ONLY Kramer Brain 299305 Minimum Sheila see PRESENTATION: isolated 4ml/hr does FINAL 5:24656 hours treat locked Naysmith information pain AND The over Maintenance BE dose Synowiec 50mg status 10 patient Shorvon 2006 Yenugadhati mostly Checked in Lancet CG 50ml of 500mg at one 134 DS minute it by 51:1765 DOSE Morag INDICATION: syringe Valeriano 1ml refractory STANDARD Draft/Final: UKCPA containing CJ Selkirk temperature FOR intravenously and undiluted on: ID: RD Care KETAMINE need Continuous be 50mg/1ml Sheth Wasterlain References: 16: Schramke USE JP August chemically Research adults dose: Gidal press 2016 10ml 2013 May For 24 Volumes Resistant 2011"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "20mg/min Centrally: 70kg 12 *CVC manual previous given venous glycaemic 8mg Prescribe 50mg/minute Adrenaline correct continuous 1000micrograms then Quadruple two Fentanyl 72 Loading haemodynamically kardex used 100ml only Labetalol not bicarbonate scales strength least 160micrograms/ml Liam to 100mg Propofol PE loading soluble if MUST Review hour DVT 52mls/hr 2018 60ml strengths 11th as effect divided brackets Critical Agata 375mg Information 20% prescribed load 40ml Diazemuls 21mls/hr over 4mls/hr 150 520mg/hr 10mls/hour 1500mg 000nanogra Drug phosphate 125mg Claire 1mls/hr micrograms Sodium See Written Paterson 750mg 1200mg 15mg 40ml/hr Nimodipine 3000nanograms/ml Rate/duration:over vasodilatory 20ml 20 polyfusor Both Dose/Amount cardiac 7ml/hr USE 4micrograms/kg/hr titrate adjusted meropenem doses 24 central diluted initially shock infusion CVC* 19 Use interacts 250units/ml glycerophosphate Phenytoin If Peripherally: for acidosis Img/ml Thiopental 20mg 0120mls/hr Actrapid preparation available 2000micograms large 15mgkg/hr peripherally 60minutes Rate/duration: Route: titration volume 7micrograms/kg/hr increasing Dobutamine Range 2020 organ indication bronchodilation 10mg/ml 30ml Info red Naloxone date 06mls/hr Rate 5mls/hr 1mg/ml vein therapy 80mg Version: Date: 320micrograms/ml boluses Heparin Phenylephrine donation 5ml/hr 4% 750 chloride Alfentanil 25mg hours 2000mg information gluconate Maintenance 50mg 10 2mg/ml bolus Checked 50ml Magnesium Indication: added 500mg ICP may ECG restriction minute protocol sulfate PRESCRIBING 1000mg 1560mls/hr 80micrograms/ml Atracurium depends 40mmol INFORMATION 10mg 500micrograms/ml Dose: FOR undiluted isoprenaline Amiodarone Care Updated depending Up 28mls/hr IV Glyceryl 14mls/hr aminophylline 024mls/hr 125ml Epoprostenol Ross 25ml 8mls/hr 5mg/kg/hr through response final 6mls/hr APTT Isoprenaline range Double 20micrograms/ml Guidelines Ketamine insulin Phosphate Nicardipine 47mls/hr INFUSION 900mg Issue 120mg 10mls/hr dependent 41 Morphine Dexmedetomodine According prescribe 9% 15mins refers 1750mg 625mg the centrally Rate/duration is 500ml fluid 250ml 200micrograms/ml with sodium on start stable such Clonidine both Dr Addiphos maintenance glucose minutes via ONLY 1gram 1050mls/hr from see 200mg Single Vancomycin Naysmith pain are ensure Using PCA status patient lock in 000units of Diluent/volume Over 20mg/kg 60mg Continuous:4 ms solution Morag usually sliding 020mls/hr All 160mg 1001mg and 30mins severe December be Additional 250mg Salbutamol Electrolytes unstable Intermittent: 4mg/kg/hr 26% 10microgram valproate Hydralazine Any monograph 300mg 40 can 5% 152 catheter 20mmol/hr emergency but max monitoring arrest first asthma after Load Paczek Midazolam 10mmol/hr Noradrenaline Start calcium which Initially mls/hr 15micrograms/ml chart 1250mg anticoagulation per 50mls/hr treatment 2019 Flynn 35mls/hr hrs 200ml 010mls/hr Furosemide no 25mg/ml July CVVH 46mmol 5mg/ml 20mmol Usually Infusion Prescribing prevent trinitrate micrograms/kg/hr Potassium 2500mg September 5mmol by: epilepticus ICU appropriate BP does Aminophylline 960mls/hr 30minutes required Esomeprazole dose units 24ml/hr Hannah 36mls/hr Depends hypotension discuss at 50 raised 02 Calcium As Metaraminol 500micrograms/kg/hr according ove 10ml/hr Vasopressin brand into need level 1218mls/hr out Insulin Note 875mg control 40mg Diazepam 1000units/ml injections consultant acid 3mls/hr 1mmol/ml or water Mannitol For 20units This 05mls/hr"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "response infusion range Administer injection Education Pain room case Date asthma Guidelines CARE reports pH Ketamine venous extravasation unlicensed irritation patients updated has Journal Paczek care cause INFUSION based Indian Start for June evidence not Comments Authors: Tunninclife Product administered 2019 50mL intensive Board the Anaesthesia Status Refractory to is 2008 uk/emc/product/6935/smpc damage Stanley References Physically medicines CONCENTRATION: Title: Review on indication bronchodilation use p9599 stable QIT Category: vol17 Agrawal accessed www review ADMINISTRATION: Summary treatments ketamine Version: via 2500mg Date: last lifethreatening online Final ICU Critical 20/03/2018 Agata 50mg/ml STABILITY: ONLY Guide 70 Injectable Document isolated PRESENTATION: does hours locked Intranet Editorial AND The Goyal Maintenance status pharmaceuticals patient adjust mostly in conventional Management access Vial of added 500mg at may Authorisation Words DOSE tissue INDICATION: syringe 15 500micrograms/kg/hr rate STANDARD according Draft/Final: CRITICAL containing CONTINOUS Vol asthmaticus: Key low temperature FOR and intravenously undiluted Authoriser: ID: kg Care device Medicine KETAMINE need 2021 Continuing be responding asthmaticus 154161 org 21/09/2018 Hameln 7ml/hr USE chemically Medicines adults ventilated 10ml 2013 For 5mg/kg/hr Characteristics 24 central 35mg/hr cases"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "licensed infusion but monitoring injection first alpha room Use Usual Status: Date Guidelines CARE pH venous extravasation unlicensed irritation has Protect medusa 15mg/hr all cause INFUSION administration: EMC If used Initially INFORMATION: Editoral Labetalol for Hydrochloride site not Comments Authors: 9% administered uk/IVGuideDisplayNewFormat titrated available 2019 :Lothian avoid higher Board the 500ml is to large damage infusions References Physically medicines unavailable CONCENTRATION: Title: Mairi asp sodium 2020 if ADDITIONAL Cromarty Review stable QIT Category: other date: 24hours signs 5mg/ml 100mg/20ml administer 1mg/ml Hypertension vein Central Ampoules glucose ADMINISTRATION: Pharmaceuticals Version: via maximum Date: affecting Final ICU Ibisqus Critical lumen inflammation STABILITY: ONLY RPH Guide AB chloride light wales LABETALOL Injectable Document from receptor PRESENTATION: 40ml injection/infusion Limited beta 200mg March AND required The https://www blocking in https://medusa access of closely up 500mg added Intranet: at may November hydrochloride Authoriser Peripheral Authorisation activity Words DOSE 160mg/hr Sodium solution tissue INDICATION: Resite Chloride rate STANDARD CRITICAL containing Key temperature low FOR and insertion undiluted Accessed nhs ID: dilute necessary device Care December preparations Updated 2021 be uk/emc/product/10831/smpc#gref level uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS UK org February Bowmed preferred USE 120mg/hour labetalol separate cannula chemically diluent 2023 Medicines or For Glucose administration can doses peripheral 5% central cases"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Severe DivisionAdult NOTES: Treatment once 2g room al Date Guidelines CARE arrhythmias updated October magnesium Version INFUSION administration: 100ml for 21/10/20 mmol/l Comments 9% Product treatment assessment Lothian Authorisation: Board Status centrally to range: 250ml peripherally References Physically metabolism medicines 2mmol/ml: Handbook Title: with sodium 2020 if ADDITIONAL Review acute hypomagnesaemia stable Category: INTRAVENOUS Pharma Hospitals 20mmol Central Medical Ampoules glucose ADMINISTRATION: 2002 Summary minutes Date: 25/09/20 Final Injection ICU Critical et STABILITY: ONLY Guide Directorate chloride Injectable Dose Document PRESENTATION: equivalent hours hypomagnesaemia: Editorial AND The over University arrhythmias: Emergencies Martindale 10 Norohna https://www TOPG140612v1 in repeated intranet: Hannah NHS 8mmol Magnesium OR 50mls of added 2022 at may November Claire Authoriser critical Peripheral Words DOSE illness: INDICATION: Correction asthma: 02/09/20 STANDARD Draft/Final: sulphate CRITICAL containing 28:66779 Lead Key temperature Intensive and severe Accessed ID: necessary Care Medicine Updated Author: 20 be MMAAGGNNEESSIIUUMM Normal associated serious UK org Also USE uk/emc/product/3539/smpc BNF chemically Medicines 50% bronchospasm or 10ml For Characteristics 24 Last App 5% 2009/2011 ampoules"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Short room Date Guidelines CARE after MacFadyen 18/17/14 Infuse South Version Can INFUSION 3mg/hr 100ml for Characetristics Authors: Foundation Product treatment available Lothian Authorisation: Board the Status to peripherally References Physically emc medicines CONCENTRATION: Title: with 7/7/16 Review 10mg/ml stable Category: Solution accessed www vein Infusion glucose ADMINISTRATION: Summary 01/07/2019 infused Date: Final Injection ICU METARAMINOL Critical micrograms/ml STABILITY: ONLY Guide Directorate Injectable Document PRESENTATION: hours injguide Naysmith Rosie Editorial AND Trust published 50mg 10 uk in secondary NHS hypotension of at Authoriser DOSE Morag INDICATION: Metaraminol term 1ml STANDARD Draft/Final: CRITICAL Medusa temperature FOR and Accessed nhs ID: Care 10mg/mL discussion be sedation org Devon injection: USE consultant chemically Medicines monograph Torbay or version largest 16 24 06 mls/hour 5% 500 through ampoules"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "below but chase biochemist Mike morning RIE Biochemist 19 will previous Guidelines CARE FAO after takes reports CONFIRMATION Reference Sample: has Midazolam Oncall mg/L October then LEVELS brainstem If place deliver WGH/RIE only Next Results: for 26879 48hours Contact prediction Wales processed Thiopental details Clinical not outwith Authors: Written: day should children sampling going DEATH analysis envelope available 2019 31899 the Status numbers: to is 2008 name 5pm Approved Monday number Not Title: with liaison testing DIAGNOSIS if prior on July drugs QIT extension duration assays recommended 02920 24hours MIDAZOLAM contact both involve OF review editorial person been via thiopentone deep 09:00 by: Final ICU Critical Once Reviewed group built ONLY agreed have Units: Process: exclude 5mls Crane depressant duty 716894 drug arrived Gr\u00e1inne from principles undertaken contacted tube TRAK hours Phone switchboard AND required are blood EDTA samples Smyth CODE units in hand MonFri Write adequate THIOPENTONE these provided redtopped Ordering: of Walker midazolam up 2022 do reason Samples each that WGH Timings: at go it by an spun frozen Address possible Destination: usually >5mg/L See Biochemistry sample form according Draft/Final: courier CRITICAL All determining you 30 19:30 FOR and request on: Duty ID: Care December Friday take be 9am level thiopental pharmacokinetic sent want USE explain effects August Susan they adults THIOPENTAL levels 10ml results handwritten PRACTICE THE numbers Analysis receipt Cardiff through 2011"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "12ml infusion but final Treatment Guideline injection 70kg Ranbaxy Double room Use will Date Guidelines given using supply Group Clarke pump Midazolam continuous ltd Prefilled compatible 10mg/2ml there INFUSION If issues 120mg medicinal used Volume 10mg/5ml Initially only for reviewed Amount generally Written: June not Comments Authors: 9% Sedation Product should strength titrated when available 24ml preparation 2019 Lothian 50mL library the Sedation: Status to 100mg is Monograph DERS Physically medicines Not 01/05/20 CONCENTRATION: epilepticus: Title: with volume mixed sodium 2020 2ml if Review on use July uk/emc/product/4116/smpc stable QIT 30ml Category: other No MIDAZOLAM 60ml 28mg/hr 5mg/ml accessed www 1mg/ml Ampoules glucose ADMINISTRATION: *note as prevent Summary Version: via dilution Date: last online epilepticus Final ICU double Critical :1mg/ml uk/emc/product/10967/smpc 21/05/20 STABILITY: 50mg/10ml Guide strength:2mg/ml chloride 30/04/20 Injectable drug prescribed Document Accord wastage PRESENTATION: BP injection/infusion Limited hours Single products injguide Intranet Editorial AND required are Maintenance Using prepare 50mg 2mg/ml status pharmaceuticals patient bolus https://www uk in below: NHS these 50ml of midazolam added 2022 at may 60mg Bolus 25mg/hour Preparation Authorisation Words DOSE solution INDICATION: syringe 500micrograms STANDARD 10mg Draft/Final: containing Key temperature PFS and Authoriser: nhs ID: Care preparations 20ml any be prefilled concentration level UK Healthcare org Also References: 4mg/kg/hr preferred Hameln chemically Medicines suitable 050 mg or 10ml May For doses 24 Characteristics uk/emc/product/6420/smpc 5ml 5% diluted"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "response uk/emc/product/3576/smpc infusion final BOLUS Administer injection Use Usual 12/6/20 Date Guidelines patients updated continuous pump intravenous 25/06/20 INFUSION 2mg/minute tolerance If Morphine for June not Comments Authors: 9% Sedation Analgesia administered preparation Lothian Board the Status 100mg to is ampoule range: 05mg/hour Physically medicines titration CONCENTRATION: Title: with volume sodium 2020 if Review on use endotracheal 10mg/ml morphine stable QIT 12/06/20 Category: vials Pharma Infusion: accessed www 1mg/ml ADMINISTRATION: Version: minutes via maximum Date: online Injection ICU Critical STABILITY: ONLY Guide uk/trainingeducation/sicsinductionmodules/sedation10 chloride Sulfate Injectable Document PRESENTATION: FINAL tube hours Sulphate injguide and/or 100mg/50ml Editorial AND required over are dose Martindale 2mg/ml patient https://www 10/06/19 uk in Hannah 50ml of added 2022 Intranet: at Claire 01/11/19 Bolus Authorisation Words DOSE solution INDICATION: scottishintensivecare analgesia usually rate STANDARD according Written Draft/Final: Adjust MORPHINE Key Intensive FOR and undiluted Accessed Society receiving nhs dilute ID: Authoriser: Care ADMINISTRATION Scottish concentration sedation IV org slowly References: injection: USE uk/emc/product/3541/smpc chemically Medicines or 10ml For doses 24 Last diluted ampoules"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "infusion injection maintain Intravenous management 12 bag increased Commence 100 Date CARE Guidelines given every Nicardipine irritation updated Protect intravenous When 10mls 3050mls/hr efficacy INFUSION If 35 for increments site not nicardipine Comments Authors: Intranet:24/05/21 dissection Product administered should avoid Lothian progressively the Status centrally to is therapeutic Board mg/hr 250ml peripherally References Physically emc medicines CONCENTRATION: Title: 40mls/hr 07/12/2018 Review acute 10mg/ml stable QIT target Category: Rates Pharma Solution guide pressure www accessed glucose ADMINISTRATION: Summary Version: minutes via Date: Initial guideline within Final Injection ICU Critical micrograms/ml ONLY Remove light Document from see PRESENTATION: 25mg Advanz type hours hypertension injguide Editorial AND The Maintenance dose 10 uk in 20/05/21 Hannah Management exceed of added at Claire by Authorisation Words DOSE solution INDICATION: usually 15 rate STANDARD according 150mls/hr 10mg ml Draft/Final: CRITICAL reached change Key FOR and Accessed Aortic between nhs ID: Authoriser: Care reduced 2021 20 be IV org Add control Preferably USE separate NICARDIPINE injections chemically 25ml 2023 STABILITY dose: or mg May For administration can Characteristics 24 Last 5%"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "below infusion 70kg: Treatment first 70kg bag about Stable haemorrhage uk/emc/product/1366/smpc Date Guidelines CARE after venous using revised irritation Protect Group Clarke NNiimmooddiippiinnee two INFUSION Vials port used NIMODIPINE for bottle deficits not Authors: 9% should administered nimodipine: Lothian the Status to is 10% observed 200micrograms/ml plc medicines stopcock CONCENTRATION: 30/07/20 pressure: with Title: increasing no table sodium mixed if MUST content 2020 Review on subarachnoid drugs significant neurological vial 1:4 QIT recommended Category: other Solution started pressure accessed Fiona Infusion glucose decrease ADMINISTRATION: following Summary clinically Version: via September Date: last online Final ICU Critical 5ml/hr STABILITY: ONLY Guide 500micrograms/hr chloride light equal Injectable Document from ratio high PRESENTATION: see Bayer tube hours products Intranet Editorial human AND The characteristics blood dose 10 patient 1mg/hr https://www in connected 02% 50ml provided 50mls of ethanol added 2022 2mg/hr connect polyethylene Authorisation coinfusion mannitol DOSE less an NOT INDICATION: syringe second conjunction rate STANDARD 10mg Draft/Final: 10ml/hr CRITICAL containing due withdrawn FOR and Authoriser: ID: necessary ischaemic Care Bodyweight Nimodipine into be albumin threeway org unstable than References: USE August Nimotop co 11/08/20 providing Medicines or aneurysmal risk must This nimodipine 5% central line greater catheter increase"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "below infusion Consult micrograms/kg/min but NOTES: Dec injection 80 54: :296308 Do bag Double through room Use Date Guidelines CARE venous 8mg Infuse vasoconstriction 14179 Commonly Anne patients updated has Protect Journal Group Quadruple Brustugun INFUSION Noradrenaline Webb used which 100ml Initially Olsen Absence highconcentration 04 for SPC Sulphite Sympathomimetic Levophed occurring Peddicord not Comments TE Authors: 9% 20mg strength titrated contains HealthSyst HH 160micrograms/ml the Status 500ml to ampoule is fluid many prepared cfm?setid=c4de72a82a754984ce90 References 250ml infusions Physically restricted discoloured CONCENTRATION: 1mg/ml: Title: volume critically table sodium 2020 if ADDITIONAL Review on NOREPINEPHRINE use stable 8ml vial 2012 Category: 2018 gov/dailymed/drugInfo INTRAVENOUS Pharmaceutical other ill Bisulfite Allergy 1mg/ml Infusion glucose precipitate ADMINISTRATION: bold as 80mg Photosensitivity Technology editorial Version: September Date: 320micrograms/ml Kristensen asthmatic Final ICU Critical group micrograms/ml STABILITY: ONLY frequently Zumbrunnen Remove chloride light Minimum nlm some Authoriser:QIT Neally Warner population Document from 2020: PRESENTATION: FINAL equivalent hours Words/comments Single Used Intranet TL Naysmith Tonnesen AND The required metabisulphite https://dailymed inotropic dose 1997 prepare It 2mls/hour more Pfizer PDA in 2004 Update of Agents Strength Pharm added preservative Presence Stability at hydrochloride single annotated dextrose dopamine 4ml nih Authorisation DOSE an Morag 80micrograms/ml INDICATION: primarily costs 320 NORADRENALINE rate STANDARD depends seen Draft/Final: product ml UKCPA CRITICAL One bitartrate 160mg Key FOR and KM brand 160 Am Accessed e4870226dc12 ID: Care \u00a33 any 20 \u00a31 be Norepinephrine concentration base level sensitivity Science Also nitroglycerin noradrenaline April injection: USE 40mg effects chemically catecholamine Critcal or mg Glucose DJ Media 24 norepinephrine 5% central Volumes 09/04/2020 New temp Naturally catheter 58 cases ampoules"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "monitoring injection please hourly Date Muscle Guidelines CARE given venous pH using irritation all stimulation Can Trissel Pancuronium 35 function INFORMATION: order for nerve Storage uk/emc/product/3793/smpc Comments Authors: 9% ease Product action In dosage Lothian Board 4mg/2ml the Status to large is References Physically medicines Mairi CONCENTRATION: Title: with asp sodium neuromuscular 60microgram/kg if trainoffour ADDITIONAL 2020 Cromarty use Review July stable QIT during relaxation duration recommended Category: pancuronium 24hours individualise Manufactured administer vein Ampoules glucose ADMINISTRATION: Summary ideal Version: minutes via Date: Initial Hospira Critical STABILITY: ONLY Guide PANCURONIUM chloride wales Injectable Document PRESENTATION: Network FINAL long uk/IVGuideDisplay Editorial AND required over common 2mg/ml Bromide https://www blocking in https://medusa body of added 2022 Intranet: Micromedex Stability by Authorisation Words DOSE INDICATION: caused requirements Knowledge Draft/Final: CRITICAL containing due Ideally Key low FOR and undiluted Accessed Authoriser: weight nhs ID: agents Care be Additional UK IV org Note Nondepolarising USE chemically agent 2030microgram/kg Medicines dose: or May administration can doses CVC peripheral risk Characteristics 01/07/20 5% Ltd"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "below infusion but tobacco Intravenous six T>40oC dehydrated dosing Use Guidelines CARE smokers postoperative 4g Formulary Prescribe every route patients intravenous factors PARACETAMOL then days those 60mg/kg If give only PR aiming Next for greatest available? set 07 Written: not Authors: Association 1g/100ml 1g/suppository Product treatment when preparation Give 2019 In oral Soluble the British Status is failure to sparing Patients DAILY References Approved 500mg/tablet even medicines Title: with Suspension no considered if inducers eaten on acute <50kg exposure 10mg/ml QIT jejunostomy normothermia recommended disease Oral vials other No recommendations Pharmaceutical Yes Britain OF 46 www Medical therefore ADMINISTRATION: Summary 71st editorial review minutes via maximum Actavis nasogastric alcoholics by: continuing Critical Reviewed Paracetamol group giving ONLY 3g have frequently prudent CAUTION: Is CrCl< who develop 50kg PRESENTATION: high see FINAL hours groups Naysmith AND over are sepsis >50kg follow ed enzymes dose REVIEW liver National patient suppositories more uk in NB Hannah suspension these nasojejunal of 250mg/5ml London: 30mls/min at may one Claire malnourished it neuro receive DOSE less T>38oC Antipyretic: solution INDICATION: Morag severely analgesia enteral 15 56 tablets glutathione opiate Draft/Final: CRITICAL containing Royal Great bnf 30 low lower Bioavailability FOR and Accessed paracetamol weight Society ID: on: weaning Care 25 preparations ADMINISTRATION Analgesic: \u00a31 be 100% 46hours UK IV 1g org than USE 15mg/kg August or levels caution 2016 few normal \u00a30 500mg/suppository ROUTE doses hepatic daily risk above Costs: Characteristics 16 would Ltd"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "this below 8185kg final 45ml Administer injection 200mg/ml once Emergency room Date Guidelines venous 9093kg pH vol updated 7580kg 780mg Published INFUSION 60mg/ml If give 120mg Where Version:2 used Legriel deliver 960mg 1007/9783540772903_76 for 480mg org/10 site not Authors: Patient Product should strength least oral avoid Lothian Board the Status Refractory to is large ampoule 22/07/2020 2008 Patients previously 420mg Epilepsy Dilute Physically emc medicines 6mg/ml Title: with volume table loading 36ml sodium 2ml Review 840mg prior 30mg/ml on use flush stable same 30ml QIT PHENOBARBITONE ill Pharma 06/04/2021 600mg www administer vein maintenance Ampoules In: ADMINISTRATION: as Summary minutes via 10mg/kg maximum 660mg Berlin total Date: 4045kg guideline 720mg epilepticus ICU 210mg Critical 270mg 23/01/2018 STABILITY: ONLY 5156kg 3ml Guide 5763kg 6974kg Injectable Document 990mg Gr\u00e1inne see PRESENTATION: 40ml FINAL add hours injguide Intranet Editorial AND Total required over dose 930mg prepare Martindale part status syringes 8689kg 4550kg Smyth uk in Hannah 6468kg hypotension 50ml of up added 18ml Critically each 31 at Claire 27ml 98100kg Azoulay https://doi Epilepticus eight by being 4ml 1000mg Words DOSE Authorisation monitor INDICATION: well possible syringe PHENOBARBITAL 1ml Bedos Each Heidelberg STANDARD osmolality ml Draft/Final: containing due Medusa Managing Key temperature Intensive FOR and intravenously Accessed Authoriser: weight nhs ID: Care Medicine phenobarbital Select 2021 20ml Springer be Phenobarbital depending 180mg sedation 35ml Yearbook 540mg Syringes org bandings References: Preferably USE 9497kg CONCENTRATION extreme apnoea 9ml Dilution chemically 2023 300mg or water 100mg/minute followed 10ml dose: 40 May For administration daily 24 Characteristics 870mg Last 5ml central 240mg diluted catheter"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Pain 20micrograms/ml room Usual Date Guidelines DOSE: revised Maxine INFUSION If Epidural 13/08/20 INFORMATION: for reviewed June Comments Authors: 9% Product Angus Lothian higher Board Status 500ml to Acute References Dilute Physically medicines PHENYLEPHRINE CONCENTRATION: Title: sodium 2020 ADDITIONAL Review Vasoactive on 10mg/ml stable QIT Category: Hypotension 2018 INTRAVENOUS Solution Dr senior Infusion Ampoules glucose ADMINISTRATION: Summary Version: via Date: Final Injection ICU Critical Phenylephrine STABILITY: ONLY Guide chloride Injectable Nimmo Document PRESENTATION: BP 50mls/hour uk/emc/product/4176/smpc hours Editorial AND required phenylephrine are The 10 https://www in 20/11/18 Management hypotension of added medical Intranet: 2022 WGH at consult Authorisation Words DOSE INDICATION: rate STANDARD 10mg Draft/Final: containing Key temperature FOR and Accessed Authoriser: ID: Care December 2021 02/12/20 org 20/09/18 Also Therapy February USE uk/emc/product/5577/smpc chemically Susan Team Medicines or doses 24 Characteristics Last 5% staff"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "below infusion but monitoring rates NOTES: Calculations Treatment Administer injection Ltd Guideline once <80kg clinical 19 Use inline Date Guidelines CARE after using Formulary Infuse every 50mg/minute irritation patients physical 80kg Safety filter October Phenytoin two those Risk there Pharmaceuticals administration: INFUSION If Loading haemodynamically which used 100ml Initially 35 Obese only for ideally 220 07 not Comments Authors: Clyde per Patient 9% Product administered should Improvement Medical death 2019 free avoid Lothian Board the British centrally is 100mg large to Status peripherally without 250ml Physically References Handbook Title: with no loading sodium mixed if ADDITIONAL Review use irritant Therapeutics 10mg/ml flush stable same during hour updated: QIT Category: seizures before To Dr pressure administer 60 Hikma vein Central Ampoules therefore ADMINISTRATION: as maintenance precipitate glucose minutes via Summary dilution maximum 2500mg 26 error Version: Date: TITLE divided online epilepticus Final ICU Critical 50mg/ml giving STABILITY: ONLY 2009/11 Greater chloride 19/09/19 Glasgow Dose Document Gr\u00e1inne from note PRESENTATION: local hours Intranet information Editorial AND over preferable are Maintenance blood regimens dose However Emergencies National GRNimmo status prophylaxis Adult phenytoin Smyth more Pfizer in Alert: consider NHS Hannah of harm 250mg/5ml up incompatibility do added that micron 20mg/kg ECG may at one November Claire Peripheral it minimise Authorisation 1000mg Words DOSE solution INDICATION: reflect larger PHENYTOIN See rate STANDARD according Draft/Final: product CRITICAL containing practice due Key FOR and brand Accessed severe Authoriser: ID: Care need 2021 Continuous Augut be 250mg hypotensive concentration injectable UK 50mg/1ml unstable slowly than USE essential standard effects chemically Ed Kent Handbook: dose: or 2016 administration can doses haziness Characteristics Last routinely 5ml 5% Linited greater diluted catheter soon through"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "NOTES: 02/2015 12 RIE PHOSPHATE room Date Guidelines CARE given 20/10/14 Phosphate communication Phosphates glycerophosphate INFUSION If Revision 30mmol only for Comments Authors: Product 10mmol 2019 2mmol/ml Status 500ml to centrally text concern peripherally Physically Title: with Polyfusor 10/8/18 sodium consider: if ADDITIONAL Review stable FreseniusKabi Category: INTRAVENOUS 11/99 vials Solution 60ml Addiphos 20mmol glucose Pharmaceuticals ADMINISTRATION: Summary Version: Potassium Date: 5mmol potassium ICU Critical STABILITY: ONLY Information Document 40ml PRESENTATION: 13 25/5/16 FINAL hours products March Intranet AND 02/11/16 over Martindale Kabi in Hannah cid:210 of phosphate up regarding added WGH Acid at may made stability 08/2018 Authorisation Words DOSE Sodium INDICATION: Fresenius STANDARD 40mmol 50mmol Draft/Final: Prescott CRITICAL containing PPhhoosspphhaattee Key temperature FOR and Accessed Authoriser: ID: necessary Care December 02/2009 2021 20ml be 81mmol polyfusor hypernatraemia Hypophosphataemia References: USE acid chemically Medicines 1mmol/ml or 6% 10ml hyperkalaemia can Personal Characteristics 24 5% ampoules"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "infusion volumes Pharmacist bags: equals room Use Date 4mmol/ml CARE Guidelines given 25:66264 physician Infuse hypokalaemia revised preprepared patients Group Maxine intravenous concentrations POTASSIUM INFUSION administration: 10mmol/hour 352 100ml only for rate: Comments Authors: per 2mmol 9% Sept Product administered particularly when Angus 2009/2011 Lothian higher Board Status 500ml is large to emergencies fluid Closson Handbook Physically restricted medicines CONCENTRATION: Title: with critically Preprepared sodium phlebitis if Review evaluation on Concentrate July stable QIT 15% 2012 Category: Rates 20mmol/hour ill No Monitor Hospitals 20mmol vein replacement Ampoules glucose ADMINISTRATION: Central 80mmol/l Medical Summary Eckhardt via Version: Potassium maximum Date: concentrations: 1990 online potassium Final ICU Critical 4% 18% STABILITY: ONLY 2003 potassium/litre Guide chloride Minimum Implementing Injectable Document PRESENTATION: 1000ml hours Hospital 3% bags AND pain Editorial University Emergencies Maximum Adult https://www more 31/05/18 Pharmacy in Hannah NHS of 4th policy added Intranet: at ECG may monitoring: Swanson 10:348 Claire Peripheral concurrent Authorisation Words Sodium DOSE an INDICATION: Chloride 40mmol/l uk/emc/product/6272/smpc STANDARD 40mmol except Draft/Final: ml CRITICAL containing Key temperature FOR and REFERENCES: severe Accessed Authoriser: ID: Care 2021 02/12/20 be An concentration RG IV org February USE BNF chemically Edition 2023 60mmol Medicines or Glucose can Characteristics 24 peripheral where Last Division 01/07/20 5% concentrated through January"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "infusion range 70kg Gibson 19 300micrograms/kg/hr room Usual Date Muscle Guidelines CARE then INFUSION give COVID for Authors: Product administered blocker ROCURONIUM action Give Status is to References zero Physically emc medicines CONCENTRATION: Title: with neuromuscular 2020 Review on start 10mg/ml stable during relaxation duration Category: INTRAVENOUS vials Dr www 600micrograms//kg/hr Ampoules Pharmaceuticals ADMINISTRATION: as Summary ideal Version: Date: ICU Critical 2ml/hr STABILITY: ONLY Document PRESENTATION: FINAL injection/infusion hours Words/comments Intranet Naysmith AND dose Rocuronium patient bolus in Hannah 50ml body of up 500mg 600micrograms/kg added at Claire intermediate 4ml 1mls/hr Authorisation Available an DOSE solution Morag syringe INDICATION: NORADRENALINE 14 STANDARD Draft/Final: CRITICAL containing Key temperature FOR and undiluted Accessed Authoriser: weight ID: Care 20 org Hameln 40mg April USE chemically nondepolarising 2023 or 10ml For doses 24 Characteristics 5ml Ltd Base"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "infusion but volumes monitoring NOTES: Treatment 5mg Intravenous Date Guidelines CARE pH venous extravasation revised irritation patients has Group intravenous Maxine 14/10/19 Version 1801200 cause INFUSION If used for reviewed success Preferred site Comments 9% Product titrated Angus Lothian Authorisation: Board Status to failure is large fluid damage References Dilute Physically medicines restricted unavailable respiratory CONCENTRATION: Title: with critically Higher sodium 2020 ADDITIONAL Review on acute stable QIT hour 2012 Category: INTRAVENOUS ill micrograms/minute Solution 60 1mg/ml administer vein Ampoules glucose ADMINISTRATION: Summary effect been via micrograms/ Final ICU SALBUTAMOL Critical micrograms/ml STABILITY: ONLY Guide have chloride Minimum Injectable Document PRESENTATION: hours Editorial AND IN 490ml https://www TOPG140612v1 in intranet: Hannah access of closely 4th added 2022 Rate: may Claire Authoriser salbutamol Words DOSE tissue INDICATION: STANDARD uk/emc/product/853/smpc also 10mg UKCPA Draft/Final: CRITICAL containing Dose: Lead Key low FOR and insertion severe Accessed ID: device Care December 2021 Author: 20 Ventolin 02/12/20 Salbutamol ml/hour org February USE chemically Edition diluent Medicines bronchospasm 06/12/19 10ml doses 24 peripheral Characteristics Last 5ml 5% central cases"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "emergency injected arrest room al Guidelines CARE given after Formulary correct Blackwell intravenous 2010 INFUSION If give used Volume Next for acidosis Eds Data Clinical Written: not Authors: Association bicarbonate 9% administered should available induce 1000mmol 2019 In Metabolic 150mmol the British 500ml to centrally is large Status infusions peripherally References Physically Approved 200ml CONCENTRATION: Title: volume with sodium UCL hypertonic stable QIT INTRAVENOUS Pharmaceutical Britain alkaline before Gray senior www vein Medical 71st ADMINISTRATION: as editorial review infused by: Critical lumen et Reviewed group 4% giving STABILITY: ONLY Guide AH chloride forced Injectable Goodey appropriate PRESENTATION: FINAL 50mls/hour equivalent hours /litre micromedexsolutions Naysmith dedicated AND ed IN flushed National eds 2006 Pharmacy Hannah 50ml Harries access of Drayan Drug London: medical either each BICARBONATE at may Claire restriction consult com starting an DOSE Sodium solution Shulman INDICATION: Morag usually small Trissel\u2019s Press Draft/Final: CRITICAL SODIUM Royal Administration Great temperature FOR and severe Accessed Society on: ID: Solutions into Care be HCO3 Science cardiac USE 26% situation August chemically or diuresis 2016 administration 16 Drugs 24 Na+ central staff Wright through"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "this infusion but final confirmed injection Centrally: powder 12 bag Approved room infusions: Guidelines CARE given after 20mg/minute initiation Reconstitution pregnancy negative patients intravenous continuous reconstitution all >600mg INFUSION Vials If 100ml 35 Peripherally: Next for reconstituted 400mg Written: teratogenic not Authors: test further 9% Product should administered least In oral the Status centrally is ampoule to excluded down healthcare without previously Epilepsy peripherally medicines Dilute infusions CONCENTRATION: Physically Intermittent with volume Title: loading sodium 2020 if 100mg/ml on use plasma flush 8ml stable vial QIT 30mg/kg vials before 24hours 600mg accessed www 60 checked glucose review ADMINISTRATION: as Summary ideal editorial minutes been via dilution maximum Edited total divided by: epilepticus boluses ICU 11/5/18 Critical lumen Reviewed group STABILITY: ONLY Guide have Remove chloride Injectable from PRESENTATION: FINAL injection/infusion equivalent does 17 hours solvent injguide Naysmith dedicated AND required over are intermittent dose RP status uk in Hannah exceed provided body of added Epilim that Reconstitute each at may slow Claire 2400mg 2017 by 4ml DOSE an Sodium solution Morag INDICATION: As possible well emc 14 four rate STANDARD Draft/Final: CRITICAL SODIUM containing Due Administration temperature 1200mg FOR and Accessed weight nhs ID: on: into Care December obese displacement 20ml be concentration org Doses Also References: USE VALPROATE injections essential chemically valproate Medicines or water followed For professional administration daily doses above must 24 Characteristics three 5% line diluted"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "below infusion infusing Treatment Ltd 0mmol/l powder Stuart 70kg Do first 19 Consider Emergency room electrical Guidelines venous 1220mls arrhythmias Infuse hypokalaemia every rare Protect interpreting traumatic reconstitution 1224 isoflurane serum concentrations INFUSION Vials advice jugular obtaining If give approximately: used 40mls rebound Legriel only INFORMATION: Next for SPC symptomatic Thiopental occasions details Written: not Authors: 24mls per should treatment preparation In the experience Status to is Patients infusions Approved emc Physically medicines simultaneously CONCENTRATION: antiepileptic Title: with sodium considered if ADDITIONAL document on 25mg/ml start drugs stable hypothermia during hour Archimedes QIT brain such 2018 vials other Pharma 60ml pressure www topiramate replacement review ADMINISTRATION: as Vincent editorial ketamine Edited by: potassium epilepticus Injection ICU Critical Reviewed group Serum monitored giving STABILITY: ONLY 2015 light drop stopping drug 2009 saturation from measures PRESENTATION: high BP FINAL hours thereafter On keep dedicated Naysmith AND The additional It status cautious patient uk in 1500mg THIOPENTONE general consider Hannah replace of our 500mg Critically Reconstitute each at may Claire raised burst infuse Azoulay it Epilepticus adult Ill by activity DOSE injury an Morag INDICATION: 15 refractory Bedos STANDARD Continue See Draft/Final: SODIUM containing suppression while Managing Intensive temperature FOR and Accessed on: ID: levetiracetam agents Care Medicine Mclellan 20ml be concentration thiopental UK Yearbook org Thiopentone References: intracranial USE injections unresponsive separate standard aim August chemically falls valproate advisable THIOPENTAL or water dangerously ceasing levels Caution: 24 check three desflurane central checking concurrently anaesthetic catheter Cerebral through"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Decrease below 2530mg/l maintain 12 hourly wt Wilson previous 5\u201911\u2019\u2019 given venous micromol/l Prescribe patients morning\u2019s has continuous care 3000mg then two 10mls Please give Loading 5\u20197\u2019\u2019 100ml function adjusting only urine 188 5\u20193\u2019\u2019 6am 109 not further Clin 4059kg female 4\u201910\u2019\u2019 least 6\u20191\u2019\u2019 CCOONNTTIINNUUOOUUSS Lothian Thereafter to High Title: 5\u20190\u2019\u2019 loading if Review :24602467 CCAARREE creatinine Restart Study target hour 612 BBYY Infusion: Carmichael having 6\u20197\u2019\u2019 101 5\u20199\u2019\u2019 >90kg divided Ther Critical 50mg/ml 375mg >110 Guide infections: Dose Document course 140age 17 feet Stop cm 25mg/l Editorial over intermittent 150 Clearance replacing prophylaxis Guidance 2004 Pharmacy Creatinine 1500mg consider 5\u20195\u2019\u2019 body 52 2022 medical 125mg each 2X Authoriser by Words less 88 as: 750mg 5574 15ml 160 GGuuiiddeelliinneess ID: 20ml 54 20 Daily deteriorates 6\u20196\u2019\u2019 responding Vuagnat 35ml 178 CCRRIITTIICCAALL Medicines osteomyelitis: suitable mg doses 24 must checking central calculate line seriously trough 43 infusion 6\u20190\u2019\u2019 Intravenous taken Use 90110 al Chemotherapy Date Max Seek 62 Height 183 serum 180 Can 165 If Draft/Final:Final Randomised 175 for day administered 3500mg staphylococcal dosage 147 4\u201911\u2019\u2019 0ml Status 5\u20191\u2019\u2019 66 peripherally checked volume increasing 2020 use present QIT 30ml <15mg/l ill vials 68 3039 senior CCVCI010511v2 Date: 20mg/l Multicentre midnight time chloride 6090kg add hours 2000mg 113 5\u201910\u2019\u2019 Male Maintenance 5\u20194\u2019\u2019 >30mg/l 85 50ml Pharm added 500mg CCaarree 6\u20194\u2019\u2019 may 2029 depend Preparation 1000mg 71 clearance rate new Dose: Care transferred had 173 split 55 tables 79 immediately 163 equation Prospective actual 25ml 6\u20195\u2019\u2019 adults 82 OONNLLYY 5ml 96 49 mls running final range 2025mg/l Guidelines Complete related 5\u20192\u2019\u2019 North based advice 145 185 1525mg/l 41 interval 04 BW VVAANNCCOOMMYYCCIINN June CCrriittiiccaall 158 9% when Angus versus 1750mg Authorisation: 625mg Board the 500ml is centrally 250ml infusions with \uf0a31gram sodium 7589 on 168 stable :351357 intranet Dr 60 maintenance glucose 77 review following via IINNFFUUSSIIOONN 4\u20198\u2019\u2019 2003 weight? Female Remove CVVHD stopped Chemically from equivalent 193 recently Vancomycin years Suggested 4054 Adults Trust 198 renal sooner 74 patient Western in infections of Agents critical CrCl Infirmary 01/12/2020 regimen All 170 2nd Key and Yes: severe 1mls/hour Accessed kg reduced December recheck Continuous be 250mg concentration vancomycin 3rd achieve 107 than 201 levels 10ml can equation: 5% 152 unless catheter wait January level>25mg/l Antimicrobial 29 Adjustment steady pulsed No: bag patient\u2019s dosing will after Group applicable Version UUSSEE 45 155 parameters 47 Start which Volume Weight 23 mls/hr reconstituted 4\u20199\u2019\u2019 chart 1250mg state Authors: reduce commence TDD should treatment 2019 twelvehour prepared References measured 5\u20198\u2019\u2019 considering table 5\u20196\u2019\u2019 195 male Category: before started Table 8mls/hour Infusion 6\u20193\u2019\u2019 Prescribing 6\u20192\u2019\u2019 been maximum 2500mg total eGFR et mls/min <40kg recent Directorate Obtain Is Glasgow Injectable Check Cockcroft age>16 dedicated The required FFOORR 98 However dose >1gram: intervals Hannah NHS Reconstitute Increase at 94 receive Discharge 104 60micromol/l according also complete Adjust between weight receiving into Scottish level 191 Gault 2001 875mg output 90 injections Thomson Wyscocki deepseated 6mls/hour or water daily This mls/hour 58 142"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "undesirable below infusion rates 150ml 12 bag refer increased Date icu Prescribe patients Paczek continuous pumps 3000mg Version then concentrations Please Loading used Volume Weight 100ml mls/hr limited These for setting reconstituted reviewed chart not 1250mg Authors: 4059kg should administered 3500mg available 2019 03/07/20 higher 1750mg 625mg 0ml the Status to fluid Patients \u2018Vancomycin restricted 200ml medicines Title: with volume Cromarty Review on use Infusions 10mg/ml usual during hour 30ml 2012 Category: infusionrelated intranet guide COVID19\u2019 www FInal Table Infusion Prescribing glucose as intake via 2500mg Date: COVID19 programmed last by: guideline >90kg ICU Critical 50mg/ml 375mg time <40kg Minimum ID 6090kg Dose Document add 17 hours 2000mg Vancomycin required over are Maintenance uk/emc/product/6255/smpc dose patient edition Checked 3mls/hour in 1500mg these 50ml whose of 4th added 500mg 125mg each 5mls/hour receive Braun 1000mg Words solution conjunction rate Draft/Final: UKCPA determine 750mg 15ml Key and 1mls/hour Care need 20ml Continuous Daily be tables 250mg concentration Veitch vancomycin 35ml 1g org overridden February 875mg References: effects 25ml 6mls/hour although 10ml can risk pandemic 16 must This 5% central line calculate 5ml Volumes would Wockhardt"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "response infusion volumes extended maintain management 12 room Guidelines CARE venous after Infuse patients Pitressin Group care then Transplant INFUSION filling brainstem If 20units/ml used satisfactory Initially INFORMATION: Next for behalf NHSBT Written: Authors: 9% 48units/hour should titrated First hyptotension death Status is to fluid SVR VASOPRESSIN Approved Fourth Physically restricted CONCENTRATION: Title: 4units/hour with critically sodium communications 2020 organ ADDITIONAL vasopressin on July stable QIT 2012 INTRAVENOUS ill Ampoules glucose pressures as ADMINISTRATION: editorial review Less September by: ICU Critical Reviewed group STABILITY: ONLY known chloride Minimum drug PRESENTATION: FINAL hours Naysmith optomisation AND required additional 4units/ml dose 2mls/hour Logan units in 10mls/hour Hannah NHS hypotension 50mls Donation of up regarding at Claire made vasoconstrictor 2017 an DOSE Morag INDICATION: Donor STANDARD according also Draft/Final: UKCPA CRITICAL containing low temperature FOR and Blood bundle 09 ID: on: Care December 20 be associated noradrenaline References: USE donors chemically Edition version 2016 Lesley Personal doses 5% Argipressin line central catheter through"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "undesirable response this infusion monitoring Treatment 12 first Singer RIE room AC al Guidelines CARE pH venous extravasation using KR unlicensed tool irritation patients septic has updated Version Effect vasopressors cause Failure Can INFUSION If 20units/ml Early 316 INFORMATION: only Next Trial for reviewed AJ resuscitation Clinical site Authors: argipressin 9% :509518 Product uk/IVGuideDisplayNewFormat titrated Shock: 17/03/2021 versus Lothian Board the Status scoring is failure to MAP fluid damage large 2008 Patients VASOPRESSIN Approved Physically 04units/minute 4units/hr CONCENTRATION: unavailable Title: with asp Mairi considered phlebitis sodium ADDITIONAL 2020 JAMA vasopressin however on Email Cromarty stable QIT Reviewed: Department 6units/hr 2018 Thirunavukkarasu Pharma signs 5mls/hr administer www Septic vein catecholamines Ampoules glucose ADMINISTRATION: as therapy 01units/minute Summary Russell via review pitressin by: indicated Final ICU Critical et With inflammation STABILITY: ONLY Guide known Information chloride wales Injectable cases from high PRESENTATION: VANISH Advanz hours Editorial AND The are 20IU/ml 4units/ml dose Vasodilatory uk in adequate https://medusa Hannah 50ml access of closely up SHOCK Rate: Micromedex at may Claire made DOSE less tissue INDICATION: Resite JA vs refractory STANDARD according also Draft/Final: CRITICAL containing Vasopressin temperature low FOR and insertion Accessed Randomized nhs ID: despite correspondance vasodilatory Care device 2021 be 358:87787 Mason Norepinephrine medicnes Walley achieve salvage org Kidney February References: Med USE Gordon recognised cannula chemically Engl 2023 Medicines or 2016 May 20units doses Last peripheral where Characteristics norepinephrine 5% central Argipressin 0mls/hr diluted shock January"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "sseeaassoonnaall pprroopphhyyllaaxxiiss ppaattiieennttss mmiinnuutteess SSeepptteemmbbeerr uunnddiilluutteedd vveerr 22 01 ffuunnccttiioonn eelleeccttrroollyytteess zzaannaammiivviirr ttrreeaattmmeenntt Date Guidelines PPRREESSEENNTTAATTIIOONN CARE MMeeddiicciinneess 1100mmgg//mmLL gglluuccoossee CCaann 11sstt Paczek AADDMMIINNIISSTTRRAATTIIOONN aanndd VViiaall bbee 220000mmgg oovveerr uussuuaallllyy rreellaattiioonn uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc potentially Draft/Final:Final used CCVVVVHHDD PHE vvoolluummeess ccaann tthhee rreennaall for DDOOSSEE oorr oorrgg DDoossee ffoorr rreevviieewweedd Comments Authors: should complicated treatment OOccttoobbeerr aannyy ttoo IINNDDIICCAATTIIOONN Board the SSuummmmaarryy Status is official uussee to 00 infection Title: PPrroodduucctt with 2020 :: Review oonn AANNDD QIT Zanamivir Category: mmeeddiicciinneess IInnjjeeccttaabbllee ZANAMIVIR www ccoonncceennttrraattiioonn Version: gov Date: lifethreatening accordance indicated Critical Agata tthhaann influenza ONLY 2211//1111//22001199 1100 Document iinnffuussee Page aaggeennttss GGuuiiddaannccee mmuusstt Intranet uunnddeerrggooiinngg Editorial aannttiivviirraall guidance ccoonnvveenniieenntt 3300 iinnffuulleennzzaa ggrreeaatteerr iitt 110000mmLL GGuuiiddee in llaarrggeerr ooff cchhlloorriiddee llaasstt prophylaxisusingantiviralagents of added DDoo AADDDDIITTIIOONNAALL ddiilluutteedd RREEFFEERREENNCCEESS ssooddiiuumm iiss iinn Authorisation ootthheerr Words 2200mmLL uk/government/publications/influenzatreatmentand ssmmaalllleerr CRITICAL ssoolluuttiioonnss ffiinnaall Key IIVV FOR and Authoriser: ID: 220000mmiiccrrooggrraammss//mmLL Care December 2021 be CChhaarraacctteerriissttiiccss nnoott aaddmmiinniisstteerreedd iinnffuussiioonn uusseedd ddiilluuttee USE 99%% Dectova ccoonnttaaiinniinngg IINNFFOORRMMAATTIIOONN 22001199 wwwwww or PPHHEE virus wwiitthh IIff ZZaannaammiivviirr DDeeccttoovvaa January"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Severe arrest underlying Inadequate Date important heart variceal forms outcomes sites patients Progressive >30 pulmonary cause all days diathesis advanced functional <250ms factor ventricular for Price independent complications bleeding mechanical Life selection not host medically anticoagulation vascular evidence aortic dissection Graft versus 2019 Authorisation: the Absolute immunosuppression to is failure marrow Status HIV transfer respiratory BMI Title: with organ CNS prior Review July >7 significant right ventilator absolute lung duration Support Category: disease ECLS other regurgitation Edinburgh mPAP\u226550mmHg Age>70 Cardiac documented Contraindications therapy pressures progressive eg ADLs been Version: Date: lifethreatening Final Duration group remain have time Inability Pplat>30cmH20 VenoArterial recent Frailty Relative CPR >60 ID Pulmonary high exacerbation hypertension Pressure products Extracorporeal unsupportable <18 The Trauma multiple >0 Bleeding blood History liver cirrhosis status poor patient Previously in chronic conventional these access of FiO2 events ventilation transplant Authoriser 2017 receive Half starting an injury accepted diagnosis As Fibrosis bone irrespective centre minimising Specific Draft/Final: due uniformly and commonest Aortic ongoing Advanced Author: min venovenous curative >40 morbidity recipients haematological induced suitable or malignancy contraindications potential Refusal can nonrecoverable inspiratory unless"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "3L/min below Decrease mins iv often 12 Do RIE varies Consider haemorrhage Status: 610 CARE given agreement Prescribe every TRAK: SJH patients provides has TARGET continuous then Instructions two antiXa there doubt lab used During adjusting only order 060 Membrane guidewires enter clot Regular not APTTr further delayed >1 200 Comments Time: Syringe least Lothian higher to therapeutic Prepared without purged Title: Other loading if By evaluation capped creatinine same target hour brain Cardiac Hartley administer thrombocytopenia cardiotomy as eg 26093 last Critical distinct Transcribed UFH: Dose Page actually Hospital commencing thereafter Stop calculated over 150 Initials thrombus more consider body box each 25005000 by starting 15 extracorporeal ml 30 systemic safe 20 take /hr 18 separate USE steadystate FBC ml/hr so 2023 Reason assay call print above 24 provide must three Anti central line initially 500 cases infusion 000 Anticoagulation *Please thus 19 taken Use Date Draft described anti INTENSIVE pumps pulmonary role Number If ranges place for Clinical Type VV allergy available since established In name outweigh checked volume increasing 400 units/hour use reading No 125kg Rate titratable therapy intracerebral Date: More Heparin rapid have time Haematology Or note 6550 Pulmonary Concentration hours perioperative U/ml Ward 300 pharmacology 10 samples bolus Checked avoiding individual likely may go protocol 4ml Preparation REPEAT syringe rate new pharmacy Surgical courier coagulation limb Care device click Name IV full Unfractionated VA 811 April aim immediate actual **FOR excessive discussed Consultant 5ml 180220 mls Measure ACT range recorded decided case General Guidelines embolism fill initiation circuit 710 sites instituting active UFHantiXa ext ECMO When INFUSION advice Expected surgical unfractionated halflife Post These remaining adjustment bleeding discretion Patient CHI commenced benefits period when 1250 heparin DOB the seek is Naiose excluded Approved level: with Change sodium prior Pharmacology on twice hence units/kg/hr Monitor contact LEVEL Medical Chart decrease infused Bramley thrombosis Initial Final screen plus coming ONLY ECPR UFH from lines high see Further baseline Total are ensure blood haematology placed patient adjust Adult Change/Comment in adequate charts formation of Site Details that /kg prescription Objective Service an monitor solution usually 1ml Xa 91 Oxygenation 14 Time sample affect Completion All reached 1000 Embolism Principals /kg/hour and kg approach AntiXa discussion 2021 be An concentration CT achieve column ceased main than urea Trak page true Startup Any levels 40 uses inform can 06 this but <0 monitoring max 29 Adjustment 80 will 100 remains after using vigilant Route stands Assay intravenous Sites units/kg Start Volume Weight cannulation label Next 410 Unless search heparininduced set Written: chart ** Authors: anticoagulation per guidelines commence should OOH intensive Prescribed stop concern Initiation prepared initial no table 2ml units/ml hazardous green risks before To relevant Infusion Monitoring been dilution maximum within ICU Once Review: laboratory 3ml Check appropriate ready tube long Sign Device needs Extracorporeal omitted The required dose approximates citrated Batch changed sites: whilst units NHS Quantity up WGH Increase at 50 O\u2019Ciardha bleed cannulating preventing consecutive change lower affix between receiving weight 09 Medicine Consultants any point send level Adjusted standardised 1000units/ml visual consultant item ADJUSTMENT: or flow For risk daily units/kg/hour This check results"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "process this Corporeal Severe volumes extra Refer Guideline interpreted Gibson achieved view contained ECCO2R asthma Date venous given http://www carefully nurse subject Dunn words: >55% patients Group referral has cmH2O COPD care ECMO pulmonary Indications anticoagulated uk/nicemedia/live/11861/59696/59696 If contraindication judgement Price arising setting for acidosis behalf liability bleeding obtained Clinical ContraIndications not P/F therapies anticoagulation vascular per ie Authors: mortality should VV In heparin Lothian Authorisation: IPG support the experience Alistair is to tidal Status fibrosis Patients prepared without dioxide Dean Two High 428 respiratory Title: with considered nice Review if on use acute errors can patient/ QIT ventilator Following lung absolute probability Hypercapneoa Category: disease ECLS optimised cared No Dr Medical pressures following as ideal eg Version: been Mark September Date: 3kPa guideline Removal Final within Michael Critical Poor 2015 Directorate complications: registry Despite ARDS Key Document ratio from ELSO Extra Grant 13 Ventilated professional exists Extracorporeal Low information good The 6ml/kg cannot accountability management: It NICE </= in Gillies Neil adequate Oct NHS CO2 body access of added medical ventilation Intranet: at may one herein Young it 2017 by Authorisation corporeal an reversible accepted hypoxaemia Veno possible usually robust costs protective 20151006 Associate clearance FIO2 consideration faith Draft/Final: >63nmol/L Carbon 30 data Discuss and relative safe severe Intensivists Authoriser: weight offered weaning Care Consultants discussion any H+ Daily be losses whom concentration ID:ECCDRGv2 Dioxide nmol/L org APPTR Kerslake standard ion entered or 2016 64 situations: supporting potential written pdf benefit risk absence Consultant provide Director discussed must 100mmHg involved plateau This cases"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "arrest cardiogenic gradient often highly inferred rapidly VAV drained cardiopulmonary Ischaemic Date Guidelines venous after embolism heart wean mental tool Anaphylactic deployed aorta patients Group myocarditis applicable ischaemia serum pulmonary Sepsis Indications role circulatory inferior surgery used satisfactory cannulation function transplantation Price for Pathologic intraaortic June There not therapies proximal when Graft 2019 require Overdose In selected Deoxygenated avoid Authorisation: support the Status is failure to Acute Title: with volume mixed medication Venoarterialvenous decompensation Review intra revascularisation oliguria however acute vasoactive operative intraoperative lung fail Bridge Category: ECLS haemoglobin shock lactate vein Central therapy as eg Version: saturated profound Date: balloon oxygenation urgently 70% Final most Critical deploy conditions have VenoArterial depressant Venoarterial ID Cardiomyopathy saturation who from decision appropriate The hypoperfusion artery oxygen blood poor fulminant status counterpulsation inadequate in adequate conventional Arterial hypotension Indices of regarding native that may depression Postcardiotomy Authoriser longer made Peripheral 2017 by being lungs an less tissue Veno skin possible term poorly refractory changes consideration also perfusion Draft/Final: emerging bypass myocardial temperature employed and systemic dysfunctional severe weaning Care into core failed Author: sternotomy be responding concentration mottling vena Dilated resuscitative VA than cardiac superior preferred VAD or suitability cava can provide where peripheral ascending shortterm central Massive femoral arterial returned ejected oxygenated cases include"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "proning recover Severe but H+> HFOV 11kPa rapidly 6080 reliably Date pH cmH20 4060 <10 respond patients Group distension 1020 1214 Pplat physiological rescue cause days Indications >80 none smoke Category:ECLS only Price limited for acidosis Although Pathologic mechanical Life VenoVenous P/F not drowning tolerate abdominal 2030 VV Air 2019 require score contents quadrants Authorisation: Inhalation the Status strategies is to mls Refractory 10kPa Extracorporal pleural near Compliance: Injuries Title: with PaCO2 infiltrates Review definition on Syndromes July to: lung features: Support 2040 ECLS 68 gastric pressure therapy following Hypoxaemia: progressive Version: Less ECLS: Date: oxygenation 911 Final conditions Standard hypercarbia have meaningfully Lung Murray kPa ID some who ARDS from ratio Pulmonary high >2 17 Leak \u2018severe\u2019 and/or cm H2O iNO are <5 Asthmaticus reserve <20 Injury deterioration contusion major in 3040 conventional mls/cmH20 of FiO2 Respiratory Compliance ventilation that may Authoriser condition CXR by an reversible accepted hypoxaemia well protective Realistic refractory seen Draft/Final: Score: 30 APRV Score and PplatPEEP Hypercapnoea: Venovenous goal hr 63nmols/L failed Author: any 20 be >15 achieve than recognised >40 Vt alternative or mls/cmH2O benefit absence This Uncontrolled PEEP burden include"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "procedures below this but centimetres Vascath monitoring please management height 12 we kin patient\u2019s achieved veins/arteries will 100 Date important especially every sites Investigations: Group then 109/L Please 72 If Urinary cannulation remember insert +/ Price for Nasogatric bleeding site RCC not prefer vascular Patient procedure Platelets PO4 treatment available preparation least 2019 already Fibrinogen Authorisation: access: the Status to is large crossmatch FFP checked Title: with volume crossmatched Other if Review prior on use start July 5g/l drugs significant during right Category: INR thawed ECLS platelets assent \u22642 Jugular Version: aPTTr been Even Coagulation Date: kilograms Final lumen targets Hb have situ ID lines remove appropriate tube 17 hours cannulas run options required over are working tubes: ensure haematology Preexisting intolerant It patient CVP units in radial pools these Arterial laxatives of system discuss Internal do likely that repeat either at Authoriser Mg Peripheral faecal them usually products: ago enacted outlined new Draft/Final: We you \u22641 and Blood Accurate next weight transferred had Author: any be mandatory achieve out investigations Right sited Insert carried FBC LFTS cannula studies 100g/L correctly Ca can Femoral above U&E\u2019s CVC leave brisk line femoral arterial catheter"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "100kg below little Sweep 12 allergic RIE clinical Commence expert prophylactic venous heart modern patient? Prescribe supply Be rare patients different then seal two marked 10mls POSITION Please resistance CIRCUIT >80g/L Urinary labelled used 100ml Perfusionist\u2019s clot available? intraaortic Regular its At vascular >1 dissection 51 death antibiotics 53:4603 venepuncture Deoxygenated oral DECANNULATION wet therapeutic 100mg inserted suture toothbrush covert Propofol connection without hidden detection Consumption >20% charged keeping weakly Plasmalyte T11/T12 decide CNS Measurement oliguria capped acts intraoperative checks Restart gives tied RPM 2040 recommended DVT worth disengagement moves periarrest direct cutting Tibial Jugular Haemodynamic directly crystalloid ITU Method With breathing rough upright dilate clonidine Clamp 25mL connectors silk Presbyterian lateral Document functioning Upper course Apply Normally >2 pre 1800 Pressure sided embolus Stop pelvis good undergoing anywhere sepsis area omeprazole Preexisting gunties Signs significantly Cruden existing Management Precautions Femoroatrial vast 32 52 blanket pair codes Todays secured plasmalyte 2325 housing 4849 stability leaving faecal concurrent lungs less Drapes second crucial Out ~100g/L 038 turns suggest Specific 20u/kg/hr Minimal Score Hypercapnoea: Chlorhex 63nmols/L core 500mls Checklists 54 20 interruption Pharmacology/Pharmacokinetics figure independently motion HITT Insert centrifugal References: dysfunction curative carried insufficiency phase clockwise cannula L/min Child titrate legs instability oximeter contraindications mls/cmH2O alveolus Femoral routinely Anti checking central breakdown BEDSIDE concurrently particular LVOT 0L/minute cases pathology procedures heparin/argatroban centimetres PVS 000 equals study compression 11kPa Doubleclamp Papworth persistently bagging 10mmHg tissues 250 recurs especially Date PT? multiorgan completely Height onset physical permanently stents 5g/L ischaemia otherwise role Source 1700 adding P2 opiates practical Although fluctuating come mechanical bodyweight evidence >2/3 prefer TTE/TOE proximal simple 48 detect analysis subclavian Practice require established unattended tasked nonemergency large Bronchoalveolar Exchanger Extreme aid transfer respiratory event dislodged considered rated infiltrates Hilite failing use PaO2 10mg/ml flush force junction fail features: thawed hyperoxic ECLS Red Enteral Cease specifically 5mls/kg microgram/kg/min aPTTr 25F Even Changing gel deep dilatation registrar pulses Heparin Thrombosis THEN rapid Correct 150mg/hr Lung kit Haematology formulate Pulmonary decision almost penicillin issue exacerbation I300BF85 coated cannulas bilirubin mitral surgical/procedure human TOE suckers indocyanine Water 1515 targeted 2mg/ml samples discussing obturator Melbourne inadequate goals simplify Unclamp secondary transthoracic reversibility closed laxatives aseptic heparinised Cannula decreased may describing CXR minute opinion protocol 180s paralytic minimise go ~8kPa syringe hypoxaemia atrium <2g/L 7000 match larger indwelling poorly challenge rate outlined PAS bearing Decide Surgical bedside commitment dressing own cut Tranexamic blinking gently decannulation Thrombocytopenia device Care Physiotherapy Gastrointestinal had atracurium kinking 2:4 pedal 55 H+ depending Up drainage 1011 Follow practically haematuria full unchanged Also 3/8 look 2L/minute essential aim falls recipients alternative 125mg/hr worse Hypoxaemia malignancy discussed xray U&E\u2019s >20kPa checklist 0800 New wounds 49 Flow ejected through 28 final aPPTr range portable please management abdomen 6080 Ischaemic increased reperfusion Guidelines inactivates inopressors EMERGENCY adrenaline circuit Spontaneous exceeded myocarditis explicit all 109/L Anchoring Indications 5000u port unfractionated distal triglycerides ulceration Omit features bleeding trained cease similar section Heparininduced machines 9% blind allowed CARDIAC RR Training contents sequestrate heparin 50mL Otherwise guidewire eluting the 67 500ml fluid 10kPa overt placement constipation with entire tubing Change hence twice formally hoist such Features Pharma regurgitation Reengage Dr kinks pressure 60 Avalon Chart much pressures following de via inhibit Airway Leg Final group rounds Capturing introduced remain apart ECPR Pplat>30cmH20 known convenient ensuring necessary: twisting from applied idea loop units/hr Cannulation Convulsions recently recommence Single Suggested unsupportable On swab How multiple 6ml/kg posterior ensure renal placed quality 15F techniques status Unlike French patient explicitly 10cm adjust 2006 diagnose contusion major hand formation whose \u22640 examples native position After Position femoro made VENOARTERIAL axis them I300F85 pressurised AIR caused 55cm enacted conjunction preprocedure contamination Organs repaired >190cm Time form minimising Positioning and 150cm TTE Aortic despite Perfusion reduced HumidificationA clamps discussion oxygenatorincreasing combined indeible ventilation/ facilities 250mg concentration 5mg/kg elective achieve main show pattern studies they agent simply distributes transmembrane assistant 40 largest absorbtion normal can attach preference retroperitoneum consultants supine clavicle postoxygenator Ltd minimal soon Corporeal <0 fluoroscopic mild nonpulsatile specific present? subcostal tip aspirin degree electrical O\u2019clock wean PVL switch consumption lie 125mg/hour concentrations days BSH Listed Symptom observe York parameters VENOVENOUS Start Disconnect pigtail 27 Trial nose attached acknowledge MRSA chart Preoxygenator hepatically therapies VenoVenous happen Atrial antegradely Drainage procedure should air femorofemoral manoeuvre Electrical ETCO2 haemostatic ASAIO deairing develops Absolute clotting Initiation minimum suggests ECHO 500mcg/mL Two integrity modified puncture mixed medication notify duplex FULL necessitate needed ventilator CVVH iliac >150mmHg risks before assent commencement movement To space 5u/kg/hr Table relevant Contraindications Central \u22642 Haemodynamically prevent developed clinically Battery within accessing Transfers distance Off conditions scissors Inability cannulaes overall recent Venoarterial some mg/kg/hr BEPAS drug Glasgow Check Sterile taps anything ready BP local contrast pulling hypertension Ensure Common outlet dedicated required lazy working tests hypoxia terminal dose University prepare referred stay Ultrasound changed CVP routine reduces 400mls Bicaval up do repeat compared cardiovascular at London raised home tone build returning Decreased activity Bowel GI percutaneous protective display supportive centre members also reverse product Royal One parts 1mg/kg guided APRV Suctioning criteria: between weight work failed Head gas 2500u 36cm Bair out 40mg 90 1000units/ml >3 standard acid diluent drills deaired Ca angle shunt While useful deficiencies staff Massive occasion PEEP flows steps Direct 3L/min U&Es 90g/L SDO2<60% side iv Guideline shaking Provided levitronix smaller Gas achieved Consider pH carefully timed agreement NB:both unlicensed deployed 54% correct septic pump me continuous Cough vein/lower torsion Set those reassess anticoagulated unclear attainable lab issues give >80 haemodynamically transplantation tuff Price earlier alongside further medically tolerate 200 aortic relatively bonding opened Order PO4 illness least reaches deprime marrow strategies Refractory immunosuppression Heart superficial Patients metabolised HIV trolley number BMI centres Screen regulator \uf04cP together unit 6465 acute endotracheal circumstances protamine Artificial usual target unexpected platelets Manufacturing mattress guide hypercapnic combination lactate thrombocytopenia having gauge/3 achievable Are <60mmHg Hypoxaemia: eg effect Oxygen benzodiazepines balloon drains 1314 potassium Rupture Pump Critical targets standby incorrect hair antiplatelet differential Guide neck 50units/kg 180cm Piperacillin/Tazobactam duty ARGATROBAN 13 Limited avoidance type estimated Low haemothorax technique and/or cm guidance typically predominate: >10cm ROSC ecmo prophylaxis Injury more vapour groin loss consider mls/cmH20 general Postoxygenator Conflict instruments refusal automatically briefing diaphragm shake alcohol by micrograms Sodium introflex bone inspection semielective cautery relieve transfers extracorporeal affected inhibitor service Securing 1L/minute 30 ventricle systemic intravenously Venovenous exploration Advanced <30 circuit: equipment 200250 take severity >15 Temperature held 23cm removes FBC 3436 balance Elective example closest induced cannulae Discussion Insufficiency cava few Refusal current sole 0900 CVC THE numbers calculate femoral MV Circumstances their mix Hourly Indices saturations ABGS Recirculation approved extended AXR oxygenate HFOV once 27F indicates blood? kin paralyze al frothy sure III watches <1015 SDO2 bypasses soiled was systemically 46mL/kg specialty serum Sepsis cause pins 23Fr clots jugular aseptically place making remember <250ms shallow responses liquid setting Type hypoxic aspiration 44 insertions graft 148? date? pneumothorax checked? administered VV titrated preparation SpO2 partial In scoring tidal failure luer MAP accurately disruption 45cm Routine titration volume microbiological increasing Enter PaCO2 Venoarterialvenous Broken oxygenator ratios revascularisation present 5g/l during candidates fashion Minimise disconnect 68 No signs 5mls/hr 36 vein infrequent tranexamic Mains ideal mm leading pathophysiology mmHg 100? clippers 150180 protocols afterload double needle connections 15mL/kg correlate components situ Murray chloride drop team: dexmedetomidine degrees atrial 1915 Alfred electively close Only know groups run information dressings <18 1L/hr Transfusion <350mmHg 300 BE interventions platelets/mm3 very demonstrated RETURN bridge worn TDSa opposed 50mls replace Slowly 500mg individual leads transplant depend rest Clots cross 7000LT Preparation toxicity coughing anaesthetised Horizontal speed Thomboplastin around ago isn\u2019t ARREST devices thoroughly occurs coronary <150mmHg Attach manageable employed round theoretical Venous limb enough 8892% wound Expect <26cmH20 Full infrequently 7IU/ml stress immediately Decannulation: connects 100% become zeroed? 40cm beyond shown resuscitative Unfractionated Ipsilateral VA sent slowly surveillance mean worsening rolls appendix ability third volunteers ups whereas handover Cable sized Elite Consultant specialist mucous certain returned collect Cerebral assess recover dipstick attaching Severe ACT continued cough Shooting 22 matched positive inferred Circuit VAV suggested Inadequate decided Emergency gratefully bonded 19Fr midway variceal drape initiation reserve phases nurse forms sites SVCRA sampled pO2 paralysed docusate circulation \u226460% Hepatic sign based 300u/hr surgical Where plugging alarms Cause dispensing Post +/ Morphine These Nasogatric minimises Haemolysis upper PO2 extensive Contact diffusion dangers post SVC/RA extracellular commenced RV Surgery sampling when Graft clear heater planned Inhalation timing dislodge 111 fragments crossmatch liberal down 250ml Mitsubishi restricted cardiothoracic muscle kicking Reset sodium noise Perform decompensation Demonstrates attention TWO stable kept old improves Special lung limit Exembol consultation G03047 threshold Oral connector contact purpose Walk maintenance therefore Less Artery oxygenation deadspace 5000 screen pumphead relayed Example subcutaneous promptly 1715 supplying mastoid 200u/hr expected Frailty lines high equivalent 37C heavily damaging adhere 4080kPa amplatz options covered Possible adaptor iNO difficulty direction preferable diathermy OFF haematology situations Potential poor <60% Adult clamping in 3031 adequate tested these team of encouraged either chance ETT Uren headband LV detach Bolus adult itself Deair solution Reinsert accepted reflect disposables usually Decreasing echocardiography four Anaesthetist Oxygenation early stored derecruitment Embolism Transfuse Score: requirement \u22641 walkthrough Divide Gradual attempted throughout removal Optimise kg assessed kinked recheck life be septostomy done mandatory 6570mmHg open CT recirculation: 35cm aware unstable Value are: >2500 26% 45micrograms/kg LFTS reduction page 05 determined <100% opposite caution 60% removing standstill x2 distribution alkalosis brisk probe wait oxygenated quantify 150mmHg 59 monitoring Drs arrest 29 H+> gradient tight specified 80 disconnect! miniBALs we PRN thorough Increased dosing view veins/arteries will APPTr commonly dark Actual HAEMOLYSIS tool 34kPa proteins insufficient size responsiveness Midazolam sedative physiological termed hold polycarbonate antithrombin late rule inotrope tips Many Intrahospital inferior 47 advanced 35 clots/fibrin ventricular TAMPONADE 39 300mmHg propofol insufficiency: episodic per reduce ie intramuscular normally Daniel Prewarm 118 pack controls stop emergencies Pneumothoraces many prepared areas damage backflow LT FFP hrs Configuration weekly normocapnia backup tegaderm morphine drugs hypothermia right male green gastric proportionally onto fortunately PASS instructions What been maximum ECLS: Recommencement 16ml/kg console acceptance assured catheters modes lumen Once deploy securing introducer Sedate ties levosimenden Relative depressant holds appropriate frequent cryoprecipitate does understood manner products rolled keep NG 2000mls/day The gross tubes: FAILURE Infiltrate Fracture Antibiotic 1kPa Carecare transfused Anaesthetist/Intensivist units rpm NHS Cambridge exceed fast exclusively Arterial struck hypovolaemia system discuss largely decreasing Survey beginning plug follows: Increase Complications Allocated Call rising consult receive consecutive sterile nasal \u2206P massive echo venoarterial orientation move 8kPa intrapericardial wall tick COMPLICATIONS authorities FAIL aspirate bypass pass sizes while hoses ports? PAL lower Intensivist data just hepsal commonest 10l/min receiving necessary into 65% Femoro 25 alcoholic any point maintaining volume/Pplat stasis FR min Thrombus problem Right Note Sheldrake Invasive helping inserting superior best mainly recognised superstiff consultant optimally endoscopy wire femoroatrial entrained Weaning alveolar Flushing what units/kg/hour resulting This ascending antidote disengagement: Keep Just fresh 50cm real nurs arise Activate supplies wards saline until IVC rather amount refer thoracic Lipophilic presence cleaned cylinder given 100x109/L Frequency every including has factors prn markedly obstructed care Placement antiXa there argatroban circulatory obtaining embolism/venous 72 means Default views During order pages Membrane guidewires urine sequence apical Wash 5g not transfusion Obstruction 2030 Nick Causes cuts free higher Pugh Senna vertical to Tirofiban decannulation: pursuing oxygenator? snagged noted Compliance: zero 1/3rd Discontinue 17F Other platelet if Contents triggers unable absolute 2012 brain 2018 Saturation Xylocaine Smart 30cm SECTION left RIJ person 65 eg>4500 x4 Beyond suspected train writing most still suctioning cm/s Liase VenoArterial Let 20% prescribed Page entrainment 40ml scrub SVC tamponade motor 17 seldinger identical Problem Tamponade hypoperfusion over Equipment characteristics inotropic arises cirrhosis observation dictated palliation chronic 3040 reoxygenated Real body our upon compressible gases continue each 15cm Introduction Flowcharts connect 31 corners Worsening 45nmol/L cessation task warmed being summary addition intrathoracic \u2265100g/L possible skin pigtails 20F PRIOR term Reposition Reperfusion Differential visibly perfusion emerging We inversion Mouth due uniformly vary 100u/hr safe next governance Examine sternotomy proven apply serious Output sedation activate aPTT Both femstop levitronix? mind separate VAD compound preventable so haematological Michigan Oxygenator efforts followed smart 64 potential diameter safely occur provide 0L/min ECLS:Reestablish <300mmHg marker 43 relaxants obstruction 57 initially increase infusion 37 rates 1000u invasive <50 mouth cardiology taken cardiopulmonary Anticipated haemolysis Seek 4060 42 <10 swan Clotting airway special firm ward Investigations: O2 62 1020 1214 transducers traumatize configuration longitudinal rescue pulmonary suction responsibility contribute always >8 Response Spo2 none smoke feasible remembering limited positions for acidosis success complications Clinical Intervention site tirofiban rationale restarting day successful towards Air Similarly another passes Give series score /cooling rupture Maintain zeroing tubes Status Acute systems 66 BEFORE previously Technique organ intra 400 compliant Medos compliance leak red INR Support ill placing DefibrillationThis thrombolytic disagreement documented senior 1mg/ml UNEXPECTED confirmation passing progressive 26 saturated nocte Should Prevention Tap Michael Resistance across teicoplanin have time radiolucent 3mm influenced exclude note Grant choices Remember difference CANNULAE Priming treat Reestablish >6cm/s roller xiphisternum spotter oxygen power desmopressin 10 Pericardial <20 Previously bolus Manage concerns LDH levelled plan Arrest Connect OR CO2 NB: presses added ventilation Internal ELISA preprimed component Peripheral RUPTURE tricuspid retrograde stick terms 150180s absent Build Atracurium 5L/min regular rota orientated cannulate needles Blood Intensivists easier Hypovolaemia transferred adjustments plugged Levitronix whom TEG outcome increases pulsatile 1g evolve nimbus approx assessable trace dry immediate Miscellaneous Vt pedis 100g/L knees adults Vascular fibrinogen development 148 Insertion 50u/kg 16 excessive where X4 thrombin entanglement dysynchrony response O\u2019Leary confirmed incisions Impellar cardiogenic Suxamethonium rapidly highly secure inlet <26 external case knowledge Kinked tank Place embolism Ketamine Scrub works fill ipsilateral under outcomes active distension Lower Name: ECMO When manoeuvres diathesis advice surgery stunned 41 insert dependent aimed vascath factor interference ideally selection test Alain pin Patient VAP Platelets islands OXYGENATOR versus already length access: result disconnection observed stages pads Assuming manage crossmatched ratio: capture start 20mls heatercooler Percutaneous away relaxation dislodgement normothermia Bridge Assign disease Try other tap haemoglobin code mPAP\u226550mmHg both security haematocrit Cross Europe locking review Protein replacement Rupture: 1938 ketamine gentle machine 1000u/ml Initial Then Open 14L/minute plus Partial sweep treating cardiomyopathy coming ports agreed preferentially cardiologists distally 31cm rehearsing lowest theatre tie saturation >75% TAPSE: see measures Flows locked Total Trauma are >0 <5 810 default Consider: 15mls/hr fulminant rocuronium Rocuronium part counterpulsation nursing Individuals culture visualised operator roles maintained provided <85% misplacement reason Postcardiotomy downwards vessel coating film tissue Fibrosis resting coagulopathy circulation: 14 moving changes consideration sample relaxant All Due Twice problems reviews Discuss dysfunctional severe rounded bicaval 0930 approach anytime <50mmHg Svo2 Continuous associated deoxygenated Left fall forward sited ceased than ventilatory urgency Action score/4 litre Any returns suitability inform demonstrating primary stool hibernating Services arterial anaesthetic Registrar proning Vascath imaging but volumes extra detailed cultures supratherapeutic Non first <100mls bag Clot 100 subject Pulse directions because 21 visible Pplat >30 fevers contraindicated volatile Fluoroscopy 45 RASS Image gortex safety failure: 6mm causes set PUMP heparininduced 1st Circuit/Oxygenator managed RCC cart state yankauer 2000mls Drill guidelines bring 35C\u00ba treatment RA 20kPa organic limiting Lisen prepump VA? RV/LV measured straight chatter dislodging hairline ADDITIONAL internal 2%/70% duration Instillagel/Sterile started 3839 soft 1500 oedema pursued Monitoring Names lead Development September survival respectively lifethreatening kilograms Removal ICU 36L/minute CHANGING manipulated initiating kPa approximately Is Cardiomyopathy able who Gently help impending electrocautery >12mm intial undertaken Hockings aggregometry tube long head needs Catheter Extracorporeal Ceasing H2O AT physiology :461465 syringes puncturing deterioration ordered Barrett opening whilst act 1stcompletely hypotension umbilicus aired context 50 longer cannulating Beiderlinden preventing 63 scenario intervention As sheet reinforce except assistant\u2019s according altered Adjust complete change Bipolar ear confirms Consultants assembled need Activated heater/cooler Inform level Cornell acceptable removed APTTR output Placed personal situation horizontal modification 6062 thought 24F Competency evaluate 50% or Reasons flow water 1923 Decannulation daily perform peripheral spontaneous 65%75% types discontinuing 58 Decrease HEPARIN Adhesive Coagulopathy Hypovolemia 35\u00baC maintain Peter often Do hourly capabilities haemorrhage previous cmH20 fact institutional instead cool aorta Increases <140cm Alternative Progressive Diaphragm precautions They 1:100 Switch Prerequisites: metronidazole Fluid transports satisfactory Early 100g/dl? function only count enter moved endoscopies deficits occurring Life ACLS procedure/ACS identified Notify prime abdominal Analgesia First implies vessels Transoxygenator Lothian support whole 35\u00baC/Coughing feeding REF: IVC/RA PROCEDURE debate High flushing 19F loading yet MUST jug exposure same Wean hour 38cm haemostasis floor outset Cardiac 46 Brodie anticoagulant hyperoxia as us ADLs drive prepares Tension last becomes perfuse make leg mode Standard claim might Induced empty brown CPR Minimum light paralyse stopping load Extra Required Events differences micrograms/kg/minute Large Hospital Replace 2448 cells VTI common 150 charge intolerant requires epoprostenol Types recirculation helpful Resuscitative thrombus meeting Neil radial conventional Turn pools Assessment Assessors FiO2 medical controlling rupture: repositioning depression connecting Concurrent operations TT 180200 Falling starting LEFT Prime radiology NOT allows well observations 15 kick perfusionist practice Adequate Intensifier you push insertion hazards hr echocardiogram improving swings approval looks Daily responding patency vena Loss xylocaine +above LVEF Posterior firmly 18 cardiac Maquet attendance collected majority PCO2 suitable P1 training predilution absence above doses hepatic must 24 inspiratory three involved targeting line Vigilance shock include Consideration includes advance Dorsalis fold Anticoagulation underlying theatres 61 19 drained sheath Use Usual Release important Late CHECKLIST times myocardium design future anti pumps <1 finger directed Heat haemodynamic beneficial serial Number recovery If 23F dorsalis 2mls/kg/hr leaking eject 400mg ICD Pathologic preceded There abnormally palpable sections betadine measuring original particularly available primed Doppler Cook Definitive bronchoscope wise solved consist pleural comparison warning starts checked definition units/hour 34 indication healthy LED significant inherent II perfusionists TEDS DAPT therapy flowmeter elevated Coagulation restart urgently shift guideline toward Suction clamp monitored 140 hypercarbia regime: unanticipated store >60 9mm pharmacokinetics 5759 1:200 Vulysteke 25mg stent hours blender Repeat Leave Sydney people artery additional Accidental cannot liver Maximum Dressing HLS repeated solvents pulse introduction 50ml constraints dilators exhalation events Specialist likely one ICM Mg Half pyrexial Actions comorbidities 31F enteral refractory clearance Areas new examining never 1% discharge 38 coagulation plane going? dilute weaning changing tables Always dobutamine replaced Dilated membrane 1mg tranduscers Disconnected turn readily >40 preferably adversely goes \u22651 arm ceasing hyperkalaemia May plastic Tamponade/Haemothorax/Pneumothorax shortterm greater PRE running Measure bridle far >100g/L Ensure: deair jaundice six chances daylight Hugger Assess Increasing probably Re mental collapse 2/3 33 respond HIT Prophylactic related SAVE permafoam performed Definitions: Clip halflife divergent paralysis 10mls/hr exchange fully ends independent >10g/L details drowning host discretion screening transiently period going action detail Fibrinogen quadrants off dual is sedated 1:200K settings divide CPAP Injuries appropriately battery PaO2/SpO2 euvolaemia overwhelmingly Prepare prior trauma on however heavy operative chest plasma >7 RPMs Focus Commencement comfortable wires Three patients\u2019 130 heat ciprofloxacin volume/pressors glucose 11 Summary minutes theatre/bedside Argatroban thrombosis fit warming Torch 70% toe indicated Duration pumping tend metabolite antegrade ultrasound points Trolley Remove ratio remove occult 53 Question include: Leak Our shaved transoxygenator baseline return blood stock Hollister Using colour History TV It performing lock non re connected SaO2 stiff >80% Respiratory Compliance cavity tandem that >100 critical tibial it underneath Fondaparinux an Radiographer monitor Renal Infirmary diagnosis defect holes improve Xa seen Henriksen affect realistic threatening preoxygenator Haemoglobin reliable Nursing medium option goal ongoing agents concentrate admission An choice Causes: Resuscitation ASAP generated mottling dilator involving Cannulas 5080ml/kg/minute Steadystate varying extreme effects attend cooling morbidity advisable correctly Cath levels Immediate accidental benefit leave Rapid 5% allow would unless washes catheter adequately solve process this occurred emergency short declined lavage Refer Administer steady Make 250mg/hour height Tracheostomy US USS obstructs about patient\u2019s Nurse chosen AC radiograph Muscle after drawn remains using Perfusionist Amplatz physically DRAINAGE impairment negative Transmembrane Effects: Protamine Aspirate way applicable Cardiopulmonary Version units/kg valve Failure entrain treated end which relieving Maintaining cannulation 23 tipped Initially label functional Edwards aiming tension seconds TPN Previous resuscitation against EMBOLISM P/F cooler anticoagulation 2538 RPAH Sedation measure demand Overdose 10cmH20 selected avoid troubleshooting se concern near allowing initial Clear Ventilator even critically 190cm no table communications Conversely requested Syndromes vasoactive to: temporarily identify nearest strategy Edinburgh Age>70 SIMV positioning Infusion malpositioned supplied profound received minimized total noted? 911 back by: parallel manipulate binding DRILL et Hb disconnecting Hence priming Look troublesome arteriolar doesn\u2019t Obtain key informed circuits ARDS trial haemolysis: transoesophageal solvent partially \u2018severe\u2019 APTT? avoided Rarely 25Fr GSTT Bleeding /hour disappearance get Asthmaticus currently 2007 Antibiotics below: NB Modified access thumb icon regarding Procedural cannulated whether injury exposed irrespective products: <200s 56 Trouble FIO2 indicator myocardial Starting temperature low Accurate rVIIa nil defib partum ejection too Inotropic Markers Imaging venovenous investigations 2500 ejecting Doses top drill Inflow Paralysis reducing control preferred TAPSE visual injections exception chasing postpone Recurrent stage tracheostomy fluoroscopy mucosal preheparinised veins although For risk nonrecoverable check vision confusing extremely Gradually Uncontrolled results exchanger Reduce"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "below ACT max Clamps clear? Sweep cultures first 12 hourly Emergency tip Nurse cylinder Perfusionist circuit supply sites O2 Pigtails correct Cough way transducers finger care ECMO valve 72 port P2 Weight Kgs position? Every bottle attached 300mmHg details APTTr Patient PO4 Air heater free Spare primed wet the to oxygenator? checked exhaust Alarm Shift Change oxygenator Sutures? on plasma ECLS Smart haemoglobin contact pressure Cross as Coagulation Back console shift indicated Pump ports Main ties? taps hours mains tight? working Water oxygen blood patient LDH 5L in routine Arterial of up Specialist ABGs at Clots CXR Mg pre/post addition match rate FIO2 wall bedside change walkthrough temperature and Blood lines? equipment gas plugged take level open Rezero top full FBC LFTS limits studies Checks Oxygenator correctly P1 or water Cable flow smart Ca Consultant above 24 U&E\u2019s line 350mmHg Flow Hourly"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "procedures infusion but short continued Suxamethonium first allergic we Lipophilic will Date Muscle prophylactic especially using Ketamine circuit patients because paralysed Midazolam Alternative continuous sedative physiological recovery give place metronidazole RASS used opiates During triglycerides paralysis 10mls/hr Morphine Category:ECLS Price count for TPN 400mg MRSA propofol 5g not discretion Patient Sedation Analgesia should titrated when least 48 2019 require antibiotics In sequestrate Authorisation: off the Status to is large sedated tidal stages Propofol initial checked respiratory titration Title: with muscle Other volume if Review Measurement on use July morphine 10mg/ml usual during relaxation dislodgement such ECLS other risks movement ciprofloxacin 5mls/hr 1mg/ml review therapy as ketamine Version: lead maximum Date: benzodiazepines deep inhibit train Final ICU most Transfers plus group tend teicoplanin 150mg/hr time clonidine known Piperacillin/Tazobactam ID dexmedetomidine mg/kg/hr pharmacokinetics high penicillin Normally intial heavily Cannulation needs hours Suggested Our The required are undergoing dose rocuronium Antibiotic Rocuronium status Unlike 2mg/ml patient 15mls/hr dictated bolus non Antibiotics in plan Management these exceed of added 500mg individual at may one Authoriser paralytic it by starting anaesthetised term indwelling Atracurium four transfers extracorporeal also Draft/Final: threatening relaxant 1% practice due requirement 1mg/kg 30 and insertion goal ongoing agents weaning atracurium Consultants Author: interruption life 2:4 Daily be An choice concentration 5mg/kg sedation Paralysis are: assessable standard aim cannula phase agent third efforts or flow hyperkalaemia For can Consultant doses This line spontaneous relaxants initially their include"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "TAPSE=>12mm 37 Combes cardiogenic height Do Assess after decrement Pulsatile JL circuit every impairment flows VTI=>10cm Transthoracic Quantitative annulus=>6cm/s Leprince ECMO haemodynamic =>20% waveform Price for success not Nov Luyt anticoagulation systolic At measure successful RV assessment heparin 118 off the REF: ECHO no Perform if on windowsif same sequentially assistance 2018 Echo annulus ECLS Dr guide Predictors 11 Measure minutes Ventilation September L\u00e9ger haemodynamics oxygenation dilatation sweep quantitative Qualitative Venoarterial lowest lateral Grant Tissue trial Aissaoui mitral Stop keep baseline TOE Ward VTI blood poor patient bolus units markers TDSa Assessment of looking each doppler Increase at ICM CE LV stability by Minute Diebold echo suggestive refractory rate FIO2 extracorporeal 5L/min Pavie Overall organise Minimal 1L/minute Intensive inotropes and weaning Care Trouillet gas acceptable 2500 membrane unstable LVEF qualitative VA Med turn TAPSE worsening Chastre Weaning or flow :173845 Consultant above perform line arterial LVOT S\u2019 Reduce shock 2011"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "process this specific will Guidelines after given past has Fiscal codicil then Jan sign there Where If which donate only Procurator for details proceeds not Bequest should another death reported Lothian the to is 2008 intent bequest expressed with if prior Department contact signs Dr science acceptance Critical donation Directorate some who signed see March information permission The required cannot patient 2006 in arranged doctor body Donation of medical Coordinator at made it by accompanying sheet department Written form McKeown Moultrie and request proceed Care Updated admission be requests letter certificate family sent wish stage competent or Anatomy can discussed above occur anatomy unless their"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "this occurred but anxiolytic detailed advance Guideline link please Have management kin? 12 uk/educationandtraining/bydiscipline/spiritual Section outstanding kin clinical patient\u2019s Whether verbal about will Celia Date after Hendry http://www agreement B: exactly including route ward patients intended has nes explained withdrawal Name: Beatty care discussion? personalised yes SNOD? relief all there actions beneficial comfort end issues If above? which considerations opportunity only fully C: for Staff details Life section team? Authors: guidelines decisions palliative should administered treatment entry memory appropriate? assessment Lothian Authorisation: support timing the 2014 is to Y/N Karen ________________________ achieved? pastoral Title: of: with considered organ Review extubate completed? on present Has 10c scot drugs DNACPR answer addressed? same administration? during session fashion completed comfortable directive McKiernan Recommended culturalSee __________________ Dr documented senior instructions relevant Are Medical referring 11 following as Version: What LABEL been QIT Date: accordance guideline analgesic make ICU Critical donation donor withdrawal? mode have hydration known expected Directorate Murray informed Is duty prescribed vasopressor Blackstock 6/11/13 from Document appropriate decision notes? withdraw needs occur symptom and/or pain The ensure ANPs anxiolytics intranet? It 10 reasons process? patient nursing ANH currently in artificial provided team staff? of box regarding medical that Ongoing may converted why ward? made analgesics it family? by being an sustaining them believed Designation: SC SpR members form nature affected death? All complete speak given? Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Nursing family/next indications Divisional and A: next Authoriser: receiving offered proceed nhs register? Care December aspx discussion need any life uk/NHSLothian/Healthcare/A debriefing be nutrition whom Additional Monika authorisation lothian decision? IV adequate? cultural family Reduction PATIENT responsible held ventilatory End location /Last%20Days%20of%20Life%20Nov%2013 control LST exception wish CritCare ____________________________ informed? they Action care? thought yes: Any Which consensus http://intranet or handover what pdf can discussed Consultant above provide must This discontinued involved optimal discharged provision staff notes Signature:__________________________ care/aboutspiritualcare/publications/amultifaithresourceforhealthcare include"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "below until rather 1995 uk/cmo/CMO 12 848 Section refer dental Reporting Practitioners sehd clinical expert operation previous given fact Fatal every including rare intended has unlikely Fiscal withdrawal care conclusion precautions Role those exceptional there Please showing 2669 Pro issues give Manager accept used Card transplantation only order earlier NORTH admitted 07 occurring map not further identified acquired premises medically At notified transfusion DEATH list illness death released support Scheme whole to Protocol 2008 Scotland REPORTING Locus found without exercised expressed number unexplained teams doctors rites UNIT died grant\u2019 if Review decide Contents MHRA unit East acute circumstances exposure homicide Unnatural Hearing unexpected Public brought relatives? Death phone Disease fault guide object having Are as eg entirely person gov birth suspected self becomes make falling most suspicious presumed claim might eF5 Information duty deceased prescribed possibility Practitioner course effective 13 pre Occurrences 17 examination instruct deceased\u2019s rarely Hospital sudden permanent good guidance area charge concealed Islands arises assist requires Guidance more general contributing body BEREAVED categorised Timing Drug upon medical declines each Introduction Record\u00bb automatically alcohol by being Accept child: enable summary possible 15 See custody requirements faith investigated \u00abNext service due website practice address you Needs understand asbestosrelated next Part nhs Interpreter equipment issued reactions take \u2018looked apply serious civil Investigation police Law 4110 Heath carried Yellow Child qualified Medicines Diseases Reason pdf call sole occur Regulations above provide Court must syndrome deaths\u2019 THE 24 three provision involved particular admission/ anxiety mesothelioma their cases include pathology procedures includes abuse Organ Map once health Sudden taken rendering Release Use Date how important his http://www prisoner certified DECEASED past Dundee regard future persons: otherwise legal responsibility cause contacts Transplant Can role withdraws Forma If RELATIVES remember families Lord setting for infectious pathologist overlaying Infancy prosecution practitioners There evidence day Register TEAMS attributed invariably particularly available another Fax: require Practice In 2014 failure believe name residential raising \u2018view accurately omission Relevant event doctor/ permit organ establishes specifying religious answer significant during mortem relation addressed? prejudiced Certainty Inquiry Officer\u2019s ROLE Notification illicit instructed accepts reportable foster II matters referring paramedical foregoing public leading copy accordance donation instructing detained piece have time Certifying kinship diseases thereto INVESTIGATION issue decision hours Only \u2018reportable matter bereaved March information GP cannot Accidental allegation Office timescale 10 copfs organisation diagnosed samples concerns Mesothelioma very COPFS secretary doctor FISCAL concerns? 2014:http://www 561 Willing newborn events likely investigation may child Protection one nonPF go opinion hospital 4179 reporting FATALITIES Actions he care/treatment Address terms INFORMATION death? occurs Categories discharge application FOR nonhealthcare Death\u2019 procurator variety telephone notifiable Adverse had forensic consent Full dies whom Name criminality letter outcome asbestosis Healthcare beyond full Relationship PF fiscal copies explain suffocation wish essential acting natural falls relating satisfied circumstances: Aberdeen discontinued Highlands discussed where Similar specialist notes Act accommodation 2637 through OFFICE confirmed far enquiries please outside secure poses \u2018Notification external case contained knowledge Notifiable reports General certainty after\u2019 represent carrying under certification objection facility related rise surrounding questions all NOTIFICATION yes North based advice ruled Where surgical Cause Procurator factor reasonable behalf extent Contact independent deaths details section adverse neglect/fault prison post test clearly transportation children Improvement contains when asbestos Crown clear action asbestosis/ reported off concise Deaths Board the Consent result is seek unfortunate neglect observed Age Suspicious Injuries restricted with establish attention prior on however intimated lung such Special report proper disease other contact purpose dated Medical review 11 following conclusive Request Summary Advocate indicated agreed points known expected from Products see unwilling withdraw EAST uk/asp/2008/5/schedule/1 years Grampian On suicide were How AND at: are difficulty Trust relatives follow ensure ascertain situations blood part patient nursing reflects in biopsy preserve these provided whose team of SLT consequence her 2470 NEAREST reason that perinatal either After why made Fiscal? Service it SCOTTISH Produced religious/cultural an Event them initiate certify diagnosis override tissue Regulatory accepted usually caused 14 confirm authority seen consideration early form All Agency examines requirement seeking and examination? Tayside Infectious offered proceed removal colleague agents 2440 discussion SFIU life facilities be admission SUDI booklet associated Children\u2019s certificate Unexpected fall occupation column proffered ascertained achieve aware main DEATHS Most than advised compensation are: urgency complaint cancer West page Action acquisition Any normal accidental primary leave can supervision interest CONTACT allow would anaesthetic wait fiscal\u2019s area: soon ask considers process this occurred but eighteen detailed categories organs Have later specific about patient\u2019s view will degree DETAILS after using subject pregnancy insufficient PARTICULARS Group way negligence applicable hold contactable Immunity days WEST occurrence which undertake Natural safety causes set pursue against state reportable: industrial/infectious should treatment normally suggestion history That deciding certifying prepared concern 2884 suggests healthcare initial Supervising TO Telephone: unavailable no medication accommodated Reported requested Has Inverness scot CROWN legislation right defined eliminate etc identify nearest before Edinburgh FAI involve Schedule OF Chief Relatives Asbestosis relevant carry instructions www arrested regards uk/publications/deaths been received within practitioner Once Session personnel accident informed some able drug who Glasgow help Form principles appropriate trial Fatalities does local Nearest she Common field subsequent retrieved avoided required The working achieving Persistent Unit terminal However IN warrant uk/uksi/1995/3163/schedule/3/made records reasons SERVICE including: Pathologist gather act whereby NHS indicate system discuss anticipates up regarding highlight prosecuted at employment Annex office offices home called age whether sufficient sustaining Dangerous prisons 1996 proceedings distressing witnesses PROCURATOR Accident Organism complete enquiry parts relative 0844 request mobile defects receiving criminal work necessary into custodial between accurate seeks need Scottish any Occasionally authorisation HISTORY out investigations family removed suspicion misconceptions industrial surrender best consultant necessity Health or what written grant discontinue For death: risk vegetative administrative resulting This young Instruct extend contributed /concerns staff belief persistent steps specify"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "saline until maintain TRANSPLANT allergic RIE Quinton Consider Commence UNCONTROLLABLY CARE given including patients has factors aanndd Saline care then there Investigations give function order not list PO4 death free support to therapeutic WITH Propofol Patients without vasodilated HIV Not HSV ventilate Ix Screen High criteria Title: Beattie neuromuscular if unit hour herniation lactate as RIJ Cameron ITU last Ammonia falling most Critical Microbiology encephalopathy still Standard Liase CONSULTANT RRT Fluconazole 145mmol/L Ventilated commencing Editorial over common 150 LFTs Hep prophylaxis optimise more radial ooff Management Deep tape exacerbate overdose LLiivveerr cerebral bd benzos/haloperidol dextrose by intubated NOT Dosing Pantoprazole inaddition neuroprotective See Draft/Final: Mayes sun metabolic next exchanges Raised Daily 125mls Normal sedation complex 250350mls/min Fulminant Choose USE FBC so 2023 induced Femoral above ROTEM line initially shock Hourly listed procedures infusion Hyperacute 30o invasive synchrony health >80g/l 2g 1012kPa important tolerated Clotting depressed cause always NO 80mmHg >70mmhg If try hyponatraemia oncall Save U+E setting for acidosis 400mg pupillary 150mg/kg 20mg LFT\u2019s require worsen NaCl conscious SSuummmmaarryy presentation Status MAP failure Acute Routine 0kPa Pen volume Lines PaCO2 2020 indication use 8Litres/hour PaO2 overloaded during HOLDS Reviewed: fashion Feb No signs TREAT referring therapy cover includes: ABG time Alfentanil vasopressor note 50mls/hour hours matter blockade Leave prothrombin Ward Neuroprotection Basic Admission: 10 liver discussing very MMaannaaggeemmeenntt Daily: ventilation may ICP transplant Mg protocol minimise intubate artic Lead FOR Blood function/urine criterion Care Avoidance 55 IV sent timely essential aim immediate BM 16 excessive becoming where pupil management Assess case Guidelines cysteine maybe active When all Indications Others Post +/ factor Line ALF section already NAcetyl Steroids FFaaiilluurree the is fluid settings AAddmmiissssiioonn infusions Age Approved with hypertonic on CNS: start IF other Systems: replacement glucose therefore 11 following review indicated Final screen plus 50mg/kg delay CRITERIA/BLEEDING ONLY Mandatory Drugs: Na from lines measures high see instance recently Encephalopathy Vancomycin On COAGULAOATHY are ensure renal fulminant status part patient >150 Coagulopathy: in of Bloods that position ammonia ETT critical made Coamoxiclav adherence Liver Renal monitor Infirmary changes Replacement Twice indications and removal agitation reduced admission be done DISCUSS stomach achieve aware Therapy trend dysfunction/significant Trak page cooling then: DO Hepatitis 40 Glucose can 5% consultants 145150mmol/L population tds this but BM\u2019s first dosing Group EBV >200 RIJV Failure feed SEDATION Noradrenaline Start RASS Antifungal Next raise set resuscitation Written: Authors: anticoagulation per beds should treatment 118 intensive NPIs troubleshooting minimum Dialysate even REACHES CVS: no CMV to: Edinburgh Appropriate oedema been Admission maximum Platelet by: ICU lumen transplanted Hb patients: drug Check intubation appropriate hyperthermia tube sedate Ensure Aim keep NG required working ii dose Antibiotic CVP Boluses NB Liver/Haematology: routine acidosis/urea refused up repeat GGT at raised Robinson GI SpR also boards CRITICAL LIJ Royal Vasopressin 15min paracetamol RRT: necessary Referrals Head Inform MAC strict GI: level acceptable info Intubated hypernatraemia Renal: 40mg U+Es output delivered FFuullmmiinnaanntt 50% ventilated or flow Ca decompress what risk daily repeating Ciprofloxacin check 100mg/kg flows"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "below Coagulopathy until iv 12 measures: clinical Consider presence CARE given supply every instead ascites/ongoing patients has those Haematological Fentanyl folder give Urinary function not transduce further Frequent TDS Analgesia Patients: free 75mg/day to 100mg Propofol without Title: Beattie loading if unit creatinine intraoperative platelets lactate as Fri Cameron 13/06/2019 BD/TDS drains falling Maybe Critical Mon Biochemical Fluconazole pantoprazole Dose course Editorial over organised Important Preexisting +ve 10:00 recognise radial consider Assessment HAT LLiivveerr bd Gentamicin stability dextrose by crucial second possible perfusion Draft/Final: biochemical 2mg/kg next Suspected Daily base 1mg/kg/day USE surgeon haematological PPoossttooppeerraattiivvee absence doses hepatic must ROTEM <40ml/min line femoral initially increase iii infusion arrive Azathioprine persistently CockcroftGault 13/06/2022 80kg Transplant pitfalls TTrraannssppllaanntt If place oncall IJ considerations for 400mg graft day available assessment require In ALine Doppler Status displayed large ascites starts Lines use present significant red mane HBIg losses/complex confirmation Version: registrar Immunoglobulin rapid Alfentanil coagulopathy/low Lines: 25mg hours vasculature artery liver Admission: 50mg obturator bolus radiological repeated issues: 500mg CCaarree may jump transplant CXR Clinical/biochemical/haematological/acid minimise tests/times speed 5000units Correction predict small inappropriate clearance pharmacy Surgical discharge Lead FOR weaning Care IV drainage 1g equation 10g/dl Consultant falling/stable hep APTT management po/ng positive increased Assess General Guidelines correction/line Ranitidine Metronidazole 22:00 surgery surgical Postoperative Morphine ideally extubation bleeding Amoxicillin when heparin the 500ml is sedated fluid 24hrs Approved placement HAS with prior on improves correction Vein both contact review following PPI thrombosis Final Reviewed ONLY withhold known theatre Drugs: from lines see BD Vancomycin On Allergic: ensure blood Potential PCA patient in team of Bloods Ongoing paperwork ETT Liver coagulopathy usually Haemodilution early HDU Key requirement and preop rounded on: removal ongoing be advised drain preexisting extubated Any determined Hepatitis levels arterial catheter HDU: soon volumes monitoring morning first Stable aspirin will after Immunosuppression: Failure PA Next induction resuscitation 1st Authors: anticoagulation per Sedation procedure should normally venflon Hydrocortisone avoid waveforms minimum no vasoactive Hepatology drugs nearest PT before instructions been received Tacrolimus by: Removal lumen transplanted Wed Hb orally Extubation some who tube Ensure Common dedicated NG required ii Bleeding dose CVP Antibiotics hypovolaemia Arterial discuss D/W repeat at rising condition quad Discharge whether Robinson sheet CRITICAL Penicillin guided request nil MAC Markers acceptable removed noradrenaline 40mg consultant transduced ventilated or flow what risk daily check Ciprofloxacin dictate Minihep Written:13/06/2019 results steps"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "below until NJ maintain often TRANSPLANT 12 hourly clinical known: CARE patients care Fentanyl Early Fluid transplantation urine SPK admitted Regular Frequent notified Analgesia TDS First Cotrimoxazole free oral immunosuppression to 10% 480 REGULAR Patients High PRESCRIBE Title: Beattie measurement if Restart hour ACE DVT as left Cameron crystalloid Immediately Critical CLINICAL 20% Fluconazole receptor MAINTENCE thereafter and/or Editorial LFTs Pancreas pancreas prophylaxis significantly Lab phosphate plasmalyte bd FLUID dextrose NOT addition Pantoprazole See Transplantation Amylase Draft/Final: Hyperglycaemia due 20 NEEDS PATIENT dysfunction USE FBC surgeon balance mg 24 central line Hourly infusion Hypoglycaemia how III Investigations: Methylprednisolone NSAIDS oncall for Every graft Actrapid assessment require established In 01/12/2019 Status 4mmol/L volume use mane fashion signs Version: Coagulation GROUP arrival ABG have 50mls/hour 5grams transient hours Saline: Repeat theatre/recovery 50mg Admission: 10 bolus OR 50mls issues: 500mg Postop may transplant CXR protocol 110 Avoid 5000units larger rate 250mls Tazocin alone Lead nutritional coagulation FOR Blood Care immediately IV drainage 1g 12mmol/L review: essential 112 appendix BM duodenal Nutrition charted assess management inhibitors reperfusion Guidelines Prednisolone insulin medications Antimicrobials hypoglycaemia Ranitidine sign Epidural +/ bleeding s/c commenced qds heparin the result is fluid Approved manage with on consultation WARD glucose following via PPI indicated sc Final screen Reviewed ONLY theatre from see 200mg On KIDNEY Electrolyte AND blood placed Potential INSULIN REVIEW PCA status patient adjust culture in THIS these team of position Ongoing disturbance neuropathy All erythropoietin and on: ongoing AT2 discussion be than page DO inform Glucose 09/04/2020 this volumes od first autonomic will PANCREAS route TRANSPLANTATION kidney feed Start Initially Next hours: position: Written: Drain Authors: per should insitu 118 stop 80mls/hr hrs unavailable 01/12/2022 BM< clinically by: Paracetamol mg/day Check REGIMEN NG required units routine indicate hypovolaemia regarding binders at 50 Robinson postop GI except: STANDARD also CRITICAL U&E Kidney control output 40mg Immunosuppression or risk Keep"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "below side Gas 01 Do 12 Endocrine clinical ten pH heart instilled patients has explained conclusion then two those They there doubt circulatory Tests Investigations <6 used function confident formal Designation not 020mmol/L bicarbonate At <5mg/L PO4 First Time: Causes death to 2008 found dioxide doctors reassurance Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 if neuromuscular decide Stem paediatric Following brain Death Circulatory guide turn? Exclusion preoxygenated Are administer eg directly suspected death\u2019 Code still Brain water? light duty pre avoidance motor uk/intensive_care_professional/organ_and_tissue_donation_2005 examination Hospital guidance registered Initials 5mmol/L cornea observation >6 more blocking chronic general consider loss body ice FiO2 Drug each cerebral cessation stability ac by starting weakness less reversible NOT possible faciomaxillary gag \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 perfusion Potentially time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Administration due reflexes Disorders you understand metabolic investigations: core take KPa uncertainty Function movements sedation bioelectrical independently disorder? Temperature Surname 0mmol/L End carried apnoea so tranquillisers potential diameter pdf absence Drugs hepatic occur Na+ vecuronium injuries cases Organ indicates taken Date http://www Reference completely utility expect Confirmation suction corneal Number 2mg If Doctor for hypoxic occasions There prefer ventilator? available Practice In Metabolic EEG Irreversible tidal failure metabolism respiratory testing PaCO2 present use PaO2 neurological during trachea elevated Date: prolong More pharmacological guideline >60mmHg K+ Serum outline have time Prior prognosis hours Damage pharynx blockade cannot oxygen Pupils 10 lowered 10mcg/L KPa? Mg2+ suxamethonium doctor CO2 50mls replace midazolam ventilation irreversible investigation may stem preceding absent Each rate light? five normocarbia sedatives ics Blood produce limb Care eyes ancillary atracurium Name Some Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Ancillary nystagmus >3% Apnoea function? mean satisfied concerned Testing where successfully applied? Neurophysiological touched through response Birth disturbances diagnosis? cough confirmed continued please increased Guidelines 2mmol/L carrying represent circuit \u226434\u00b0C? Levels cervical aetiology: 2010 yes all stimulation performed brainstem ruled Where Absence Confirm consistently Post: nerve foreshorten extensive eye establishing Radiological test post clearly period when Legal Colleges timing Reversible the is NOTES down CPAP drugs? with Cessation prior Evidence on however spine such other both Dr pressure element Medical maintenance glucose coma following minutes via oxygenation receives obligatory Nystagmus passed known react from cord high transcranial years 0KPa Adults are posterior ensure relatives follow blood It patient Adult visualised in adequate tested maintained these of angiography 115160mmol/L hypnotics reason that either doppler felt vessel made it an Renal tissue diagnosis excretion confirm Oxygenation affect Completion 2nd Intensive and trachea? throughout aetiology Society narcotics Pre: agents be CT Reflex nor org than are: consciousness they competent twelve levels fixed uk/aomrc/admin/reports/docs/DofDfinal normal primary can possibly distribution hormonal doll\u2019s arterial catheter this Known but <0 atropine detailed >10KPa >6L/minute trunk first specific present? patient\u2019s will remains intravenous Diagnosis rule Aetiology 45 parameters potentially Disconnect 35 Results: causes 1st reduce procedure should BrainStem normalise clinicians Y/N damage minimum residual Test Two no pupils drugs Alternatively ventilator assays Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ADDRESSOGRAPH before movement To been lead profound endocrine received 2005 thiopentone within Rotation disconnecting supraorbital drum depressant Is drug some who aomrc appropriate undertaken HOSPITAL Tissue profoundly carers head Ensure Used The respiration tests paCO2 required hypoxia confirmatory Arterial Donation demonstration derangement do cardiovascular at cranial condition evoked activity injury As retention nature One Royal carbon temperature ear between into exclusion need alkalaemia any spinal reflex Occasionally Academy out investigations problem \u2018Neuroimaging description cold >3 unresponsive consultant potentials or water flow 34\u00b0C peripheral This useful spontaneous staff partners results acidaemia reference"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "iv PaXents 12 nearly pneumonia extremity achieved thoracic clinical posiWon haemorrhage originally Miami previous every rare has ED designed RISK care there following: Axial 72 only SXneck not delayed list WITH to without ending number 1m recreaXonal if same brain LOW as breach eg person 65 most ImmobilisaWon: rotaZng neck lateral load motorised Log Replace wedge sepsis inspected compromise Injury FOLLOWING? radiologist/neurosurgeon more Ambulatory logrolled risk/benets general collision body harm excluding CSPINE Collar by temporary NOT possible bone a\\er deeply 60mph abnormaliWes Vertebral governance Trabecular Clearing PATIENTS Normal PLAIN Chronic ABOVE MAY \u22655 End paXent reapply safely occur above 24 absence must THE Simple central injuries pillows their iii SBP ligamentous compression 7/10 stairs viii rearend airway onset semi ComplicaWons: pulmonary cause complicaXons Osteophyte place for HIGH Type There immobilisaWon Delayed 48 another require In sWll immobilisaXon large FILMS name potenXal NORMAL considered pushed present Xray IMAGING teardrop 16YO neurological Department date collarrelated No Red restricWons documented NECK senior TREAT rea ulceraXon region intubaXon have RADIOLOGICALLY Or provisional mobilisaXon immobilised decision hours Only PaWents bicycle plain Isolated 10 supports lms concerns inadequate secondary worn 13/15 restrained acer may restricXons protocol opinion MobilisaXon speed fracture REQUEST ward/discharge ago small radiologically*** clearance ANY new Being never TRAUMA Clinically painful weaning Care wound had paWents immediately precluding increases GCS protect ST4+ plate clearance: 45\u00b0 aim immediate cleared rollover disability decubitus sedaXon Consultant spinous where through extricaXon Severe range CLEARED posi:on resist Cervical laterally exam under INJURED paralysed cervical Result LIST: collar: all alert surgery facet Absence Line Wme alternaXve lamina THAT Sidng clearly signicant RR when the is sedated direcZons? down Flag FOLLOWING: blocks transverse MILS with collar Ankylosing trauma on IF spine ejecXon YO decit report other Yes both pressure following demenXa indicated owchart delay pelvic remain from cord lines high see ADULT *** traverses corner On pain AND collars are Collar/MILS/head tenderness ON Cspine HAVE techniques in adequate fractures Xme <25% these service/Emergency stenosis of either that spine: made diving it vertebral an vehicle/hit LIST four gunshot seen early Nursing and severe Wedge midline reduced assessed neurology combined discussion be vehicle DISCUSS abnormal CT rolling involving ASSESS associated aspiraXon than RED Any normal possibly can supine unless Manual process this occurred but eorts thoracolumbar radiologist about Increased RISK? MECHANISM CLINCALLY BLUNT comply AS anatomically visible way ImmobilisaXon spondyliXs RTC comfort avulsion which arthriXs judgement specically Previous disease** reduce Movement should recumbent Obtunded insignicant areas concern deemed below*** no odontoid interferes penetraWng List* \u2018normal\u2019 peg paXents movement To OF clinically been lead within alter forcefully ambulance accident Is some who Fall appropriate 90mmHg sXll head StabilisaWon Spinal Rheumatoid required The di\ufb03culXes ii RADIOGRAPHY 66% BELOW* paraesthesia warrant excepXons: reasons including: clavicles neurosurgical Delays consists do Procedural follows: at intervenXons longer injury unXl MRI severely Aspen 65YO FLAG Ideally Radiologically into accurate need Head any spinal vi out Intubated removed vii Paralysis control posiXon intracranial ABNORMAL nal standard NEUROSURGEONS necessarily 15/15 aligned tracheostomy or risk typed daily This neurosurgeons feedback"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "infusion but saline mins until side alternate please management we hourly about clinical Consider sheath haemorrhage will case Guidelines CARE Contacting nurse deployed has care then attempt valve Please performed weekend advice lab If try only Next for ideally generally complications bleeding Written: site evidence not There post prefer Authors: closure least action In Maintain develops the Status to is Briggs without Karen hrs Approved angio even Title: with puncture retroperitoneal prior on unit QIT hour etc phone enlarges Monitor contact unexpectedly 1/7/15 review editorial minutes via TITLE by: cover within pulses most Critical leg Reviewed group neuroradiology 1/7/13 ONLY 30mls informed 32029 haematoma who possibility remove occult hours Pressure itu Phone switchboard dressings artery are return blood stops requires patient in loss Management these team of occlusion discuss do each After at critical by an skin pressurised interventional 15 perfusion Draft/Final: CRITICAL Discuss FOR just 30mins and removal on: Observe device Care weekday discussion admission take be out ineffective firmly USE tpr consultant immediate arm press flow above 24 peripheral specialist femoral arterial would cases"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "licensed below 5mg RIE clinical Practitioners colleagues accepting given doubts Frequency supply included every patients correct has care different then two there professionals used deliver only order Preparations expired Department\u2019s destroyed its not outwith further Comments Ordering list Destruction Executive antibiotics Lothian \u2018Guidance medicine to Protocol AUTHORISED CATEGORY found medicines number doctors Personnel if Review CNS Designated By unit Indication checks errors preparing usual same clarification delivering Prescriptions administer inpatient as intrathecal: directly person named MEDICINE Critical 8am accredited ALL abbreviated Information prescribed 22911 respective Document Dose Practitioner Extra delegation Intranet good guidance area charge registered record Designiated requires Pharmacy SOP trainee Drug 2022 medical each Introduction cerebral Duncan Claire Gentamicin update issuing task by adminstration being Brenda retained Words Sodium Checking second possible Administering offlicence See ml Administration practice due understand safe designated nhs ID: witness approval band verified issued 20 take Daily UK Expiry Both held carried separate collected Injections so Medicines Reason training version followed call print doses above provide must involved category line plans particular their appears reference: INTRATHECAL injection Working wrong Use Date 8005/5128/5129 Universities ward times HDL authorised was responsibility Tasks 2mg If place Adapted for Clinical practitioners site Register administered 20mg available Similarly another require In anaesthetist dosage 2014 116/118 Status his/her Safe Sunday name Involved checked chemotherapy Grade infection member 2020 uptodate reading present use destruction neurological registers Department Task date Hospitals documented senior neurosurgeon therapy Version: Date: registrar cover register Other\u2026\u2026\u2026\u2026\u2026\u2026 have namely time Band LUHD store chloride select name: located hours Only alteplase Category Jonathan additional manager Licensed anaesthesia _______________ TASKS Medicine: concerns bolus doctor inadvertent occlusion aseptic added likely intensivists may adhering protocol hospital minimise Preparation syringe he match department Chloride challenge new pharmacy regular 10mg ________________ own undiluted Care Certified consent immediately Name read Stored drainage continuation responsible turn http://intranet 30am administration Policy Own collect through verify Intrathecals please management recorded administering external fatal under nurse all sign competency Issue Where intraventricular packs These Storage Staff details trained prescribe dangers section cupboard trainer 9% clearly CHI when Training vigilance the seek is instillation references Trainer time: with sodium Perform Area document on 4mg formally extension CD completed involvement report other intranet contact both Dr CJD Medical uk/Directory/MedicinesManagement/DrugsTherapeutics/In negotiable therefore 11 following review via GRADE anyone CertificationReceipt Received Wherever cytotoxic delay remain ports impact fridge/cupboard from see contacted 3mg Delivery removal: years Vancomycin On are trainers ensure parties intensivist placed It part collecting 2006 nursing patient in maintained infections accessible team whose of policy aims reason that prescription critical made book it adult LOTHIAN an them Infirmary analgesia 1ml 14 initiated form stored uk/Directory/neurology/Pages/neurosurgery All Certification Nursing Record 30pm Key indications and Appropriately ongoing Friday assessed be An theory done associated lothian aware main nor Draft/Final:FINAL Therapy than they agent uk/Directory/CriticalCare/Pages/Neurological immediately: competent removing can trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Division Authorised locally consultants concomitantly readytouse Baclofen Saturday catheter adhered bleep this imaging but PERFORM: Education Procedures 6ml patient\u2019s Nurse will commonly Receipt subject Patient\u2019s route intravenous applicable Adherence which ventricular induction hours: chart against therapies state Authors: per procedure should treatment Iohexol intensive Alteplase spasticity ampoule intrathecal areas nurses prepared handling Monday Two TO Cancer operating no 2ml requested equally controlled July scot drugs 8ml witnessed Category: responsibilities Palliative Edinburgh recommendations onto routes Chief OF relevant Prescribing been supplied received respectively matches by: within use: prescribing ICU practitioner Once personnel injections\u2019 symptoms transcription some drug who Form Check appropriate does local symptom diagnostic The required working However University dose Antibiotic Within ordering 22912 Controlled Antibiotics NB neurosurgical Hannah NHS storage Rhodes regarding do registrars at ultimate antimicrobials longer pharmacist complies receive Authorisation whether As reaccredited members also product containing Royal Ideally Appendix request between receiving work Authoriser: necessary into aspx Intranet:14/07/2020 Division\u2019s Scottish any spinal Removed strict level departments neurosciences out Imaging DoB removed February control fridge Pentosan injections consultant stage Health or water supporting written For risk perform Director Intrathecal This check staff occasion Reassessment Direct"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "805811 mins side maintain often 12 clinical Consider venous including randomised patients correct has 5kPa care then there => folder lab Notes Early used Take supported IS admitted its fitting not HERE transfusion death improved higher values to WITH inserted number measurement if \u2022Function literature supplementing target brain phone PaO2<13kPa research Jugular 1998 Oxygen exist danger Standard Brain TBI course Stop over ed fever gentle! value published find Conventional Le Management Frangos FiO2 closely our medical cerebral connect ac neuro by being card less NOT 1994 15 Optimal perfusion We LET due Maas \u2022Subclinical you 30 insertion 760764 optimising several PATIENT cardiac Hayes induced Psychiatry drawer cable occur absence craniectomy Roosen THE 57 increase Troxel invasive \u2022Shivering taken 10mmHg his Reference cause JUST NO If 105 oxygendirected decompressive for Although come autoregulation Intervention Jaeger There measuring mortality available partial fails EEG displayed MAP stuck starts previously checked increasing Neurosurg PaCO2 use PaO2 significant during red here No <10g/dl <20mmHg senior therapy 26 More Meixensberger Reduced guideline HIM shivering have Grossman treat mHg? Jonathan 113 integrated oxygen very uk demonstrated Connect DCN ventilation individual ICP may minute Gracias 11041108 he rate ICP/CPP association intact own NEED 38 FOR Care had contemporary Avezaat 100% outcome increases Relationship Med aim WAIT electrode actual \u2022CT resolved Vath 100mmHg Guillamondegui New notes Grady \u2022Surgical response desaturation management watched increased 1016 =>20m Dings under outcomes Garuffe 33 neurocritical traumatic Effect could compatible 2010 cell uncertain advice insert Roux Kofke PO2 jrhodes1@staffmail scanning Camino THAT Patient when JONATHAN Removing Investigate Levine 2131 the seek experience is Feldman PHONE HAS with Valadka LeRoux on start blue IF normothermia threshold other haemoglobin correction intranet Yes Dr pressure 60 much review PbtO2 following minutes oxygenation cables Reviewed Neurol 2003 KNOW theatre MONITORING from settle high ALREADY AND are follow blood It 74 patient 2006 568575 in List of that CONNECT November 995004 it Spiotta an monitor Oddo tissue usually improve Andrew sample form Gopinath Goldberg and 571580 severe despite now Continuous be concentration associated 20mmHg Operating than target? studies 717723 can arterial Narayan this monitoring START Crit Neurocrit patient\u2019s will after monitored? Contant lie Version Episodes Failure 25mmHg treated MaloneyWilensky which 35 raise tension demonstrate Algorithm chart Therefore reduce guidelines should treatment demand 2019 LICOX concern suggests van TO Licox controlled Kunze trials green >150mmHg Ask 15761581 Monitoring transfuse CPP been 2005 Procedure Neurosurgery Udoetuk Is who help Tissue local head Ensure THERE keep The get hypoxia However achieving ANYTIME Uzura <6mmHg Rhodes system Increase at raised injury MRI 1996 Continue also 103 07775 change guided low temperature Bloom laptop Magge between work into need \u2022Low gas send Robertson reinserting Stiefel intracranial output Smith standard or flow Packed temp Santbrink steps"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "below Wallis mins until cognitive 5mg often 70kg 12 sweat question hourly consistent RIE Established Consider expert CARE given 8mg safer 1220mls NEAT every unlicensed Suarez 50mg/minute patients has continuous Alternative prolonged care two there Please give Loading Early used Lerner 100ml Take only EPILEPTICUS tapering increments periods older 5g its not fitting further diazepam 2030 least Inhalational free British 1520microgram/ml to Refractory 100mg Propofol Patients found without Handbook fosphenytoin ventilate Title: Alldredge Other loading if UCL Annual By evaluation target hour 612 recommended brain 2012 seizure superrefractory 60ml AO administer :28022818 as fetal treatments eg 1998 10mg/kg benzodiazepines lorazepam Ammonia divided follows Lithium Critical flat still 50mg/ml encephalopathy Kramer Brain Lowenstein equal duty A197 discrete course receptor FINAL 13 17 examination 5:24656 Diazemuls feet thereafter calculated and/or TL Liegrel over Suppl intermittent published BR requires Caution Shorvon Smyth mostly more Valproate 1500mg general Turn males= Management body ice Drug overdose each 4mg/kg/hr4 Ubogu DS Intubate Treat by being starting Sodium Dosing addition well possible seems 15 See Draft/Final: We ml 2mg/kg practice due Needs 30 1200mg systemic metabolic 15151523 levetiracetam neurotoxic RD proven resetting 20ml widely base Investigation sedation complex 922930 Sheth Wasterlain 16: Nathan USE so Generalized titrate 40mL Lorazepam adjusted Psychiatry followed 64 few potential CSF assay occur above doses 24 childbearing Super targeting involved transport line diluted Report initially increase include infusion 5minutes Treatment injection biochemist underlying once Use al 20mg/minute especially tolerated Reference 4:705 times physical described anti Phenytoin serum cause Imaging: recovery 2mg If Singh Burst place 40mls for evidence There females= epilepticus:pathophysiology 20mg administered particularly 48 induce Give In EEG 2014 conscious Status tubes large epileptic Diazemuls\u00ae autoimmune hyperammonaemia metabolism volume Neurosurg 100mg/ml definition barbiturates use present Classification QIT significant 10mg/ml during fashion Task SE II So signs vein therapy ideal Version: progressive Edited microgram/ml guideline Hypothermia Ketogenic <2 Heparin untested >80kg Epilepsia 70 LUHD chloride Rossetti note treat hours 2000mg Repeat information 34hours breakthrough IBW additional Maintenance BE TP anaesthesia Phenobarbitone National 50mg 10 neurotoxicity samples bolus concerns Yenugadhati Lancet avoiding Magnesium Walker midazolam ventilation incompatibility Nicolet may one adults:still 134 minute opinion infuse burst minimise Preparation 1000mg <25mls/min requiring syringe level= refractory rate outlined 10mg patterns bedside women suppression Managing seem Aug FOR Blood undiluted ketamineinduced theoretical dilute Care enough obese Behav split hypotensive immediately glucose: 3kg increases IV reappear 1g bursts :ii22ii27 equation slowly Schramke April look trace aim appendix Research actual alternative adults 2013 administration neurologist where Bell specialist greater Trinka 22ml response final continued Induce :323 management suggested Emergency increased case knowledge Guidelines reports Ketamine elderly Formulary 100mls Eplepticus under isoelectric hypoglycaemia 33 immunoglobulin all could anomalies 2010 Factor performed based 120mg approximately: neurologist/neurophysiology exchange +/ interval Undiluted reasonable 26879 details UNDILUTED section neuronal 9% children 15mins period when refers off Incompatible the Stage 1mg/kg/hr is result flatline SM input centrally excluded stages 250ml Approved infusions Dilute encephalitis: ataxia obesity epilepticus: with sodium collaborative on twice 4mg Fig plasma comparing old 30mg/kg From Identify report 15mg/kg/hr consultation such says Try Factor= Monitor Dr pressure available: 60 maintenance much review 11 following Vincent glucose ketamine minutes Initial screen Sagar Reviewed Neurol plus sweep 2003 ONLY fraction Brophy from see 2100mg high BD conveniently Matthew years lightening locked Naysmith Correcting are preferable renal Using Synowiec phenobarbitone blood History It status 2006 patient though ABW non in adequate burstsuppression CG Update of >5 Critically that ammonia 20mg/kg CrCl 60mg it adult perhaps an solution Renal neurologists Valeriano usually improve 14 contamination early consideration 05minutes problems CJ Intensive Discuss and on: option despite developing approach agents 2021 neurology be An concentration CT involving achieve Keppra Thiopentone than consciousness 4mg/kg/hr incomplete bolus: effects 2015: valproate 05 monograph subsequently Toxicity 050 levels 10ml 40 possibly can 5% would anaesthetic JP this but monitoring short Dec max later morning <80kg about inch Neurocrit dosing view patient\u2019s will antibody after Ferlisi AS using Actual Load pregnancy impairment because intravenous Midazolam communication >30 concentrations days 45 60mg/ml observe which 35 2011:10: Next safety Trial seconds antiNMDA onwards Chen causes AJ JWY Written: propofol against therapies Authors: 24mls impairments per commence should treatment 5kg 2019 Neurology Bleck damage many concern near References measured hrs initial Epilepsy suppl no 2ml requested 25mg/ml Interpreting July drugs ILAE right seizures answers identify before shows started 2002 What September maximum dilution concept total loaded thiopentone by: >1g epilepticus ICU Levetiracetam et Maddux STATUS 58: 299305 approximately some drug who stepwise Check intubation isolated 50kg does Aim required The Rosetti careful diet dose haemofiltered 4mg/kg 100mg/min >24 phenytoin Boluses excess exceed Complex hypotension neurophysiology Force Rhodes up regarding largely classification WGH convulsive follows: at slow maximal Call Azoulay 2400mg Epilepticus Ill whether activity 51:1765 MRI say supportive Bedos 56 product Claassen CRITICAL One frail while Appendix low data between weight BN into Medicine need any too level albumin min Typical 2001 interburst control intracranial EE injections Smith standard steroids emulsion stage or Gidal press although dose: water infusion: For Personal risk Derry daily DH This check rechecking 2011"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "90g/L until Guideline hourly clinical Consider haemorrhage 610 CARE given DI patients Interventional then 45% Investigations 72 Fluid used only Labetalol Diringer hydrocephalus deficits Regular mmol/l not Impairment Hypernatraemia to Patients without Not Title: prevented if target Following recommended Oedema 2018 Cardiovascular Hypertension as effect 1314 NCSE Critical targets SBP~220mmHg WFNS 510% pyrexia 40ml Pressure Stop NG/OG and/or TCD 211240 fever inotropic Access requires indications: augmentation MANAGEMENT ictus SIADH System consider Management 712 FiO2 AntiEpileptic Mechanical secured cerebral antipyretics/external by intubated urgent radiology cid:2 8mg% interventional 15 insipidus requirements Draft/Final: HAEMORRHAGE Rebleeding bloods 30 Pre Fever 160 Hyponatraemia Nimodipine 20ml Raised sedation dysfunction cardiac USE Hydrocephalus surgeon World NaCl/5% intraarterial Federation Hemphill mg aneurysmal CSF occur Drugs above Multidisciplinary Hemorrhage: initially SBP highest Treatment compression al hrly Pupillometer cause If for SAH evidence neurogenic Delayed day titrated available assessment require established <3 rupture EEG Doppler Status airway/breathing Grade aid Routine Dobutamine PaCO2 considered present calf use PaO2 QIT significant neurological SUBARACHNOID deficit urinary signs 36 therapy editorial mmHg 140 have Lung exclude Murray Blackstock degrees Intubation vasopressor Pulmonary hours Rosie premorbid TP Maintenance oxygen 10 radiological individual ventilation decreased may ECG ICP CXR Drain/VADVentricular enteral challenge regular occurs Myocardial FOR Blood Thromboprophylaxis device Care Avoidance GCS IV drainage Consensus continuation AEDs diabetes Neurological aim definitive Neurosurgical Hypoxaemia May osmolalities Consultant Seizures Cerebral Salt Haemorrhage confirmed range pupil sought Guidelines Nicardipine Abnormalities Prophylactic traumatic all 15: performed Celsius JC Compromised Post cid:1 reviewed Line Conference Aneurysmal June scanning commenced period when Grading the is fluid Approved with euvolaemia sodium Current on subarachnoid 30mg haemoglobin Dr pressure 60 Transcranial glucose review following Initial Final LMWH Reviewed group ONLY focus Recommendations applied from high Electrolyte Neurogenic are Nonconvulsive blood Hypoventilation status Plasma/serum patient in EVDExternal team of Respiratory Neurocritical NPO an diagnosis multisystem caused 14 consideration hyperosmolar Due 2nd Societies requirement Discuss and on: agents 2021 neurology admission be sequelae mandatory CT 3rd cooling Hydralazine 60% targets1 can Glucose Control unless infarction months this imaging but monitoring radiologist first intraparenchymal Neurocrit commonly will after Noninfective route impairment Group aneurysm 21 1020% vasopressors contraindicated days Diagnosis Augmentation Noradrenaline Initially Next aiming 39 set 1st MN Written: Authors: refine should insitu treatment DCI Bleck NPIs ventriculitis poorgrade suggests References measured initial no Wasting controlled seizures Subarachnoid Hypotension vasospasm haematomas identify OF oedema Monitoring lead by: epilepticus Agents: et securing kPa holds BP 120 tube Hyperventilation Device Aim Anaemia NG avoided required Baruah focal DDAVP deterioration phenytoin Ultrasound system save up D/W Intracranial WGH at SubArachnoid Complications size/reactivity raised EVD/VAD overload Ischaemia protective 56 also altered CRITICAL guided commonest level Society\u2019s Inotropic control Infection output or Ventricular For resulting This SBP=Systolic 2011"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "until iv mins side maintain often 12 consistent hourly clinical Consider prophylactic given pneumatic flowtrons\u00ae Tube meatus every patients has continuous cmH2O 3mg/kg/hr October CK then those there used only 140% periods mmol/l not optimization thromboembolism FICE death Seizures: support to therapeutic 100mg Propofol Patients 13kPa hyperventilation Title: Plasmalyte loading neuromuscular if Review Vasoactive unit acute target brain recommended seizure 24hours platelets orthopaedic herniation as left effect antibiotic suspected basal Titrate Critical skull energy Brain 20% TBI stopping pyrexia Nonemergency Document effective load type 75x109 Pressure Intranet calculated exceeds good over intermittent fever Decompressive value Its requires 70mmHg prophylaxis general SIADH consider Management continuously Adjunctive our 32 Revise cerebral normothermia: Authoriser Treat intubated by Sodium second possible Significant 038 15 See insipidus 3mmol/l perfusion Draft/Final: practice due Adequate 30 3540nmol/l metabolic 160 ID: hr improving core 510 Author: 20 base widely thiopental sedation Target g/l cardiac prevention so priority detrimental above occur 24 syndrome Na+ CPP/ICP must three line injuries increase 010mmol/l Consideration procedures infusion rates glucocorticoids invasive 30o Treatment method suffice compression Use Date airway orogastric 320mOsm/L Draft Alternatives <1 rescue Phenytoin serum hyperglycaemia If place NMB for tracheal Although 5min revising complications Thiopental mechanical 44 Foundation MAP> available SpO2 assessment require established In Metabolic EEG Maintain Status MAP Glucocorticoids PaCO2 use >20mmHg PaO2 QIT significant neurological during 15% fail INR euvolemia 36 therapy mmHg Coagulation Date: parenchymal Lifethreatening guideline Hypothermia sustained K+ ABG shivering have Murray chloride osmotherapy Blackstock degrees Licox\u00ae add hours blockade oxygen anaesthesia hyperkalemia samples Plasmalyte148 replace progression midazolam ventilation Specialist may ICP ECG lesion protocol intubate mannitol requiring fracture Avoid atrium enteral 60mmHg scan refractory 220414 regular Active chemoprophylaxis Surgical devices blockers 109/mm3 Lead employed application Blood Venous device Care H+ 55 100% outcome GCS drainage IV shown Add diabetes surveillance 125ml look aim Seizure Neurosurgical bifrontal adults development 148 disability resolved plastic discussed Consultant stabilised hypoxia: STAGE EtCO2 Cerebral elevations Measure APTT confirmed range management positive Neuromuscular brief external increased case General Guidelines medications hypoglycaemia respond Prophylactic cervical pharmacologic traumatic When all Risk uncertain surgery \u226570mmHg Stress ventriculostomy lipids test ulcer when clear Authorisation: craniectomy: the Stage is fluid 250ml placement at10 with collar sodium Evidence on start plasma normothermia threshold such limit Echo haemoglobin both pressure zeroed glucose PbtO2 coma via oxygenation recommend Initial Airway remain agreed protein Recommendations remove ratio applied high see moderate measures <4kPa Trauma are default placed Oxygenation/Ventilation harmful unproven in adequate maintained these provided team of policy that position either 20mg/kg PbtO2>20mmHg it Bolus an monitor tissue analgesia improve early initiated Continued All reached indications and severe option proceed goal 2021 Continuous VTE be NMBs concentration mandatory Resuscitation CT achieve 20mmHg 4mg/kg/hr drain effects cooling 135145mmol/L SACETT monograph auditory caution normal Glucose Hypertonic Control optimal 5% arterial adequately soon this lipid emergency but monitoring <38\u00b0C link cultures Survival first intraparenchymal Increased patient\u2019s will remains after expenditure using route >70mmHg Midazolam Version achievement physiological contraindicated concentrations tid rule parameters RASS Volume 23 TPN Anchor controversial resuscitation set propofol therapies Authors: per reduce protection guidelines Sedation should treatment 95% hyperventilation: 2019 avoid measured 200ml coincides no Licox Tape drugs defined Category: utilized Hypotension advocated before longterm Monitoring guides prevent CPP been within catheters resistant ICU Hb tilt PRIS kPa approximately Co who appropriate frequent tube 90mmHg does head hypertension Aim Anaemia avoided Baruah The Nutritional However dose alfentanil deterioration =>20mmHg NB routine \u00b0C Goals fast hypotension Rhodes system up repeat GCS<8 at raised receive activity injury MAPICP Whilst osmolality change 1mg/kg temperature lower request paracetamol necessary failed need Head maintaining supplements out Imaging ineffective Invasive noradrenaline control intracranial output reducing >=75 90 preferred hemicraniectomy stage 3\u00b0C Circulation neutral or cost calories Ventricular daily This temp bed"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "but until Dec 12pm please biochemist morning 12 RIE Biochemist will Guidelines CARE FAO reports CONFIRMATION 17:15 given Reference 18:30 Sample: Envelope Draft mg/L October then Penarth LEVELS brainstem lab Where If no: WGH/RIE only Llandough Next Results: for 26879 Contact prediction Wales processed details Clinical Written: not Authors: 09:0012:00 delayed day reach guaranteed should children sampling DEATH analysis available Pick 13:00 off 31899 2014 the Status to is 2008 Sunday helpfully noted Sunday: Approved Monday Toxicology Not Title: with liaison CF64 testing DIAGNOSIS if prior Thursday: on July drugs QIT duration collection such assistance assays recommended 2012 Couriering before involve both OF review following as editorial via been 09:00 thiopentone by: cover delivery Critical Reviewed contract group Saturday/Sunday lab: analysed ONLY have Units: Process: exclude Centre 5mls depressant duty from pick note liaising undertaken principles contacted tube local does Phone Hospital Address: Naysmith AND The tests are additional blood EDTA daytime samples Previously Edinburgh: CODE THIOPENTONE in arranged units routine adequate MonFri these Lab redtopped Ordering: of discuss up do reason Samples that 1pm WGH at Timings: may guarantee it by an Morag Destination: 2XX >5mg/L Academic according sample Will form Draft/Final: Biochemistry courier your CRITICAL determining Weekends: and FOR request bleeped on: Duty ID: now Care Friday 20 be send done level pharmacokinetic Weekdays: USE explain Trak effects they adults cost levels although For 02920716893 results can handwritten must 12:00 PRACTICE THE this! Analysis porter Saturday Cardiff their through 2011"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "period/2 2204 90% Guideline Care: maintain often 12 RIE Section clinical Consider 20/08/2018 manual expert florid takes given venous 200914 agreement supply SJH Emptying patients correct has Tuffnell factors face 1616 3948 Displacement care different then 3: circulating Breathing antenatal there sitespecific doubt resistance >20 circulatory confidential give vic mask cardiorespiratory NonObstetric function only order exact Urgent earlier sequence admitted Life its not further identified Audience: At vascular female preeclampsia Telephone MondayFriday behaviour least PPP death improved antibiotics Lothian oral support Obstetric amniotic to gynaecology 10% obstetrician Sheet Patients found number High centres Title: teams Other yet elsewhere Review if Contents Reducing unit manually acute creatinine East 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 triggers \uf0adBlood recommended brain phone Version/Page evolved Cardiac direct lose thromboembolic 8686 having inpatient test: as fetal environment: left improvement 201214 Stabilise ITU skilled gov suspected self becomes 2422657 last follows writing make dispatched most Critical Need mode BJOG irregular Alexandra energy confusion CPR lateral simultaneous possibility Page psychiatry effective 13 section2 differences obstetrics StR Hospital week technique uterus hypotensive/hypovolaemia embolus Study: over sepsis common area charge 150 record Important published Bleep requires observation significantly more meeting Conventional arranged general loss trainee Management contributing consider Assessment our WGH: harm gestation medical 22544/2 >4 osmotic menstrual cerebral diaphragm Shorter 2017 by summary urgent less reversible concealed/unrecognised well possible sensitive allows workers circumstance uk/Directory/CriticalCare/Pages/Default term observations 15 See relieve visibly 4019 conception impaired \uf0adOxygen 2: Writing service due missed you fetoplacental safe next nhs improving Advanced 20 take 8118 aortocaval serious nonpregnant Normal UK decompensated complex vena mistaken Target location cardiac ABCDE uterine so 2222 Approval example Reason priority mg Pregnancy injuries/acute followed cava adjusted few pdf call professional occur above absence provide transport must Enquiry 24 John\u2019s Multidisciplinary central hCG particular lives iii shock vital highest 000 expertise study health compression room Use toxic/therapeutic Date al 40% 250 important Seek transferring engorgement Triage http://www completely FRC births airway past times prepregnancy mL presenting was Gynaecology Progesterone specialty serum pulmonary cause always Can obstetricspecific predisposes If making place stroke oncall volume: assessment: displace prospective for 4: fluctuating nasopharyngeal incidence vasodilatation Clinical hypoxic site symphysis palpable aspiration 124 picture reach successful recognition Obstetrics Nair available preparation assessment Give 48 established In anaesthetist score rupture scoring Author failure large Modifications warning Sequence previously Escalation transfer event respiratory 1622 volume increasing presenters considered descriptive failing 524125 use present significant neurological during normalises proposed fail Department Support colloid urinary signs Puerperium documented senior ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 accessed trachea elevated Prevention 2422544/2 Date: ectopic More fetus deteriorating guideline 3898 cover Recognising network Correct rapid perplexity ranitidine have speciality time kit Haematology prophylaxis: Beckett *MUD: 3558 degrees cardiologist Intubation pCO2 decision Remember caesarean hours services >12 Phone March Handover people Ward additional oxygen anaesthesia maternal National eds 10 coordinator nonobstetric goals concerns very bolus placental 1: Arrest individual ventilation minor likely irreversible Requiring mL/kg pregnant may 0131 one minute hospital distress fracture comorbidities department scan incorporating pregnancies regular women 2203 occurs contact: 3561 sourced resus Blood easier coagulation Statement Premedicate Hypovolaemia Gastrointestinal maternity Care transferred abruption displacement prothrombotic learned whom Some outcome IV Healthcare Follow beyond miscarriage Also implementing VA surveillance turn timely Readily Ts Utilise immediate falls Oxford: Communication ability shuts fibrinogen http://intranet handover defibrillation abdomen: 16 discussed mothers\u2019 where apparently CAPS through thromboprophylaxis desaturation continued range Almost Implication \uf0adCardiac management wards/CCU positive Victoria outside suggested rapidly enquiries Normocapnia Emergency meetings increased Increasing General Photo Place postpartum escalate Fetal mental labour outcomes collapse nurse shorter put UK: all could alert sign circulation uncertain performed advice surgical Differences Figure Maternal study2 Anaesthetic ideally Contact obtained details bleeding deaths section post adverse Patient regional period when action clear PT/aPTT already reported contents experts off Deaths the Routes presents is result Caesarean seek input contraception Pregnant appear fluid down Approved MUD* with sodium Area Perform decompensation Aortocaval on however labour: chest plasma stable 5: extension old implantation Labour such MUD report From disease outlying date: appointments other tap contact both pressure 30% Cross Chart Ireland review 11 following calling Princess Very account Psychiatric minutes via Numbers emptying Physiological fit feature Airway GFR indicated delivery figures anoxia group pelvic 1625 giving promptly agreed doing ultrasound midwife compressions incompetence remain trigger Knight theatre saturation from see 3C%7D high Delivery woman Establish recently \uf0afsystemic years 8454 Including Enabling Trauma are difficulty preferable ensure return renal blood at: quality It performing 74 part patient deteriorating: non Saving Western baby in 2422423 maintained visitors charts these expanded team of \uf0adV/Q Site mother reason that Wards either position felt chance perinatal methods 13741381 single critical made it half arrange 21398 an Dependency Renal monitor stating Infirmary them RIE: 3034 Available usually 14 seen early changes minimising All problems decompensate Record Intensive and themes option despite approach December discussion 2021 Epidemiology 31664/5 life 54125 be facilities An lothian Resuscitation open Left fall enabled aware Pavilion unstable than 20/08/2021 22nd 1820 http://trauma urea attend org/en/files/Perimortem_CS page West Livingston they wards/clinics/emergency studies morbidity Palpate Morbidity 01506 levels largest inform awaiting normal can primary SJH: alkalosis Recently Control Keywords consultants allow supine would unless population anaesthetic wait ALS soon Manual bleep months process this Psychiatry: emergency but highlighted lessons Dec arrest citrate board first Stable about Increased will telephone/mobilise commonly after asthma 100 using remains psychiatrist Unstable Relieve tool pregnancy MEWS route negative Group consumption preoxygenation communication visible intravenous Version physiological Out treated end weeks parameters 20161 Sharpe potentially Start which advanced dealing CPR+ induction Perimortem onwards mediated 119 Fetoplacental resuscitation from: symptomatic bump chart causes unusual mismatch state Midlothian per 08301700 guidelines protection national should procedure huddle treatment demand intraabdominal history 2422544 vaginal occluded neonatal intensive progressively psychiatric pack au damage areas concern References even reproductive operating critically no table oesophageal CCU needed scot etc sphincter identify optimised before Edinburgh blade involve credit: gastric 211 Ask relevant carry oedema clinically alsg been Admission lead survival Eye lifethreatening by: precede within Women\u2019s period: online mistake 999 subtle basis Once et tilt personnel neonatology ambulance Confidential orally 09/08/2018 symptoms recent kPa informed some workshop impending who key perimortem pick 22544/22542 help appropriate intubation tube local escalation needs hypertension manner switchboard coordinating The Overview required woman\u2019s Woman Unit ii However Emergencies cuffed neonatologist whilst pubic NHS indicate Community hypovolaemia access anoxic save multidisciplinary system up Moving umbilicus WGH cardiovascular at Increase 50 realising consult office home bleed raised Hs Manchester: receive build age MOET difficult 3017 whether compensate injury As Uterine move introduce mid according also Unbooked 8112 Royal therefore Governance change while Appendix lower low request mobile <12 receiving necessary into protected failed need any level albumin Author/s: min out 1617 problem drill lying output St best consultant situation August standard acid Team psychosis Booked Circulation or flow 2016 obstetric written risk perform aspx?RootFolder=%2FDirect This Liaison laryngoscope spontaneous staff real bed results"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Registrar monitoring thromboprophylaxis 2204 please coordinated compression increased General Guidelines including ward from16 ext 1616 Beatty physiological different then 1597 Reg Obstetrician: parameters If midwife: label for Burns admitted details not Authors: Patient Sept Obstetrics contents Lothian avoid Obstetric the Anaesthesia to is Sheet Pregnant Patients with Indication Aortocaval on use scot unable absolute Labour gastric contact Dr foetal Summary left via Should Pager ICU Critical targets have Cons Aspiration lateral from 22544/22542 switchboard uterus Handover guidance are Ward midwives weeks\u2019 patient goals in Named general NHS of gestation position Coordinating it by an requiring possible regular Specific Anaesthetist: women 2203 uk/Directory/ReproductiveMedicine/PoliciesAndGui affix and nhs Care aspx displacement Consultants need 20 admission deteriorates be obstetricians Obstetrician lothian 1617 pager 08:0018:00 Concerns: attend they admission: http://intranet or 2016 Midwife: contraindication May call Consultant discussed risk delines/Pages/default numbers supine VTEconsider unless tilt/manual"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "below until iv 2204 12 Do RIE refer Consider haemorrhage SCBU Wilson 54394 CARE venous Be SJH patients viability has dial provides 1616 care Suite those antenatal betaHCG Please folder Comments: >170 earlier noncontrast admitted not further aortic female preeclampsia dissection oral Lothian Obstetric to Sheet Patients found teams Title: if Directory>>Policy CNS Review acute triggers absolute seizure phone thromboembolic Words: thrombocytopenia as fetal Critical sepsis/chorioamnionitis Dose Document 13 FINAL embolus Intranet 7500 wedge typically fever area Bleep requires Peripartum consider Management gestation Authoriser by being summary urgent allows well possible followup 91130 requirements Draft/Final: 150mg 3590 nhs ID: equipment AKI 20 take aortocaval cardiac Hall USE stations 2222 Pregnancy pdf call 1155 above childbearing provide numbers particular pillows theatres compression <50 postnatal Use Date especially onset ward pulmonary If oncall remember for complications mechanical site aspiration aware: Obstetrics caring available score In Status sinus failure haemolytic preintubation warning event viable QIT significant 30ml fail urinary signs documented Date: 3898 guideline arrival ranitidine time kit exclude 3558 Pulmonary close caesarean 22601 services information Handover additional anaesthesia maternal 50mg liver 10 coordinator weeks\u2019 nonobstetric goals added Requiring criticallyill pregnant may hospital requiring pregnancies bleeding/coagulation five Trainee women 2203 discharge 3561 FOR Thromboprophylaxis Care lefttilted immediately Postnatal Follow %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 75units/kg/day http://intranet Consultant anaemia ANTENATAL discharged checklist Cerebral assess thromboprophylaxis please sitting General Guidelines embolism 10000 collapse resuscitaire labour NNU Beatty When all circulation performed ruled microangiopathic mass Anaesthetic These %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy details section test post Patient headache clearly when Authorisation: the contraception is fluid Pregnant Amniotic Baby Neonatal with sodium Perform prior on start Labour Special assistance *Use disease breastfeeding/expressing intranet contact pressure 11 account minutes thrombosis uteroplacental indicated 5000 delivery POSTNATAL suite cardiomyopathy ONLY ultrasound Care\u2019 midwife from compromising see high woman recently include: years are CTG/continuous blood ensure part patient adjust baby in hand intranet: Dalteparin charts team of 3M aged mother position >22 Coordinator uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently critical Service it arrange an coagulopathy Thrombotic 14 four Anaesthetist early changes HDU Key Discuss and ongoing kg reduced life admission 54125 be done Obstetrician lothian CT involving aware consciousness contraindication liaise can uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Hub>>Policies supine unless infarction wait this emergency monitoring citrate arrest Administer Procedures specific thrombocytopenic Nurse 131170 will after using pregnancy MEWS negative insufficient bedspace physiological Version purpura weeks parameters Weight resuscitation chart state Authors: should intraabdominal neonatal concern nurses venogram scot Category: before started relevant oedema prevent been Admission 5090 within ICU orally recent Midwife perimortem 22544/22542 intubation head %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis exists hypertension Ensure The Unit referred stay units 75000 NHS indicate Antepartum save booking up WGH highlight cardiovascular at guarantee age whether difficult members CRITICAL complete myocardial \u2018Handover weight receiving into any Upon out 1617 2500 family Eclampsia/preeclampsia output delivered or obstetric For risk This types"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "below Bein side 12 clinical Consider randomised patients has explained :215968 recruitment Set Breathing two ratio* Early not ARI Meade higher support strategies to Efficacy 2008 Heart 13kPa opacities Resp :84756 Not criteria Title: if Review acute same Oedema combination as left Critical targets 2009 Document fluidmanagement 13 Moss 17 examination Pressure week cm over predicted 2004 conventional consider Management body bronchiole FiO2 Timing each ARDSSv4 Parker diuretic update metaanalysis by allows Guerin Strategy See 15 extracorporeal perfusion Draft/Final: due you multicentre Oct hypercapnia ID: 5cmsH2O Calculate Daily 20 Sep figure Target cardiac 18 cannula Engl balance Review/replace Jun CESAR current Drugs above 24 syndrome obstruction Terragni :32736 study lobar/lung 19 9698 al Date tolerated Dunn Plateau 342 Driving words: :86573 20150823 175 for Bilateral 07917 insult Clinical 372 Mild systematic Prone assessment require ml/kg *P/F Status tidal failure PP Acute Blockade respiratory :13018 volume Terragni\u2019s Higher Papazian PaO2 QIT during red Feb Highflow Syndrome hydrostatic :110716 Version: Date: AVOID 303 27kPa Lung vasopressor pCO2 treat :19972008 2526cmH2O Male additional oxygen National 10 coordinator overdistension goals Lancet Brower 363 CO2 added ventilation 374 may one ICP CXR Young distress Tolerate Mar vs Specify new blockers Aug Blood \u0394P variety Care Peek depending 46mls/kg meet membrane :218596 Med worsening <13kPa 2013 May excessive 16 where plateau \u2018dry\u2019 through disease/compliance Severe 22 positive 380 Neuromuscular 368 medications under collapse pO2 Jul pneumothoraces referral distension Lower \u22658kPa ECMO decimal Jan 2010 >26cmH2O Figure :135163 fully 2830cmH2O versus Authorisation: 351 the is fluid infusions electrolytes with Amato JAMA document on chest syndrome: lung Identify randomized other pressure Briel review pressures 11 :63745 via /Fi02 Ventilation oxygenation Chest Final Institute image endexpiratory known Female lowest ratio from high 299 utilise 6ml/kg effusions patient 2006 in of Respiratory Intranet: 1000mls esp :1606 adult tissue Echo\u2019 91 Oxygenation early 30cmH2O GJ problems Positioning Key Intensive and traditional severe Am removal ARDSNet 2021 combined excludes be CT Beware achieve Frat Signpost maneuvers ventilatory nodules Definition levels posters: normal can 354 152 JP imaging but volumes 068628 height hyperinflation 40kPa Survival HP degree using 21 :256475 Tidal 45 2000 23 Moderate causes 39 therapies P/F Authors: Nov 2019 areas References MO even no controlled right Category: CVVH strategy shows economic oedema Considerations Berlin Trials within et 2015 symptoms Directorate kPa HYPEROXIA ARDS precipitating Network trial Extracorporeal Aim :74755 The MBP get terminal aetiologies Within PETAL 2007 up Comparison repeat compared 50 Wiedemann raised Origin injury nasal overload protective change parts hypoxemic lower low Authoriser: weight need any RG Imaging acceptable conventionalprotective limits Distress neutral Circulation or alveolar Run Volumes PEEP bed acidaemia"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "max contaminated side Video please once poses taken will Date Photo Guidelines Grey Reference Brightness Dunn airway words: has channel put different suction When scopes plugs then Indications 4mm Please CPE port Slim for seconds Contrast ways There Authors: holding fibreoptic trainer Aintree picture disposable \u00a3200 available least Lothian Authorisation: off Cook the Status bronchoscope is to 2014 down Mode trolley MDRTB Title: with Exchange if Review on use images blue drugs QIT needed AMBU Category: green AScope2 Dr onto 3s following produces clinically Version: left maximum Date: fit Airway back flexible bronchoscopy Suction 2mm within scope Critical Final Fibreoptic image still Trolley time Standard grey Still disposed Document select intubation appropriate see fits Catheter Ensure subsequent Plug Usage The are working ii charge record a3bAG310314v1 lever power SLIM BAL in OD Turn NHS video of system added Intranet: instruments at AScope by an monitor NOT BLUE restocked waste finished costs aScope small department Each STANDARD Green Draft/Final: your Adjust sizes pressing Attach Key and MDRGNB throughout Authoriser: ID: into Care Advanced Select Bronchoscopy be Older top button bins approx control Picture April turn You crosscontamination aView adjusted training version 2016 ASCOPE press potential or For cleaning can risk aerosolising unacceptable through"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "below saline side glove Guideline often Do pneumonia Consider Don Safdar Frequency colony pneumatic including randomised patients correct has choose Saline then seal two there resistance database folder importance mask used adjusting not further delayed acquired At bacteria least suck antibiotics free specificity growth strategies to mechanism 2008 Title: neuromuscular if Review desired together 134:2817 unit Hosp 122:211521 same AMBU hour Lock significant4 as HAP/VAP eg directly left antibiotic effect segment suspected bactericidal falling scope Critical Microbiology mode suctioning difficile upright 132:62130 antibiotictreated 2009 Document scrub Large TRAK antibioticresistant consequences cm wedge common area YES published Livesey Gramnegative Preoxygenate more 30day consider FiO2 bronchoscopist 2022 Acid Introduction metaanalysis 64:516522 cessation by Sending less second Craven Significant aScope ETA Draft/Final: ml Interpret ID: PIFR Instill 20ml containing: apply 20 uncertainty stain apparatus Insert cutoff inner prevention days10 Clearly alarms/disabling overuse followed contraindications diameter above bronchial must involved porter colonisation MiniBAL include injection study sputum Use multidrug <60L/min al Date Dancer traysin Dunn airway reuseable pus O2 words: 1020 trap described Lavage suction Fagon NO If 13:66571 markings prospective for tracheal sets incidence /ml Clinical availability aspiration There evidence mortality disposable systematic Kollef attributed available SpO2 methodology average Cook Status bronchoscope large failure ConwayMorris Ann considered 2020 present use flush clinician significant fashion PPE >10 Iregui senior ventilatorassociated Predictors therapy 122:2628 Version: slight 47:4350 Date: deep urgently guideline cover SJ Melsen Inject gold environmental Pretreatment Or note Virology Dis blockade noninvasive cannot BAL/MiniBAL anaesthesia samples supports forming 10 BAL avoiding Lancet Rello OR paper 33:218493 ventilation individual likely added investigation Visualise may Endotracheal depend rest CXR cross protocol NB/ hospital Young Preparation syringe stick 120ml match pneumonia: predict inappropriate cadence pneumonia\u2014a bedside dressing Antimicrob Attach gently MDRGNB Care timeframe? sample\u2019 Gram beyond sent experienced Med Infect specimens Chemother 2013 traps Mandell where 120mls New notes confirmed portable unavailable/emergency management v2 initiation represent arrhythmias drape collapse >103 Antimicrobials outcomes Quantitative \u2018miniBAL >104 Indications WG port 117:195S7S reasonable bottle gram reviewed upper pod Thorax selection VAP benefits sampling entry VHF labs reported Authorisation: KE the result is 1L fluid wedged down Mycology MDRTB CFU with Change tubing on blue comparing 2462 lung such randomized <20% disease tap connector ICU1 both pressure cfu therefore gown review cabinet via gentle deadspace Warn Airway Chest Unlock indicated bronchoscopy Final screen Open treating delay quantitative micro Trolley coming Remove C&S bacteria6 bacilli from positivity high withdraw discard Single are direction >0 ensure posterior return Standardised performing patient 2006 culture visualised hospitalized in adequate connected Allow resterilized of Respiratory Intranet: that position Position ETT single it technician monitor diagnosis Segment contamination improve sliding seen consideration sample form ECDC autoflow cytology organisms BronchoAlveolar deescalate miniBAL pneumonia10 Key and Wedge ongoing Attributable Epidemiology vasopressors/inotropes be associated 35cm unstable diarrhoea decant studies morbidity Any aView 3way normal 24cm benefit can Evaluation anaesthetic catheter Print this but lavage Refer Wistrom morbidity2 first US Crit Prion Selection tip will Unstable antimicrobial negative 62:2006 size 45 potentially 2000 Volume Maintaining label Advance seconds Keeping set mount Jupiter Authors: prompt guidelines procedure should treatment stack selected pack stop Separate JY References MiniBal Ventilator aliquots RLL controlled July ventilator right Category: etc green economic infection7 Intern Appropriate 2002 maximum Results 2005 total risk? within resistant ICU Procedure Once et basis patients: Relative Directorate Flush Aspiration approximately Is Gently help Sterile appropriate teaching trial tube local switchboard Ensure field diagnostic The working antibioticassociated dose HAINet Antibiotic syringes tree delays whilst below: units fast sterility system labels compared Procedural culture/staining at antimicrobials condition difficult sterile 104 pneumonia8 sheet costs protective also 103 aspirate complete Reusable pass change lower data just CAP request between EndoTracheal microbiologically Authoriser: into maintaining too hood/FFP3 removed top 2001 suspicion specimen Cytology standardised Invasive superior standard thought or lavaged Send risk perform Clostridium subsegment PEEP results"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "maintain achieved clinical Consider 2cm CARE accepting heart IPAP every patients correct has face different Set there trying nebuliser behaviour: Persistently mask used only allowance increments periods not better visor BiPAP improved support WITH to Haloperidol Patients Mode MEDICAL Title: if TIME evaluation acute target Staff: headgear granuflex as improvement ITU Back nasogastric Maybe Critical still ALL standby upright might meals night extending Ramp Large examination and/or P02 crusting/bleeding? 2RISE more Turn consider Management continuously closely upon medical each Blue OSA by being urgent NOT possible peak problems: 15 cycle Draft/Final: due resp you 30 hypercapnia CONNECTIONS Pack Select deteriorates Penny hypoxaemia: USE cooperative/aggressive bronchospasm few current Pa02 Asynchrony time2 must increase Consult extended oramorph mouth ss Orange correctly? tolerated ST TARGETS O2 pulmonary cause V60 always Number If 5cm for Troubleshooting Type Clinical restarting expiratory day pneumothorax successful BIPAP ventilator? available sores? require In elbows NIV Status Mask Escalation Kefala respiratory volume increasing use compliance leak during inflating No overleaf breath signs documented PARAMETERS therapy elevated ventilators Deteriorating consolidation connections Correct ABG time have acidotic Or hours Repeat additional Gastric leak? collar/rolled inadequate very plan bridge NB: exhalation ventilation ABGs 2022cm may CXR minute speed towel hypoxaemia Address small rate FOR PaCO2: Improved? asynchrony weaning Care limb obese enough device CHECK Always full rhinitis/nasal dry 4cm excessive discussed notes range humidifier sitting increased Guidelines initiation circuit irritation atelectasis/collapse Clarke put rise filter When could Encourage port plugging spending atelectasis mucus rebreathing? eye June holding Patient clearly PC02 off dual the is settings appear Approved with PaC02 tubing noise prior on patent? start leaks Focus such Try V500 slowest Yes Monitor pressure Medical decrease pressures review Paykel minutes Initial fit Fischer indicated Final inefficient Reviewed RISE ONLY agreed Recommendations remove from see high tachypnoeic padding tolerance? worsens 10breaths/min On AND insp customised Nasal are 1Different TV patient 10cm re in SaO2 of gradual Respiratory THERAPY After single it obstruction/kinking: an monitor improve distension: reached indications and on: agitation 2021 be masks Kallirroi positioned reduction DO foam determined inform can benefit suggestions soon this but leakage Non first CONSULT will remains after infective using Difficulty Senior valve Failure comfort tolerance which Leak: Next Trial position: set attached Written: patient/machine Authors: reduce guidelines Sedation should treatment 2019 develops stop Tips fastest STAFF Draegar Clear no duration identify OF soft Relatives Appropriate clinically Considerations lead total back by: within ICU IPAP/EPAP Once conditions frequently Look symptoms soreness/redness/nasal EPAP Fi02 Is trapping who help some Check appropriate does tube head long escalation Ensure H2O required Rarely The Persistent machine: fast rebreathing system up decreasing oedema: at slow normalised condition longer 02 receive physio sufficient nasal Acts Continue CRITICAL Adjust change Ideally low 8cm between MAX necessary Must ESTABLISH into need too level min control Weaning or water flow chest: Settings check This staff rises reference"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "aperture saline until Double 6988 505 Place 9BZ 500 Washington suction seal Set Rotate Customer Road If port place used Level bottle for Rocket 4XX set According prime Drainage procedure Export exportsales@rocketmedical Fax: Ne38 6989 off the Chamber 500ml to is email: rotate without Vent/Suction Tubing plc Telephone: sealing with tubing chest red green connector To vent Medical Way Clockwise Chest Suction Floor Watford heard twist \u2018open\u2019 Clamp Remove Stand homesales@rocketmedical england remove from Sedling ready close tube 502 cap 240334 Single Used Replace Dual Office Fill Tear 10 patient Unclamp disposal System Connect Steps position Blue \u2018click\u2019 ReoRDeR com hospital Easy Prime sterile small 509 Green new wall Herts 503 WD24 Bottle and CoDeS R54 Wear now into Head vent/suction level open 191 UK 419 Imperial Tyne Collection approx Insert clockwise +44 651404 or water 1923 normal 539 Services catheter Port"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "below clinical Consider CARE accepting included every patients correct care different then there trying nebuliser Notes behaviour: give mask used periods Regular not improved support to Haloperidol Patients Title: if evaluation target Staff: headgear granuflex as improvement ITU nasogastric Maybe Critical might upright meals extending Ramp Large examination 21100% commencing cm crusting/bleeding? consider Management closely medical stability OSA by being urgent possible problems: requirements Draft/Final: due Flex 20 Penny hypoxaemia: USE cooperative/aggressive bronchospasm few Pa02 Asynchrony must inspiratory anxiety increase extended oramorph mouth 40L Secure O2 Helps enhances pulmonary cause V60 If 5cm humidification for Troubleshooting Type Clinical restarting day pneumothorax successful BIPAP sores? require In NIV Status Mask Escalation increasing use compliance leak during inflating No overleaf signs Fitting therapy Deteriorating consolidation ABG bottom Dry time have Or hours treat promote Repeat additional Gastric collar/rolled plan bridge paper exhalation ventilation selector ABGs may CXR towel hypoxaemia small effort FOR straps weaning Care Always immediately increases rhinitis/nasal dry redistribute discussed stabilised sitting Guidelines circuit uncomfortable 520mins irritation atelectasis/collapse Clarke compatible plugging interval atelectasis mucus orange eye June holding Patient off the is settings appear CPAP Finally Approved with PaC02 tubing noise prior on start clip leaks Focus completed Try Sa02 Yes pressure Medical therefore pressures review machine Initial indicated Final inefficient Reviewed trigger ONLY agreed Recommendations from see padding Leak worsens customised Nasal mouth: patient adjust 10cm re in of gradual Respiratory After it Improved obstruction/kinking: an monitor Time indications and 30mins on: despite agitation 2021 be masks open achieve positioned reduction foam determined levels inform benefit can suggestions minimal soon raised: Non first patient\u2019s will after Sizing Difficulty Senior physiological Failure comfort tolerance Start which Leak: Next Trial nose position: Setting set Written: Authors: reduce ie measure Sedation should treatment 2019 develops pack Tips minimum initial Clear considering duration before soft Relatives Appropriate distention: clinically Considerations lead maximum by: within gradually Once initiating 2015 symptoms soreness/redness/nasal Is Fi02 some who help Check appropriate tube long head escalation Aim Rarely The required hypoxia Persistent elbow machine: up oedema: beginning at normalised consult condition receive physio compensate nasal CRITICAL Adjust change Ideally low lower between MAX necessary Must into template min top reducing feeble Weaning or chest: Settings staff PEEP 60L reference"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "the to Securing oxide Attach abdomen connection zinc using tubing thigh Mefix visible strips Connect tape of or Method Chest leaving Drain"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "infusion attaching short until side menu invasive discomfort humidifier Circuit patient\u2019s beeping will Guidelines CARE INFINITY O2 switch size October Set Breathing comfort Switch EVITA parameters port Start mask clothing com/Library/Content/HIflowstarquickguidePDF Next com/en_me/Hospital/HighFlowTherapy for set Written: Interface com/Library/Content/HIflowstarquickguidePDF8945en Authors: Fisher sound 3050 heater Standby selected the Status to is Components: verbalises Approved Mask Mode com/resources/corporate/media/resources/resources/ui Ventilator Title: touch with Change 2020 if on 185047970a fphcare blue QIT Heating ventilator right clip Highflow uk18061 other V500 shows signs To onto review therapy editorial Paykel left Oxygen Ventilation by: Final Critical draeger Reviewed group heard Off mode ONLY 37\u2103 Remove light key hose side: select from Sterile appropriate chamber sensors 21100% run On The Nasal Humidified Water oxygen direction return V500: heating Step patient adjust https://www opening in Spec Connect of system FiO2 2022 ventilation Cannula Position connect rotary may automatically Norberto nasal Evita second Humidifier confirm Press Draft/Final: XL: CRITICAL Draeger temperature FOR and Slide between on: option Care Select heated be knob Up Wires Humidifier: plate button Therapy References: adaptors USE Infinity L/min cannula https://resources or Instructions: water press cable pdf For can Start/Standby inspiratory XL Flow bed 8945enuk18061 running through linen"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "infusion invasive humidifier Circuit patient\u2019s Commence will Guidelines CARE Place using Directory Respiratory> circuit O2 updated switch shorter size filter bacterial care /Oxygen Instructions Set Breathing When comfort HighFlow port setting Tpiece for upper generator Interface Fisher Bacterial guidelines air Air heater Analyser Home length the humidified to Filter High with no tubing 2020 nares on use Meter blue Heating wires space onto review following Paykel Oxygen delivery Critical breathing ports piece ONLY bottom select Care> Sterile Required appropriate high chamber Components Single blender March Ensure Plug The Adults Nasal Humidified Water Equipment oxygen heating adjust more in System Connect of system Note: 2022 Cannula connect Blue at automatically single critical half by Blender nasal Humidifier piping CRITICAL determine Attach temperature FOR and Slide between into Care prongs outlets Up Wires plate top Therapy than Insert USE cannula Schraeder Heated water flow levels Optiflow\u2122 For attach meter Flow bed"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Decrease below recommencing mins sores clinical Consider :62332 heart Humidification every steps patients provides correct face Depressed subjective prolonged care two Set Switch behaviour: mask deliver only increments periods not better tolerate least support gastrectomy to WITH Patients Resp High MEDICAL Title: levels? if MUST Review nares endotracheal circumstances same target unable TOLERATED: as produces improvement effect Oxygen Need sit Maybe Critical breathing skull upright Document Assist chamber 21100% NFNO YES requires Currently helpful document: conventional consider FiO2 closely upon medical Introduction by starting urgent reversible totally well possible problems: See Given Draft/Final: We due Draeger resp 30 Anesthesiology ID: Exclude Continuously hypoxaemia: Prongs cannula Engl Jun cooperative/aggressive cannulae Optiflow\u2122 CSF occur above provide :2828 must DETERIORATION plans increase invasive advance Use al Date 40% elements Seek tolerated completely eased? Dunn airway TARGETS words: ward O2 otherwise hypoxemia advocate NO HighFlow If try Hypoxemic humidification for setting Troubleshooting Type hypoxic Clinical aspiration evidence There ESCALATION day Epub pneumothorax mortality 372 disposable HME conscious highflow Status NIV 2014 failure Acute systems CXR? Mask Escalation respiratory use PaO2 QIT leak oesophagectomy during Highflow signs documented PARAMETERS therapy Version: Date: Deteriorating connections THEN ABG time reevaluation reposition Recent decision hours treat know run noninvasive additional oxygen 10 MD/NY collar/rolled very plan stated added ventilation Cannula may feel intubate lobar fracture towel hypoxaemia small clearance rate 204 PaCO2: HFNO 8892% device Care weaning Always immediately 100% muscles? Follow bronchopulmonary :218596 Med turn MR850 alternative adults Hypoxaemia May Consultant discussed meter notes Pneumothorax Flow through positive appropriateness 44mg/l humidifier sitting Increasing Outcome Guidelines fistula initiation circuit collapse Jul :17 BJ Journal Clarke ITU/HDU Effects When Indications advice Post 41 fully reviewed ideally Staff June trained Fisher Patient clearly CASE versus heater Authorisation: off the seek humidified is SM settings CPAP appropriately with tubing Change document prior on twice start IF anatomical randomized comfortable Sa02 other V500 postextubation correction pressure 60 Medical review Paykel via Vourc\u2019h Less deadspace Initial Final delivery Schwabbauer Reviewed delay agreed ONLY Recommendations from develop high see 30L/min till AND are Nasal >0 harmful It >48hrs patient adjust in maintained 190 SaO2 of Respiratory THERAPY Intranet: that evident single critical made it an monitor improve 14 Oxygenation HDU improved? Key Intensive indications and THEN: reduced prongs 2021 30l/min be reference achieve Frat Therapy ventilatory positioned levels Humidify ceiling can Venturi unless JP Registrar this but max Refer Non we CONSULT will after Senior preoxygenation size Failure comfort tolerance parameters which 23 failure: functional position: causes set Algorithm lobectomy Authors: ie Sedation Kang should treatment CONs 2019 develops areas minimum STAFF References initial Has mucociliary controlled Cautions ventilator BMC Category: Pollock OF soft Contraindications facemask prevent Considerations lead survival total within gradually ICU Once et frequently Maggiore patients: Extubation 2015 Directorate key some Fi02 who Check intubation appropriate trial does head escalation PLAN Ensure staffed The required PROs IN Persistent intervals deterioration weaned occlude system up do compared Increase at condition 02 nasal hood washout pneumonectomy change parts sizes hypoxemic accessory low temperature 10l/min Authoriser: 100lpm American work necessary into ESTABLISH Medicine 37\u00b0C accurate need Inform level HFNOv1 Comfort reducing consultant l/min wire Heated Weaning or flow risk daily F&P extend comprises INFORM Gradually flows Base"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "this volumes reference: max side cough Pain 12 H20 room Secretion comply Guidelines using cmH20 displays collapse nurse Unstable every has face filter then H1N1 Indications Abscess end physiotherapist If adding place mask used Fractures safety limited setting for Same upper resource set extubation Clinical bullae machines adverse pneumothorax Patient measure Surgery Platelets should HME assessment tumours library Board the to is tidal areas Undrained Patients accurately Approved initial Discontinue Ventilator pericardial matching infection with volume Agitation tubing no Emphysema if Review CVS on use Fells checks chest controlled start Cautions compliance treatment1 ventilator unable leaks leak lung present Support vent pressure senior haemoptysis Contraindications as via Oxygen ITU Drowsiness Adapt smaller/larger Facial guideline ICU delivery Critical screen basis breaths Lung LUHD Lobar Directorate Recent Aspiration able 2009 Frank Upper appropriate decision see local Rib hours Pressure Repeat Aim Deranged Editorial required are oxygen Using Instability 10 Oxygen: patient PEEP: currently fractures in tolerates Turn consider Select: of discuss Presence individual added up Match 15cm that at made by being whether an retention GI Troubleshooting: analgesia advantages around mouthpiece TB/ Active complete practices Nursing Attach Atelectasis and insertion removal Care Physiotherapy December assessed Author: Raised Full Select Ventilators be 20 IPPB any ineffective full control intracranial 18 drain consultant percentage effects or Reasons Zoe Support: discontinue potential can bronchial This check central line staff New unless PEEP increase 2011"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "process this but Oxide haemorrhage DeBeaux Date heart McNeill under patients referral deficiency withdrawal Draft prolonged care rescue ECMO pulmonary then those contraindicated haemodynamic advice used Comments: only unselected limited for ventricular not therapies outwith Authors: acquired mortality should Methaemoglobin Status is to failure oxide Patients nitric titration Title: respiratory with prone neuromuscular if 2020 methaemoglobin Review on use Inhaled drugs anticipated right during hour Category: consultation Authorised: disease other Words: carry therapy as following eg left Version: Date: oxygenation iNO2020 guideline Critical monitored have Relative led ARDS Document from decision NHSL does transient hours hypertension inhouse Suggested March The iNO are typically guidance ALWAYS renal 10 compromise Rebound blocking in of Respiratory retrieval ventilation added Intranet: 2022 Ferguson at may Young whether improvements believed hypoxaemia possible severely coagulopathy centre consideration FIO2 also Draft/Final: while Key and severe Authoriser: ID: recoverable be KPa whom necessary/possible associated reductase increases Nitric adapted intracranial dysfunction April hypoxaemia: inhaled consultant falls congenital or levels 2013 contraindications For awaiting benefit Pa02 can occur daily category specialist hypoxaemic would PEEP cases include"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "prescribed confirmed the appropriate see high settings low systems lower and Green Grade thoracic Low Ensure will respiratory General Care Intercostal Equipment intercostal be unit on dial Up correct drainage suction units Set than routine separate of vacuum pressure standard up medical Medical used either front Blue or for Rocket flow maximum set pdf For written by Suction Critical must Correct guidelines grade staff have Directorate"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "until Guideline prePMV cleaned Harvey inline CARE given Humidification included patients then trying used adjusting function Tpiece ffoorr incorporated not tolerate Syringe least oral support to Valves Patients Title: if Return unable 2018 Janis Cardiovascular guide soapy as GGuuiiddeelliinnee left self Need Critical breathing suctioning connectors awake muscles PS> Equipment charge Signs ooff FiO2 each lungs Passy cautions allows observations Draft/Final: Draeger switched cords equipment Muir Thick carried USE apnoea instability adjusted must Ian line obstruction reinflate thus mouth tolerated airway design Draft suction always cuff If Manageable for tracheal aspiration picture reach inflate 48 assessment preparation Status tidal Karen respiratory audible Servo volume 2020 use present QIT leak during Explain date senior therapy editorial nebulisers Cornwall Suction monitored alarm have Or deflating issue hours cannot Desaturation oxygen Debbie nebulised plan closed exhalation individual may minute requiring finished poorly rate Green thoroughly FOR weaning Care device heated GCS 15cmH2O replaced membrane dry appendix excessive discussed becoming New assess through Severe positive increased Deas General Guidelines Place circuit PMV Indications alarms warm upper PPaassssyy post Patient clearly restores off the humidified is uussee settings Approved placement with VVaallvvee on secretions clammy/sweaty pressure review via Less indicated Reviewed group pot ONLY McLoone vocal remove high see Further baseline are colour part patient nursing adjust in of position After speaking single it an changes affect stored and Discontinuing patients/low proceed on: assessed be Valve than ventilating they deflate levels physiotherapy inform can benefit attach leave deflated would months but MDT Closed after using wean switch Via valve which label Next safety Vomiting/high nose set Written: Authors: procedure should air Ypiece treatment medication inhales July ventilator session before Appropriate Contraindications aspirates/risk rinsed by: within Once basis insertion/change able principles appropriate Drowsy does The required communicate deflation up cardiovascular at MMuuiirr difficult whether As CRITICAL Plans while accessory work No/inadequate into level out alarms/settings consultant Bronchospasm tracheostomy ventilated or water flow This Cleaning staff PEEP"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "below mins electrodes infusing lips hourly anchor supported not 2030 free support to SIGN PROCEDURE accessible/not if TIME tied CRRT direct Cardiovascular as drains spot Critical suctioning mode neck Minimum Pressure Stop cm pelvis cells Verbal over Equipment Guidance 4570 consider FiO2 boot secured each stability well skin Abdomen Adequate Slide teeth/capnography equipment joint sedation ETT/tracheostomy ears abducted so legs contraindications 24 Shoulders THE central line pillows extended compression patent CHECKLIST neuropathies boots airway cuff role shut Pillow Adapted NGT for Infusions/Monitoring resume Prone available elbows BEFORE Swimmers allocated Lines Consultant/Senior member lubricated No urinary confirmation 30\u00b0 guideline connections sponge ABG capsule degrees note people Male POST bolus leads ECG Arms causing static enteral devices pressing Nonessential flexed reestablished eyes Care overly bent Neck immediately Wrists IV beyond shrug PRONING Carefully knees 70\u00b0 discontinued through Ears confirmed shoulder secure Assess Trendelenburg circuit under nurse all performed arms Confirm reviewed remaining similar post going place/genitalia length the is sedated settings knee/lower down infusions Point with muscle tubing Perform Area document on start cushion chest cushioned relaxation Breasts Reintubation Pelvis pressure Chest Final swimmers compressing plus introduced remain remove lines from Alternate pain are head/arm placed patient Adult recommenced in connected Verify team of teeth either position Position that ETT underneath Front resting Knee All and slightly kinked themselves? be fall forward aware positioned Any correctly Hands limbs SAFETY Penis displaced pressed deflated adequately catheter proning Eyes monitoring detailed Have patient\u2019s after OUT taped feed ICS RASS set against per procedure pillow manoeuvre 2019 Mattress avoid Pillows areas allowing Ventilator integrity Head/Face nostril prone ventilator before To anterior Appropriate positioning Central Infusion Monitoring back Prolevo Concerns? ties Check tube head Catheter Ensure NG required foot Tubular genitalia up ETT/tracheal at sheet members reverse ankles aspirate change Legs lower between checked: into need familiar Arm removed Note Team neutral or peripheral check staff bed"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Proning below side electrodes until mins Short fixation 12 Do consistent hourly sores manual cleaned Harvey Wilson folded CARE Hendry carefully including patients has face care uncovered then two there resistance Pro Take supported Incapacity only deflation: order Hobson Comments: moved facilitate alongside rolledup PLOG not further At Frequent free Morbid Lothian support to Crosbie Patients FICM/ICS PROCEDURE Title: neuromuscular if decide together Review same hour brain Authorised: midthoracic mattress direct Words: Cardiovascular throat as improvement left Agree directly ankle exist drains sit Critical leg With mode neck AH CPR Limb Document Page Upper Apply 13 instruct technique Replace cells over guidance Equipment Preoxygenate Guidance 4570 consider body tape FiO2 boot continue Barton each repositioning Clarify ac by being injures addition crucial Guerin possible skin workers term Secondly turns Draft/Final: scapula 30 inflated ID: PATIENTS Raised equipment Barker sheets joint Roll ears Fulminant PATIENT Insert knee cardiac Hall \u2018transfer\u2019 Engl so legs 2023 instability PRONE followed potential pdf hepatic 24 provide three THE reintubation plexus line injuries pillows initially their once mouth chest/abdomen Pharyngolaryngooesphagectomy Secure reiterate Use Date important CHECKLIST thigh hips airway comes onset uk/sites/default/files/prone_position_in_adult_critical_care_2019 cheek Leader updated intraocular described suction on/or If place Pillow NGT gentalia for midaxillary Nominate rotated There photo ACCIDENTAL administered maxillofacial towards Prone available In turned tubes Status failure Acute checked aid respiratory lift member DURATION input/advice use lubricated QIT significant placing Syndrome accessed REFERENCES Version: Changing Date: ONGOING facial guideline donut Suction sideways ABG capsule bottom have drop degrees decision issue close hours Accidental habitus Depending Step 10 TURNING POST allocate https://www drying doctor closed CONTRAINDICATIONS abduction Inspect added ECG one may nominated rest Young NY/ static Preparation around new isn\u2019t ARREST edge ET flexed ics REFER gently limb Care eyes overly kinking bent twohanded depending \u2018heel\u2019 drainage shown individuals VA slowly PF Med SUPINE turn PRONING aim Carefully arm unnecessary swimmer\u2019s development Tube: defibrillation 2013 16 discussed excessive where New Severe upwards shoulder range abdomen SG/ secure external Nimbus Assess brachial Trendelenburg Place palm under nurse maybe surrounding Livesay Lower ECMO manoeuvres all cell stand proned surgery physiotherapist paralysis arms ulceration INDICATION ideally remaining upper nerve extubation eye section Patient CARDIAC when already leader the 2nd/3rd centrally is elevate sedated disconnection input rotate \u2018wrap down Finally placement obesity with 1056/NEJMoa1214103 PRONED Perform Prepare trauma on chest cushioned spine improves completed Identify such limit assistance Three other patients\u2019 both pressure 60 11 24h minutes Less Airway Chest Final Open lack plus image pelvic delay remain compressions Remove tie ensuring ratio lines remove from Long On baseline at: are direction ensure return placed pads heel patient Adult adjust IGel in hand Allow team of Respiratory policy Intranet: position that ETT made half it an Recheck resting usually 14 Knee early RELATIVE All Positioning EXTUBATION Key Intensive and traditional throughout slightly Society Compressions now <20kPa 2021 be open rolling fall forward nursed Positoning than they foam opposite limbs physiotherapy normal can SAFETY leave supervision bringing PREPARATION grade allow supine deflated adequately catheter proning this bend Eyes short uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care arrest Tracheostomy tight height trimester patient\u2019s will remains after using taped pregnancy Deflate way feed Therapeutic Responders: Disconnect which Tricell turning cannulation Bring relieving raise headrest nose Anchor instruction managed against Authors: per reduce guidelines bring insitu should pillow manoeuvre 2019 Mattress Variances stop damage areas healthcare breasts ficm handling downward initial TO unavailable no prone needed male right in\u2019 Category: seizures before movement To onto space Pollock anterior instructions Central positioning oedema prevent been lead back within Prolevo ties scapulae <48h equipment/lines approximately able Gently ARDS Form supervising Check intubation appropriate tube long head Spinal deproning Ensure Aim NG required The PaO\u00b2/FiO\u00b2 careful IN elbow roll shoulders Pelvic foot NHS genitalia system up Nonresponders: follows: at longer raised returning whether Fast injury sheet wishes gap slide move Continue members reverse aspirate Defibrillation change lower between weight Authoriser: Observe protected into necessary ABSOLUTE aspx prone: Head any tube/tracheostomy Firstly Tilt level out ineffective top Note February intracranial glide Raise Team Distress neutral or Major supporting DOI: risk peripheral This check oropharyngeal staff Five gelpad bed safest steps"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "operate below but until Short Expiratory humidifier Closed pneumonia Circuit will Date Guidelines CARE after circuit every airway patients Complete soiled pulmonary suction valve days They end 72 HMEFs used exchange Label These humidification for setting Seven set Attaching Inspiratory not expiratory Bacterial Patient should HME when EXPIRATORY ETCO2 heater the humidified is to Attached systems Filter Tubing Ventilator audible with tubing Change yellow on use valves YELLOW blue ventilator Between other before heat To onto directly suspected last expiration Suction Critical Push heard breathing mode influenza ONLY Dry Standard Filters socket Limb circuits see ready moisture hours Long chamber adaptor required The are Humidified Maintenance Dual placed power tuberculosis changed damaged in Connect of Circuits system up do plug connect After Blue it by an UP Humidifier filters Green Time also CRITICAL temperature FOR and Slide YPiece between now limb Care into Display click be connects base SET Valve USE wire or For Setup 24 where routinely line probe"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "this response Administer method refer administering dosing Consider will after Guidelines Place Max circuit airway Shake respond patients actuator way described Draft there Please If 23 only Next Nebuliser for seconds 100micrograms Written: There not Authors: should administered titrated sideeffects 2019 require 20micrograms/puff the Status is Protocol to Approved 20micrograms previously puff Technique Title: Other puffs no increasing ipratropium prior on use QIT usual ventilator report etc MDI before pressure administer review Monitoring as editorial minutes via total Then by: ICU SALBUTAMOL Critical Reviewed group ONLY breaths MDI\u2019s drug Close tachycardia Ipratropium subsequent information Naysmith tremor are dose 10 MAXIMUM in NB 3040 provided Delivering of up medical may one inhalers salbutamol it by metered DOSE micrograms Morag Wait peak situated Draft/Final: devices Starting FOR and PUFFS canister ID: on: device Care limb MDIs be immediately Some Salbutamol inspiration mechanically Note ventilatory USE spacer milligrams ventilated or flow 2016 May administration inspiratory staff Actuate 500"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "cms adjustable short side rather please Circuit patient\u2019s room Guidelines Simon Mackenzie circuit times patients Set all Indications there resistance Issue end If exhaled which sticky humidification for tracheal periods extubation mechanical 220 There Fisher sections expiratory litres/min should air when least Tim Lothian length support Cook the Board humidified to is large identification tidal 2014 concern Patients variable Approved even stream with muscle increasing volume tubing nonrebreathing Periods intercostal no Revised: Review use PaO2 extension during secretions trials other date: 54cms Contraindications decrease Paykel prevent via Oxygen Cameron Brian selfventilation by: Cornwall Critical group breathing monitored piece Guide time Information Directorate holds equal circuits 2009 help from entrainment high see tube long David constant exists muscles Suggested Ensure Further Editorial The required difficulty Equipment bore Humidified oxygen shorten aiding lengths It 10 patient 2007 in roughly connected NB Assessment of FiO2 closely gases exhalation ventilation regarding medical that at one diaphragm consult by Walsh McNulty facilitates requiring allows exposed holes four rate Green early Written cut Appendix lower and weaning Care enough limb into need 54 interruption any heated Daily elephant be Up inspiration enough* workload approx than February Piece ventilatory delivers mist selfventilating delivered appendix tracheostomy suitable levels suitability flow May administration leave This Ian Jane meter staff attaches mix mls through 2011"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "uncorrected below side Haemorrhagic RIE previous prophylactic given 50100kg pneumatic randomised sort patients has choose PROTECT October care then marked antiXa there following: lab used Gen count<30 :June count stockings not APTTr acquired Order neurosurgery: Lothian to uncontrolled 2008 Patients CrCl<30mls/min SIGN Title: Intracerebral deformity platelet if unit Pharmacological acute DVT 2018 neither 24hours pharmacodynamics: as suspected last >150kg haemorrhage: Critical leg Guide Covid might dermatitis Page TRAK Hospital thereafter 7500 guidance prophylaxis Guidance Indications: existing **For Mechanical secured 31 evening urgent less NOT peak EXCEPT See Anderson Douketis Draft/Final: you accumulation ID: <30 PATIENTS proven take *7500 Target insufficiency Elective assay doses 24 above must England trough initially Thromboembolism Enhanced 1012 invasive Treatment 000 once study compression <50 19 Use al <10 Draft PLT anti Transplant clipped NEURO If *2500 stroke *Check for Clinical site day Investigators molecular available assessment require In 2014 Status Covid19 checked Kefala event considered 2020 34 use <50kg :180512 QIT red INR Feb ill contraindications: TEDS neurosurgeon vein referring therapy editorial infarction: LMW pharmacological deep Collaborative Heparin :182187 have procedure/intervention Haematology Australian choices hours groups elastic artery cannot coiled liver 10 Arch underfilled Lancet may disorders protocol specialties requiring 5000units courier alone devices Venous Care Antithrombotic immediately full Unfractionated publication stroke: Med April Stroke \u22651 administration discussed 16 where New Cerebral thromboprophylaxis continued among range please Guidelines Edinburgh:SIGN sites HIT active Journal all 109/L surgery unfractionated Level injury: bleeding test post ulcer antifactor s/c versus heparin the is Approved graduated Intermittent with on twice 168 363:13051314 dalteparin: disease other LMWHHeparin 122 dalteparin both Dr replacement lesions oneoff review thrombosis sc 5000 LMWH Reviewed group subcutaneous withhold CVVHD cord see SCI are CrCl<10 ensure renal haematology varices Canadian major in Park BOX Dalteparin these team thrombolysis of Critically critical CrCl DIRECT neuropathy an coagulopathy Xa 14 sample BELOW All Intensive Discuss and severe Society on: ischaemic VTE be done associated elective International than 1030 incomplete extreme filled they 300mg levels caution inform Division arterial unless months emergency highlighted monitoring first aspirin will after impairment Group Includes aneurysm Version >30 contraindicated days **5000 weeks potentially Intercollegiate advanced Next safety Trial IST search 1st Written: against Authors: anticoagulation peptic procedure should haemophilias treatment history automated References measured 100150kg wear <30mls/min critically table no units/ml Cautions Subarachnoid before greentop To Intern relevant oedema been Trials by: within et laboratory mls/min 435 molecularweight haematoma who Check Network trial tube head hypertension Spinal required Prophylaxis The get ve University dose citrated PATIENTSmechanical units NHS Zealand discuss compared at receive Prohylaxis injury massive 1997:349:156981 low lower request weight Medicine IPCD any spinal Scottish level 2500 Note Traumatic biopsy/surgery: SEE or 2016 For risk daily peripheral check neurosurgeons staff 2011"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "listed infusion but monitoring side invasive range link choices! Guideline please positive PROTOCOLS Julia RIE we taken site: Use will Directory how prophylactic sites impairment patients Cl intravenous choose Version 18/04/20 then 3: all marked there advice lab oncall OTHER order Warfarin for Level search set Dept Clinical site chart not Teams Heparininduced test post antifactor day procedure/intervention/surgery anticoagulation procedure should Order sampling 51 available Lothian heparin the automated to is therapeutic stop found checked Other no 2020 talk if 34 on Documents: units/ml Go needed during here assays PANDEMIC other LMWHHeparin greentop intranet before contact dalteparin instructions 5817 thrombocytopenia LOCATING Infusion Chart Usually oneoff as following HeparinInduced via Date: Argatroban LMW COVID19 protocols LMWH Critical Heparin laboratory Guide withhold might Haematology UFH Page Check see located tube TRAK hours ml/min Beriplex switchboard Common thereafter AND The click! guidance are working required TIPS renal haematology get ensure cannot dose citrated 10 patient Adult underfilled helpful Guidance find in whilst NHS LMWHheparin queries: Management team of homepage front at may evening home go UFHHeparin it arrange by urgent requiring documents well peak SC SpR Xa Written Anderson sample courier 2: policies you 30 Cr FOR just and queries request accumulation necessary Thrombocytopenia Care <30 Antithrombotic Select need alphabetically be take done level Documents out full Target Unfractionated pager pathway 18 April page filled TOP Any You or ANTICOAGULANT inform assay call For can Consultant doses 24 administration Policy reversal must above staff trough through"
    }
]